|
10 STEPS TO COMMUNITY READINESS
|
2021
|
|
10th General Meeting Global Alliance Against Chronic Respiratory Diseases:
3–4 July 2015, Lisbon, Portugal
|
2015
|
|
13.° Programa General de Trabajo (13.° PGT):
Métodos para la medición del impacto
|
2021
|
|
14TH MEETING OF THE MEASLES / RUBELLA REGIONAL REFERENCE LABORATORIES OF THE WHO EUROPEAN REGION
|
2020
|
|
16 Ideas for addressing violence against women in the context of the HIV epidemic:
A programming tool
|
2013
|
|
2008-2013 Action Plan:
for the Global Strategy for the Prevention and Control of Noncommunicable Diseases
|
2008
|
|
2015 PLAN DE RIPOSTE STRATÉGIQUE DE L’OMS:
Flambée de maladie à virus Ebola en Afrique de l’Ouest
|
2015
|
|
2015 WHO STRATEGIC RESPONSE PLAN:
West Africa Ebola Outbreak
|
2015
|
|
2016 WORLD MALARIA REPORT
|
2016
|
|
2016 WORLD MALARIA REPORT:
SUMMARY
|
2017
|
|
THE 2018 OPTIMAL FORMULARY AND LIMITED-USE LIST FOR PAEDIATRIC ARVS
|
2018
|
|
2019 ANTIBACTERIAL AGENTS IN CLINICAL DEVELOPMENT:
an analysis of the antibacterial clinical development pipeline
|
2019
|
|
2019 Novel Coronavirus (2019-nCoV)::
STRATEGIC PREPAREDNESS AND RESPONSE PLAN
|
2020
|
|
2020 ANTIBACTERIAL AGENTS IN CLINICAL AND PRECLINICAL DEVELOPMENT:
an overview and analysis
|
2021
|
|
2021 ANTIBACTERIAL AGENTS IN CLINICAL AND PRECLINICAL DEVELOPMENT::
an overview and analysis
|
2022
|
|
2021 global progress report on implementation of the Protocol to Eliminate Illicit Trade in Tobacco Products
|
2022
|
|
2021 MID-YEAR REPORT:
WHO STRATEGIC ACTION AGAINST COVID-19
|
2021
|
|
2021 WHO health and climate change global survey report
|
2021
|
|
2023 WHO review of health in Nationally Determined Contributions and long-term strategies::
health at the heart of the Paris Agreement
|
2023
|
|
2030 targets for soil-transmitted helminthiases control programmes
|
2020
|
|
20th Meeting of the European Technical Advisory Group of Experts on Immunization (ETAGE):
Virtual meeting, hosted in Copenhagen, Denmark 11-12 November 2020
|
2021
|
|
9th Meeting of the Measles/Rubella Reference Laboratories of the WHO European Region 10–11 March 2014, Copenhagen, Denmark:
MEETING REPORT
|
2014
|
|
Abordar el tema de la salud al elaborar planes de acción nacionales sobre la extracción de oro artesanal y en pequeña escala en el marco del Convenio de Minamata sobre el Mercurio
|
2019
|
|
Abordar o tema da saúde ao desenvolver planos nacionais de ação acerca da extração de ouro artesanal e em pequena escala ao abrigo da Convenção de Minamata sobre o Mercúrio
|
2021
|
|
Abortion care guideline
|
2022
|
|
Abortion care guideline:
Web Annex A. Key international human rights standards on abortion
|
2022
|
|
Abortion care guideline:
executive summary
|
2022
|
|
Abortion care guideline Web Annex B.:
Technical meetings during guideline development
|
2022
|
|
ABORTION IN VIET NAM::
AN ASSESSMENT OF POLICY, PROGRAMME AND RESEARCH ISSUES
|
1999
|
|
ABORTION LAWS IN COMMONWEALTH COUNTRIES
|
1979
|
|
ABORTO SIN RIESGOS:
Guía técnica y de políticas para Sistemas de Salud
|
2003
|
|
Aborto sin riesgos::
guía técnica y de políticas para sistemas de salud
|
2012
|
|
ABRIDGED REPORT:
THE GLOBAL HEALTH SECTOR STRATEGY ON HIV/AIDS 2011–2015: AN INTERIM REVIEW OF PROGRESS
|
2014
|
|
Abschlussberichte – In Kinder investieren::
Strategie der Europäischen Region zur Förderung der Gesundheit von Kindern und Jugendlichen (2015–2020) und Aktionsplan der Europäischen Region zur Prävention von Kindesmisshandlung (2015–2020)
|
2020
|
|
Accelerated Action for the Health of Adolescents (AA-HA!):
A manual to facilitate the process of developing national adolescent health strategies and plans
|
2019
|
|
Accelerating access to hepatitis C diagnostics and treatment:
Overcoming barriers in low- and middle-income countries
|
2021
|
|
Accelerating action to reduce the harmful use of alcohol
|
2020
|
|
Accelerating actions for implementation of decade of action for road safety:
Technical report
|
2017
|
|
Accelerating Nutrition Improvements in sub-Saharan Africa (ANI):
Report of the baseline and end-line perception surveys in ten countries
|
2017
|
|
ACCELERATING NUTRITION IMPROVEMENTS IN SUB-SAHARAN AFRICA SCALING UP NUTRITION INTERVENTIONS:
FINAL REPORT 2012-2016
|
2017
|
|
ACCELERATING PROGRESS ON HIV TESTING AND TREATMENT FOR CHILDREN AND ADOLESCENTS THROUGH IMPROVED STRATEGIC INFORMATION
|
2020
|
|
ACCELERATING PROGRESS on HIV, tuberculosis, malaria, hepatitis and neglected tropical diseases:
A new agenda for 2016 . 2030
|
2015
|
|
ACCELERATING SALT REDUCTION IN EUROPE:
A COUNTRY SUPPORT PACKAGE TO REDUCE POPULATION SALT INTAKE IN THE WHO EUROPEAN REGION
|
2020
|
|
ACCELERATING WORK TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES:
A ROADMAP FOR IMPLEMENTATION
|
2012
|
|
ACCELERATING WORK TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES:
A ROADMAP FOR IMPLEMENTATION
|
2012
|
|
Accès équitable aux ressources COVID-19:
Aligner le secteur privé sur les efforts de riposte nationaux
|
2022
|
|
Access to Modern Energy Services for Health Facilities in Resource-Constrained Settings:
A Review of Status, Significance, Challenges and Measurement
|
2014
|
|
Access to rehabilitation in primary health care::
an ongoing challenge
|
2018
|
|
Acesso equitativo a ferramentas COVID-19:
Alinhamento do setor privado com esforços de resposta nacionais
|
2022
|
|
ACHIEVING HEALTH BENEFITS FROM CARBON REDUCTIONS:
Manual for CaRBonH calculation tool
|
2018
|
|
ACT-A Health Systems Connector Health financing for the COVID-19 response:
Process guide for national budgetary dialogue
|
2021
|
|
Action Agenda for Antimicrobial Resistance in the Western Pacific Region
|
2015
|
|
Action de l’OMS dans les situations d’urgence sanitaire:
Renforcement de la préparation aux situations d’urgence sanitaire : application du Règlement sanitaire international (2005)
|
2021
|
|
ACTION DE SANTÉ PUBLIQUE POUR LA PRÉVENTION DU SUICIDE:
UN CADRE DE TRAVAIL
|
2014
|
|
ACTION FRAMEWORK FOR DEVELOPING AND IMPLEMENTING PUBLIC FOOD PROCUREMENT AND SERVICE POLICIES FOR A HEALTHY DIET
|
2021
|
|
Action framework to advance universal access to safe, effective and quality-assured blood products 2020–2023
|
2020
|
|
Action required to address the impacts of the COVID-19 pandemic on mental health and service delivery systems in the WHO European Region:
Recommendations from the Technical Advisory Group on the Mental Health Impacts of COVID-19 in the WHO European Region
|
2021
|
|
Actions for consideration in the care and protection of vulnerable populations from COVID-19:
Interim guidance
|
2021
|
|
ACTIONS FOR IMPROVED CLINICAL AND PREVENTION SERVICES AND CHOICES:
PREVENTING HIV AND OTHER SEXUALLY TRANSMITTED INFECTIONS AMONG WOMEN AND GIRLS USING CONTRACEPTIVE SERVICES IN CONTEXTS WITH HIGH HIV INCIDENCE
|
2020
|
|
Actividades en curso relacionadas con los artículos 9 y 10 del Convenio Marco de la OMS para el Control del Tabaco:
Informe de la iniciativa OMS Liberarse del Tabaco
|
2012
|
|
Activités de remplacement de la culture du tabac économiquement viables (en relation avec les articles 17 et 18 de la Convention-cadre de l’OMS pour la lutte antitabac):
Rapport du groupe de travail
|
2012
|
|
ACTUALIZACIÓN TÉCNICA SOBRE LA OPTIMIZACIÓN DEL TRATAMIENTO:
USO DEL TENOFOVIR EN NIÑOS Y ADOLESCENTES INFECTADOS POR EL VIH: UNA PERSPECTIVA DE SALUD PÚBLICA
|
2012
|
|
Acute Care:
INTEGRATED MANAGEMENT OF ADOLESCENT AND ADULT ILLNESS
|
2004
|
|
AD HOC VIRTUAL MEETING ON COVID-19:
Managing the evolving COVID-19 pandemic and preparing primary health care to meet future health needs
|
2021
|
|
AD HOC VIRTUAL MEETING ON COVID-19:
(ENHANCING THE ROLE OF PARLIAMENTARIANS IN CONTINUING TO SUPPORT THE COVID-19 RESPONSE, INCLUDING IN RELATION TO VACCINES AND VIRUS VARIANTS)
|
2021
|
|
AD HOC VIRTUAL MEETING ON COVID-19 Calling for Solidarity to Enhance the Role of Parliamentarians in the COVID-19 Response 23 April 2020:
MEETING REPORT
|
2020
|
|
AD HOC VIRTUAL MEETING ON COVID-19 Investing in Universal Health Coverage for the Future 28 September 2020:
MEETING REPORT
|
2020
|
|
Adapting the WHO Rehabilitation Competency Framework to a specific context:
A stepwise guide for competency framework developers
|
2020
|
|
Adapting to Climate Sensitive Health Impacts:
Undernutrition
|
2019
|
|
ADDICTION
|
2019
|
|
Address by DR ALA ALWAN REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION to the MEETING OF THE REGIONAL ANTIMICROBIAL RESISTANCE STEERING COMMITTEE AND TASKFORCE
|
2015
|
|
Address by Dr Tedros Adhanom Ghebreyesus, Director-General
|
2021
|
|
Address by Her Excellency Angela Merkel, the Federal Chancellor of the Federal Republic of Germany, to the Sixty eighth World Health Assembly:
Geneva, Monday, 18 May 2015
|
2015
|
|
Addressing alcohol consumption and socioeconomic inequalities::
how a health promotion approach can help
|
2022
|
|
Addressing and managing conflicts of interest in alcohol control policies
|
2022
|
|
Addressing climate change:
Supplement to the WHO Water, Sanitation and Hygiene strategy 2018–2025
|
2023
|
|
Addressing health when developing national action plans on artisanal and small-scale gold mining under the Minamata Convention on Mercury
|
2019
|
|
Addressing Human Rights as Key to the COVID-19 Response
|
2020
|
|
ADDRESSING SOCIAL DETERMINANTS OF HEALTH THROUGH INTERSECTORAL ACTIONS::
FIVE PUBLIC POLICY CASES FROM MEXICO
|
2013
|
|
Addressing the socioeconomic determinants of healthy eating habits and physical activity levels among adolescents
|
2006
|
|
ADDRESSING VIOLENCE AGAINST CHILDREN, WOMEN AND OLDER PEOPLE DURING THE COVID-19 PANDEMIC::
KEY ACTIONS
|
2020
|
|
Addressing violence against women in health and multisectoral policies::
a global status report
|
2021
|
|
Addressing violence against women in health and multisectoral policies::
a global status report Web annexes
|
2021
|
|
Addressing violence against women in pre-service health training:
Integrating content from the Caring for women subjected to violence curriculum
|
2022
|
|
Ad-hoc meeting of the European Technical Advisory Group of Experts on Immunization (ETAGE):
Virtual meeting, hosted in Copenhagen, Denmark 28 April 2021
|
2021
|
|
Administración de artesunato rectal como tratamiento prederivación para el paludismo grave por P. falciparum
|
2022
|
|
Administración masiva de medicamentos contra el paludismo por Plasmodium falciparum:
Manual práctico
|
2020
|
|
Administration de masse de médicaments contre le paludisme à falciparum:
Manuel pratique
|
2020
|
|
Adolescent alcohol-related behaviours::
trends and inequalities in the WHO European Region, 2002–2014
|
2018
|
|
Adolescent Friendly Health Services:
An Agenda for Change
|
2002
|
|
Adolescent friendly health services::
Supervisory/Self-assessment checklist and User's guide
|
2020
|
|
Adolescent Health and Development in the WHO European Region::
Can we do better?
|
2019
|
|
Adolescent Health Research Priorities::
Report of a Technical Consultation
|
2015
|
|
Adolescent pregnancy
|
2019
|
|
Adolescent pregnancy
|
2014
|
|
The Adolescent with a Chronic Condition:
Epidemiology, developmental issues and health care provision
|
2007
|
|
Adolescents, social support and help-seeking behaviour:
An international literature review and programme consultation with recommendations for action
|
2007
|
|
Advancing Food Safety Initiatives:
Strategic Plan for Food Safety Including Foodborne Zoonoses 2013–2022
|
2013
|
|
ADVANCING HEALTH EMERGENCY PREPAREDNESS IN CITIES AND URBAN SETTINGS IN COVID-19 AND BEYOND:
Report on a series of global technical working group meetings February-April 2021
|
2021
|
|
Advancing Health through Attention to Gender, Equity and Human Rights:
SUMMARY OF STORIES
|
2017
|
|
Advancing health through attention to gender, equity and human rights:
Stories from the Western Pacific Region
|
2017
|
|
Advancing the right to health::
the vital role of law
|
2017
|
|
Advancing the right to health through the UNIVERSAL PERIODIC REVIEW:
A review of health under the first and second cycles of the Universal Periodic Review
|
2019
|
|
Advancing tobacco control during the COVID-19 pandemic:
MPOWER implementation Tobacco Free Initiative
|
2021
|
|
Advancing universal health coverage through knowledge translation for healthy ageing:
Lessons learnt from the Japan Gerontological Evaluation Study
|
2018
|
|
ADVERSE CHILDHOOD EXPERIENCES:
and associated health-risk behaviours in university students from the Republic of Moldova
|
2018
|
|
Adverse childhood experiences and health-harming behaviours among students in Ukraine:
Report on survey results
|
2018
|
|
ADVERSE CHILDHOOD EXPERIENCES SURVEY AMONG UNIVERSITY STUDENTS IN TURKEY:
STUDY REPORT-2013
|
2014
|
|
Advice on the use of masks in the community, during home care, and in health care settings in the context of COVID-19:
Interim guidance
|
2020
|
|
Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak:
Interim guidance
|
2020
|
|
Advice on the use of masks in the context of COVID-19:
Interim guidance
|
2020
|
|
Advice on the use of masks in the context of COVID-19:
Interim guidance
|
2020
|
|
Advice on the use of point-of-care immunodiagnostic tests for COVID-19:
Scientific brief
|
2020
|
|
Advisory note:
Global Nicotine Reduction Strategy WHO Study Group on Tobacco Product Regulation (TobReg)
|
2015
|
|
Afghanistan:
Contraception within the context of adolescents’ sexual and reproductive lives: Country profile
|
2020
|
|
Afghanistan:
Contraception within the context of adolescents’ sexual and reproductive lives: Country profile
|
2020
|
|
Age-friendly environments in Europe:
A handbook of domains for policy action
|
2017
|
|
Age-friendly environments in Europe::
Indicators, monitoring and assessments
|
2018
|
|
AGEISM IN ARTIFICIAL INTELLIGENCE FOR HEALTH:
WHO POLICY BRIEF
|
2022
|
|
AGIR CONTRE L’ÉPILEPSIE:
Un impératif de santé publique
|
2019
|
|
AGIR PLUS VITE POUR RÉDUIRE L’IMPACT MONDIAL DES MALADIES TROPICALES NÉGLIGÉES:
FEUILLE DE ROUTE POUR LA MISE EN OEUVRE
|
2013
|
|
Agua, saneamiento, higiene y gestión de desechos en relación con el SARS-CoV-2, el virus causante de la COVID-19:
Orientaciones provisionales
|
2020
|
|
Agua, saneamiento, higiene y gestión de desechos en relación con el virus de la COVID-19:
Orientaciones provisionales
|
2020
|
|
AIDE-MÉMOIRE:
for ministries of health
|
2015
|
|
AIDS Free Framework to accelerate paediatric and adolescent HIV treatment
|
2018
|
|
AIR POLLUTION AND CHILD HEALTH:
Prescribing clean air SUMMARY
|
2018
|
|
AirQ+::
Krebserregende Schadstoffe und ihre Risikoanalyse
|
2020
|
|
AirQ+::
carcinogenic pollutants and risk analysis
|
2020
|
|
Akilah and Carlos’s:
Big Day of Discovery!
|
2017
|
|
Alcohol and inequities:
Guidance for addressing inequities in alcohol-related harm
|
2014
|
|
ALCOHOL AND INJURIES:
Emergency Department Studies in an International Perspective
|
2009
|
|
Alcohol and Interpersonal Violence:
Policy Briefing
|
2005
|
|
Alcohol, Gender and Drinking Problems:
Perspectives from Low and Middle Income Countries
|
2005
|
|
Alcohol Policy in the WHO South-East Asia Region::
A Report
|
2017
|
|
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST):
Manual de uso na atenção primária
|
2010
|
|
Alcohol Use and Sexual Risk Behaviour::
A Cross-Cultural Study in Eight Countries
|
2005
|
|
Algorithm for COVID-19 triage and referral:
Patient triage and referral for resource-limited settings during community transmission
|
2020
|
|
Aligning incentives for pharmaceutical innovation to achieve fair pricing
|
2021
|
|
Alkol, Sigara ve Madde Tutulumu Tarama Test (ASSIST):
Birinci basamak tedavi için kullanım kılavuzu
|
2010
|
|
Alliance mondiale de l’OMS pour l’élimination du trachome d’ici 2020:
Deuxième réunion scientifique mondiale sur le trichiasis trachomateux Le Cap, 4–6 novembre 2015
|
2016
|
|
Allocution de Son Excellence Angela Merkel, Chancelière de la République fédérale d’Allemagne, à la Soixante-Huitième Assemblée mondiale de la Santé:
Genève, lundi 18 mai 2015
|
2015
|
|
Alocución de la Excma. Sra. Angela Merkel, Canciller Federal de la República Federal de Alemania, ante la 68.ª Asamblea Mundial de la Salud:
Ginebra, lunes 18 de mayo de 2015
|
2015
|
|
Alternativas económicamente viables al cultivo de tabaco (en relación con los artículos 17 y 18 del Convenio Marco de la OMS para el Control del Tabaco):
Informe del grupo de trabajo
|
2012
|
|
AMBIENT AIR POLLUTION:
TRAINING FOR HEALTH CARE PROVIDERS SECOND EDITION
|
2019
|
|
Ambient air pollution::
A global assessment of exposure and burden of disease
|
2016
|
|
Ambient air pollution and health in Accra, Ghana
|
2021
|
|
AMBITION AND ACTION IN NUTRITION 2016–2025
|
2017
|
|
AMBITION AND ACTION IN NUTRITION 2016–2025
|
2017
|
|
AMBITION ET ACTION POUR LA NUTRITION 2016–2025
|
2017
|
|
Améliorer la santé des nouveau-nés prématurés
|
2015
|
|
Amiăng trắng
|
2014
|
|
Amor Youth Clinic Network in Estonia
|
2009
|
|
ANÁLISIS Y USO DE DATOS SISTEMÁTICOS PARA EL SEGUIMIENTO DE LOS EFECTOS DE LA COVID-19 EN LOS SERVICIOS DE SALUD ESENCIALES:
Guía práctica para los responsables nacionales y subnacionales
|
2021
|
|
Analyse mondiale de la situation dans les pays ::
Réponse à la résistance aux antimicrobiens
|
2015
|
|
ANALYSER ET UTILISER LES DONNÉES DE ROUTINE POUR SURVEILLER LES EFFETS DE LA COVID-19 SUR LES SERVICES DE SANTÉ ESSENTIELS:
Guide pratique à l’intention des décideurs aux niveaux national et infranational
|
2021
|
|
Analyses de laboratoire pour le diagnostic de l’hépatite aiguë sévère d’étiologie inconnue chez l’enfant:
Orientations provisoires
|
2022
|
|
ANALYSING AND USING ROUTINE DATA TO MONITOR THE EFFECTS OF COVID-19 ON ESSENTIAL HEALTH SERVICES:
Practical guide for national and subnational decision-makers
|
2021
|
|
ANALYSING AND USING ROUTINE DATA TO MONITOR THE EFFECTS OF COVID-19 ON ESSENTIAL HEALTH SERVICES:
Practical guide for national and subnational decision-makers
|
2021
|
|
ANALYSIS AND USE OF HEALTH FACILITY DATA:
Guidance for hepatitis programme managers
|
2019
|
|
Analysis of stakeholder views on future development in chemical safety in the WHO European Region
|
2017
|
|
Anexo a Prevención y control de infecciones durante la atención de salud a casos presuntos o confirmados de enfermedad por coronavirus (COVID-19):
Orientaciones provisionales
|
2021
|
|
Anexos a las recomendaciones para el uso de la vacuna contra la COVID-19 CoronaVac, desarrollada por Sinovac
|
2021
|
|
Angola Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Animal Waste, Water Quality and Human Health
|
2012
|
|
ANNEX 11 (b)::
Values and preferences: ALHIV care, treatment, and attitudes – literature review
|
2013
|
|
ANNEX 13::
Adolescent ARV service delivery: a review of the literature
|
2013
|
|
ANNEX 16::
Implementation plan
|
2013
|
|
ANNEX 2::
PICO questions and references
|
2013
|
|
ANNEX 3::
Systematic review – HTC for adolescents
|
2013
|
|
ANNEX 4::
Systematic review – ALHIV: Disclosure, adherence and retention in care
|
2013
|
|
ANNEX 7::
Evidence summaries and findings
|
2013
|
|
ANNEX 9::
Review methods
|
2013
|
|
Annex to Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed:
Interim guidance
|
2021
|
|
Annexe au document Lutte anti-infectieuse lors de la prise en charge des cas suspects ou confirmés de maladie à coronavirus (COVID-19):
Orientations provisoires
|
2021
|
|
Annexes aux recommandations pour l’utilisation du vaccin Sinovac-CoronaVac contre la COVID-19
|
2021
|
|
Annexes to the interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19:
Grading of evidence – Evidence to recommendations tables
|
2021
|
|
Annexes to the interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
|
2021
|
|
Annexes to the interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™):
Grading of evidence - Evidence to recommendations tables
|
2022
|
|
Annexes to the interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm:
Grading of evidence Evidence to recommendation tables
|
2021
|
|
Annexes to the interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm:
Grading of evidence Evidence to recommendation tables
|
2022
|
|
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
|
2021
|
|
Annexes to the recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19:
Grading of evidence Evidence to recommendation tables
|
2022
|
|
Annexes to the recommendations for use of the Janssen AD26.COV2.S vaccine against COVID-19
|
2021
|
|
Annexes to the recommendations for use of the Janssen AD26.COV2.S vaccine against COVID-19:
Grading of evidence Evidence to recommendation tables
|
2022
|
|
Annexes to the recommendations for use of the Janssen AD26.COV2.S vaccine against COVID-19
|
2021
|
|
Annexes to the recommendations for use of the Moderna mRNA 1273 vaccine against COVID 19:
Grading of evidence Evidence to recommendation tables
|
2022
|
|
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
|
2021
|
|
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19:
Grading of evidence Evidence to recommendation tables
|
2021
|
|
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19:
Grading of evidence Evidence to recommendation tables
|
2022
|
|
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
|
2022
|
|
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
|
2021
|
|
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19
|
2021
|
|
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19:
Grading of evidence — Evidence to recommendation tables
|
2022
|
|
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19:
Grading of evidence – Evidence to recommendation tables
|
2022
|
|
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19
|
2022
|
|
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19:
Grading of evidence — Evidence to recommendation tables
|
2022
|
|
Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19:
Grading of evidence Evidence to recommendation tables
|
2021
|
|
Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19
|
2022
|
|
Annexes to the recommendations for use of the V alneva VLA2001 vaccine against COVID 19:
Grading of evidence Evidence to recommendations tables
|
2022
|
|
Annexes to Weekly Epidemiological Record (WER) Evidence Review – Public health measures in the aviation sector in the context of COVID-19::
Quarantine and isolation
|
2021
|
|
Annexes to Weekly Epidemiological Record (WER) Evidence Review – Public health measures in the aviation sector in the context of COVID-19: Quarantine and isolation:
Tables and figures for ethical and equity considerations
|
2021
|
|
Annotated Bibliography of Key Information from the World Health Organization relevant to the Minamata Convention on Mercury
|
2015
|
|
ANNUAL REPORT 2020:
WORLD HEALTH ORGANIZATION SOMALIA
|
2022
|
|
ANTIBACTERIAL AGENTS IN CLINICAL DEVELOPMENT:
An analysis of the antibacterial clinical development pipeline, including tuberculosis
|
2017
|
|
ANTIBACTERIAL AGENTS IN PRECLINICAL DEVELOPMENT:
an open access database
|
2019
|
|
ANTIBIOTIC RESISTANCE::
MULTI-COUNTRY PUBLIC AWARENESS SURVEY
|
2015
|
|
Anticorps monoclonal neutralisant mAb114 contre la maladie à virus Ebola (MVE)
|
2022
|
|
Antigen-detection in the diagnosis of SARS-CoV-2 infection:
Interim guidance
|
2021
|
|
Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays:
Interim guidance
|
2020
|
|
Anti-interleukin-6 therapies for hospitalized patients with COVID-19::
a protocol for a prospective meta-analysis of randomized trials
|
2021
|
|
Antimicrobial drug resistance:
Report by the Secretariat
|
2014
|
|
Antimicrobial drug resistance:
Report by the Secretariat
|
2013
|
|
Antimicrobial resistance:
Report by the Director-General
|
2020
|
|
Antimicrobial resistance
|
2019
|
|
ANTIMICROBIAL RESISTANCE:
Global Report on Surveillance
|
2014
|
|
Antimicrobial resistance
|
2014
|
|
Antimicrobial resistance:
Report by the Secretariat
|
2016
|
|
Antimicrobial resistance:
Summary report on progress made in implementing resolution WHA67.25 on antimicrobial resistance Report by the Secretariat
|
2014
|
|
Antimicrobial resistance:
Draft resolution proposed by Argentina, Australia, Canada, Chile, China, Israel, Kenya, Oman, Panama, Russian Federation, South Africa, Sri Lanka, Switzerland, United States of America, and Member States of the European Union
|
2019
|
|
ANTIMICROBIAL RESISTANCE:
Global Report on Surveillance
|
2014
|
|
Antimicrobial resistance:
Draft global action plan on antimicrobial resistance Report by the Secretariat
|
2015
|
|
Antimicrobial resistance:
Report by the Secretariat
|
2017
|
|
Antimicrobial resistance:
Draft global action plan on antimicrobial resistance Report by the Secretariat
|
2014
|
|
Antimicrobial resistance
|
2019
|
|
Antimicrobial Resistance:
A MANUAL FOR DEVELOPING NATIONAL ACTION PLANS
|
2016
|
|
Antimicrobial resistance and primary health care:
Brief
|
2018
|
|
Antimicrobial resistance and primary health care
|
2018
|
|
Anti-Microbial Resistance in Leprosy:
Report of the virtual consultation New Delhi, India 14-17 June 2021
|
2021
|
|
Antimicrobial Resistance in the Western Pacific Region:
A Review of Surveillance and Health Systems Response
|
2015
|
|
Antimicrobial stewardship interventions::
a practical guide
|
2021
|
|
Antimicrobials supplied in community pharmacies in eastern Europe and central Asia in the early phases of the COVID-19 pandemic
|
2022
|
|
Antimicrobianos de importancia crítica para la medicina humana:
6.ª revisión, 2018
|
2019
|
|
Antimicrobiens d’importance critique pour la médecine humaine:
6e révision 2018
|
2019
|
|
Antimikrobiyal yönetimi uygulamaları::
pratik bir rehber
|
2022
|
|
ANTIRETROVIRAL THERAPY FOR HIV INFECTION IN ADULTS AND ADOLESCENTS:
Recommendations for a public health approach
|
2010
|
|
ANTIRETROVIRAL THERAPY FOR HIV INFECTION IN INFANTS AND CHILDREN: TOWARDS UNIVERSAL ACCESS:
Recommendations for a public health approach
|
2010
|
|
ANTIRETROVIRAL THERAPY FOR HIV INFECTION IN INFANTS AND CHILDREN: TOWARDS UNIVERSAL ACCESS:
Recommendations for a public health approach
|
2007
|
|
ApartTogether survey:
PRELIMINARY OVERVIEW OF REFUGEES AND MIGRANTS SELF-REPORTED IMPACT OF COVID‑19
|
2020
|
|
APPENDIX 1::
Survey on child environmental health awareness of health care professionals
|
2019
|
|
APPENDIX 2::
Model of workshop evaluation form
|
2019
|
|
APPENDIX 3::
Example of post-workshop knowledge evaluation
|
2019
|
|
Approches de la:
PRÉVENTION DE L’OBÉSITÉ DE L’ENFANT dans la population
|
2012
|
|
Approches prospectives de la santé publique mondiale:
Guide pratique à l’usage du personnel de l’OMS
|
2023
|
|
Appui à la santé mentale et soutien psychosocial en cas de violence sexuelle liée aux conflits ::
principes et interventions
|
2012
|
|
Artemisinin and artemisinin-based combination therapy resistance:
STATUS REPORT
|
2016
|
|
Artemisinin and artemisinin-based combination therapy resistance:
STATUS REPORT
|
2017
|
|
Artemisinin and artemisinin-based combination therapy resistance:
STATUS REPORT
|
2016
|
|
Artemisinin resistance and artemisinin-based combination therapy efficacy
|
2019
|
|
Artemisinin resistance and artemisinin-based combination therapy efficacy:
STATUS REPORT
|
2018
|
|
Artisanal and small-scale gold mining and health
|
2016
|
|
As crianças e as lixeiras digitais:
A exposição ao lixo eletrónico e a saúde infantil
|
2022
|
|
Asbesto crisotilo
|
2015
|
|
Asbesto in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2021
|
|
ASBESTOS:
ECONOMIC ASSESSMENT OF BANS AND DECLINING PRODUCTION AND CONSUMPTION
|
2017
|
|
ASEAN mutual recognition arrangements for doctors, dentists and nurses
|
2019
|
|
Asia Pacific Strategy for Emerging Diseases:
2010
|
2011
|
|
Aspectos prácticos del uso del SMVRG para la vigilancia de la COVID-19:
Orientaciones provisionales
|
2020
|
|
ASPECTS ÉCONOMIQUES DES DÉTERMINANTS SOCIAUX DE LA SANTÉ ET DES INÉGALITÉS EN SANTÉ
|
2014
|
|
ASPIRACIONES Y ACCIONES EN MATERIA DE NUTRICIÓN 2016–2025
|
2017
|
|
ASSESSING FISCAL SPACE FOR HEALTH EXPANSION IN LOW-AND-MIDDLE INCOME COUNTRIES::
A REVIEW OF THE EVIDENCE
|
2016
|
|
ASSESSING NATIONAL CAPACITY TO IMPLEMENT EFFECTIVE TOBACCO CONTROL POLICIES:
Operational manual on planning, conduct and follow-up of joint national capacity assessments
|
2013
|
|
Assessing the development of palliative care worldwide::
a set of actionable indicators
|
2021
|
|
ASSESSING THE EPIDEMIOLOGY OF SOIL-TRANSMITTED HELMINTHS DURING A TRANSMISSION ASSESSMENT SURVEY IN THE GLOBAL PROGRAMME FOR THE ELIMINATION OF LYMPHATIC FILARIASIS
|
2015
|
|
ASSESSING THE EXISTING EVIDENCE BASE ON SCHOOL FOOD AND NUTRITION POLICIES::
A SCOPING REVIEW
|
2021
|
|
ASSESSING THE IMPACT OF COVID-19 ON OLDER PEOPLE IN THE AFRICAN REGION:
A study conducted by the World Health Organisation Regional Office for Africa
|
2021
|
|
Assessment and Management of Conditions Specifically Related to Stress:
mhGAP Intervention Guide Module
|
2013
|
|
Assessment and management of Guillain-Barré syndrome in the context of Zika virus infection:
Interim guidance update
|
2016
|
|
ASSESSMENT CRITERIA FOR NATIONAL BLOOD REGUlATORY SYSTEMS
|
2012
|
|
Assessment of barriers to accessing health services for disadvantaged adolescents in Nigeria
|
2019
|
|
Assessment of chemical risks for human health: training and capacity building sub-regional workshop for Estonia, Latvia and Lithuania:
Vilnius, Lithuania, 14-15 October 2015
|
2015
|
|
ASSESSMENT OF HIV TESTING SERVICES AND ANTIRETROVIRAL THERAPY SERVICE DISRUPTIONS IN THE CONTEXT OF COVID-19::
LESSONS LEARNED AND WAY FORWARD IN SUB-SAHARAN AFRICA
|
2021
|
|
Assessment of risk factors for coronavirus disease 2019 (COVID-19) in health workers::
protocol for a case-control study
|
2020
|
|
Assessment tool for laboratories implementing COVID-19 virus testing:
Interim guidance
|
2020
|
|
Assessment tool for laboratories implementing SARS-CoV-2 testing:
Interim guidance
|
2020
|
|
ASSIST:
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)
|
2010
|
|
ASSIST Alkoholin, tupakan ja huumeiden käytön seulontatesti:
Käyttöopas perusterveydenhuoltoa varten
|
2010
|
|
Assisting community health workers in India:
Dimagi’s CommCare
|
2013
|
|
Assisting community health workers in Rwanda:
MOH’s RapidSMS and mUbuzima
|
2013
|
|
Assistive product specifications and how to use them
|
2021
|
|
Assistive technology capacity assessment (ATA-C):
Instruction Manual
|
2021
|
|
ASSISTIVE TECHNOLOGY PROCUREMENT STUDY:
Technical Report
|
2020
|
|
The ASSIST-linked brief intervention for hazardous and harmful substance use:
Manual for use in primary care
|
2010
|
|
ASSURER LA SÉCURITÉ DES INTERVENTIONS DE CHIMIOPRÉVENTION POUR LA LUTTE CONTRE LES MALADIES TROPICALES NÉGLIGÉES:
CONSEILS PRATIQUES À L’INTENTION DES ADMINISTRATEURS DE PROGRAMMES NATIONAUX SUR LA PRÉVENTION, LE DÉPISTAGE ET LA PRISE EN CHARGE DES ÉVÉNEMENTS INDÉSIRABLES GRAVES
|
2012
|
|
Asthma and COVID-19
|
2021
|
|
Atención en el domicilio a casos sospechosos o confirmados de COVID-19 y manejo de sus contactos:
Orientaciones provisionales
|
2020
|
|
Atención en el domicilio a pacientes presuntamente infectados por el nuevo coronavirus (COVID-19) que presentan síntomas leves, y gestión de sus contactos.:
Orientaciones provisionales
|
2020
|
|
Atención en el domicilio de pacientes presuntamente infectados por el nuevo coronavirus (nCoV) que tengan síntomas leves y gestión de los contactos:
Orientaciones provisionales
|
2020
|
|
Atención integrada para personas mayores (AIPM):
Directrices para las intervenciones comunitarias dirigidas a limitar el deterioro de la capacidad intrínseca
|
2017
|
|
Atención oftálmica integrada y centrada en la persona, incluidas la ceguera y la discapacidad visual prevenibles:
Informe del Director General
|
2020
|
|
ATENCIÓN OTOLÓGICA Y AUDIOLÓGICA::
INSTRUMENTO DE ANÁLISIS DE LA SITUACIÓN
|
2016
|
|
Atlas:
PSYCHIATRIC EDUCATION AND TRAINING ACROSS THE WORLD 2005
|
2005
|
|
ATLAS:
COUNTRY RESOURCES FOR NEUROLOGICAL DISORDERS
|
2017
|
|
ATTACKS ON HEALTH CARE
|
2019
|
|
ATTACKS ON HEALTH CARE INITIATIVE 2019 - 2022
|
2019
|
|
Attraction and Retention of Rural Primary Health-care Workers in the Asia Pacific Region
|
2018
|
|
Autism spectrum disorders & other developmental disorders From raising awareness to building capacity:
World Health Organization, Geneva, Switzerland 16 - 18 September 2013
|
2013
|
|
Avian Influenza A(H7N9) Response::
AN INVESTMENT IN PUBLIC HEALTH PREPAREDNESS
|
2013
|
|
Avoir le but à l’esprit dès le début:
La planification des projets pilotes et d’autres recherches programmatiques pour un passage à grande échelle réussi
|
2013
|
|
Avort fără riscuri::
recomandări pentru sistemele de sănătate în probleme de strategie şi practică
|
2015
|
|
Avortement médicalisé ::
Directives techniques et stratégiques à l’intention des systèmes de santé
|
2004
|
|
Avortement sécurisé ::
Directives techniques et stratégiques à l’intention des systèmes de santé
|
2013
|
|
AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca::
Background paper
|
2021
|
|
Bacille Calmette-Guérin (BCG) vaccination and COVID-19:
Scientific brief
|
2020
|
|
Background document on the AZD1222 vaccine against COVID-19 developed by Oxford University and AstraZeneca
|
2021
|
|
Background document on the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
|
2021
|
|
Background document on the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (ConvideciaTM) against COVID-19:
Background document to the WHO Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S vaccine (ConvideciaTM) against COVID-19
|
2022
|
|
Background document on the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm
|
2021
|
|
Background document on the inactivated vaccine Sinovac-CoronaVac against COVID-19:
Background document to the WHO Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
|
2021
|
|
Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine
|
2021
|
|
Background document on the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19
|
2021
|
|
Background document on the mRNA-1273 vaccine (Moderna) against COVID-19:
Background document to the WHO Interim recommendations for use of the mRNA-1273 vaccine (Moderna)
|
2021
|
|
Background document on the Novavax (NVX-CoV2373) vaccine against COVID-19
|
2021
|
|
BACKGROUND PAPER FOR MEDICO-LEGAL TOOLKIT
|
2015
|
|
Background paper on Covid-19 disease and vaccines
|
2020
|
|
Background to the recommendations for use of the Valneva VLA2001 vaccine against COVID 19:
Background document to the WHO Interim recommendations for use of the Valneva vaccine VLA2001 against COVID-19
|
2022
|
|
Bacterial vaccines in clinical and preclinical development 2021:
An overview and analysis
|
2022
|
|
BAHRAIN COVID-19 CASE STUDIES
|
2022
|
|
Baltic workshop on building capacity in parenting programmes to prevent violence:
Vilnius, Lithuania 8 9 January 2019
|
2019
|
|
Bangladesh Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Bangladesh Health System Review
|
2015
|
|
BANISHED from Bhutsn:
The story of how a small mountain kingdom eliminated measles
|
2017
|
|
Báo cáo Thế giới về phòng chống thương tích ở trẻ em
|
2008
|
|
BASELINE ASSESSMENT OF COMMUNITY BASED TB SERVICES IN 8 ENGAGE-TB PRIORITY COUNTRIES
|
2018
|
|
BASIC EAR AND HEARING CARE RESOURCE
|
2020
|
|
Basic methods for assessment of renal fluoride excretion in community prevention programmes for oral health
|
2014
|
|
BCG vaccines::
WHO position paper — February 2018
|
2018
|
|
BE HE@LTHY BE MOBILE:
A handbook on how to implement mDementia
|
2021
|
|
BE HE@LTHY BE MOBILE:
A handbook on how to implement mBreatheFreely mHealth for asthma and COPD
|
2017
|
|
Be smart Drink water:
A guide for school principals in restricting the sale and marketing of sugary drinks in and around schools
|
2016
|
|
BEHAVIOURAL CONSIDERATIONS FOR ACCEPTANCE AND UPTAKE OF COVID-19 VACCINES:
WHO TECHNICAL ADVISORY GROUP ON BEHAVIOURAL INSIGHTS AND SCIENCES FOR HEALTH
|
2020
|
|
Belgium in the time of the COVID-19 pandemic:
A snapshot in January 2021
|
2021
|
|
Benefits of Action to Reduce Household Air Pollution (BAR-HAP) Tool
|
2022
|
|
Benin Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Bentazone in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2020
|
|
Besoins de réadaptation des personnes en convalescence après la COVID-19
|
2021
|
|
BETTER HOSPITAL CARE FOR CHILDREN:
Improving quality of paediatric care at first-level referral hospitals in Angola, Ethiopia, Kyrgyzstan and Tajikistan
|
2016
|
|
Better Laws for Better Health:
Western Pacific Regional Action Agenda on Strengthening Legal Frameworks for Health in the Sustainable Development Goals
|
2020
|
|
Beyond the barriers:
Framing evidence on health system strengthening to improve the health of migrants experiencing poverty and social exclusion
|
2017
|
|
Big Data and Artificial Intelligence for Achieving Universal Health Coverage::
An International Consultation on Ethics
|
2018
|
|
BILHARZIOSE GÉNITALE CHEZ LA FEMME:
ATLAS DE POCHE POUR LES PROFESSIONNELS DE LA SANTÉ
|
2017
|
|
BIOLOGICAL MECHANISMS RELATED TO CARDIOVASCULAR AND METABOLIC EFFECTS BY ENVIRONMENTAL NOISE
|
2018
|
|
Biomedical equipment for COVID-19 case management - inventory tool:
Harmonized health service capacity assessments in the context of the COVID-19 pandemic
|
2020
|
|
Biotechnologie alimentaire moderne, santé et développement::
étude à partir d'exemples concrets
|
2005
|
|
Biotecnología moderna de los alimentos, salud y desarrollo humano::
estudio basado en evidencias
|
2005
|
|
BIPOLAR DISORDER
|
2019
|
|
Biregional Workshop on Restricting the Marketing of Foods and Non-Alcoholic Beverages to Children in the Western Pacific and South-East Asia:
Kuala Lumpur, Malaysia 1 to 4 December 2015
|
2016
|
|
BIRTH DEFECTS SURVEILLANCE:
A MANUAL FOR PROGRAMME MANAGERS SECOND EDITION
|
2020
|
|
BIRTH DEFECTS SURVEILLANCE:
QUICK REFERENCE HANDBOOK OF SELECTED CONGENITAL ANOMALIES AND INFECTIONS
|
2020
|
|
BIRTH DEFECTS SURVEILLANCE:
A MANUAL FOR PROGRAMME MANAGERS
|
2014
|
|
BIRTH DEFECTS SURVEILLANCE TRAINING:
FACILITATOR’S GUIDE
|
2015
|
|
Birth spacing — report from a WHO technical consultation
|
2006
|
|
Blood and other medical products of human origin:
Report by the Secretariat
|
2014
|
|
Blood Donor Counselling:
Implementation Guidelines
|
2014
|
|
Blood Donor Selection:
Guidelines on Assessing Donor Suitability for Blood Donation
|
2012
|
|
Blood Transfusion Services in The South-East Asia Region:
A 5-year review
|
2018
|
|
A blueprint for dementia research
|
2022
|
|
BOIL WATER
|
2015
|
|
Boîte à Outils D’Évaluation Des Risques Pour La Santé Humaine::
Dangers Chimiques
|
2017
|
|
BOTSWANA:
Bordering Africa’s Epicenter: How early action and careful border control policies have so far contained COVID-19 to clusters
|
2020
|
|
Breaking the cycle: public health perspectives on interpersonal violence in the Russian Federation:
Policy briefing
|
2007
|
|
Breastfeeding and COVID-19:
Scientific brief
|
2020
|
|
Bridging the gap between ethics and decision-making in pandemics:
Report of the WHO Pandemic Ethics and Policy Summit
|
2021
|
|
Brief guide to analytical methods for measuring lead in blood:
Second edition
|
2020
|
|
Brief model disability survey::
2019 results for India, Lao People’s Democratic Republic and Tajikistan
|
2021
|
|
Brief Model Disability Survey::
Results for India, Lao People’s Democratic Republic and Tajikistan
|
2019
|
|
A BRIEF ON THE WHO POSITION:
Building health systems resilience for universal health coverage and health security during the COVID-19 pandemic and beyond
|
2021
|
|
Briefing Note:
Antimicrobial Resistance: An Emerging Water, Sanitation and Hygiene Issue
|
2014
|
|
BUDGETS ANNUELS GÉNÉRIQUES POUR LES APPROCHES DE LA SURVEILLANCE DE LA TOXICITE DES ANTIRETROVIRAUX
|
2020
|
|
BUILD BACK FAIRER ACHIEVING HEALTH EQUITY IN THE EASTERN MEDITERRANEAN REGION:
REPORT OF THE COMMISSION ON SOCIAL DETERMINANTS OF HEALTH IN THE EASTERN MEDITERRANEAN REGION
|
2021
|
|
Building an adolescent-competent workforce
|
2015
|
|
Building Countries’ Capacity for Action against Antimicrobial Resistance:
MULTICOUNTRY ANTIMICROBIAL RESISTANCE WORKSHOP
|
2015
|
|
The bumpy road to better health:
How embedded research strengthened health services in Ghana
|
2019
|
|
Burden of disease attributable to unsafe drinking-water, sanitation and hygiene:
2019 Update
|
2023
|
|
The burden of foodborne diseases is substantial
|
2015
|
|
Burkina Faso Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Burkina Faso national action plan on antimicrobial resistance:
Review of progress in the human health sector Antimicrobial resistance policy information and action brief series 2021
|
2021
|
|
BURNING OPPORTUNITY::
Clean Household Energy for Health, Sustainable Development, and Wellbeing of Women and Children
|
2016
|
|
Burundi Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Cadre centré sur la personne pour la planification et la priorisation des activités des programmes de lutte contre la tuberculose:
Guide de l’utilisateur
|
2021
|
|
Cadre de mise en œuvre de l’Initiative mondiale contre le cancer du sein Évaluation, renforcement et amplification des services de détection précoce et de prise en charge du cancer du sein:
Résumé d’orientation
|
2023
|
|
Cadre de préparation en cas de grippe pandémique:
pour l’échange des virus grippaux et l’accès aux vaccins et autres avantages
|
2012
|
|
Cadre de préparation en cas de grippe pandémique (PIP):
La Contribution de Partenariat destinée aux activités de préparation Deuxième plan de mise en œuvre de haut niveau 2018-2023
|
2018
|
|
Cadre de préparation en cas de grippe pandémique pour l’échange des virus grippaux et l’accès aux vaccins et autres avantages
|
2021
|
|
CADRE DE SUIVI ET D’ÉVALUATION DE LA RÉPONSE À LA COVID-19 DANS LA RÉGION AFRICAINE DE L’OMS
|
2020
|
|
Cadre de valeurs du SAGE de l’OMS pour l’attribution des vaccins anti-COVID-19 et la détermination des groupes à vacciner en priorité
|
2020
|
|
CADRE DECOMPÉTENCES EN Réadaptation
|
2021
|
|
Cadre d’indicateurs et de cibles pour le renforcement des laboratoires en ligne avec la Stratégie pour mettre fin à la tuberculose
|
2017
|
|
Cadre opérationnel pour renforcer la résilience des systèmes de santé face au changement climatique
|
2016
|
|
CADRE POUR LA MISE EN ŒUVRE DE LA STRATÉGIE MONDIALE VISANT À ÉLIMINER LE CANCER DU COL DE L’UTÉRUS EN TANT QUE PROBLÈME DE SANTÉ PUBLIQUE DANS LA RÉGION AFRICAINE DE L’OMS
|
2021
|
|
Cadre pour la prise de décision : mise en oeuvre de campagnes de vaccination de masse dans le contexte de la COVID-19:
Orientations provisoires
|
2020
|
|
Cadre pour le renforcement de la préparation aux situations d’urgence sanitaire dans les villes et les milieux urbains
|
2022
|
|
Cadre pour l’élimination du paludisme
|
2017
|
|
CAHIER D’EXERCICES:
EXERCICES POUR GUIDER LE PROCESSUS DE SUIVI DES INÉGALITÉS EN MATIÈRE DE SANTÉ SEXUELLE ET REPRODUCTIVE ET DE SANTÉ DE LA MÈRE, DU NOUVEAU-NÉ, DE L’ENFANT ET DE L’ADOLESCENT (SSRMNEA)
|
2022
|
|
Calibrating long-term non-pharmaceutical interventions for COVID-19:
Principles and facilitation tools
|
2022
|
|
CẨM NANG AN TOÀN SINH HỌC PHÒNG XÉT NGHIỆM LAO
|
2012
|
|
Cambodia Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Cameroon Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Capacidades de gestão e liderança dos recursos humanos de Saúde na Região Africana:
Análise da s unidades de recursos humanos de Saúde integradas nos Ministérios da Saúde
|
2013
|
|
Capacité de gouvernance et de direction du personnel de santé dans la Région africaine:
Examen des unités des ressources humaines pour la santé dans les ministères de la santé
|
2012
|
|
Capacités de prise en charge des cas de COVID-19 ::
produits de diagnostic, traitements, préparation à la vaccination et autres produits de santé – outil d’évaluation des établissements
|
2021
|
|
Capacity-building for consultants on the new WHO recommendations for the treatment of drug-resistant tuberculosis International online training 15–18 June 2020
|
2020
|
|
Capacity-building for the public health management of chemical incidents and IHR implementation:
Awareness-raising and training workshop for SEE countries Belgrade, Serbia, 26‒27 March 2013
|
2013
|
|
Capturando la diferencia que hacemos:
Manual de Indicadores de Rehabilitación Basada en la Comunidad
|
2015
|
|
Capturing the difference we make:
Community-based Rehabilitation Indicators Manual
|
2015
|
|
Capturing the evidence on access to essential antibiotics in refugee and migrant populations
|
2022
|
|
CARE AND TREATMENT OF PERSONS DIAGNOSED WITH CHRONIC HEPATITIS C VIRUS INFECTION:
POLICY BRIEF
|
2018
|
|
Care of chronic respiratory disease in the United Kingdom in the time of the COVID-19 pandemic:
A snapshot in January 2021
|
2021
|
|
CARE OF GIRLS & WOMEN LIVING WITH FEMALE GENITAL MUTILATION:
A CLINICAL HANDBOOK
|
2018
|
|
Caregiver skills training for families of children with developmental delays or disabilities:
Home visit guide for facilitators
|
2022
|
|
Caregiver skills training for families of children with developmental delays or disabilities:
Adaptation and implementation guide
|
2022
|
|
Caregiver skills training for families of children with developmental delays or disabilities
|
2022
|
|
Caregiver skills training for families of children with developmental delays or disabilities:
Facilitators’ guide group sessions 1–9
|
2022
|
|
Caring for the child’s healthy growth and development:
PARTICIPANT'S MANUAL
|
2015
|
|
Caring for the newborn at home:
PARTICIPANT'S MANUAL
|
2015
|
|
Caring for women subjected to violence::
A WHO training curriculum for health care providers. Revised edition, 2021
|
2021
|
|
Caring for women subjected to violence::
A WHO curriculum for training health-care providers
|
2019
|
|
CASE STUDY:
Implementation of the Guidance on organizing an advocacy or awareness-raising campaign on lead paint in Georgia
|
2021
|
|
CASE STUDY:
An assessment of industrial capacity for the sound management of chemicals in Montserrado County in Liberia
|
2021
|
|
CASE STUDY:
Chemicals Management Plan (CMP) Science Committee in Canada
|
2020
|
|
CASE STUDY:
COVID-19 and methanol poisoning in Azerbaijan
|
2021
|
|
CASE STUDY:
Implementation of the Guidance on organizing an advocacy or awareness-raising campaign on lead paint in Georgia
|
2021
|
|
CASE STUDY:
Development of the National Road Map for enhancing health sector engagement/contribution to sound management of chemicals in Serbia till 2030
|
2021
|
|
CASE STUDY:
Development of a road map towards sound management of biocides in Georgia
|
2020
|
|
CASE STUDY:
Successful collaborative multi-agency approach to deliver on the WHO Chemicals Road Map in New Zealand
|
2021
|
|
CASE STUDY:
Implementation of the Minamata Convention by the health sector in Brazil
|
2021
|
|
CASE STUDY:
Reducing the impact of endocrine-disrupting chemicals (EDCs) on health in Belgium - Mutualites Librés
|
2021
|
|
CASE STUDY:
Health Care Without Harm Europe SAICM 2.0 Project: Promoting safer disinfectants in the health-care sector Over 80 health providers from 19 countries
|
2021
|
|
CASE STUDY:
Chemical safety in schools
|
2020
|
|
CASE STUDY:
Action Plan Phase 2 under the National Chemical Management Plan in Thailand
|
2021
|
|
CASE STUDY:
Using the WHO Chemicals Road Map and Workbook to determine country priorities for sound management of chemicals and waste in Bhutan
|
2020
|
|
Case study on socially determined inequities in alcohol consumption patterns in Estonia
|
2013
|
|
Case-based payment systems for hospital funding in Asia::
an investigation of current status and future directions
|
2015
|
|
Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance
|
2021
|
|
Ce qu’il faut faire et ne pas faire dans le cadre des programmes psychosociaux communautaires relatifs aux violences sexuelles dans les situations de conflit
|
2012
|
|
Celebración de reuniones durante la pandemia de COVID-19
|
2021
|
|
Central African Republic Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Centre de traitement des infections respiratoires aiguës sévères:
Manuel pratique pour la mise en place et la gestion d’un centre de traitement des IRAS et d’une unité de dépistage des IRAS dans les établissements de soins
|
2020
|
|
Centro de tratamiento de infecciones respiratorias agudas graves:
Manual práctico para instalar y gestionar un centro de tratamiento de las infecciones respiratorias agudas graves y una zona para el tamizaje de estas en los establecimientos de asistencia médica
|
2020
|
|
Certification of deaths during pregnancy, childbirth, or the puerperium where confirmed or suspected COVID-19 is a cause of death
|
2022
|
|
Chad Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
The challenge of extending universal coverage to non-poor informal workers in low- and middle-income countries in Asia:
IMPACTS AND POLICY OPTIONS
|
2015
|
|
Chăm Sóc Phẫu Thuật tại Bệnh Viện Tuyến Huyện
|
2003
|
|
Changement climatique, genre et santé
|
2016
|
|
Chapter 6 - Vaccine-preventable diseases and vaccines
|
2020
|
|
A checklist for pandemic influenza risk and impact management:
Building capacity for pandemic response
|
2018
|
|
Checklist for rapid assessment of policies and actions in environment, climate change and health:
Scaling up country actions for environment, climate change and health
|
2023
|
|
Checklist to support schools re-opening and preparation for COVID-19 resurgences or similar public health crises
|
2020
|
|
CHECKLISTS TO ASSESS VULNERABILITIES IN HEALTH CARE FACILITIES IN THE CONTEXT OF CLIMATE CHANGE
|
2021
|
|
CHEMICAL MIXTURES IN SOURCE WATER AND DRINKING-WATER
|
2017
|
|
Chemical policy and programmes to protect human health and environment in a sustainability perspective:
Report of a WHO Meeting Bonn, Germany, 4–5 July 2016
|
2017
|
|
CHEMICAL RELEASES ASSOCIATED WITH CYCLONES
|
2018
|
|
CHEMICAL RELEASES ASSOCIATED WITH EARTHQUAKES
|
2018
|
|
CHEMICAL RELEASES ASSOCIATED WITH FLOODS
|
2018
|
|
CHEMICAL RELEASES CAUSED BY NATURAL HAZARD EVENTS AND DISASTERS:
INFORMATION FOR PUBLIC HEALTH AUTHORITIES
|
2018
|
|
CHEMICAL SAFETY AND PROTECTION OF HUMAN HEALTH::
THE SLOVENIAN EXPERIENCE
|
2016
|
|
Chemicals Road Map:
Workbook
|
2018
|
|
Chemicals Road Map
|
2017
|
|
Child development and motorcycle safety
|
2015
|
|
Child, early and forced marriage legislation in 37 Asia-Pacific countries
|
2016
|
|
CHILDHOOD HEARING LOSS:
ACT NOW, HERE’S HOW!
|
2016
|
|
CHILDHOOD HEARING LOSS:
Strategies for prevention and care
|
2016
|
|
Childhood Stunting: Challenges and Opportunities:
Report of a webcast colloquium on the operational issues around setting and implementing national stunting reduction agendas 14 October 2013 – WHO Geneva
|
2014
|
|
CHILDREN AND CHEMICALS:
TRAINING FOR HEALTH CARE PROVIDERS THIRD EDITION
|
2023
|
|
CHILDREN AND CHEMICALS:
TRAINING FOR HEALTH CARE PROVIDERS
|
2019
|
|
Children and digital dumpsites:
E-waste exposure and child health
|
2021
|
|
Children and digital dumpsites E-waste exposure and child health:
SUMMARY FOR POLICY-MAKERS
|
2021
|
|
Children and digital dumpsites E-waste exposure and child health:
WEB ANNEX Literature review on the health effects of exposure to e-waste
|
2021
|
|
China country assessment report on ageing and health
|
2015
|
|
Chirurgie du trichiasis trachomateux:
Seconde Édition
|
2015
|
|
Chlamydia, gonorrhoea, trichomoniasis and syphilis::
global prevalence and incidence estimates, 2016
|
2019
|
|
Chromium in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2020
|
|
Chronic HIV Care with ARV Therapy:
INTEGRATED MANAGEMENT OF ADOLESCENT AND ADULT ILLNESS
|
2004
|
|
Chrysotile Asbestos
|
2014
|
|
Cibles mondiales de nutrition 2025:
Note d’orientation sur le retard de croissance
|
2017
|
|
Ciguatera poisoning
|
2020
|
|
Cinco claves para cultivar frutas y hortalizas más seguras::
promover la salud mediante la disminución de la contaminación microbiana
|
2012
|
|
Cinco claves para una mayor inocuidad de los productos de acuicultura con objeto de proteger la salud pública
|
2016
|
|
Cinq clefs pour cultiver des fruits et des légumes plus sûrs ::
promouvoir la santé en réduisant la contamination microbienne
|
2012
|
|
Cinq clefs pour des produits d’aquaculture plus sûrs afin de protéger la santé publique
|
2016
|
|
Cinquième rapport de la Commission A
|
2014
|
|
Clasificación recomendada por la OMS de los plaguicidas por el peligro que presentan y directrices para la clasificación 2019
|
2020
|
|
CLASSIFICATION AND MINIMUM STANDARDS FOR EMERGENCY MEDICAL TEAMS
|
2021
|
|
Classification of Digital Health Interventions v1.0:
A shared language to describe the uses of digital technology for health
|
2018
|
|
Classification OMS recommandée des pesticides en fonction des dangers qu'ils présentent et lignes directrices pour la classification 2019
|
2020
|
|
Clean Household Energy Solutions Toolkit (CHEST)
|
2022
|
|
Cleaning and disinfection of environmental surfaces in the context of COVID-19:
Interim guidance
|
2020
|
|
CLEANING AND STORING MICROSCOPE SLIDES:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-01
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE:
ITALY
|
2018
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
ETHIOPIA
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
COLOMBIA
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
JORDAN
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
MEXICO
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
KUWAIT
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
CHINA
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
BOTSWANA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
IRAN
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
OMAN
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
UNITED REPUBLIC OF TANZANIA
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
LAO PEOPLE'S DEMOCRATIC REPUBLIC
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
UNITED KINGDOM
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
PERU
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
BANGLADESH
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
FRANCE
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
MALAYSIA
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
GERMANY
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
PAKISTAN
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
BRUNEI DARUSSALAM
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
UNITED STATES OF AMERICA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
GHANA
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
THAILAND
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
PHILIPPINES
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
MADAGASCAR
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
MALDIVES
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
BRAZIL
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
BHUTAN
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
TUNISIA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
TIMOR-LESTE
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
NIGERIA
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
EGYPT
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
CAMBODIA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
SRI LANKA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
FIJI
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
MYANMAR
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
ALGERIA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
SOUTH AFRICA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
NEPAL
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
INDONESIA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
UGANDA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
MOROCCO
|
2015
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2015:
KENYA
|
2016
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2017:
JAMAICA
|
2018
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2017:
KIRIBATI
|
2018
|
|
CLIMATE AND HEALTH COUNTRY PROFILE – 2017:
VANUATU
|
2018
|
|
CLIMATE AND HEALTH COUNTRY PROFILES - 2015:
A GLOBAL OVERVIEW
|
2015
|
|
CLIMATE CHANGE AND HEALTH:
VULNERABILITY AND ADAPTATION ASSESSMENT
|
2021
|
|
Climate Change and Health in Small Island Developing States::
A WHO Special Initiative
|
2018
|
|
CLIMATE CHANGE AND HEALTH IN SMALL ISLAND DEVELOPING STATES:
A WHO SPECIAL INITIATIVE
|
2018
|
|
CLIMATE CHANGE AND HEALTH RESEARCH:
CURRENT TRENDS, GAPS AND PERSPECTIVES FOR THE FUTURE
|
2021
|
|
Climate-resilient water safety plans::
Managing health risks associated with climate variability and change
|
2017
|
|
Clinical Care for Severe Acute Respiratory Infection
|
2022
|
|
Clinical Care for Severe Acute Respiratory Infection:
Toolkit
|
2020
|
|
Clinical Care for Severe Acute Respiratory Infection:
Toolkit Update 2022
|
2022
|
|
Clinical Care for Severe Acute Respiratory Infection
|
2022
|
|
Clinical care for survivors of Ebola virus disease
|
2016
|
|
A clinical case definition of post COVID-19 condition by a Delphi consensus
|
2021
|
|
Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection
|
2021
|
|
CLINICAL MANAGEMENT AND INFECTION PREVENTION AND CONTROL FOR MONKEYPOX:
Interim rapid response guidance
|
2022
|
|
Clinical management of COVID-19:
LIVING GUIDELINE
|
2022
|
|
Clinical management of COVID-19:
LIVING GUIDELINE
|
2022
|
|
Clinical management of COVID-19::
living guidance
|
2021
|
|
Clinical management of COVID-19:
LIVING GUIDELINE
|
2022
|
|
Clinical management of COVID-19:
Interim guidance
|
2020
|
|
Clinical management of COVID-19:
Interim guidance
|
2020
|
|
Clinical management of patients with viral haemorrhagic fever:
A pocket guide for front-line health workers Interim emergency guidance for country adaptation
|
2016
|
|
Clinical management of rape and intimate partner violence survivors:
Developing protocols for use in humanitarian settings
|
2020
|
|
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected:
Interim guidance
|
2020
|
|
Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected:
Interim guidance
|
2019
|
|
Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected:
Interim guidance
|
2020
|
|
Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected:
Interim guidance
|
2020
|
|
Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected:
Interim guidance
|
2020
|
|
Clinical practice handbook for Safe abortion
|
2014
|
|
CLINIC-BASED SURVEY OF ACQUIRED HIV DRUG RESISTANCE
|
2021
|
|
Closing the gap in a generation:
Health equity through action on the social determinants of health
|
2008
|
|
CLOSING THE LEADERSHIP GAP::
GENDER EQUITY AND LEADERSHIP IN THE GLOBAL HEALTH AND CARE WORKFORCE
|
2021
|
|
Coadministration of seasonal inactivated influenza and COVID-19 vaccines:
Interim guidance
|
2021
|
|
Cocktail d’anticorps monoclonaux neutralisant REGN-EB3 contre la maladie à virus Ebola (MVE)
|
2022
|
|
CODE INTERNATIONAL DE COMMERCIALISATION DES SUBSTITUTS DU LAIT MATERNEL
|
2017
|
|
CÓDIGÓ INTERNACIÓNAL DE CÓMERCIALIZACIÓN DE SUCEDANEÓS DE LA LECHE MATERNA
|
2017
|
|
Cohort study to measure COVID-19 vaccine effectiveness among health workers in the WHO European Region:
Guidance Document
|
2021
|
|
Collaborative framework for addressing Autism Spectrum Disorder in the South-East Asia Region
|
2017
|
|
Collaborative study to evaluate the proposed WHO 1st International Reference Panel for Genomic JAK2 V617F
|
2016
|
|
COLLECTION OF BLOOD BY VENIPUNCTURE AND PREPARATION OF BLOOD FILMS FROM VENOUS BLOOD COLLECTED IN TUBES CONTAINING ANTICOAGULANT:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-05B
|
2016
|
|
COLOMBIA:
Through a structured and coordinated response, Colombia seeks to leave no one behind in the fight against COVID-19
|
2020
|
|
COLORATION AU GIEMSA DES ÉTALEMENTS DE SANG À LA RECHERCHE DE PLASMODIUM:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-07A
|
2016
|
|
Combating antimicrobial resistance, including antibiotic resistance
|
2014
|
|
Combating antimicrobial resistance, including antibiotic resistance
|
2014
|
|
Combatir el maltrato de las personas mayores:
Cinco prioridades para la Década de las Naciones Unidas del Envejecimiento Saludable [2021–2030]
|
2022
|
|
Combattre la résistance aux antimicrobiens, y compris la résistance aux antibiotiques
|
2014
|
|
Combattre la résistance aux antimicrobiens, y compris la résistance aux antibiotiques
|
2014
|
|
COMBATTRE LES MNT:
« Meilleurs choix » et autres interventions recommandées pour lutter contre les maladies non transmissibles
|
2017
|
|
Combined course on growth assessment and IYCF counselling
|
2012
|
|
Combler le fossé en une génération:
Instaurer l’équité en santé en agissant sur les déterminants sociaux de la santé
|
2008
|
|
COMBLER L’ÉCART EN MATIÈRE DE LEADERSHIP ::
ÉQUITÉ DE GENRE ET LEADERSHIP AU SEIN DES PERSONNELS DE SANTÉ ET D’AIDE À LA PERSONNE DANS LE MONDE
|
2021
|
|
COMERCIO ILEGAL DE PRODUCTOS DE TABACO:
LO QUE DEBE SABER PARA DETENERLO
|
2015
|
|
Comité consultatif de surveillance indépendant du Programme OMS de gestion des situations d’urgence sanitaire
|
2021
|
|
Comité de Expertos de la OMS en Farmacodependencia:
41.º informe
|
2021
|
|
Comité Independiente de Asesoramiento y Supervisión para el Programa de Emergencias Sanitarias de la OMS
|
2021
|
|
Comité OMS d’experts de la Pharmacodépendance:
Trente-cinquième rapport
|
2012
|
|
Comité OMS d’experts de la pharmacodépendance:
Quarante et unième rapport
|
2021
|
|
Comment collecter sans risque des échantillons de sang par phlébotomie chez un patient suspect d'être infecté par le virus Ebola
|
2014
|
|
COMMENT CONTRÔLER LA TEMPÉRATURE DANS LA CHAÎNE D’APPROVISIONNEMENT EN VACCINS
|
2015
|
|
COMMENT METTRE AU POINT UN SYSTÈME POUR LA RÉPARATION ET LA MAINTENANCE DES ÉQUIPEMENTS DE LA CHAÎNE DU FROID
|
2017
|
|
Comment procéder sans risque à des écouvillonnages oraux (prélèvements de salive) chez des patients décédés, que l’on suspecte d’être infectés par le virus Ebola
|
2014
|
|
COMMERCE ILLICITE DES PRODUITS DU TA BAC:
CE QU’IL FAUT SAVOIR POUR Y METTRE FIN
|
2015
|
|
Committing to implementation of the Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030)
|
2023
|
|
COMMUNICATING THE ECONOMICS OF SOCIAL DETERMINANTS OF HEALTH AND HEALTH INEQUALITIES
|
2013
|
|
Communicating with health workers about COVID-19 vaccination
|
2021
|
|
Communicating with patients about COVID-19 vaccination:
Evidence-based guidance for effective conversations to promote COVID-19 vaccine uptake
|
2021
|
|
Communication sur les risques et participation communautaire (RCCE)::
préparation et riposte face au nouveau coronavirus 2019 (2019-nCoV)
|
2020
|
|
Community Engagement in Tuberculosis
|
2018
|
|
COMMUNITY ENGAGEMENT THROUGH WOMEN’S SELF-HELP GROUPS:
Leveraging mobile technology for capacity building during COVID-19 lockdown in India
|
2021
|
|
Community experiences of the 2022–2023 mpox outbreak in Europe and the Americas:
Technical brief
|
2023
|
|
Community genetics services:
Report of a WHO Consultation on community genetics in low- and middle-income countries Geneva, Switzerland, 13–14 September 2010
|
2011
|
|
Community management of opioid overdose
|
2014
|
|
Community mental health centres:
Promoting person-centred and rights-based approaches
|
2021
|
|
Community needs, perceptions and demand: community assessment tool:
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic
|
2021
|
|
Community outreach mental health services:
Promoting person-centred and rights-based approaches
|
2021
|
|
COMMUNITY SURVEY ON PREVALENCE OF ADVERSE CHILDHOOD EXPERIENCES INALBANIA
|
2013
|
|
COMMUNITY-BASED REDUCTION OF MALARIA TRANSMISSION
|
2012
|
|
Community-Based Rehabilitation:
Promoting ear and hearing care through CBR
|
2012
|
|
Companion of choice during labour and childbirth for improved quality of care
|
2020
|
|
Companion of choice during labour and childbirth for improved quality of care
|
2016
|
|
COMPANION WORKBOOK:
EXERCISES TO GUIDE THE PROCESS OF INEQUALITY MONITORING IN SEXUAL, REPRODUCTIVE, MATERNAL, NEWBORN, CHILD AND ADOLESCENT HEALTH
|
2022
|
|
COMPANION WORKBOOK:
Exercises to guide the process of inequality monitoring in HIV, tuberculosis and malaria
|
2022
|
|
Comparative Quantification of Health Risks:
Global and Regional Burden of Disease Attributable to Selected Major Risk Factors
|
2004
|
|
Compendium of data and evidence-related tools for use in TB planning and programming
|
2021
|
|
Compendium of WHO and other UN guidance on health and environment
|
2021
|
|
Compendium of WHO and other UN guidance on health and environment 2022 update
|
2022
|
|
COMPENDIUM OF WHO MALARIA GUIDANCE:
prevention, diagnosis, treatment, surveillance and elimination
|
2019
|
|
COMPÉTENCES DE BASE EN SANTÉ ET DÉVELOPPEMENT DE L’ADOLESCENT POUR LES PRESTATAIRES DE SOINS PRIMAIRES:
ET OUTIL POUR ÉVALUER LE VOLET « SANTÉ ET DÉVELOPPEMENT DE L’ADOLESCENT » DANS LA FORMATION INITIALE DES PRESTATAIRES DE SOINS DE SANTÉ
|
2015
|
|
COMPETENCIAS BÁSICAS EN MATERIA DE SALUD Y DESARROLLO DE LOS ADOLESCENTES PARA LOS PROVEEDORES DE ATENCIÓN PRIMARIA:
INCLUIDO UN INSTRUMENTO PARA EVALUAR EL COMPONENTE DE SALUD Y DESARROLLO DE LOS ADOLESCENTES EN LA FORMACIÓN PREVIA AL SERVICIO DE LOS PROVEEDORES DE ATENCIÓN SANITARIA
|
2015
|
|
Comprehensive and coordinated efforts for the management of autism spectrum disorders:
Report by the Secretariat
|
2014
|
|
Comprehensive and coordinated efforts for the management of autism spectrum disorders:
Report by the Secretariat
|
2013
|
|
Comprehensive and coordinated efforts for the management of autism spectrum disorders
|
2013
|
|
Comprehensive cervical cancer control:
A guide to essential practice
|
2014
|
|
COMPREHENSIVE MENTAL HEALTH ACTION PLAN 2013-2030
|
2021
|
|
Comprehensive mental health service networks:
Promoting person-centred and rights-based approaches
|
2021
|
|
comprehensive Multi-Year Planning (cMYP):
A Tool and User Guide for cMYP Costing and Financing
|
2014
|
|
Comprender y abordar la violencia contra las mujeres:
Trata de personas
|
2013
|
|
Comprender y abordar la violencia contra las mujeres:
Violencia sexual
|
2013
|
|
Comprender y abordar la violencia contra las mujeres:
Panorama general
|
2013
|
|
Comprender y abordar la violencia contra las mujeres:
Femicidio
|
2013
|
|
Comprendre et lutter contre la violence à l’égard des femmes:
La violence sexuelle
|
2012
|
|
Comprendre et lutter contre la violence à l’égard des femmes:
La traite des personnes
|
2012
|
|
Comprendre et lutter contre la violence à l’égard des femmes
|
2012
|
|
Comprendre et lutter contre la violence à l’égard des femmes:
Le fémicide
|
2012
|
|
COMUNICACIÓN DE LA ECONOMÍA DE LOS DETERMINANTES SOCIALES DE LA SALUD Y DE LAS INEQUIDADES SANITARIAS
|
2014
|
|
Comunicación de riesgos y participación comunitaria (RCCE) en la preparación y respuesta frente al nuevo coronavirus de 2019 (2019-nCoV):
Orientaciones provisionales
|
2020
|
|
CONCENTRACIONES DE FERRITINA EN SUERO PARA EVALUAR EL ESTADO DE NUTRICIÓN EN HIERRO EN LAS PERSONAS Y LAS POBLACIONES::
INFORME TÉCNICO
|
2020
|
|
Concentraciones de folato en suero y eritrocitos para evaluar el estado de nutrición en folato en las poblaciones
|
2012
|
|
CONCENTRATIONS SÉRIQUES DE FERRITINE PERMETTANT D’ÉVALUER LE STATUT EN FER AU NIVEAU INDIVIDUEL ET DANS LES POPULATIONS ::
DOCUMENT D’INFORMATION TECHNIQUE
|
2020
|
|
Concentrations sériques et érythrocytaires de folates permettant d’évaluer le statut en folates dans les populations
|
2012
|
|
Conception et validation d’une enquête sur le seul trichiasis trachomateux:
Groupe consultatif stratégique et technique sur les maladies tropicales négligées Groupe de travail du contrôle et de l’évaluation
|
2017
|
|
Concilier les pratiques du ramadan et la sécurité des personnes lors de la pandémie de COVID-19:
Orientations provisoires
|
2021
|
|
Concilier les pratiques du ramadan et la sécurité des personnes lors de la pandémie de COVID-19:
Orientations provisoires
|
2020
|
|
Conducta clínica ante los casos asintomáticos con PCR-RT positiva para el coronavirus causante del síndrome respiratorio de Oriente Medio (MERS-CoV):
Orientación provisional
|
2015
|
|
Conduite à tenir en matière de lutte anti-infectieuse pour la prise en charge sécurisée du corps d’une personne décédée dans le contexte de la COVID-19:
Orientations provisoires
|
2020
|
|
Conduite à tenir en matière de lutte anti-infectieuse pour la prise en charge sécurisée du corps d’une personne décédée dans le contexte de la COVID-19
|
2020
|
|
CONFRONTING THE TOBACCO EPIDEMIC IN A NEW ERA OF TRADE AND INVESTMENT LIBERALIZATION
|
2012
|
|
Congo Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Conseils sur le port du masque dans le cadre de la COVID-19:
Orientations provisoires
|
2020
|
|
Conseils sur le port du masque par les enfants dans la communauté dans le cadre de la pandémie de COVID-19:
Annexe des Conseils sur le port du masque dans le cadre de la COVID-19
|
2020
|
|
Consejos para una audición responsable y segura
|
2019
|
|
Consejos sobre la utilización de mascarillas en el entorno comunitario, en la atención domiciliaria y en centros de salud en el contexto del brote de nuevo coronavirus (2019-nCoV):
Directrices provisionales
|
2020
|
|
Consensus Meeting Report:
Development of a Target Product Profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease
|
2017
|
|
Consideraciones acerca de la realización de tratamientos masivos, búsquedas activas de casos y encuestas poblacionales en relación con las enfermedades tropicales desatendidas en el contexto de la pandemia de COVID-19:
Orientaciones provisionales
|
2020
|
|
Consideraciones en la investigación de casos y conglomerados de casos de COVID-19:
Orientaciones provisionales
|
2020
|
|
Consideraciones operacionales para la gestión de casos o brotes de COVID-19 a bordo de los buques:
Orientaciones provisionales
|
2020
|
|
Consideraciones para la cuarentena de los contactos de casos de COVID-19:
Orientaciones provisionales
|
2020
|
|
Consideraciones psicosociales y de salud mental durante el brote de COVID-19
|
2020
|
|
Consideraciones relativas a las medidas de salud pública y sociales en el lugar de trabajo en el contexto de la COVID-19:
Anexo a las Consideraciones relativas a los ajustes de las medidas de salud pública y sociales en el contexto de la COVID-19
|
2020
|
|
Consideraciones relativas al consentimiento en la vacunación de niños y adolescentes entre 6 y 17 años
|
2014
|
|
Considerações psicossociais e de saúde mental durante o surto de COVID-19
|
2020
|
|
Considérations éthiques liées à l’utilisation d’interventions non homologuées contre la maladie à virus Ebola:
Rapport à l’OMS d’un groupe consultatif
|
2014
|
|
Considerations for community hand hygiene practices in low- resource situations
|
2022
|
|
Considerations for COVID-19 surveillance for vulnerable populations:
Interim guidance
|
2021
|
|
CONSIDERATIONS FOR HEALTH GOVERNANCE::
STRENGTHENING INSTITUTIONAL CAPACITY AND CONNECTEDNESS THROUGH COVID-19 RESPONSES
|
2021
|
|
Considerations for implementing and adjusting public health and social measures in the context of COVID-19:
Interim guidance
|
2020
|
|
Considerations for implementing and adjusting public health and social measures in the context of COVID-19:
Interim guidance
|
2021
|
|
Considerations for implementing mass treatment, active case-finding and population-based surveys for neglected tropical diseases in the context of the COVID-19 pandemic:
Interim guidance
|
2020
|
|
CONSIDERATIONS FOR INTRODUCING NEW ANTIRETROVIRAL DRUG FORMULATIONS FOR CHILDREN
|
2020
|
|
Considerations for mass gathering events and Middle East respiratory syndrome coronavirus (MERS-CoV):
Interim guidance
|
2018
|
|
Considerations for Mass Gatherings in the context of COVID-19:
Annex: Considerations in adjusting public health and social measures in the context of COVID-19
|
2020
|
|
Considerations for public health and social measures in the workplace in the context of COVID-19:
Annex to Considerations in adjusting public health and social measures in the context of COVID-19
|
2020
|
|
Considerations for quarantine of contacts of COVID-19 cases
|
2021
|
|
Considerations for quarantine of contacts of COVID-19 cases:
Interim guidance
|
2020
|
|
Considerations for sports federations/sports event organizers when planning mass gatherings in the context of COVID-19:
Interim guidance
|
2020
|
|
Considerations for strengthening legal frameworks for digital contact tracing and quarantine tools for COVID-19:
Interim guidance
|
2021
|
|
Considerations for the provision of essential oral health services in the context of COVID-19:
Interim guidance
|
2020
|
|
Considerations in the investigation of cases and clusters of COVID-19:
Interim guidance
|
2020
|
|
Considerations regarding consent in vaccinating children and adolescents between 6 and 17 years old
|
2014
|
|
Considérations relatives à la communication des risques et à l'engagement communautaire (CREC) ::
Réponse d'Ebola en République démocratique du Congo
|
2018
|
|
Considérations relatives au consentement à la vaccination des enfants et adolescents âgés de 6 à 17 ans
|
2014
|
|
Considérations relatives au placement en quarantaine des personnes ayant été en contact avec des cas de COVID-19:
Orientations provisoires
|
2020
|
|
Consolidated guideline on sexual and reproductive health and rights of women living with HIV
|
2017
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES:
5Cs: CONSENT, CONFIDENTIALITY, COUNSELLING, CORRECT RESULTS AND CONNECTION
|
2015
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES 2019:
Web Annex A. GRADE Table: which demand creation approaches are effective for increasing uptake of HIV testing and onward linkage to prevention, treatment and care?
|
2020
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES 2019:
Web Annex J. Ensuring the quality of HIV testing services
|
2020
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES 2019:
Web Annex D. GRADE table: should western blotting and line immunoassays be used in national testing strategies and algorithms?
|
2020
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES 2019:
Web Annex C. GRADE table: should social network-based approaches be offered as an additional HIV testing approach for key populations and their contacts?
|
2020
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES 2019:
Web Annex K. Global examples of HIV testing services
|
2020
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES 2019:
Web Annex L: Symptom and risk-based screening to optimize HIV testing services: a scoping review
|
2020
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES 2019:
Web Annex I. In vitro diagnostics for HIV diagnosis
|
2020
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES 2019:
Web Annex H. Considerations for monitoring HIV testing services programmes
|
2020
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES 2019:
Web Annex B. GRADE table: should HIV self-testing be offered as an additional HIV testing approach?
|
2020
|
|
CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES FOR A CHANGING EPIDEMIC
|
2019
|
|
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations:
Web Annex A. Summaries of declarations of interest
|
2022
|
|
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations:
Web Annex C. Systematic review findings and GRADE tables
|
2022
|
|
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations:
Web Annex D. Evidence to decision making tables
|
2022
|
|
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations:
Policy brief
|
2022
|
|
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations:
Web Annex B. Values and preferences report
|
2022
|
|
CONSOLIDATED GUIDELINES ON PERSON-CENTRED HIV STRATEGIC INFORMATION STRENGTHENING ROUTINE DATA FOR IMPACT:
WEB ANNEX G SAMPLING, ABSTRACTION AND REPORTING GUIDANCE FOR EARLY WARNING INDICATORS OF HIV DRUG RESISTANCE
|
2022
|
|
CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION:
WHAT’S NEW
|
2015
|
|
CONSOLIDATED HIV STRATEGIC INFORMATION GUIDELINES:
DRIVING IMPACT THROUGH PROGRAMME MONITORING AND MANAGEMENT
|
2020
|
|
CONSOLIDATED HIV STRATEGIC INFORMATION GUIDELINES DRIVING IMPACT THROUGH PROGRAMME MONITORING AND MANAGEMENT:
WEB ANNEX C ADDITIONAL INDICATORS
|
2020
|
|
CONSOLIDATED HIV STRATEGIC INFORMATION GUIDELINES DRIVING IMPACT THROUGH PROGRAMME MONITORING AND MANAGEMENT:
WEB ANNEX B INDICATOR ALIGNMENT ACROSS GLOBAL MONITORING AND EVALUATION FRAMEWORKS
|
2020
|
|
CONSOLIDATED HIV STRATEGIC INFORMATION GUIDELINES DRIVING IMPACT THROUGH PROGRAMME MONITORING AND MANAGEMENT:
EXECUTIVE SUMMARY
|
2020
|
|
CONSOLIDATED HIV STRATEGIC INFORMATION GUIDELINES DRIVING IMPACT THROUGH PROGRAMME MONITORING AND MANAGEMENT:
WEB ANNEX A MAPPING OF 2020 INDICATORS TO 2015 GUIDELINE INDICATORS
|
2020
|
|
Consolidated report by the Director-General
|
2021
|
|
CONSOLIDATED STRATEGIC INFORMATION GUIDELINES FOR HIV IN THE HEALTH SECTOR
|
2015
|
|
Constraints to Scaling Up the Health Millennium Development Goals::
Costing and Financial Gap Analysis
|
2010
|
|
Consultation in south-eastern Europe on WHO guidelines for the health sector response to child maltreatment:
Budva, Montenegro 29–30 January 2019
|
2019
|
|
CONSULTATION ON THE DEVELOPMENT OF THE GLOBAL DEMENTIA OBSERVATORY:
World Health Organization, Geneva 5-6th July, 2016
|
2017
|
|
Contact tracing and quarantine in the context of COVID-19:
Interim guidance
|
2022
|
|
Contact tracing and quarantine in the context of the Omicron SARS-CoV-2 variant:
Interim guidance
|
2022
|
|
Contact tracing in the context of COVID-19:
Interim guidance
|
2020
|
|
Containment Certification Scheme to support the WHO Global Action Plan for Poliovirus Containment:
GAPIII−CCS
|
2017
|
|
CONTAMINACIÓN ATMOSFÉRICA Y SALUD INFANTIL:
Prescribir aire limpio RESUMEN
|
2018
|
|
Continuer à agir pour réduire l’impact mondial des maladies tropicales négligées:
Deuxième rapport de l’OMS sur les maladies tropicales négligées
|
2013
|
|
Continuing essential Sexual Reproductive, Maternal, Neonatal, Child and Adolescent Health services during COVID-19 pandemic
|
2020
|
|
Continuity of essential health services: Facility assessment tool:
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic
|
2020
|
|
Continuum of care for noncommunicable disease management during the migration cycle
|
2022
|
|
Contraceptifs appropriés pour les femmes à risque élevé d’infection par le VIH
|
2019
|
|
Contraception
|
2019
|
|
Contraception
|
2004
|
|
CONTRACEPTIVE DELIVERY TOOL FOR HUMANITARIAN SETTINGS
|
2018
|
|
Contraceptive eligibility for women at high risk of HIV:
Guidance statement Recommendations on contraceptive methods used by women at high risk of HIV
|
2019
|
|
CONTRIBUICÃO DO GOVERNO ANGOLANO AO FUNDO FIDUCIÁRIO DA APOC
|
2014
|
|
CONTRIBUTION DU GOUVERNEMENT ANGOLAIS AU FOND FIDUCIAIRE D’APOC
|
2014
|
|
Contributions of public and private sectors to the Iranian cataract surgery output
|
2015
|
|
Control and prevention of Chagas disease in Europe:
Report of a WHO Informal Consultation (jointly organized by WHO headquarters and the WHO Regional Office for Europe)
|
2010
|
|
Control and surveillance of human African trypanosomiasis:
Report of a WHO Expert Committee
|
2013
|
|
CONTROL DE LA CALIDAD DE LA SOLUCIÓN MADRE DE COLORANTE DE GIEMSA Y DE LA SOLUCIÓN AMORTIGUADORA:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-03C
|
2016
|
|
Control of epidemic meningococcal disease.:
WHO practical guidelines. 2nd edition
|
1998
|
|
CONTRÔLE DE LA QUALITÉ DE LA SOLUTION MÈRE DE GIEMSA ET DE L’EAU TAMPONNÉE:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-03C
|
2016
|
|
Controlling the spread of COVID-19 at ground crossings:
Interim guidance
|
2020
|
|
Convenio de Minamata sobre el Mercurio:
Bibliografía anotada con información de la OMS
|
2021
|
|
Convention de Minamata sur le mercure:
Bibliographie annotée des ressources d’information de l’OMS
|
2021
|
|
Cooperación con la Organización Mundial del Comercio en cuestiones de control del tabaco relacionadas con el comercio:
Informe de la Secretaría de la OMS
|
2012
|
|
Cooperación Sur-Sur y triangular para la aplicación del Convenio Marco de la OMS para el Control del Tabaco:
Informe de la Secretaría del Convenio
|
2012
|
|
Coopération avec l’Organisation mondiale du Commerce sur les questions de lutte antitabac touchant au commerce:
Rapport du Secrétariat de l’OMS
|
2012
|
|
Coopération Sud-Sud et coopération triangulaire pour la mise en œuvre de la Convention-cadre de l’OMS:
Rapport du Secrétariat de la Convention
|
2012
|
|
Cooperation with the World Trade Organization on trade-related tobacco-control issues:
Report by the WHO Secretariat
|
2012
|
|
COP24 SPECIAL REPORT:
HEALTH & CLIMATE CHANGE
|
2018
|
|
COP26 SPECIAL REPORT ON CLIMATE CHANGE AND HEALTH THE HEALTH ARGUMENT FOR CLIMATE ACTION:
In memory of Ella Kissi-Debrah — and all other children who have suffered and died from air pollution and climate change.
|
2021
|
|
CORE COMPETENCIES FOR INFECTION PREVENTION AND CONTROL PROFESSIONALS
|
2020
|
|
CORE COMPETENCIES IN ADOLESCENT HEALTH AND DEVELOPMENT FOR PRIMARY CARE PROVIDERS:
INCLUDING A TOOL TO ASSESS THE ADOLESCENT HEALTH AND DEVELOPMENT COMPONENT IN PRE-SERVICE EDUCATION OF HEALTH-CARE PROVIDERS
|
2015
|
|
Core questions on household energy use
|
2022
|
|
Core voluntary contributions account:
2022 annual report
|
2023
|
|
Coronavirus disease 2019 (COVID-19) Situation Report – 55
|
2020
|
|
Coronavirus disease (COVID-19) outbreak: rights, roles and responsibilities of health workers, including key considerations for occupational safety and health:
Interim guidance
|
2020
|
|
Corticosteroids for COVID-19:
LIVING GUIDANCE
|
2020
|
|
Cost-plus pricing for setting the price of pharmaceutical products:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
Cote d’Ivoire Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Cotonou Declaration on Buruli Ulcer
|
2009
|
|
COUNTDOWN TO 2023::
WHO REPORT ON GLOBAL TRANS FAT ELIMINATION 2019
|
2019
|
|
COUNTDOWN TO 2023:
WHO REPORT ON GLOBAL TRANS FAT ELIMINATION 2020
|
2020
|
|
COUNTDOWN TO 2023:
WHO REPORT ON GLOBAL TRANS FAT ELIMINATION 2021
|
2021
|
|
Countries of the Greater Mekong are stepping up to end malaria
|
2018
|
|
Countries of the Greater Mekong making inroads in the race towards elimination:
BULLETIN #6
|
2017
|
|
Countries of the Greater Mekong ready for the “last mile” of malaria elimination
|
2020
|
|
Countries of the Greater Mekong zero in on falciparum malaria
|
2019
|
|
Countries¹ with risk of yellow fever transmission² and countries requiring yellow fever vaccination
|
2019
|
|
Country Cooperation Strategy at a glance:
Tonga
|
2018
|
|
COUNTRY COOPERATION STRATEGY GUIDE 2020:
Implementing the Thirteenth General Programme of Work for driving impact in every country
|
2020
|
|
COUNTRY IMPLEMENTATION OF THE INTERNATIONAL CODE OF MARKETING OF BREAST-MILK SUBSTITUTES::
STATUS REPORT 2011
|
2013
|
|
Country Support Package for Equity, Gender and Human Rights:
in Leaving No One Behind in the path to Universal Health Coverage
|
2017
|
|
COVID-19::
Occupational health and safety for health workers
|
2021
|
|
COVID-19 and mandatory vaccination::
Ethical considerations
|
2022
|
|
COVID-19 and mandatory vaccination::
Ethical considerations and caveats
|
2021
|
|
COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers:
Scientific brief
|
2020
|
|
COVID-19 and violence against women:
What the health sector/system can do
|
2020
|
|
COVID-19 case management capacities: diagnostics, therapeutics, vaccine readiness, and other health products - facility assessment tool:
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic
|
2021
|
|
COVID-19 Clinical management::
Living guidance, 25 January 2021
|
2021
|
|
COVID-19 disease in children and adolescents:
Scientific brief
|
2021
|
|
COVID-19 e a violência contra a mulher:
O que o setor/sistema de saúde pode fazer
|
2020
|
|
COVID-19 Essential Supplies Forecasting Tool:
Frequently Asked Questions (FAQ)
|
2020
|
|
COVID-19 Essential Supplies Forecasting Tool:
Overview of the structure, methodology, and assumptions used
|
2020
|
|
COVID-19 et violence à l’égard des femmes:
Ce que le secteur et le système de santé peuvent faire
|
2020
|
|
COVID-19 Global Risk Communication and Community Engagement Strategy December 2020 — May 2021:
Interim Guidance
|
2020
|
|
COVID-19 Health System Response Monitor:
New Zealand
|
2021
|
|
COVID-19 Health System Response Monitor:
Singapore
|
2021
|
|
COVID-19 Health System Response Monitor:
Sri Lanka
|
2022
|
|
COVID-19 Health System Response Monitor:
Singapore
|
2021
|
|
COVID-19 Health System Response Monitor:
Republic of Indonesia
|
2021
|
|
COVID-19 Health System Response Monitor:
REPUBLIC OF KOREA
|
2020
|
|
COVID-19 Health System Response Monitor:
Republic of Indonesia
|
2021
|
|
COVID-19 Health System Response Monitor:
Sri Lanka
|
2022
|
|
COVID-19 Health System Response Monitor:
Sri Lanka
|
2022
|
|
COVID-19 Health System Response Monitor:
JAPAN
|
2021
|
|
COVID-19 Health System Response Monitor:
THAILAND
|
2020
|
|
COVID-19 Information - SMS Message Library
|
2020
|
|
COVID-19 management in hotels and other entities of the accommodation sector:
Interim guidance
|
2020
|
|
COVID-19 natural immunity:
Scientific brief
|
2021
|
|
COVID-19 Prise en charge clinique:
Orientations évolutives
|
2021
|
|
COVID-19 response:
Main report of the Independent Panel for Pandemic Preparedness and Response
|
2021
|
|
COVID-19 STRATEGIC PREPAREDNESS AND RESPONSE PLAN:
MONITORING AND EVALUATION FRAMEWORK
|
2021
|
|
COVID-19 STRATEGIC PREPAREDNESS AND RESPONSE PLAN
|
2021
|
|
COVID‑19 Strategic Preparedness and Response Plan:
OPERATIONAL PLANNING GUIDELINES TO SUPPORT COUNTRY PREPAREDNESS AND RESPONSE
|
2020
|
|
COVID-19 STRATEGIC PREPAREDNESS AND RESPONSE PLAN OPERATIONAL PLANNING GUIDELINE
|
2021
|
|
COVID‑19 Strategic Preparedness and Response (SPRP):
Monitoring and Evaluation Framework
|
2020
|
|
COVID-19 Stratégie de communication sur les risques mondiaux et d’engagement communautaire Décembre 2020 — mai 2021:
Orientations provisoires, 23 décembre 2020
|
2021
|
|
COVID‑19 STRATEGY UPDATE
|
2020
|
|
COVID-19 Supply Chain System Purchasing Consortia Status as of 28 April 2020
|
2020
|
|
COVID-19 Supply Portal Frequently Asked Questions
|
2020
|
|
COVID-19 Supply Portal Supply Coordinators
|
2020
|
|
COVID-19 v4
|
2020
|
|
COVID-19 Vaccine ChAdOx1-S [recombinant]
|
2021
|
|
COVID-19 VACCINES: SAFETY SURVEILLANCE MANUAL:
MODULE: SAFETY SURVEILLANCE OF COVID-19 VACCINES IN PREGNANT AND BREASTFEEDING WOMEN
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2022
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 Weekly Epidemiological Update
|
2021
|
|
COVID-19 y violencia contra la mujer:
Lo que el sector y el sistema de salud pueden hacer
|
2020
|
|
Creating an Environment for Emotional and Social Well-Being:
An important responsibility of a Health-Promoting and Child Friendly School
|
2012
|
|
Créer des lieux de travail sains qui favorisent l'équité pour les femmes et pour les hommes:
Ouvrage de référence à l'úsage des employeurs et des représentants des travailleurs
|
2012
|
|
Crimean-Congo haemorrhagic fever
|
2014
|
|
Crimean–Congo haemorrhagic fever outbreak investigation in the Western Region of Afghanistan in 2008
|
2012
|
|
Critères de choix recommandés pour l’achat de tests de diagnostic rapide du paludisme
|
2018
|
|
CRITÈRES DE QUALITÉ APPLICABLES AUX PLANS NATIONAUX D’ADAPTATION DU SECTEUR DE LA SANTÉ
|
2021
|
|
Critères de recevabilité médicale pour l’adoption et l’utilisation continue de méthodes contraceptives
|
2016
|
|
Critères de recevabilité pour l’adoption et l’utilisation continue de méthodes contraceptives:
Cinquième édition 2015
|
2016
|
|
Criteria for releasing COVID-19 patients from isolation:
Scientific brief
|
2020
|
|
CRITERIA FOR VALIDATION OF ELIMINATION OF VIRAL HEPATITIS B AND C::
REPORT OF SEVEN COUNTRY PILOTS
|
2022
|
|
CRITERIOS DE CALIDAD PARA LOS PLANES NACIONALES DE ADAPTACIÓN DE LA SALUD
|
2021
|
|
Criterios de selección recomendados para la compra de pruebas diagnósticas rápidas del paludismo
|
2018
|
|
Criterios médicos de elegibilidad para el uso de anticonceptivos:
Cuarta edición, 2009
|
2012
|
|
Criterios médicos de elegibilidad para el uso de anticonceptivos Quinta edición 2015
|
2014
|
|
Critical Path Analysis:
From Detection to Protection
|
2015
|
|
Critical preparedness, readiness and response actions for COVID-19:
Interim guidance
|
2020
|
|
Critical preparedness, readiness and response actions for COVID-19:
Interim guidance
|
2021
|
|
Critically Important Antibacterial Agents for Human Medicine for Risk Management Strategies of Non-Human Use:
Report of a WHO working group consultation 15 - 18 February 2005 Canberra, Australia
|
2005
|
|
Critically Important Antimicrobials for Human Medicine:
4th Revision 2013
|
2016
|
|
Critically Important Antimicrobials for Human Medicine:
3rd Revision 2011
|
2012
|
|
Critically Important Antimicrobials for Human Medicine:
6th Revision 2018
|
2019
|
|
Critically Important Antimicrobials for Human Medicine::
Categorization for the Development of Risk Management Strategies to contain Antimicrobial Resistance due to Non-Human Antimicrobial Use Report of the Second WHO Expert Meeting Copenhagen, 29–31 May 2007
|
2007
|
|
Critically Important Antimicrobials for Human Medicine:
6th Revision 2018 Ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use
|
2019
|
|
Critically Important Antimicrobials for Human Medicine:
4th Revision 2013
|
2016
|
|
Critically Important Antimicrobials for Human Medicine:
2nd Revision
|
2011
|
|
Critically Important Antimicrobials for Human Medicine:
5th Revision 2016
|
2017
|
|
Cross-border response to Ebola at points of entry: difficult but possible with rapid response:
Case Study
|
2021
|
|
CROSSING THE BILLION
|
2017
|
|
CUADERNO DE TRABAJO COMPLEMENTARIO:
EJERCICIOS PARA GUIAR EL PROCESO DE MONITOREO DE LAS DESIGUALDADES EN LA SALUD SEXUAL, REPRODUCTIVA, MATERNA, NEONATAL, INFANTIL Y ADOLESCENTE
|
2022
|
|
Cuarto informe de la Comisión A
|
2016
|
|
Cuestiones relativas al comercio y las inversiones relacionadas con la aplicación del CMCT de la OMS:
Informe de la Secretaría del Convenio
|
2014
|
|
CUIDADO DEL OÍDO Y LA AUDICIÓN:
PLANIFICACIÓN Y GESTIÓN DE ESTRATEGIAS NACIONALES UN MANUAL
|
2015
|
|
CUIDADO DEL OÍDO Y LA AUDICIÓN INTEGRADO Y CENTRADO EN LA PERSONA:
RESUMEN DE POLÍTICAS
|
2021
|
|
Culture and Mental Health in Liberia::
A Primer
|
2017
|
|
Cum să faci ceea ce contează în perioade stresante::
Un ghid ilustrat
|
2020
|
|
Current capabilities for human genome editing::
report for the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing
|
2021
|
|
Cutaneous leishmaniasis: control in selected countries of the WHO Eastern Mediterranean and African Regions:
Report of an interregional network meeting Casablanca, Morocco 23–24 June 2014
|
2015
|
|
Cutting-edge global research on family planning and improving adolescent sexual and reproductive health
|
2012
|
|
Cyanobacterial toxins: anatoxin-a and analogues:
Background document for development of WHO Guidelines for drinking-water quality and Guidelines for safe recreational water environments
|
2020
|
|
Cyanobacterial toxins: cylindrospermopsins:
Background document for development of WHO Guidelines for drinking-water quality and Guidelines for safe recreational water environments
|
2020
|
|
Cyanobacterial toxins: microcystins:
Background document for development of WHO Guidelines for drinking-water quality and Guidelines for safe recreational water environments
|
2020
|
|
Cyanobacterial toxins: saxitoxins:
Background document for development of WHO Guidelines for Drinking-water Quality and Guidelines for Safe Recreational Water Environments
|
2020
|
|
Cyclist safety:
An information resource for decision-makers and practitioners
|
2020
|
|
Data requirements and protocol for determining non-inferiority of insecticide-treated net and indoor residual spraying products within an established WHO intervention class
|
2019
|
|
DECADE OF HEALTHY AGEING:
BASELINE REPORT
|
2020
|
|
DECISION
|
2012
|
|
DECISIÓN
|
2014
|
|
DECISION
|
2012
|
|
DÉCISION
|
2014
|
|
DECISION
|
2014
|
|
DECISION
|
2014
|
|
DECISION
|
2012
|
|
DECISIÓN
|
2014
|
|
DECISION
|
2012
|
|
DÉCISION
|
2014
|
|
DECISIÓN
|
2014
|
|
DECISION
|
2014
|
|
DÉCISION
|
2014
|
|
Decisiones y lista de resoluciones
|
2016
|
|
Décisions et liste des résolutions
|
2016
|
|
Déclaration relative aux mesures à prendre pour renforcer la participation des communautés, des organisations non gouvernementales et autres organisations de la société civile à la mise en oeuvre de la Stratégie Mettre fin à la tuberculose:
Conclusions d’une réunion de consultation de l’OMS, 11-13 novembre 2015, Addis-Abeba, Éthiopie
|
2015
|
|
Decontamination and Reprocessing of Medical Devices for Health-care Facilities
|
2016
|
|
DEFEATING MENINGITIS BY 2030:
A GLOBAL ROAD MAP
|
2021
|
|
DÉFICIENCE AUDITIVE CHEZ L’ENFANT:
MARCHE À SUIVRE POUR AGIR DÈS MAINTENANT!
|
2016
|
|
DEFINING CRITERIA TO DECLARE ELIMINATION OF LEPROSY:
Report of an informal consultation Mexico City, Mexico, 10-12 February 2020
|
2020
|
|
Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2:
Scientific brief
|
2021
|
|
DELIVERED BY WOMEN, LED BY MEN::
A GENDER AND EQUITY ANALYSIS OF THE GLOBAL HEALTH AND SOCIAL WORKFORCE
|
2019
|
|
DELIVERING QUALITY-ASSURED MEDICAL PRODUCTS FOR ALL 2019-2023:
WHO’s five-year plan to help build effective and efficient regulatory systems
|
2019
|
|
Delivery of immunization services for refugees and migrants:
Technical guidance
|
2019
|
|
Démence:
Projet de décision proposé par les délégations de l’Allemagne, de l’Autriche, du Canada, du Danemark, des États-Unis d’Amérique, de l’Éthiopie, de la Finlande, du Japon, du Luxembourg, de Malte, de Monaco, du Panama, des Pays-Bas, de la République de Corée, de la République dominicaine, du Royaume-Uni de Grande-Bretagne et d’Irlande du Nord, de la Suisse, de l’Uruguay et de la Zambie
|
2016
|
|
Demencia:
Proyecto de decisión presentado por las delegaciones siguientes: Alemania, Austria, Canadá, Dinamarca, Estados Unidos de América, Etiopía, Finlandia, Japón, Luxemburgo, Malta, Mónaco, Países Bajos, Panamá, Reino Unido de Gran Bretaña e Irlanda del Norte, República de Corea, República Dominicana, Suiza, Uruguay y Zambia
|
2016
|
|
Demencia:
Informe de la Secretaría
|
2016
|
|
Dementia:
Report by the Secretariat
|
2016
|
|
DEMENTIA:
A Public Health Priority
|
2023
|
|
DEMENTIA:
A PUBLIC HEALTH PRIORITY
|
2012
|
|
Dementia:
Draft decision proposed by the delegations of Austria, Canada, Denmark, Dominican Republic, Ethiopia, Finland, Germany, Japan, Republic of Korea, Luxembourg, Malta, Monaco, Netherlands, Panama, Switzerland, United Kingdom of Great Britain and Northern Ireland, United States of America, Uruguay and Zambia
|
2016
|
|
Democratic Republic of the Congo Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
DEMOCRATIC REPUBLIC OF THE CONGO – Integrating tuberculosis screening into community-based HIV activities
|
2020
|
|
DENGUE:
GUIDELINES FOR DIAGNOSIS, TREATMENT, PREVENTION AND CONTROL
|
2009
|
|
DENGUE:
GUIAS PARA EL DIAGNÓSTICO, TRATAMIENTO, PREVENCIÓN Y CONTROL
|
2009
|
|
DÉPARASITAGE CHEZ LES ADOLESCENTES ET LES FEMMES EN ÂGE DE PROCRÉER:
NOTE D’ORIENTATION
|
2021
|
|
Depression and Other Common Mental Disorders:
Global Health Estimates
|
2017
|
|
Des premiers pas à la grande échelle::
le Programme Geração Biz du
|
2008
|
|
DES SOINS DE L’OREILLE ET DE L’AUDITION INTÉGRÉS ET AXÉS SUR LA PERSONNE (IPC-EHC):
DOCUMENT DE POLITIQUE GÉNÉRALE
|
2021
|
|
Des systèmes alimentaires au service de la santé:
Résumé analytique
|
2021
|
|
Desarrollo de estrategias de salud pública para la extracción de oro artesanal y en pequeña escala en el marco del Convenio de Minamata sobre el Mercurio::
hallazgos y lecciones aprendidas de los talleres por países
|
2021
|
|
Desarrollo de estrategias nacionales para la eliminación progresiva de los termómetros y de los esfigmomanómetros QUE CONTIENEN MERCURIO de la asistencia sanitaria, incluso en el contexto del Convenio de Minamata sobre el Mercurio:
CONSIDERACIONES CLAVE Y GUÍA PASO A PASO
|
2017
|
|
DESIGNING TAXATION AND PRICING POLICIES
|
2018
|
|
Detección de antígenos para el diagnóstico de la infección por el SARS-CoV-2 mediante inmunoanálisis rápidos:
Orientaciones provisionales
|
2020
|
|
DEVELOPING AN APPROACH FOR USING HEALTH TECHNOLOGY ASSESSMENTS IN REIMBURSEMENT SYSTEMS FOR MEDICAL PRODUCTS
|
2015
|
|
DEVELOPING AN ETHICAL FRAMEWORK FOR HEALTHY AGEING:
Report of a WHO meeting Tübingen, Germany, 18 March 2017
|
2017
|
|
DEVELOPING AND VALIDATING AN IRON AND FOLIC ACID SUPPLEMENTATION INDICATOR FOR TRACKING PROGRESS TOWARDS GLOBAL NUTRITION MONITORING FRAMEWORK TARGETS:
FINAL REPORT
|
2018
|
|
Developing national strategies for phasing out mercury-containing thermometers and sphygmomanometers in health care, including in the context of the Minamata Convention on Mercury
|
2015
|
|
Developing public health strategies for artisanal and small-scale gold mining within the Minamata Convention on Mercury::
findings and lessons learned from country workshops
|
2021
|
|
DEVELOPMENT OF A SYSTEMATIC EVIDENCE REVIEW FOR THE WHO GUIDELINE ON PROTECTING WORKERS FROM POTENTIAL RISKS OF MANUFACTURED NANOMATERIALS:
What training should be provided to workers who are at risk from exposure to the specific nanomaterials or groups of nanomaterials?
|
2017
|
|
Développer les compétences du personnel de santé dans le domaine de la santé de l’adolescent
|
2015
|
|
DEWORMING FOR ADOLESCENT GIRLS AND WOMEN OF REPRODUCTIVE AGE:
POLICY BRIEF
|
2021
|
|
DEZ ESTRATÉGIAS PARA A SEGURANÇA DE CRIANÇAS NO TRÂNSITO
|
2015
|
|
Día Mundial de la Inocuidad de los Alimentos 2021:
Panorama general de la conmemoración y las actividades creativas conexas
|
2021
|
|
THE DIAGNOSIS, PREVENTION AND MANAGEMENT OF CRYPTOCOCCAL DISEASE IN HIV-INFECTED ADULTS, ADOLESCENTS AND CHILDREN:
SUPPLEMENT TO THE 2016 CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION
|
2018
|
|
THE DIAGNOSIS, PREVENTION AND MANAGEMENT OF CRYPTOCOCCAL DISEASE IN HIV-INFECTED ADULTS, ADOLESCENTS AND CHILDREN:
SUPPLEMENT TO THE 2016 CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION
|
2018
|
|
Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy
|
2013
|
|
Diagnostic en laboratoire de la maladie à virus Ebola
|
2014
|
|
Diagnostic stewardship:
A guide to implementation in antimicrobial resistance surveillance sites
|
2016
|
|
Diagnostic test for lymphatic filariasis to support decisions for stopping triple-therapy Mass Drug Administration:
TARGET PRODUCT PROFILE
|
2021
|
|
Diagnostic test for surveillance of lymphatic filariasis:
TARGET PRODUCT PROFILE
|
2021
|
|
Diagnostic testing for SARS-CoV-2:
Interim guidance
|
2020
|
|
The diagnostics landscape for sexually transmitted infections
|
2023
|
|
Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19:
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic
|
2020
|
|
DID YOU KNOW THAT SUPERBUGS CAN BE FOUND IN FOOD?
|
2017
|
|
Die Rolle des Gesundheitswesens in dem Strategischen Konzept für ein internationales Chemikalienmanagement auf dem Weg zu dem Ziel für 2020 und danach::
Konsultation mit den Mitgliedstaaten
|
2016
|
|
Dietary and inhalation exposure to nano- and microplastic particles and potential implications for human health
|
2022
|
|
DIEZ ESTRATEGIAS PARA PRESERVAR LA SEGURIDAD DE LOS NIÑOS EN LAS CARRETERAS
|
2015
|
|
Digital Adaptation Kit for Antenatal Care:
Operational requirements for implementing WHO recommendations in digital systems
|
2021
|
|
Digital Adaptation Kit for Family Planning:
Operational requirements for implementing WHO recommendations in digital systems
|
2021
|
|
Digital education for building health workforce capacity
|
2020
|
|
Digital health and universal health coverage::
opportunities and policy considerations for Pacific Island health authorities
|
2022
|
|
Digital health for the End TB strategy: progress since 2015 and future perspectives:
Meeting Report 7-8 February 2017
|
2017
|
|
Digital implementation investment guide (DIIG)::
integrating digital interventions into health programmes
|
2020
|
|
Digital marketing of alcoholic beverages:
what has changed?
|
2022
|
|
DIGITAL TECHNOLOGY AND COVID-19 IN THE WESTERN PACIFIC REGION
|
2021
|
|
Digital tools for COVID-19 contact tracing:
Annex: Contact tracing in the context of COVID-19
|
2020
|
|
Direct household payments for health services in Asia and the Pacific:
IMPACTS AND POLICY OPTIONS
|
2012
|
|
Directive ::
Utilisation d’associations de micronutriments en poudre pour l’enrichissement à domicile de l’alimentation des femmes enceintes
|
2012
|
|
Directive ::
Utilisation d’associations de micronutriments en poudre pour l’enrichissement à domicile de l’alimentation des nourrissons et des enfants de 6 à 23 mois
|
2012
|
|
Directive ::
Supplémentation intermittente en fer et en acide folique chez les femmes menstruées
|
2012
|
|
Directive ::
Supplémentation intermittente en fer chez les enfants d’âge préscolaire et scolaire
|
2012
|
|
Directive : Apport en sucres chez l’adulte et l’enfant:
Résumé d’orientation
|
2015
|
|
Directives de l’OMS relatives à la protection de la santé contre les effets du changement climatique grâce à la planification de l’adaptation du secteur de la santé
|
2015
|
|
DIRECTIVES DE L’OMS SUR LA POLITIQUE DE SANTÉ ET L’ACCOMPAGNEMENT AU SEIN DU SYSTÈME EN VUE D’OPTIMISER LES PROGRAMMES RELATIFS AUX AGENTS DE SANTÉ COMMUNAUTAIRES:
Points saillants
|
2018
|
|
DIRECTIVES POUR LA PREVENTION DES DEFORMATIONS DUES A LA POLIOMYELITE
|
1992
|
|
Directives relatives à la conduite d’évaluations de l’efficacité vaccinale dans le contexte des nouveaux variants du SARS-CoV-2
|
2021
|
|
Directives relatives à la microplanification opérationnelle de la vaccination contre la COVID-19
|
2021
|
|
DIRECTRICES DE LA OMS SOBRE ACTIVIDAD FÍSICA Y HÁBITOS SEDENTARIOS:
DE UN VISTAZO
|
2020
|
|
Directrices de la OMS sobre desarrollo, atracción, contratación y fidelización del personal de salud en zonas rurales y remotas::
resumen
|
2021
|
|
DIRECTRICES DE LA OMS SOBRE EL USO DE ANTIMICROBIANOS DE IMPORTANCIA MÉDICA EN ANIMALES DESTINADOS A LA PRODUCCIÓN DE ALIMENTOS:
RESEÑA DE POLÍTICA
|
2017
|
|
DIRECTRICES DE LA OMS SOBRE EL USO DE ANTIMICROBIANOS DE IMPORTANCIA MÉDICA EN ANIMALES DESTINADOS A LA PRODUCCIÓN DE ALIMENTOS:
Sinopsis
|
2017
|
|
Directrices de la OMS sobre intervenciones de autocuidado para la salud y el bienestar, revisión 2022:
Resumen ejecutivo
|
2022
|
|
Directrices de la OMS sobre la calidad del aire de interiores::
quema de combustibles en los hogares
|
2014
|
|
DIRECTRICES DE LA OMS SOBRE POLÍTICA SANITARIA Y APOYO AL SISTEMA PARA OPTIMIZAR LOS PROGRAMAS DE AGENTES DE SALUD COMUNITARIOS:
ASPECTOS MÁS DESTACADOS
|
2018
|
|
Directrices de la OMS sobre salud mental en el trabajo:
Resumen ejecutivo
|
2022
|
|
DIRECTRICES DE LA OMS SOBRE VIVIENDA Y SALUD:
RESUMEN DE ORIENTACIÓN
|
2018
|
|
Directrices mundiales de la OMS sobre la calidad del aire:
Materia particulada (MP2,5 y MP10), ozono, dióxido de nitrógeno, dióxido de azufre y monóxido de carbono Resumen ejecutivo
|
2021
|
|
Directrices operativas sobre el intercambio de virus gripales potencialmente pandémicos para el hombre (IVPP*),:
de acuerdo con Marco de Preparación para una gripe pandémica (PIP)
|
2017
|
|
DIRECTRICES PARA EL CONTROL DE VECTORES DEL PALUDISMO
|
2019
|
|
Directrices para las consideraciones éticas en la planificación y evaluación de estudios de investigación sobre salud sexual y reproductiva en adolescentes
|
2019
|
|
Directrices sobre capacitación básica y seguridad en la acupuntura
|
2002
|
|
Directrices sobre el manejo del dolor crónico en niños:
Resumen ejecutivo
|
2021
|
|
Directrices sobre la atención para el aborto:
Resumen ejecutivo
|
2022
|
|
Directrices sobre las intervenciones de promoción y prevención en materia de salud mental destinadas a adolescentes: Estrategias para ayudar a los adolescentes a prosperar:
RESUMEN EJECUTIVO
|
2021
|
|
Directrices Unificadas sobre Intervenciones de Autoasistencia Sanitaria:
Salud Sexual y Reproductiva y Derechos Conexos
|
2019
|
|
DIRECTRICES UNIFICADAS SOBRE LOS SERVICIOS DE DETECCIÓN DEL VIH PARA UNA EPIDEMIA CAMBIANTE
|
2019
|
|
Directriz::
Uso de micronutrientes en polvo para la fortificación domiciliaria de los alimentos consumidos por mujeres embarazadas
|
2012
|
|
Directriz::
Administración intermitente de suplementos de hierro y ácido fólico en mujeres menstruantes
|
2012
|
|
Directriz ::
Administración intermitente de suplementos de hierro a niños de edad preescolar y escolar
|
2012
|
|
Directriz::
Administración intermitente de suplementos de hierro y ácido fólico a embarazadas no anémicas
|
2014
|
|
Directriz ::
Uso de micronutrientes en polvo para la fortificación domiciliaria de los alimentos consumidos por lactantes y niños de 6 a 23 meses de edad
|
2012
|
|
Directriz::
Administración diaria de suplementos de hierro y ácido fólico en el embarazo
|
2014
|
|
Directriz de la OMS para el tratamiento clínico de la exposición al plomo
|
2022
|
|
Directriz de la OMS para el tratamiento clínico de la exposición al plomo:
Resumen ejecutivo
|
2021
|
|
Directriz: Ingesta de azúcares para adultos y niños:
Resumen
|
2015
|
|
Diretriz ::
Suplementação intermitente de ferro em crianças de idade pré-escolar e escolar
|
2013
|
|
Diretriz sobre cuidados no aborto:
resumo
|
2022
|
|
Diretrizes para o desenvolvimento de programas de qualidade no atendimento ao trauma
|
2009
|
|
Disability considerations during the COVID-19 outbreak
|
2020
|
|
Discurso de la Sra. Thoraya Ahmed Obaid, Directora Ejecutiva del Fondo de Población de las Naciones Unidas, ante la 60a Asamblea Mundial de la Salud:
Ginbera, martes 15 de mayo de 2007
|
2007
|
|
Discussion paper::
Climate, Sanitation and Health
|
2019
|
|
Diseño y validación de una encuesta solo sobre triquiasis-tracomatosa:
Grupo Consultivo estratégico y técnico para enfermedades tropicales desatendidas Grupo de trabajo sobre Monitoreo y evaluación
|
2017
|
|
Dispositif de certification du confinement en appui au Plan d’action mondial de l’OMS pour le confinement des poliovirus:
GAPIII−DCC
|
2017
|
|
DISQUE POUR LE CHOIX DES MÉTHODES CONTRACEPTIVES SELON LES CRITÈRES DE RECEVABILITÉ MÉDICALE 2015
|
2016
|
|
DISTANCE LEARNING COURSE Introduction:
Self-study modules
|
2014
|
|
DIX STRATÉGIES POUR LA SÉCURITÉ DES ENFANTS SUR LA ROUTE
|
2015
|
|
Document d’orientation sur la traçabilité des produits médicaux
|
2021
|
|
Documento de orientación sobre la trazabilidad de los productos médicos
|
2021
|
|
Doing What Matters in Times of Stress::
An Illustrated Guide
|
2020
|
|
Domestic water quantity, service level and health
|
2020
|
|
Don’t pollute my future!:
THE IMPACT OF THE ENVIRONMENT ON CHILDREN’S HEALTH
|
2017
|
|
Do’s and don’ts in community-based psychosocial support for sexual violence survivors in conflict-affected settings
|
2012
|
|
The double burden of malnutrition:
Policy Brief
|
2017
|
|
THE DOUBLE BURDEN OF MALNUTRITION::
PRIORITY ACTIONS ON ENDING CHILDHOOD OBESITY
|
2020
|
|
Double-duty actions for nutrition:
Policy Brief
|
2017
|
|
Draft global action plan on the public health response to dementia:
Report by the Director-General
|
2017
|
|
Draft guidelines for implementation of Article 6 of the WHO Framework Convention on Tobacco Control:
Report of the open-ended intersessional drafting group
|
2014
|
|
Draft guidelines for the implementation of Article 6 of the WHO Framework Convention on Tobacco Control:
Report of the working group
|
2012
|
|
Draft protocol to eliminate illicit trade in tobacco products:
Note by the Convention Secretariat
|
2011
|
|
Draft protocol to eliminate illicit trade in tobacco products
|
2012
|
|
Draft protocol to eliminate illicit trade in tobacco products
|
2012
|
|
Driving commitment for nutrition within the UN Decade of Action on Nutrition
|
2018
|
|
Driving progress towards rabies elimination::
New WHO recommendations on human rabies immunization and results of Gavi’s Learning Agenda on rabies & 2nd international meeting of the Pan-African Rabies Control Network (PARACON)
|
2019
|
|
Driving progress towards rabies elimination: Results of Gavi’s Learning Agenda on rabies and new WHO position on rabies immunization:
Meeting Report 1-3 May 2018 Kathmandu, Nepal
|
2019
|
|
Drug use and road safety
|
2016
|
|
DRUG-RESISTANT TB SURVEILLANCE & RESPONSE:
SUPPLEMENT GLOBAL TUBERCULOSIS REPORT 2014
|
2014
|
|
DU MERCURE DANS LES PRODUITS ÉCLAIRCISSANTS POUR LA PEAU
|
2019
|
|
DUAL HIV/SYPHILIS RAPID DIAGNOSTIC TESTS CAN BE USED AS THE FIRST TEST IN ANTENATAL CARE
|
2019
|
|
Dual Practice by Health Workers in South and East Asia:
IMPACTS AND POLICY OPTIONS
|
2013
|
|
Dual use life science research (DUR/C): perspective from donors of life sciences research:
MEETING REPORT 1 December 2020
|
2021
|
|
D’une charge élevée à un fort impact:
Une riposte ciblée contre le paludisme
|
2019
|
|
Dynamics of decision-making and change in the practice of female genital mutilation in the Gambia and Senegal
|
2010
|
|
THE E-2020 INITIATIVE OF 21 MALARIA-ELIMINATING COUNTRIES:
2019 progress report
|
2019
|
|
EAR AND HEARING CARE:
SITUATION ANALYSIS TOOL
|
2015
|
|
EAR AND HEARING CARE:
INDICATORS FOR MONITORING PROVISION OF SERVICES
|
2019
|
|
EAR AND HEARING SURVEY HANDBOOK
|
2020
|
|
Ebola and Marburg virus disease epidemics::
preparedness, alert, control and evaluation
|
2014
|
|
EBOLA RESPONSE ROADMAP
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT UPDATE
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT UPDATE
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT UPDATE
|
2014
|
|
EBOLA RESPONSE ROADMAP SITUATION REPORT UPDATE
|
2014
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2016
|
|
EBOLA SITUATION REPORT
|
2016
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT:
INCORPORATING THE WHO ACTIVITY REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2015
|
|
EBOLA SITUATION REPORT
|
2015
|
|
Ebola surveillance in countries with no reported cases of Ebola virus disease
|
2014
|
|
EBOLA VIRUS DISEASE:
Democratic Republic of the Congo
|
2020
|
|
Ebola virus disease::
Key questions and answers concerning water, sanitation and hygiene
|
2014
|
|
Ebola virus disease::
Key questions and answers concerning health care waste
|
2014
|
|
EBOLA VIRUS DISEASE:
Democratic Republic of the Congo
|
2020
|
|
Ebola virus disease and household pets
|
2014
|
|
Ebola Virus Disease (EVD):
Key questions and answers concerning water, sanitation and hygiene
|
2021
|
|
Ebola Virus Disease (EVD):
Key questions and answers concerning health-care waste
|
2021
|
|
Ebola virus disease (EVD) Occupational Health and Safety
|
2014
|
|
Ebola virus disease preparedness strengthening team:
Gambia country visit 17–22 November 2014
|
2014
|
|
EBOLA VIRUS INACTIVATION DURING STAINING OF BLOOD FILMS WITH GIEMSA STAIN:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-07B
|
2016
|
|
Economic costs of air pollution in Accra, Ghana
|
2020
|
|
Economically sustainable alternatives to tobacco growing (in relation to Articles 17 and 18 of the WHO Framework Convention on Tobacco Control):
Report by the working group
|
2012
|
|
THE ECONOMICS OF SOCIAL DETERMINANTS OF HEALTH AND HEALTH INEQUALITIES::
a resource book
|
2013
|
|
Écouter sans risque::
norme mondiale OMS-UIT pour les appareils et systèmes audio
|
2019
|
|
Écouter sans risque
|
2015
|
|
ÉDITION DU GÉNOME HUMAIN ::
CADRE DE GOUVERNANCE
|
2022
|
|
EDUCATION SECTOR RESPONSES TO THE USE OF ALCOHOL, TOBACCO AND DRUGS
|
2017
|
|
Educational course:
Mercury and human health
|
2021
|
|
EDUCATIONAL MODULES ON CLINICAL USE OF BLOOD
|
2021
|
|
Effect and safety of salt iodization to prevent iodine deficiency disorders::
a systematic review with meta-analyses
|
2014
|
|
Effect of increased potassium intake on blood pressure and potential adverse effects in children
|
2012
|
|
Effect of increased potassium intake on blood pressure, renal function, blood lipids and other potential adverse effects
|
2012
|
|
Effect of increased potassium intake on cardiovascular disease, coronary heart disease and stroke
|
2012
|
|
Effect of reduced sodium intake on blood pressure, renal function, blood lipids and other potential adverse effects
|
2012
|
|
The effects of contraception on obstetric outcomes
|
2004
|
|
Effects of female genital mutilation on childbirth in Africa
|
2008
|
|
Effects of reduced sodium intake on cardiovascular disease, coronary heart disease and stroke
|
2012
|
|
Effects of saturated fatty acids on serum lipids and lipoproteins::
a systematic review and regression analysis
|
2016
|
|
Effects of transfatty acid intake on blood lipids and lipoproteins::
a systematic review and meta-regression analysis
|
2016
|
|
EFFICACY-TESTING OF TRAPS:
FOR CONTROL OF AEDES SPP. MOSQUITO VECTORS
|
2018
|
|
Egypt Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Eighth meeting of the WHO Vector Control Advisory Group
|
2018
|
|
El género y la COVID-19:
Documento de apoyo
|
2020
|
|
El paquete técnico SAFER UN MUNDO LIBRE DE LOS DAÑOS RELACIONADOS CON EL ALCOHOL:
Cinco áreas de intervención a nivel nacional y subnacional
|
2020
|
|
EL PODER DE LAS CIUDADES::
LUCHA CONTRA LAS ENFERMEDADES NO TRANSMISIBLES Y LOS TRAUMATISMOS CAUSADOS POR EL TRÁNSITO
|
2020
|
|
El proyecto ha terminado, pero todavía podemos aprender de él!:
Orientaciones prácticas para llevar a cabo evaluaciones posteriores a proyectos de salud sexual y reproductiva dirigidos a los adolescentes
|
2020
|
|
EL SALVADOR:
Territorial community teams
|
2018
|
|
EL SALVADOR:
The New Law on Medicines and its implementation
|
2015
|
|
EL TABACO ROMPE CORAZONES:
Elija salud, no tabaco
|
2018
|
|
Élaboration de stratégies de santé publique concernant l’extraction minière artisanale et à petite échelle d’or dans le cadre de la Convention de Minamata sur le mercure ::
résultats et enseignements tirés des ateliers nationaux
|
2021
|
|
Élaboration de stratégies nationales en vue de l'élimination progressive des thermomètres et sphygmomanomètres CONTENANT DU MERCURE dans les services de soins de santé, notamment dans le contexte de la Convention de Minamata sur le mercure:
ASPECTS ESSENTIELS ET ORIENTATIONS ÉTAPE PAR ÉTAPE
|
2017
|
|
ELECTRICAL/ ELECTRONIC WASTE AND CHILDREN’S HEALTH:
TRAINING FOR HEALTH CARE PROVIDERS SECOND EDITION
|
2023
|
|
ELECTRICAL/ELECTRONIC WASTE AND CHILDREN’S HEALTH:
TRAINING FOR HEALTH CARE PROVIDERS
|
2019
|
|
Electronic nicotine delivery systems, including electronic cigarettes:
Report by the Convention Secretariat
|
2012
|
|
Éléments à prendre en considération concernant les mesures de santé publique et les mesures sociales sur le lieu de travail dans le cadre de l’épidémie de COVID-19:
Annexe du document Éléments à prendre en considération lors de l’ajustement des mesures de santé publique et des mesures sociales dans le cadre de l’épidémie de COVID-19
|
2020
|
|
Eliminación de las enfermedades relacionadas con el asbesto
|
2014
|
|
Eliminating Female genital mutilation:
An interagency statement
|
2008
|
|
Eliminating forced, coercive and otherwise involuntary sterilization:
An interagency statement
|
2014
|
|
ELIMINATING MALARIA IN THE GREATER MEKONG SUBREGION:
UNITED TO END A DEADLY DISEASE
|
2016
|
|
Eliminating Virginity Testing::
An Interagency Statement
|
2018
|
|
Élimination des maladies liées à l’amiante
|
2014
|
|
Elimination of asbestos-related diseases
|
2014
|
|
Emergence and spread of artemisinin resistance calls for intensified efforts to withdraw oral artemisinin-based monotherapy from the market
|
2014
|
|
Emergency Global Supply Chain System (COVID-19)
|
2021
|
|
EMERGENCY GUIDANCE:
Selection and use of Ebola in vitro diagnostic (IVD) assays
|
2015
|
|
EMERGENCY RESPONSE TO ARTEMISININ RESISTANCE IN THE GREATER MEKONG SUBREGION:
REGIONAL Framework for action 2013-2015
|
2013
|
|
Emergency Use Designation of COVID-19 candidate vaccines::
Ethical considerations for current and future COVID-19 placebo-controlled vaccine trials and trial unblinding
|
2020
|
|
Emergency use of unproven clinical interventions outside clinical trials::
ethical considerations
|
2022
|
|
Emerging antimicrobial resistance reporting:
Guide for emerging AMR event sharing
|
2018
|
|
Emerging antimicrobial resistance reporting framework
|
2018
|
|
Emerging technologies and scientific innovations:
A global public health perspective — Preview of horizon scan results
|
2023
|
|
Emerging technologies and scientific innovations::
A global public health perspective
|
2023
|
|
EMISIONES DE SUSTANCIAS QUÍMICAS ASOCIADAS CON CICLONES
|
2018
|
|
EMISIONES DE SUSTANCIAS QUÍMICAS ASOCIADAS CON INUNDACIONES
|
2018
|
|
EMISIONES DE SUSTANCIAS QUÍMICAS ASOCIADAS CON TERREMOTOS
|
2018
|
|
EMISIONES DE SUSTANCIAS QUÍMICAS CAUSADAS POR PELIGROS Y DESASTRES NATURALES:
INFORMACIÓN PARA LAS AUTORIDADES DE SALUD PÚBLICA
|
2019
|
|
ENABLING QUICK ACTION TO SAVE LIVES:
The Contingency Fund for Emergencies replenishment strategy
|
2018
|
|
Enabling researchers to report concerns about human genome editing research::
report for the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing
|
2021
|
|
Encuestas de conocimientos, actitudes y prácticas Enfermedad por el virus de Zika y posibles complicaciones:
Carpeta de recursos
|
2016
|
|
ENDING CHILDHOOD DENTAL CARIES
|
2019
|
|
ENDING HOSPITAL DETENTION FOR NON-PAYMENT OF BILLS::
LEGAL AND HEALTH FINANCING POLICY OPTIONS
|
2020
|
|
Ending the neglect to attain the Sustainable Development Goals:
A sustainability framework for action against neglected tropical diseases 2021–2030
|
2021
|
|
Ending the neglect to attain the Sustainable Development Goals:
A framework for monitoring and evaluating progress of the road map for neglected tropical diseases 2021−2030
|
2021
|
|
Ending the neglect to attain the Sustainable Development Goals:
A road map for neglected tropical diseases 2021–2030
|
2020
|
|
Ending the neglect to attain the Sustainable Development Goals:
One Health: Approach for action against neglected tropical diseases 2021–2030
|
2022
|
|
Ending the neglect to attain the Sustainable Development Goals One Health: Approach for action against neglected tropical diseases 2021–2030:
Executive Summary
|
2022
|
|
End-to-end integration of SARS-CoV-2 and influenza sentinel surveillance:
REVISED INTERIM GUIDANCE
|
2022
|
|
Enfoques poblacionales de la:
PREVENCIÓN DE LA OBESIDAD INFANTIL
|
2016
|
|
Enfoques prospectivos en el ámbito de la salud pública mundial:
Guía práctica para el personal de la OMS
|
2023
|
|
ENFRENTANDO PROBLEMAS PLUS (EP+):
Ayuda psicológica individual para adultos con problemas de angustia en comunidades expuestas a la adversidad
|
2016
|
|
ENGAGEMENT DU PUBLIC ET FINANCEMENT PARTICIPATIF DANS LA RECHERCHE EN SANTÉ:
Guide pratique
|
2022
|
|
ENGAGE-TB:
Integrating community-based tuberculosis activities into the work of NGOs and other CSOs Training Manual Curriculum and Facilitators’ Guide
|
2014
|
|
ENGAGE-TB:
Integración de las actividades comunitarias de lucha contra la tuberculosis en el trabajo de las ONG y otras OSC Manual de capacitación Programa y guía del moderador
|
2014
|
|
ENGAGE-TB:
Integración de las actividades comunitarias de lucha contra la tuberculosis en el trabajo de las organizaciones no gubernamentales y otras organizaciones de la sociedad civil Manual de aplicación
|
2014
|
|
ENGAGE-TB:
Integración de las actividades comunitarias de lucha contra la tuberculosis en el trabajo de las organizaciones no gubernamentales y otras organizaciones de la sociedad civil Orientaciones operacionales
|
2012
|
|
ENGAGE-TB:
Intégrer les activités communautaires de lutte contre la tuberculose dans le travail des ONG et des autres organisations de la société civile Manuel de formation Programme et guide de l’animateur
|
2014
|
|
ENGAGE-TB:
Integrating community-based tuberculosis activities into the work of nongovernmental and other civil society organizations Operational guidance
|
2012
|
|
ENGAGE-TB:
Intégrer les activités communautaires de lutte contre la tuberculose dans le travail des ONG et des autres organisations de la société civile Directives opérationnelles
|
2012
|
|
ENGAGE-TB:
Integrating community-based tuberculosis activities into the work of nongovernmental and other civil society organizations Training of community health workers and community volunteers Facilitators’ guide
|
2015
|
|
ENGAGE-TB:
Intégrer les activités communautaires de lutte contre la tuberculose dans le travail des ONG et des autres organisations de la société civile Formation des agents de santé bénévoleset bénévoles communautaires Guide de l’animateur
|
2015
|
|
ENGAGE-TB:
Integrating community-based tuberculosis activities into the work of nongovernmental and other civil society organizations Implementation manual
|
2013
|
|
Engaging the private health service delivery sector through governance in mixed health systems:
strategy report of the WHO Advisory Group on the Governance of the Private Sector for Universal Health Coverage
|
2020
|
|
Enhanced Capacity Building Training for Frontline Staff on Building Trust and Communication:
Facilitator’s Guide
|
2015
|
|
Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)::
GENERAL PROTOCOL
|
2021
|
|
Enhancing mental health pre-service training with the mhGAP Intervention Guide::
experiences and lessons learned
|
2020
|
|
Enhancing response to Omicron SARS-CoV-2 variant::
Technical brief and priority actions for Member States
|
2022
|
|
ENHANCING THE ROLE OF COMMUNITY HEALTH NURSING FOR UNIVERSAL HEALTH COVERAGE
|
2017
|
|
ENQUETES EPIDEMIOLOGIQUES DE L’ONCHOCERCOSE, DE LA LOASE ET DE LA FILARIOSE LYMPHATIQUE DANS 16 VILLAGES DU DEPARTEMENT DE LA LIKOUALA/ REGION NORD DE LA REPUBLIQUE DU CONGO:
PERIODE DU 24 Juin AU 20 JUILLET 2015
|
2015
|
|
ENREGISTREMENT ET NOTIFICATION DES RÉSULTATS DE L’EXAMEN MICROSCOPIQUE:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-06B
|
2016
|
|
ENSEMBLE DE CARTES, REGISTRES ET RAPPORTS REMPLIS:
COMPLÉMENT AU CAHIER D’EXERCICES SUR LES TROIS SYSTÈMES INTÉGRÉS DE SUIVI DU PATIENT MATÉRIEL DIDACTIQUE POUR FACILITER L’UTILISATION DE:
|
2013
|
|
Ensuring a safe environment for patients and staff in COVID-19 health-care facilities:
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic
|
2020
|
|
Ensuring human rights in the provision of contraceptive information and services:
Guidance and recommendations
|
2014
|
|
Ensuring the integration of refugees and migrants in immunization policies, planning and service delivery globally
|
2022
|
|
Environmental cleaning and infection prevention and control in health care facilities in low- and middle-income countries
|
2022
|
|
Environmental cleaning and infection prevention and control in health care facilities in low- and middle-income countries:
Modules and resources
|
2022
|
|
Environmental Health Criteria 237:
PRINCIPLES FOR EVALUATING HEALTH RISKS IN CHILDREN ASSOCIATED WITH EXPOSURE TO CHEMICALS
|
2006
|
|
Environmental Health Criteria 242:
DERMAL EXPOSURE
|
2014
|
|
Environmental Health Criteria 244:
PRINCIPLES AND METHODS TO ASSESS THE RISK OF IMMUNOTOXICITY ASSOCIATED WITH EXPOSURE TO NANOMATERIALS
|
2019
|
|
Environmental surveillance for SARS-COV-2 to complement public health surveillance:
Interim Guidance
|
2022
|
|
Environmentally sustainable health systems::
a strategic document
|
2017
|
|
Epidemic meningitis surveillance in the African meningitis belt:
Deciding on the most appropriate approach
|
2014
|
|
Epidemic Risk Analysis:
Informal Consultation WHO Geneva, 21-22 March 2017
|
2018
|
|
The epidemiology and impact of gambling disorder and other gambling-related harm
|
2017
|
|
Epidemiology of alcohol use in the WHO South-East Asia Region
|
2017
|
|
EPILEPSIA:
Un imperativo de salud pública
|
2019
|
|
EPILEPSY:
A public health imperative
|
2019
|
|
EPILEPSY:
A public health imperative
|
2019
|
|
Equipo biomédico para manejar los casos de COVID-19: herramienta de inventario:
Módulos armonizados para evaluar los establecimientos de salud en el contexto de la pandemia de COVID-19
|
2020
|
|
Equitable access to COVID-19 tools:
Aligning the private sector with national response efforts
|
2022
|
|
Équité femmes-hommes parmi les personnels de santé ::
une analyse de 104 pays
|
2019
|
|
Equity considerations for achieving the Global Nutrition Targets 2025
|
2018
|
|
Equity, social determinants and public health programmes
|
2010
|
|
Éradication du paludisme : avantages, scénarios futurs et faisabilité:
Rapport du Groupe consultatif stratégique sur l’éradication du paludisme
|
2021
|
|
Eradication of yaws:
Procedures for verification and certification of interruption of transmission
|
2018
|
|
ERADICATION OF YAWS:
Surveillance, monitoring and evaluation A manual for yaws eradication programme managers
|
2021
|
|
Eritrea Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Erradicación del paludismo: beneficios, perspectivas futuras y viabilidad:
Informe del Grupo Consultivo Estratégico sobre la Erradicación del Paludismo
|
2021
|
|
Esquema de clasificación de los países en relación con el virus de Zika:
Orientaciones provisionales
|
2017
|
|
Esquema para la elaboración de programas nacionales de eliminación de las enfermedades relacionadas con el asbesto
|
2007
|
|
ESSENTIAL NUTRITION ACTIONS:
mainstreaming nutrition through the life-course
|
2019
|
|
Essential steps for developing or updating a national pandemic influenza preparedness plan
|
2018
|
|
Essential Surgery in Leprosy:
Techniques for District Hospitals
|
1997
|
|
Establecimiento de áreas de acción prioritarias para la prevención de la:
OBESIDAD INFANTIL
|
2016
|
|
ESTABLECIMIENTOS DE SALUD RESILIENTES AL CLIMA Y AMBIENTALMENTE SOSTENIBLES:
ORIENTACIONES DE LA OMS
|
2021
|
|
Establishing External Quality Assessment Programmes for Screening of Donated Blood for Transfusion-Transmissible Infections:
Implementation Guide
|
2016
|
|
Establishing syndromic surveillance and event-based surveillance systems for Ƶika, dengue and other arboviral diseases
|
2020
|
|
Establishing syndromic surveillance and event-based surveillance systems for Zika, dengue and other arboviral diseases
|
2020
|
|
Estimación de la carga de las enfermedades transmitidasporlos alimentos: un manual práctico para los países:
Diapositivas 3 de 3 del manual Módulo 3
|
2021
|
|
Estimación de la carga de morbilidad de transmisión alimentaria::
manual práctico para los países
|
2021
|
|
Estimación de la carga de morbilidad de transmisión alimentaria: manual práctico para los países:
Diapositivas 1 a 3 del manual Módulo 1
|
2021
|
|
Estimación de la cargade morbilidad de transmisión alimentaria: un manual práctico para los países:
Diapositivas 2 de 3 del manual Módulo 2
|
2021
|
|
ESTIMACIONES DE LA OMS SOBRE LA CARGA MUNDIAL DE ENFERMEDADES DE TRANSMISIÓN ALIMENTARIA:
SINOPSIS
|
2015
|
|
ESTIMACIONES DE LA PREVALENCIA DE LA VIOLENCIA CONTRA LA MUJER, 2018
|
2021
|
|
Estimaciones mundiales y regionales de la violencia contra la mujer::
prevalencia y efectos de la violencia conyugal y de la violencia sexual no conyugal en la salud
|
2013
|
|
Estimating mortality from COVID-19:
Scientific brief
|
2020
|
|
Estimating the burden of foodborne diseases: A practical handbook for countries:
A guide for planning, implementing and reporting country-level burden of foodborne disease
|
2021
|
|
Estimating the burden of foodborne diseases: a practical handbook for countries:
Slide set 2 of 3 belonging to the handbook Module 2
|
2021
|
|
Estimating the burden of foodborne diseases: a practical handbook for countries:
Slide set 1 of 3 belonging to the handbook Module 1
|
2021
|
|
Estimating the burden of foodborne diseases: a practical handbook for countries:
Slide set 3 of 3 belonging to the handbook Module 3
|
2021
|
|
Estimating the burden of foodborne diseases: A practical handbook for countries:
A guide for planning, implementing and reporting country-level burden of foodborne disease
|
2021
|
|
ESTIMATING THE FISCAL AND ECONOMIC IMPACTS OF HEALTH TAXES ON FOOD, ALCOHOL, AND TOBACCO
|
2018
|
|
Estimation de la charge des maladies d’origine alimentaire : un manuel pratique à l’usage des pays:
Jeu de diapositives 2 sur 3 du manuel Module 2
|
2021
|
|
Estimation de la charge des maladies d’origine alimentaire : un manuel pratique à l’usage des pays:
Jeu de diapositives 3 sur 3 du manuel Module 3
|
2021
|
|
Estimation de la charge des maladies d'origine alimentaire : un manuel pratique à l'usage des pays:
Jeu de diapositives 1 sur 3 du manuel Module 1
|
2021
|
|
ESTIMATIONS DE LA PRÉVALENCE DE LA VIOLENCE À L’ÉGARD DES FEMMES, 2018
|
2021
|
|
ESTIMATIONS DE L’OMS SUR LA CHARGE MONDIALE DE MORBIDITÉ IMPUTABLE AUX MALADIES D’ORIGINE ALIMENTAIRE:
RÉSUMÉ D’ORIENTATION
|
2015
|
|
Estimations mondiales et régionales de la violence à l’encontre des femmes ::
prévalence et conséquences sur la santé de la violence du partenaire intime et de la violence sexuelle exercée par d’autres que le partenaire
|
2013
|
|
ESTONIA:
The development of family practice to support universal health coverage
|
2018
|
|
Estrategia de la OMS sobre medicina tradicional:
2014-2023
|
2013
|
|
Estrategia global de comunicación de riesgos y participación de la comunidad para la COVID-19 Diciembre del 2020 – mayo del 2021:
Orientaciones provisionales, 23 de diciembre del 2020
|
2021
|
|
ESTRATEGIA MUNDIAL DE INVESTIGACIÓN E INNOVACIÓN CONTRA LA TUBERCULOSIS
|
2020
|
|
ESTRATEGIA MUNDIAL DEL SECTOR DE LA SALUD CONTRA EL VIH 2016–2021:
HACIA EL FIN DEL SIDA
|
2016
|
|
ESTRATEGIA MUNDIAL DEL SECTOR DE LA SALUD CONTRA LAS HEPATITIS VÍRICAS 2016-2021:
HACIA EL FIN DE LAS HEPATITIS VÍRICAS
|
2016
|
|
ESTRATEGIA MUNDIAL DEL SECTOR DE LA SALUD CONTRA LAS INFECCIONES DE TRANSMISIÓN SEXUAL 2016-2021:
HACIA EL FIN DE LAS ITS
|
2016
|
|
Estrategia mundial para reducir el uso nocivo del alcohol
|
2010
|
|
Estrategia OMS de cooperación en los países
|
2017
|
|
ESTRATEGIA PARA LA IGUALDAD DE GÉNERO:
2019-2023
|
2019
|
|
Estrategia Técnica Mundial contra la Malaria 2016-2030
|
2021
|
|
ESTRATEGIA TÉCNICA MUNDIAL CONTRA LA MALARIA 2016–2030
|
2015
|
|
ESTRATEGIAS DE AUTOAYUDA:
Para reducir o eliminar el consumo de sustancias
|
2011
|
|
Estrategias mundiales del sector de la salud contra el VIH, las hepatitis víricas y las infecciones de transmisión sexual para el periodo 2022-2030
|
2022
|
|
ÉTABLISSEMENTS DE SANTÉ RÉSILIENTS FACE AU CHANGEMENT CLIMATIQUE ET ÉCOLOGIQUEMENT VIABLES:
ORIENTATIONS DE L’OMS
|
2021
|
|
État d’avancement du Protocole pour éliminer le commerce illicite des produits du tabac
|
2014
|
|
Ethical and safety recommendations for intervention research on violence against women:
Building on lessons from the WHO publication Putting women first: ethical and safety recommendations for research on domestic violence against women
|
2016
|
|
Ethical considerations for use of unregistered interventions for Ebola viral disease:
Report of an advisory panel to WHO
|
2014
|
|
ETHICAL CONSIDERATIONS IN RESEARCH ON FEMALE GENITAL MUTILATION
|
2021
|
|
Ethical considerations to guide the use of digital proximity tracking technologies for COVID-19 contact tracing:
Interim guidance
|
2020
|
|
Ethical Framework for WHO’s work in the ACT-Accelerator
|
2021
|
|
ETHICAL ISSUES ASSOCIATED WITH VECTOR-BORNE DISEASES:
REPORT OF A WHO SCOPING MEETING GENEVA, 23–24 FEBRUARY 2017
|
2017
|
|
Ethical issues in Patient Safety Research:
Interpreting existing guidance
|
2013
|
|
Ethical issues related to study design for trials on therapeutics for Ebola Virus Disease:
WHO Ethics Working Group Meeting 20-21 October Summary of Discussion
|
2014
|
|
Ethical Recruitment of Health Workers::
Using Bilateral Cooperation to Fulfill the World Health Organization’s Global Code of Practice
|
2021
|
|
Ethical standards for research during public health emergencies::
Distilling existing guidance to support COVID-19 R&D
|
2020
|
|
ETHICS AND GOVERNANCE OF ARTIFICIAL INTELLIGENCE FOR HEALTH:
WHO GUIDANCE
|
2021
|
|
ETHICS AND GOVERNANCE OF ARTIFICIAL INTELLIGENCE FOR HEALTH:
WHO GUIDANCE
|
2021
|
|
Ethics and vector-borne diseases::
WHO guidance
|
2020
|
|
ETHICS GUIDANCE FOR THE IMPLEMENTATION OF THE END TB STRATEGY
|
2017
|
|
Ethics in epidemics, emergencies and disasters: research, surveillance and patient care:
Training manual
|
2015
|
|
ETHICS IN IMPLEMENTATION RESEARCH:
FACILITATOR’S GUIDE
|
2019
|
|
Ethics of using convalescent whole blood and convalescent plasma during the Ebola epidemic:
Interim guidance for ethics review committees, researchers, national health authorities and blood transfusion services
|
2015
|
|
Ethiopia Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
ÉTHIQUE ET GOUVERNANCE DE L’INTELLIGENCE ARTIFICIELLE POUR LA SANTÉ:
ORIENTATIONS DE L’OMS
|
2021
|
|
Éthique et maladies à transmission vectorielle ::
Orientations de l’OMS
|
2021
|
|
Ética y enfermedades transmitidas por vectores::
orientaciones de la OMS
|
2021
|
|
ÉTICA Y GOBERNANZA DE LA INTELIGENCIA ARTIFICIAL EN EL ÁMBITO DE LA SALUD:
ORIENTACIONES DE LA OMS
|
2021
|
|
ÉTIQUETAGE DES ÉTALEMENTS DE SANG À LA RECHERCHE DE PLASMODIUM:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-06A
|
2016
|
|
Études sur les connaissances, attitudes et pratiques Maladie transmise par le virus Zika et ses possibles complications:
Kit de ressources
|
2016
|
|
EUROHEALTH:
Commercial Determinants of Cancer Control Policy
|
2022
|
|
EUROPEAN REGION CONSULTATION ON THE IMPLEMENTATION AND ACHIEVEMENTS OF THE WHO EUROPEAN ACTION PLAN TO REDUCE THE HARMFUL USE OF ALCOHOL 2012–2020
|
2019
|
|
EUROPEAN REGIONAL STATUS REPORT ON PREVENTING VIOLENCE AGAINST CHILDREN 2020
|
2021
|
|
EUROPEAN REPORT ON CHILD INJURY PREVENTION
|
2008
|
|
European report on preventing child maltreatment
|
2013
|
|
European report on preventing child maltreatment:
Summary
|
2013
|
|
European report on preventing violence and knife crime among young people
|
2010
|
|
European status report on preventing child maltreatment
|
2018
|
|
EVALUACIÓN DE LA CAPACIDAD NACIONAL PARA APLICAR POLÍTICAS EFICACES DE CONTROL DEL TABACO:
Manual de operaciones sobre planificación, realización y seguimiento de evaluaciones conjuntas de la capacidad nacional
|
2014
|
|
Evaluación de los factores de riesgo de enfermedad por el coronavirus de 2019 (COVID-19) entre trabajadores de salud::
protocolo para un estudio de casos y testigos
|
2020
|
|
Evaluación de los riesgos para la salud del accidente nuclear posterior al terremoto y maremoto del Japón de 2011, basada en una estimación preliminar de la dosis de radiación
|
2013
|
|
Evaluación del desarrollo de los cuidados paliativos en el mundo::
conjunto de indicadores factibles
|
2022
|
|
Evaluación del lactante con microcefalia en el contexto del brote de virus de Zika:
Orientación provisional
|
2016
|
|
Evaluación preliminar del mecanismo de coordinación mundial de la OMS sobre la prevención y el control de las enfermedades no transmisibles
|
2018
|
|
Evaluación preliminar del mecanismo de coordinación mundial de la OMS sobre la prevención y el control de las enfermedades no transmisibles
|
2018
|
|
Evaluación y designación pública de las autoridades reguladoras como autoridades catalogadas por la OMS:
Documento de política
|
2021
|
|
Evaluating and publicly designating regulatory authorities as WHO listed authorities:
Policy document
|
2021
|
|
EVALUATING INTERSECTORAL PROCESSES FOR ACTION ON THE SOCIAL DETERMINANTS OF HEALTH::
LEARNING FROM KEY INFORMANTS
|
2013
|
|
Evaluation::
annual report
|
2016
|
|
Évaluation des facteurs de risque de maladie à coronavirus 2019 (COVID-19) chez les agents de santé ::
protocole pour une étude cas-témoins
|
2020
|
|
Évaluation des nouveau-nés atteints de microcéphalie dans le contexte du virus Zika
|
2016
|
|
Évaluation des risques pour la santé de l’accident nucléaire survenu après le grand tremblement de terre et le tsunami qui ont touché l’est du Japon en 2011 (sur la base d’une estimation préliminaire des doses)
|
2013
|
|
Évaluation du développement des soins palliatifs dans le monde ::
série d’indicateurs pratiques
|
2022
|
|
Évaluation et désignation publique des autorités de réglementation en tant qu’autorités reconnues par l’OMS:
Document d’orientation
|
2021
|
|
Évaluation et prise en charge des affections spécifiquement liées au stress ::
Module Guide d’intervention mhGAP
|
2013
|
|
ÉVALUATION EXTERNE CONJOINTE DES PRINCIPALES CAPACITÉS RSI en RÉPUBLIQUE GABONAISE:
Rapport de mission: 1–5 Juillet 2019
|
2019
|
|
EVALUATION OF CENTRALIZED ASSAYS FOR TB DETECTION AND DETECTION OF RESISTANCE TO RIFAMPICIN AND ISONIAZID::
WHO Technical Expert Consultation Report
|
2019
|
|
Evaluation of certain food additives and contaminants:
Eightieth report of the Joint FAO/WHO Expert Committee on Food Additives
|
2016
|
|
Evaluation of certain food additives and contaminants:
Seventy-seventh report of the Joint FAO/WHO Expert Committee on Food Additives
|
2013
|
|
Evaluation of certain veterinary drug residues in food:
Eighty-first report of the Joint FAO/WHO Expert Committee on Food Additives
|
2016
|
|
Evaluation of certain veterinary drug residues in food:
Seventy-eighth report of the Joint FAO/WHO Expert Committee on Food Additives
|
2014
|
|
Evaluation of certain veterinary drug residues in food:
Seventy-fifth report of the Joint FAO/WHO Expert Committee on Food Additives
|
2012
|
|
Evaluation of implementation of Regional Flagship Areas in the WHO South-East Asia Region 2014–2018
|
2020
|
|
Evaluation of two International Reference Standards for antibodies to Trypanosoma cruzi in a WHO collaborative study
|
2011
|
|
Évaluation préliminaire du mécanisme mondial de coordination de l’OMS pour la lutte contre les maladies non transmissibles
|
2018
|
|
Évaluation préliminaire du mécanisme mondial de coordination de l’OMS pour la lutte contre les maladies non transmissibles
|
2018
|
|
Évaluer la charge de morbidité d’origine alimentaire : guide pratique à l’intention des pays:
Un guide pour la planification, la mise en œuvre et la notification de la charge des maladies d'origine alimentaire au niveau des pays
|
2021
|
|
Évaluer la charge de morbidité d’origine alimentaire : guide pratique à l’intention des pays:
Un guide pour la planification, la mise en oeuvre et la notification de la charge des maladies d’origine alimentaire au niveau des pays
|
2021
|
|
ÉVALUER L’ÉLARGISSEMENT DE L’ESPACE BUDGÉTAIRE ALLOUÉ À LA SANTÉ DANS LES PAYS À REVENU FAIBLE OU INTERMÉDIAIRE:
ANALYSE DES DONNÉES FACTUELLES
|
2016
|
|
ÉVALUER L’ÉPIDÉMIOLOGIE DES GÉOHELMINTHES PENDANT UNE ENQUÊTE D’ÉVALUATION DE LA TRANSMISSION (TAS) DANS LE CADRE DU PROGRAMME MONDIAL D’ÉLIMINATION DE LA FILARIOSE LYMPHATIQUE
|
2015
|
|
Every Woman, Every Child: A Post-2015 Vision:
The Third Report of the independent Expert Review Group on Information and Accountability for Women’s and Children’s Health
|
2014
|
|
Every Woman, Every Child, Every Adolescent: Achievements and Prospects:
The Final Report of the independent Expert Review Group on Information and Accountability for Women’s and Children’s Health
|
2015
|
|
Every Woman, Every Child: Strengthening Equity and Dignity through Health:
The Second Report of the independent Expert Review Group (iERG) on Information and Accountability for Women’s and Children’s Health
|
2013
|
|
Evidence and research gaps identified during development of policy guidelines for tuberculosis
|
2021
|
|
Evidence for gender responsive actions for the prevention and management of HIV/AIDS and STIs:
Young people’s health as a whole-of-society response
|
2011
|
|
Evidence for gender responsive actions to prevent and manage adolescent pregnancy:
Young people’s health as a whole-of-society response
|
2011
|
|
Evidence for gender responsive actions to prevent and manage chronic conditions:
Young people’s health as a whole-of-society response
|
2011
|
|
Evidence for gender responsive actions to prevent and manage injuries and substance abuse:
Young people’s health as a whole-of-society response
|
2011
|
|
Evidence for gender responsive actions to prevent and manage overweight and obesity:
Young people’s health as a whole-of-society response
|
2011
|
|
Evidence for gender responsive actions to prevent violence:
Young people’s health as a whole-of-society response
|
2011
|
|
Evidence for gender responsive actions to promote mental health:
Young people’s health as a whole-of-society response
|
2011
|
|
Evidence for gender responsive actions to promote well-being:
Young people’s health as a whole-of-society response
|
2011
|
|
Evidence of hand hygiene as the building block for infection prevention and control
|
2017
|
|
Evidence profile::
visual impairment
|
2017
|
|
Evidence profile::
malnutrition
|
2017
|
|
Evidence profile::
depressive symptoms
|
2017
|
|
Evidence profile::
hearing loss
|
2017
|
|
Evidence profile::
mobility loss
|
2017
|
|
Evidence profile::
cognitive impairment
|
2017
|
|
Evidence profile::
malnutrition
|
2017
|
|
Evidence profile::
depressive symptoms
|
2017
|
|
Evidence profile::
urinary incontinence
|
2017
|
|
Evidence profile::
visual impairment
|
2017
|
|
Evidence profile::
urinary incontinence
|
2017
|
|
Evidence profile::
caregiver support
|
2017
|
|
Evidence profile::
hearing loss
|
2017
|
|
Evidence profile::
risk of falls
|
2017
|
|
Evidence to recommendations: COVID-19 mitigation in the aviation sector:
Interim guidance
|
2020
|
|
Evidence-based strategies to reduce the burden of household air pollution in Accra, Ghana
|
2021
|
|
EVIDENCE-INFORMED GUIDELINE DEVELOPMENT FOR WORLD HEALTH ORGANIZATION NUTRITION-RELATED NORMATIVE WORK:
CONTINUOUS QUALITY IMPROVEMENT FOR EFFICIENCY AND IMPACT
|
2018
|
|
The evolving threat of antimicrobial resistance:
Options for action Executive Summary
|
2012
|
|
The evolving threat of antimicrobial resistance Options for action
|
2012
|
|
EXAMEN MICROSCÓPICO DE EXTENSIONES DE SANGRE GRUESAS Y FINAS PARA LA IDENTIFICACIÓN DE PARÁSITOS PALÚDICOS:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR — DMP-POE-08
|
2016
|
|
EXAMEN MICROSCOPIQUE DES FROTTIS MINCES ET DES GOUTTES ÉPAISSES POUR L’IDENTIFICATION DE PARASITES DU PALUDISME:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS — DMP-MON-08
|
2016
|
|
Examples of current practices in the implementation of Article 12 (Free zones and international transit) of the Protocol to Eliminate Illicit Trade in Tobacco Products
|
2021
|
|
EXECUTIVE SUMMARY:
Guidance and technical packages on community mental health services
|
2021
|
|
Expanding health worker roles for safe abortion in the first trimester of pregnancy
|
2016
|
|
EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 12 to 16 October 2015:
Collaborative Study to Enlarge the First WHO Repository of Platelet Transfusion-Relevant Bacterial Reference Strains
|
2015
|
|
Expert Consultation on the Use of Placebos in Vaccine Trials
|
2013
|
|
Experts Consultative Meeting on Alternative Treatment Strategies for the Elimination and Lymphatic Filarisis in Areas requiring intensified interventions:
Ouagadougou, 6-7 September 2014
|
2014
|
|
Exploratory meeting to review new evidence for Integrated Management of Childhood Illness (IMCI) danger signs:
Geneva, Switzerland 4–5 September 2018
|
2019
|
|
EXPOSÉ DE POSITION SUR LES ARGUMENTS ÉCONOMIQUES EN FAVEUR D’INTERVENTIONS INTERSECTORIELLES VISANT À RENFORCER LES DÉTERMINANTS SOCIAUX DE LA SANTÉ ::
MEXIQUE
|
2014
|
|
EXPOSURE TO HIGHLY HAZARDOUS PESTICIDES::
A MAJOR PUBLIC HEALTH CONCERN
|
2019
|
|
External reference pricing:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
Extração de ouro artesanal:
e em pequena escala e a saúde
|
2022
|
|
Eye care competency framework
|
2022
|
|
Eye care in health systems:
Guide for action
|
2022
|
|
Eye care indicator menu (ECIM)::
a tool for monitoring strategies and actions for eye care provision
|
2022
|
|
Eye care service assessment tool
|
2015
|
|
Eye care situation analysis tool (ECSAT)
|
2022
|
|
FACILITATOR GUIDELINES FOR CONDUCTING A PLANNING WORKSHOP
|
2015
|
|
Fact sheet on reduced ignition propensity (RIP) cigarettes
|
2014
|
|
Fact sheet on Sustainable Development Goals (SDGs): health targets:
Road safety
|
2017
|
|
FACT SHEET TO THE WHO CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES
|
2015
|
|
FACTORES GENETICOS Y MALFORMACIONES CONGENITAS
|
1970
|
|
Factors conducive to the development of health technology assessment in Asia:
IMPACTS AND POLICY OPTIONS
|
2015
|
|
FAIR PRICING FORUM:
INFORMAL ADVISORY GROUP MEETING
|
2017
|
|
FAIR PRICING FORUM:
2017 MEETING REPORT
|
2017
|
|
Fair Pricing Forum 2019 Meeting Report
|
2019
|
|
Fair Pricing Forum 2021:
Fair pricing in times of public health emergency and to accelerate achievements of Sustainable Development Goals health targets
|
2021
|
|
Fair Pricing Forum 2021 meeting report
|
2021
|
|
Faire ce qui compte en période de stress ::
Un guide illustré
|
2020
|
|
False-negative RDT results and P. falciparum histidine-rich protein 2/3 gene deletions
|
2016
|
|
FAQ on Health and Sexual Diversity:
An Introduction to Key Concepts
|
2016
|
|
Fare ciò che conta nei momenti di stress::
Una guida illustrata
|
2020
|
|
FATAL INJURY SURVEILLANCE IN MORTUARIES AND HOSPITALS::
A MANUAL FOR PRACTITIONERS
|
2012
|
|
The fatal link between tobacco and cardiovascular diseases in the WHO South-East Asia Region
|
2018
|
|
Feasibility, Potential Value and Limitations of Establishing a Closely Monitored Challenge Model of Experimental COVID-19 Infection and Illness in Healthy Young Adult Volunteers
|
2020
|
|
Female genital mutilation
|
2019
|
|
Female genital mutilation and obstetric outcome::
WHO collaborative prospective study in six African countries*
|
2006
|
|
Female Genital Mutilation Integrating the Prevention and the Management of the Health Complications into the curricula of nursing and midwifery.:
A Teacher's Guide
|
2001
|
|
Female Genital Mutilation Integrating the Prevention and the Management of the Health Complications into the curricula of nursing and midwifery.:
A Student’s Manual
|
2001
|
|
Female Genital Mutilation programmes to date::
what works and what doesn’t
|
2011
|
|
FEMALE GENITAL SCHISTOSOMIASIS:
A POCKET ATLAS FOR CLINICAL HEALTH-CARE PROFESSIONALS
|
2015
|
|
FEUILLE DE ROUTE DU SAGE DE L’OMS POUR L’ÉTABLISSEMENT DES PRIORITÉS CONCERNANT L’UTILISATION DES VACCINS ANTI-COVID-19
|
2022
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION
|
2014
|
|
Feuille de route pour les produits chimiques
|
2017
|
|
Feuille de route pour les produits chimiques Manuel de travail:
Feuille de route pour accroître la participation du secteur de la santé dans l’Approche stratégique de la gestion internationale des produits chimiques dans la perspective de l’objectif fixé pour 2020 et au-delà
|
2018
|
|
Feuille de route pour mettre fin à la tuberculose de l’enfant et de l’adolescent
|
2019
|
|
Field situation::
how to safely collect oral swabs (saliva) from deceased patients suspected to be infected with Ebola
|
2014
|
|
Fifteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases:
7-8 February 2022
|
2022
|
|
Fifth meeting of the Eastern Mediterranean Acute Infection Surveillance (EMARIS) network and the second scientific conference on acute respiratory infections in the Eastern Mediterranean Region:
Better data, better policy, better action Casablanca, Morocco 12–15 November 2019
|
2020
|
|
Fifth Meeting of the WHO South-East Asia Regional Verification Commission for measles and rubella:
Meeting report 6–7 July 2020 (Virtual)
|
2020
|
|
Fifth report of Committee A
|
2014
|
|
Fifth virtual WHO infodemic management conference 2, 4, 9 and 11 November 2021: meeting report:
Steps towards measuring the burden of infodemics
|
2022
|
|
The Fiji Islands Health System Review
|
2011
|
|
FILARIOSE LYMPHATIQUE:
GUIDE DES APPRENANTS
|
2014
|
|
FILARIOSE LYMPHATIQUE:
GUIDE DES INSTRUCTEURS
|
2014
|
|
A FINANCIAL MODEL FOR AN IMPACT INVESTMENT FUND FOR THE DEVELOPMENT OF ANTIBACTERIAL TREATMENTS AND DIAGNOSTICS:
A User Guide
|
2020
|
|
A FINANCIAL MODEL FOR AN IMPACT INVESTMENT FUND FOR THE DEVELOPMENT OF ANTIBACTERIAL TREATMENTS AND DIAGNOSTICS:
A User Guide
|
2020
|
|
Findings from a rapid review of literature on ghost workers in the health sector::
towards improving detection and prevention
|
2020
|
|
The First Few X cases and contacts (FFX) investigation protocol for coronavirus disease 2019 (COVID-19)
|
2020
|
|
First formal meeting of the Foodborne Disease Burden Epidemiology Reference Group (FERG):
Implementing Strategy, Setting Priorities and Assigning the Tasks
|
2008
|
|
FIRST MALARIA VACCINE IN AFRICA::
A potential new tool for child health and improved malaria control
|
2019
|
|
First meeting of the network on Buruli ulcer PCR laboratories in the WHO African Region:
Centre Pasteur du Cameroon, Yaoundé, 21–24 October 2019
|
2018
|
|
FIRST MEETING OF THE WHO ANTIFUNGAL EXPERT GROUP ON IDENTIFYING PRIORITY FUNGAL PATHOGENS:
Meeting Report
|
2020
|
|
First meeting of the WHO Scientific and Technical Advisory Group on Inappropriate Promotion of Foods for Infants and Young Children:
24–25 June 2013 WHO headquarters, Geneva, Switzerland
|
2013
|
|
First meeting of the WHO Strategic and Technical Advisory Group working group on access to safe, efficacious and quality-assured health products for neglected tropical diseases:
Virtual meeting, 15–16 September 2022
|
2022
|
|
First teleconference on regulatory approaches for expediting development and availability of Ebola vaccines
|
2014
|
|
FIRST WHO GLOBAL MINISTERIAL CONFERENCE:
ENDING TB IN THE SUSTAINABLE DEVELOPMENT ERA: A MULTISECTORAL RESPONSE 16-17 NOVEMBER 2017, MOSCOW, RUSSIAN FEDERATION
|
2017
|
|
FIRST WHO MINISTERIAL CONFERENCE ON GLOBAL ACTION AGAINST DEMENTIA:
16-17 MARCH 2015, GENEVA, SWITZERLAND MEETING REPORT
|
2015
|
|
First WHO Model List of Essential In Vitro Diagnostics
|
2019
|
|
First Workshop of the Partners Group on Ebola Vaccines Deployment:
24-26 February 2015, Geneva, Switzerland
|
2015
|
|
First Workshop of the Partners Group on Ebola Vaccines Deployment
|
2015
|
|
FISCAL POLICIES TO PROMOTE HEALTHY DIETS::
POLICY BRIEF
|
2022
|
|
Five keys to growing safer fruits and vegetables::
promoting health by decreasing microbial contamination
|
2012
|
|
Five Keys to safer aquaculture products to protect public health
|
2016
|
|
Flambées épidémiques de maladie à virus Ebola et Marburg::
préparation, alerte, lutte et évaluation
|
2014
|
|
Flutool plus:
WHO Seasonal Influenza Immunization Costing Tool (SIICT)
|
2020
|
|
Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues:
Antimicrobial resistance Report by the Director-General
|
2018
|
|
Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues:
Antimicrobial resistance Report by the Director-General
|
2019
|
|
FOOD CONTROL SYSTEM ASSESSMENT TOOL:
DIMENSION B CONTROL FUNCTIONS
|
2019
|
|
FOOD CONTROL SYSTEM ASSESSMENT TOOL:
INTRODUCTORY BOOKLET
|
2021
|
|
FOOD CONTROL SYSTEM ASSESSMENT TOOL:
DIMENSION D SCIENCE/KNOWLEDGE BASE AND CONTINUOUS IMPROVEMENT
|
2019
|
|
FOOD CONTROL SYSTEM ASSESSMENT TOOL:
DIMENSION A INPUTS AND RESOURCES
|
2019
|
|
FOOD CONTROL SYSTEM ASSESSMENT TOOL:
INTRODUCTION AND GLOSSARY
|
2019
|
|
FOOD CONTROL SYSTEM ASSESSMENT TOOL:
DIMENSION C INTERACTIONS WITH STAKEHOLDERS
|
2019
|
|
FOOD SAFETY:
Climate Change and the ROLE OF WHO
|
2018
|
|
Food systems delivering better health:
Executive summary
|
2021
|
|
FOOD SYSTEMS FOR HEALTH:
Information Brief
|
2021
|
|
Foodborne disease outbreaks::
Guidelines for investigation and control
|
2008
|
|
Foodborne diseases in the WHO African Region
|
2015
|
|
Foodborne diseases in the WHO Eastern Mediterranean Region
|
2015
|
|
Foodborne diseases in the WHO Eastern Mediterranean Region
|
2015
|
|
Foodborne diseases in the WHO European Region
|
2015
|
|
Foodborne diseases in the WHO Region of the Americas
|
2015
|
|
Foodborne diseases in the WHO South-East Asia Region
|
2015
|
|
Foodborne diseases in the WHO Western Pacific Region
|
2015
|
|
For cutting down or stopping substance use:
A guide
|
2010
|
|
Foresight approaches in global public health:
A practical guide for WHO staff
|
2022
|
|
Formar a un personal sanitario competente en salud del adolescente
|
2015
|
|
Fortalecimiento de la preparación ante emergencias sanitarias en las ciudades y los entornos urbanos::
orientaciones para las autoridades nacionales y locales
|
2022
|
|
A FoundAtion to Address equity, Gender And HumAn riGHts in tHe 2030 AGendA::
Progress in 2014–2015
|
2016
|
|
Fourteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases:
22–24 June 2021
|
2021
|
|
Fourth Annual Meeting of the Global Task Force on Cholera Control:
Cape Town, South Africa 21–22 June 2017
|
2018
|
|
FOURTH MEETING OF THE TECHNICAL ADVISORY GROUP ON UNIVERSAL HEALTH COVERAGE IN THE WESTERN PACIFIC REGION
|
2020
|
|
Fourth WHO Global Forum on Medical Devices REPORT:
AMTZ-Kalam Convention Centre, Visakhapatnam, India 13 to 15 December 2018
|
2019
|
|
Framework for Accelerating Action to Fight Antimicrobial Resistance in the Western Pacific Region
|
2020
|
|
FRAMEWORK FOR CLINICAL EVALUATION OF DEVICES FOR MALE CIRCUMCISION
|
2012
|
|
Framework for decision-making: implementation of mass vaccination campaigns in the context of COVID-19:
Interim guidance
|
2020
|
|
A FRAMEWORK FOR IMPLEMENTING THE SET OF RECOMMENDATIONS on the marketing of foods and non-alcoholic beverages to children
|
2012
|
|
A framework for malaria elimination
|
2017
|
|
A FRAMEWORK for mental health and psychosocial support in radiological and nuclear emergencies
|
2020
|
|
FRAMEWORK FOR STRENGTHENING HEALTH EMERGENCY PREPAREDNESS IN CITIES AND URBAN SETTINGS
|
2021
|
|
Framework for the use of systematic review in chemical risk assessment
|
2021
|
|
Framework for Verification of Measles and Rubella Elimination in the WHO South-East Asia Region
|
2020
|
|
A FRAMEWORK FOR VOLUNTARY MEDICAL MALE CIRCUMCISION::
EFFECTIVE HIV PREVENTION AND A GATEWAY TO IMPROVED ADOLESCENT BOYS’ & MEN’S HEALTH IN EASTERN AND SOUTHERN AFRICA BY 2021
|
2016
|
|
Framework forcollaborative actionon tuberculosis and comorbidities
|
2022
|
|
Framework of indicators and targets for laboratory strengthening under the End TB Strategy
|
2016
|
|
Freedom from coercion, violence and abuse:
WHO QualityRights core training: mental health & social services
|
2019
|
|
FREQUENTLY ASKED QUESTIONS::
Breastfeeding and COVID-19 For health care workers
|
2020
|
|
FROM EMERGENCY RESPONSE TO LONG-TERM COVID-19 DISEASE MANAGEMENT::
SUSTAINING GAINS MADE DURING THE COVID-19 PANDEMIC
|
2023
|
|
FROM MALARIA CONTROL TO MALARIA ELIMINATION:
A Manual for Elimination Scenario Planning
|
2014
|
|
Función del sector de la salud en el Enfoque Estratégico de la Gestión Internacional de los Productos Químicos de cara al objetivo fijado para 2020 y años posteriores
|
2016
|
|
Función del sector de la salud en el Enfoque Estratégico de la Gestión Internacional de los Productos Químicos de cara al objetivo fijado para 2020 y años posteriores:
Informe de la Secretaría
|
2016
|
|
Función del sector de la salud en el Enfoque Estratégico de la Gestión Internacional de los Productos Químicos de cara al objetivo fijado para 2020 y años posteriores:
Informe del Director General
|
2021
|
|
Función del sector de la salud en el Enfoque Estratégico de la Gestión Internacional de los Productos Químicos de cara al objetivo fijado para 2020 y años posteriores:
Informe de la Secretaría
|
2017
|
|
Función del sector de la salud en el Enfoque Estratégico de la Gestión Internacional de los Productos Químicos de cara al objetivo fijado para 2020 y años posteriores:
Proyecto de resolución presentado por las delegaciones de la Argentina, el Canadá, los Estados Unidos de América, Mónaco, Panamá, Tailandia, el Uruguay y los Estados Miembros de la Unión Europea
|
2016
|
|
Funciones del personal sanitario en la atención para un aborto sin riesgos y los métodos anticonceptivos después del aborto
|
2015
|
|
Funciones y deberes de los miembros de INFOSAN
|
2015
|
|
GAPIII AUDITOR QUALIFICATION AND AUDIT SUPPORT PLAN 2021–2023
|
2021
|
|
Garantir les droits de l’homme lors de la fourniture d’informations et de services en matière de contraception ::
Orientations et recommandations
|
2014
|
|
Garantir un approvisionnement en sang sûr et suffisant pendant les flambées de virus Zika:
Lignes directrices provisoires
|
2016
|
|
GEMS/FOOD:
REPORT OF THE WHO WORKING GROUP ON COLLECTION OF FOOD CONSUMPTION DATA (COFOCO)
|
2012
|
|
Gender and COVID-19:
Advocacy brief
|
2020
|
|
Gender, Climate Change and Health
|
2014
|
|
GENDER EQUALITY STRATEGY 2019-2023
|
2019
|
|
Gender equity in the health workforce::
Analysis of 104 countries
|
2019
|
|
Generación de resiliencia en los sistemas de salud en pro de la cobertura sanitaria universal y la seguridad sanitaria durante y después de la pandemia de COVID-19:
DOCUMENTO DE POSICIÓN DE LA OMS
|
2021
|
|
General Principles of Good Chronic Care:
INTEGRATED MANAGEMENT OF ADOLESCENT AND ADULT ILLNESS
|
2004
|
|
GENERATING EVIDENCE FOR ARTIFICIAL INTELLIGENCE-BASED MEDICAL DEVICES::
A FRAMEWORK FOR TRAINING, VALIDATION AND EVALUATION
|
2021
|
|
GENERIC ANNUAL BUDGETS FOR ANTIRETROVIRAL TOXICITY MONITORING APPROACHES
|
2020
|
|
GENERIC FRAMEWORK FOR CONTROL, ELIMINATION AND ERADICATION OF NEGLECTED TROPICAL DISEASES
|
2016
|
|
Generic protocol A prospective cohort study investigating maternal, pregnancy and neonatal outcomes for women and neonates infected with SARS-CoV-2
|
2020
|
|
Generic risk assessment model for indoor and outdoor space spraying of insecticides:
2nd Edition
|
2018
|
|
Generic risk assessment model for insecticides used for larviciding and mollusciciding:
2nd Edition
|
2018
|
|
Generic risk assessment models for insecticide-treated clothing, skin-applied repellents and household insecticides
|
2019
|
|
Género, cambio climático y salud
|
2016
|
|
Genomic sequencing of SARS-CoV-2:
A guide to implementation for maximum impact on public health
|
2021
|
|
GESTIÓN DE LOS RESIDUOS GENERADOS EN LAS PRUEBAS DE DIAGNÓSTICO DEL PALUDISMO:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-13
|
2016
|
|
GESTION DES DÉCHETS ISSUS DE TESTS DE DIAGNOSTIC DU PALUDISME:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-13
|
2016
|
|
GESTION DES PROBLÈMES PLUS (PM+):
Soutien psychosocial individuel pour adultes affectés par la détresse dans les communautés exposées à l’adversité
|
2018
|
|
GESTION DES RISQUES DE PANDÉMIE DE GRIPPE:
Guide de l’OMS pour prise de décisions éclairées et harmonisation, à l'échelle nationale et internationale, de la préparation et la réponse en cas de grippe pandémique
|
2017
|
|
GESTIONE DEI PROBLEMI PLUS (PM+):
Assistenza psicologica individuale per adulti colpiti da situazioni di disagio in comunità in condizioni di avversità.
|
2016
|
|
Getting your workplace ready for COVID-19
|
2020
|
|
GHANA
|
2018
|
|
Ghana Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Ghana country assessment report on ageing and health
|
2014
|
|
GIEMSA STAINING OF MALARIA BLOOD FILMS:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-07A
|
2016
|
|
GLASS Guidance for national reference laboratories
|
2020
|
|
GLASS guide for national surveillance systems for monitoring antimicrobial consumption in hospitals
|
2020
|
|
GLASS Manual on the management of antimicrobial consumption data
|
2020
|
|
GLASS method for estimating attributable mortality of antimicrobial resistant bloodstream infections
|
2020
|
|
GLASS Methodology for surveillance of national antimicrobial consumption
|
2020
|
|
GLASS The detection and reporting of colistin resistance Second edition:
Global Antimicrobial Resistance and Use Surveillance System (GLASS)
|
2021
|
|
GLASS Whole-genome sequencing for surveillance of antimicrobial resistance
|
2020
|
|
Global Accelerated Action for the Health of Adolescents (AA-HA!):
Guidance to Support Country Implementation – Summary
|
2017
|
|
Global Accelerated Action for the Health of Adolescents (AA-HA!)::
Guidance to Support Country Implementation
|
2017
|
|
Global Accelerated Action for the Health of Adolescents (AA-HA!):
Guidance to Support Country Implementation
|
2017
|
|
GLOBAL ACCESS TO HEPATITIS DRUGS AND DIAGNOSTICS:
CONSULTATION WITH PHARMACEUTICAL AND DIAGNOSTICS COMPANIES
|
2014
|
|
GLOBAL ACTION PLAN:
ON ANTIMICROBIAL RESISTANCE
|
2015
|
|
GLOBAL ACTION PLAN:
ON ANTIMICROBIAL RESISTANCE
|
2015
|
|
GLOBAL ACTION PLAN FOR HEALTHY LIVES AND WELL-BEING FOR ALL:
Uniting to accelerate progress towards the health-related SDGs
|
2018
|
|
GLOBAL ACTION PLAN FOR HIV DRUG RESISTANCE 2016-2021
|
2016
|
|
GLOBAL ACTION PLAN FOR THE PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASES 2013-2020
|
2013
|
|
Global action plan on antimicrobial resistance:
Draft resolution with amendments resulting from informal consultations
|
2015
|
|
Global action plan on antimicrobial resistance
|
2015
|
|
Global action plan on antimicrobial resistance:
Options, including potential deliverables, for the conduct of a high-level meeting in 2016, in the margins of the United Nations General Assembly Report by the Secretariat
|
2015
|
|
Global action plan on antimicrobial resistance:
Options for establishing a global development and stewardship framework to support the development, control, distribution and appropriate use of new antimicrobial medicines, diagnostic tools, vaccines and other interventions Report by the Secretariat
|
2016
|
|
GLOBAL ACTION PLAN ON HIV DRUG RESISTANCE:
2017-2021
|
2017
|
|
GLOBAL ACTION PLAN ON HIV DRUG RESISTANCE 2017–2021:
2018 PROGRESS REPORT
|
2018
|
|
Global action plan on the public health response to dementia:
2017 - 2025
|
2017
|
|
Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae
|
2012
|
|
GLOBAL ANAEMIA REDUCTION EFFORTS AMONG WOMEN OF REPRODUCTIVE AGE::
IMPACT, ACHIEVEMENT OF TARGETS AND THE WAY FORWARD FOR OPTIMIZING EFFORTS
|
2020
|
|
GLOBAL ANALYSIS OF HEALTH CARE WASTE IN THE CONTEXT OF COVID-19:
STATUS, IMPACTS AND RECOMMENDATIONS
|
2022
|
|
Global and regional estimates of violence against women::
prevalence and health effects of intimate partner violence and non-partner sexual violence
|
2013
|
|
Global Antimicrobial Resistance and Use Surveillance System:
GLASS guide for national surveillance systems for monitoring antimicrobial consumption in hospitals
|
2020
|
|
Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report:
Early implementation 2020
|
2020
|
|
Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report:
2021
|
2021
|
|
Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2021
|
2021
|
|
Global Antimicrobial Resistance Surveillance System:
Manual for Early Implementation
|
2015
|
|
Global Antimicrobial Resistance Surveillance System (GLASS):
Molecular methods for antimicrobial resistance (AMR) diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
|
2019
|
|
Global Antimicrobial Resistance Surveillance System (GLASS):
Guide to completing the GLASS implementation questionnaire
|
2016
|
|
Global Antimicrobial Resistance Surveillance System (GLASS):
Implementation questionnaire
|
2016
|
|
Global Antimicrobial Resistance Surveillance System (GLASS):
Implementation questionnaire
|
2016
|
|
Global Antimicrobial Resistance Surveillance System (GLASS):
Guide to uploading aggregated antimicrobial resistance data
|
2016
|
|
Global Antimicrobial Resistance Surveillance System (GLASS):
Guide to preparing aggregated antimicrobial resistance data files
|
2016
|
|
Global Antimicrobial Resistance Surveillance System (GLASS):
Early implementation protocol for inclusion of Candida spp.
|
2019
|
|
Global Antimicrobial Resistance Surveillance System (GLASS):
The detection and reporting of colistin resistance
|
2018
|
|
Global Antimicrobial Resistance Surveillance System (GLASS):
Guide to enrolment for antimicrobial resistance national focal points
|
2016
|
|
Global Antimicrobial Resistance Surveillance System (GLASS) Report:
Early implementation 2016-17
|
2017
|
|
Global Antimicrobial Resistance Surveillance System (GLASS) Report:
Early implementation 2017-18
|
2018
|
|
Global Atlas on cardiovascular disease prevention and control
|
2011
|
|
Global Breast Cancer Initiative Implementation Framework:
Assessing, strengthening and scaling up services for the early detection and management of breast cancer
|
2023
|
|
Global Breast Cancer Initiative Implementation Framework Assessing, strengthening and scaling up services for the early detection and management of breast cancer:
Executive summary
|
2023
|
|
A global brief on HYPERTENSION:
Silent killer, global public health crisis
|
2013
|
|
A global brief on vector-borne diseases
|
2014
|
|
GLOBAL CLIMATE CHANGE AND CHILD HEALTH:
TRAINING FOR HEALTH CARE PROVIDERS
|
2008
|
|
Global Clinical Data Platform:
Severe acute hepatitis of unknown aetiology in children
|
2022
|
|
Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030:
Report of the virtual meeting 26-30 October 2020
|
2020
|
|
Global Consultation on Diagnostics Interoperability Standards:
11-12 June 2015 Geneva, Switzerland
|
2015
|
|
Global COVID-19 Clinical Platform:
RAPID CORE CASE REPORT FORM (CRF)
|
2020
|
|
Global COVID-19 Clinical Platform: Case Record Form for suspected cases of:
Multisystem inflammatory syndrome (MIS) in children and adolescents temporally related to COVID-19
|
2020
|
|
Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF)
|
2021
|
|
Global COVID-19 Clinical Platform WITH PREGNANCY MODULE – CRF-P
|
2020
|
|
The Global Dementia Observatory Reference Guide
|
2018
|
|
Global diffusion of eHealth::
Making universal health coverage achievable
|
2016
|
|
Global Evidence Review on Health and Migration:
Refugees and migrants in times of COVID-19: mapping trends of public health and migration policies and practices
|
2021
|
|
Global genomic surveillance strategy:
for pathogens with pandemic and epidemic potential 2022–2032
|
2022
|
|
Global Health Ethics:
Key Issues
|
2015
|
|
GLOBAL HEALTH SECTOR RESPONSE TO HIV, 2000–2015:
FOCUS ON INNOVATIONS IN AFRICA
|
2015
|
|
GLOBAL HEALTH SECTOR RESPONSE TO HIV, 2000–2015:
FOCUS ON INNOVATIONS IN AFRICA
|
2015
|
|
GLOBAL HEALTH SECTOR RESPONSE TO HIV, 2000–2015 FOCUS ON INNOVATION IN AFRICA:
SIX INNOVATIONS IN AFRICA WHICH CHANGED THE COURSE OF THEIR HIV EPIDEMICS
|
2015
|
|
Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030
|
2022
|
|
GLOBAL HEALTH SECTOR STRATEGY ON:
SEXUALLY TRANSMITTED INFECTIONS 2016–2021
|
2016
|
|
GLOBAL HEALTH SECTOR STRATEGY ON HIV 2016–2021:
TOWARDS ENDING AIDS
|
2016
|
|
GLOBAL HEALTH SECTOR STRATEGY ON VIRAL HEPATITIS 2016–2021:
TOWARDS ENDING VIRAL HEPATITIS
|
2016
|
|
GLOBAL HEPATITIS REPORT, 2017
|
2017
|
|
GLOBAL HEPATITIS REPORT, 2017
|
2017
|
|
GLOBAL HIV, HEPATITIS AND STIs PROGRAMME:
WHAT’S NEW IN PERSON-CENTRED HIV PATIENT AND ANTIRETROVIRAL DRUG TOXICITY MONITORING
|
2020
|
|
Global incidence and prevalence of selected curable sexually transmitted infections – 2008
|
2012
|
|
GLOBAL INFLUENZA STRATEGY 2019-2030:
Prevent. Control. Prepare.
|
2019
|
|
GLOBAL INVESTMENTS IN TUBERCULOSIS RESEARCH AND DEVELOPMENT:
PAST, PRESENT, AND FUTURE
|
2017
|
|
Global Leprosy Strategy 2016–2020:
Accelerating towards a leprosy-free world Monitoring and Evaluation Guide
|
2017
|
|
GLOBAL MEASLES AND RUBELLA
|
2012
|
|
GLOBAL NCD TARGET:
REDUCE HIGH BLOOD PRESSURE
|
2016
|
|
The Global Network for Age-friendly Cities and Communities:
Looking back over the last decade, looking forward to the next
|
2018
|
|
Global Network of WHO Collaborating Centres for BIOETHICS:
PROGRESS REPORT 2017-2018
|
2020
|
|
Global Network of WHO Collaborating Centres for Bioethics
|
2018
|
|
GLOBAL NUTRITION:
POLICY REVIEW 2016–2017
|
2018
|
|
GLOBAL NUTRITION POLICY REVIEW 2016-2017:
COUNTRY PROGRESS IN CREATING ENABLING POLICY ENVIRONMENTS FOR PROMOTING HEALTHY DIETS AND NUTRITION
|
2018
|
|
Global Nutrition Targets 2025:
Anaemia Policy Brief
|
2014
|
|
Global Nutrition Targets 2025:
Stunting Policy Brief
|
2014
|
|
GLOBAL PLAN OF ACTION:
to strengthen the role of the health system within a national multisectoral response to address interpersonal violence, in particular against women and girls, and against children
|
2016
|
|
Global policy report on the prevention and control of viral hepatitis:
IN WHO MEMBER STATES
|
2013
|
|
GLOBAL POLIO ERADICATION INITIATIVE:
Annual Report 2017
|
2018
|
|
GLOBAL POLIO ERADICATION INITIATIVE ANNUAL REPORT 2019:
SEMI-ANNUAL STATUS UPDATES JANUARY-JUNE & JULY-DECEMBER 2019
|
2020
|
|
GLOBAL POLIO ERADICATION INITIATIVE INVESTMENT CASE 2022-2026:
INVESTING IN THE PROMISE OF A POLIO-FREE WORLD
|
2022
|
|
Global Polio Surveillance Action Plan:
2022–2024
|
2022
|
|
THE GLOBAL PREVALENCE OF ANAEMIA IN 2011
|
2015
|
|
Global Programme to Eliminate Lymphatic Filariasis:
Report of an informal meeting on transmission assessment surveys for review of the training modules and coordination for country support WHO headquarters, Geneva, 12–13 September 2012
|
2013
|
|
Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021:
Accountability for the global health sector strategies 2016–2021: actions for impact Web Annex 2: Data methods
|
2021
|
|
Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021 Accountability for the global health sector strategies 2016-2021: actions for impact:
Web Annex 1: Key data at a glance
|
2021
|
|
Global protocol:
for measuring fatty acid profiles of foods, with emphasis on monitoring trans-fatty acids originating from partially hydrogenated oils
|
2020
|
|
GLOBAL REPORT ON:
AGEISM
|
2021
|
|
GLOBAL REPORT ON DROWNING:
PREVENTING A LEADING KILLER
|
2014
|
|
GLOBAL REPORT ON DROWNING:
PREVENTING A LEADING KILLER
|
2014
|
|
GLOBAL REPORT ON EARLY WARNING INDICATORS OF HIV DRUG RESISTANCE
|
2016
|
|
Global report on infection prevention and control
|
2022
|
|
Global report on infection prevention and control Executive summary
|
2022
|
|
Global report on insecticide resistance in malaria vectors::
2010–2016
|
2018
|
|
Global School Health Initiatives: Achieving Health and Education Outcomes:
REPORT OF A MEETING Bangkok, Thailand, 23–25 November 2015
|
2017
|
|
Global Spending on Health::
Weathering the storm
|
2020
|
|
GLOBAL STANDARDS FOR QUALITY HEALTH-CARE SERVICES FOR ADOLESCENTS:
A GUIDE TO IMPLEMENT A STANDARDS-DRIVEN APPROACH TO IMPROVE THE QUALITY OF HEALTH-CARE SERVICES FOR ADOLESCENTS
|
2015
|
|
Global Status Report::
Alcohol and Young People
|
2001
|
|
Global Status Report on Alcohol 2004
|
2004
|
|
Global status report on alcohol and health 2014
|
2014
|
|
Global status report on alcohol and health 2018:
EXECUTIVE SUMMARY
|
2018
|
|
Global status report on alcohol and health 2018
|
2018
|
|
Global Status Report on Blood Safety and Availability:
2016
|
2016
|
|
GLOBAL STATUS REPORT ON BLOOD SAFETY AND AVAILABILITY 2021
|
2022
|
|
Global status report on the:
public health response to dementia
|
2021
|
|
Global status report on the public health response to dementia
|
2021
|
|
Global status report on the public health response to dementia:
Web Annex Methodology for producing global dementia cost estimates
|
2021
|
|
Global strategic directions for NURSING AND MIDWIFERY 2021-2025
|
2021
|
|
Global strategic directions for strengthening nursing and midwifery 2016–2020
|
2016
|
|
Global strategy and action plan on ageing and health
|
2017
|
|
GLOBAL STRATEGY FOR DENGUE PREVENTION AND CONTROL 2O12–2O2O
|
2012
|
|
GLOBAL STRATEGY FOR TUBERCULOSIS RESEARCH AND INNOVATION
|
2020
|
|
Global Strategy for Women’s, Children’s and Adolescents’ Health (2016—2030)::
early childhood development
|
2018
|
|
Global strategy to accelerate the elimination of cervical cancer as a public health problem
|
2020
|
|
Global strategy to reduce the harmful use of alcohol
|
2010
|
|
Global strategy to reduce the harmful use of alcohol
|
2010
|
|
Global strategy to stop health-care providers from performing female genital mutilation:
UNAIDS, UNDP, UNFPA, UNHCR, UNICEF, UNIFEM, WHO, FIGO, ICN, IOM, MWIA, WCPT, WMA
|
2010
|
|
Global Surveillance of Antibacterial Resistance in Humans:
2nd WHO Technical Consultation 18-19 March 2014 WHO Headquarters, Geneva
|
2014
|
|
Global surveillance, prevention and control of CHRONIC RESPIRATORY DISEASES:
A comprehensive approach
|
2007
|
|
GLOBAL TECHNICAL STRATEGY FOR MALARIA 2016–2030
|
2021
|
|
GLOBAL TECHNICAL STRATEGY FOR MALARIA 2016–2030
|
2015
|
|
GLOBAL TUBERCULOSIS REPORT 2018
|
2018
|
|
GLOBAL TUBERCULOSIS REPORT 2020
|
2020
|
|
GLOBAL UPDATE:
ON THE HEALTH SECTOR RESPONSE TO HIV, 2014
|
2014
|
|
GLOBAL UPDATE ON THE HEALTH SECTOR RESPONSE TO HIV, 2014
|
2014
|
|
GLOBAL VECTOR CONTROL RESPONSE:
Progress in planning and implementation
|
2020
|
|
GLOBAL VECTOR CONTROL RESPONSE 2017–2030
|
2017
|
|
Global vector control response 2017–2030
|
2017
|
|
Global workshop on enhancing sequencing to monitor SARS-CoV-2 evolution:
Report of a virtual meeting, 19 March 2021
|
2022
|
|
Good practice statement on the use of second booster doses for COVID-19 vaccines
|
2022
|
|
GRADE tables::
How accurately do the WHO 2010 immunological and clinical criteria predict virological failure in adults on ART?
|
2013
|
|
GROUP B STREPTOCOCCUS VACCINE:
POLICY AND IMPLEMENTATION ISSUES
|
2021
|
|
GROUP B STREPTOCOCCUS VACCINE:
FINANCIAL ANALYSIS
|
2021
|
|
GROUP B STREPTOCOCCUS VACCINE
|
2021
|
|
GROUP INTERPERSONAL THERAPY (IPT) FOR DEPRESSION
|
2016
|
|
GROUP PROBLEM MANAGEMENT PLUS (GROUP PM+):
Group psychological help for adults impaired by distress in communities exposed to adversity
|
2020
|
|
Groupe de travail informel sur le projet de protocole pour éliminer le commerce illicite des produits du tabac:
Résultat des deux réunions du groupe de travail
|
2011
|
|
GROUPE SPÉCIAL DE LA SOCIÉTÉ CIVILE SUR LA TUBERCULOSE DE L’OMS:
La mobilisation de la société civile : moteur du changement
|
2020
|
|
Grupo de trabajo oficioso sobre el proyecto de protocolo para la eliminación del comercio ilícito de productos de tabaco:
Resultados de las dos reuniones del grupo de trabajo
|
2011
|
|
GRUPO ESPECIAL DE LA SOCIEDAD CIVIL SOBRE LA TUBERCULOSIS ESTABLECIDO POR LA OMS:
Colaboración con la sociedad civil como impulsora del cambio
|
2020
|
|
Guía breve de los métodos analíticos para determinar las concentraciones de plomo en la sangre
|
2020
|
|
Guía breve de métodos analíticos para determinar las concentraciones de plomo en la sangre
|
2013
|
|
Guía consolidada sobre la salud y los derechos sexuales y reproductivos de las mujeres que viven con VIH
|
2017
|
|
GUÍA DE BOLSILLO::
Tratamiento médico del aborto
|
2019
|
|
GUÍA DE IMPLEMENTACIÓN DE LOS CRITERIOS MÉDICOS DE ELEGIBILIDAD Y LAS RECOMENDACIONES SOBRE PRÁCTICAS SELECCIONADAS PARA EL USO DE ANTICONCEPTIVOS DE LA OMS:
Guía de integración de los Criterios médicos de elegibilidad para el uso de anticonceptivos (MEC) y las Recomendaciones sobre prácticas seleccionadas para el uso de anticonceptivos (SPR) de la Organización Mundial de la Salud (OMS) a las pautas nacionales de planificación familiar
|
2018
|
|
Guía de planificación familiar:
para agentes de salud comunitarios y sus clientes
|
2012
|
|
Guía para la evaluación post introducción de la vacuna contra La COVID-19 (EPIc):
GUÍA PROVISIONAL
|
2021
|
|
Guía paso a paso para desarrollar una estrategia de salud pública para la extracción de oro artesanal y en pequeña escala en el contexto del Convenio de Minamata sobre el Mercurio
|
2021
|
|
Guía práctica para la preparación y ejecución de ejercicios de simulación destinados a poner a prueba y validar los planes de preparación ante la gripe pandémica
|
2019
|
|
Guía sobre la realización de evaluaciones de la eficacia de las vacunas en el contexto de las nuevas variantes del SARS-CoV-2
|
2021
|
|
Guía sobre la reglamentación relativa al Transporte de sustancias infecciosas 2013–2014
|
2012
|
|
Guía sobre la reglamentación relativa al transporte de sustancias infecciosas 2019–2020
|
2019
|
|
GUÍAS PARA EL SANEAMIENTO Y LA SALUD
|
2019
|
|
Guías para programas de mejora de la calidad en el trauma
|
2012
|
|
Guida agli interventi mhGAP:
per i disturbi psichici, neurologici e da uso di sostanze in contesti non specialistici
|
2016
|
|
A GUIDANCE DOCUMENT FOR MEDICAL TEAMS RESPONDING TO HEALTH EMERGENCIES IN ARMED CONFLICTS AND OTHER INSECURE ENVIRONMENTS
|
2021
|
|
Guidance document for WHO monographers and reviewers evaluating contaminants in food and feed
|
2017
|
|
GUIDANCE DOCUMENT ON EVALUATING AND EXPRESSING UNCERTAINTY IN HAZARD CHARACTERIZATION
|
2018
|
|
Guidance for aligning disease and hazard specific plans with national health security and International Health Regulations (2005) plans
|
2021
|
|
Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19):
Web Annex B. Treatment options for patients diagnosed with TTS following COVID-19 vaccination: Evidence-to-decision tables
|
2023
|
|
Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19):
Interim guidance
|
2021
|
|
Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19):
Web Annex A. Background document
|
2023
|
|
GUIDANCE FOR CONDUCTING A COUNTRY COVID-19 INTRA-ACTION REVIEW (IAR)
|
2020
|
|
GUIDANCE FOR CONDUCTING A COUNTRY COVID-19 INTRA-ACTION REVIEW (IAR):
ADDENDUM 1
|
2021
|
|
Guidance for laboratories shipping specimens to WHO reference laboratories that provide confirmatory testing for COVID-19 virus:
Interim guidance
|
2020
|
|
Guidance for Managing Ethical Issues in Infectious Disease Outbreaks
|
2016
|
|
Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2nd ed.:
Web Annex: Evidence summary tables
|
2014
|
|
Guidance for post-market surveillance and market surveillance of medical devices, including in vitro diagnostics
|
2020
|
|
Guidance for procurement of in vitro diagnostics and related laboratory items and equipment
|
2017
|
|
Guidance for research ethics committees for rapid review of research during public health emergencies
|
2020
|
|
GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND 48+ MONTHS
|
2017
|
|
Guidance for surveillance of SARS-CoV-2 variants
|
2021
|
|
Guidance for the surveillance of drug resistance in tuberculosis:
Sixth edition
|
2020
|
|
Guidance Framework for Testing the Sterile Insect Technique as a Vector Control Tool against Aedes-Borne Diseases
|
2020
|
|
GUIDANCE ON CENTRALIZATION OF BLOOD DONATION TESTING AND PROCESSING
|
2021
|
|
Guidance on community mental health services:
Promoting person-centred and rights-based approaches
|
2021
|
|
Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants
|
2021
|
|
Guidance on control materials for antigen detecting malaria RDTs:
Tools for preparation and validation
|
2019
|
|
Guidance on COVID-19 for the care of older people and people living in long-term care facilities, other non-acute care facilities and home care
|
2020
|
|
Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines:
INTERIM GUIDANCE
|
2020
|
|
Guidance on ethical considerations in planning and reviewing research studies on sexual and reproductive health in adolescents
|
2018
|
|
GUIDANCE ON INCREASING SUPPLIES OF PLASMA-DERIVED MEDICINAL PRODUCTS IN LOW- AND MIDDLE-INCOME COUNTRIES THROUGH FRACTIONATION OF DOMESTIC PLASMA
|
2021
|
|
Guidance on mainstreaming biodiversity for nutrition and health
|
2020
|
|
Guidance on maintaining a safe and adequate blood supply during the coronavirus disease 2019 (COVID-19) pandemic and on the collection of COVID-19 convalescent plasma:
Interim guidance
|
2020
|
|
Guidance on operational microplanning for COVID-19 vaccination:
INTERIM GUIDANCE
|
2021
|
|
Guidance on person-centred assessment and pathways in primary care
|
2019
|
|
GUIDANCE ON PRE-EXPOSURE ORAL PROPHYLAXIS (PrEP) FOR SERODISCORDANT COUPLES, MEN AND TRANSGENDER WOMEN WHO HAVE SEX WITH MEN AT HIGH RISK OF HIV::
Recommendations for use in the context of demonstration projects
|
2012
|
|
Guidance on Pre-exposure oral prophylaxis (PrEP) for serodiscordant couples, men who have sex with men and transgender women at high risk of HIV in implementation research
|
2012
|
|
Guidance on regulations for the Transport of Infectious Substances 2013–2014
|
2012
|
|
Guidance on regulations for the Transport of Infectious Substances 2015–2016
|
2015
|
|
Guidance on regulations for the Transport of Infectious Substances 2017–2018
|
2017
|
|
Guidance on regulations for the transport of infectious substances 2019–2020
|
2019
|
|
Guidance on regulations for the Transport of Infectious Substances 2021-2022:
Applicable as from 1 January 2021
|
2021
|
|
Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease)
|
2010
|
|
Guidance on the analysis and use of routine health information systems::
eye and ear care module
|
2023
|
|
Guide de déclassement des établissements de soins Ebola
|
2015
|
|
Guide de la planification familiale:
à l'usage des agents de santé communautaires et de leurs clients
|
2012
|
|
GUIDE DE MISE EN OEUVRE DES CRITÈRES D’ÉLIGIBILITÉ MÉDICALE ET DE LA SÉLECTION DE RECOMMANDATIONS PRATIQUES, RELATIFS À L’UTILISATION DE MÉTHODES CONTRACEPTIVES DE L’OMS
|
2018
|
|
Guide for clinical case management and infection prevention and control during a measles outbreak
|
2020
|
|
Guide for decision making and implementation of vector control as Alternative Treatment Strategies for elimination of onchocerciasis
|
2015
|
|
Guide for establishing a pathology laboratory in the context of cancer control
|
2019
|
|
A GUIDE FOR ORAL DISEASE PATIENTS TO QUIT TOBACCO USE
|
2017
|
|
A guide for surveillance of antimicrobial resistance in leprosy:
2017 update
|
2017
|
|
Guide for the formulation of a WHO Country Cooperation Strategy
|
2015
|
|
Guide GLASS pour les systèmes nationaux de surveillance de la consommation d’antimicrobiens en milieu hospitalier
|
2021
|
|
Guide pas-à-pas pour l’élaboration d’une stratégie de santé publique concernant l’extraction minière artisanale et à petite échelle d’or dans le cadre de la Convention de Minamata sur le mercure
|
2021
|
|
Guide pour la formulation des stratégies OMS de coopération avec les pays
|
2015
|
|
Guide pour la mise en place d’un système national d’hémovigilance
|
2017
|
|
GUIDE POUR LA PRISE EN CHARGE CLINIQUE DE LA DENGUE
|
2013
|
|
Guide pour la surveillance de la pharmacorésistance aux médicaments antituberculeux:
Sixième édition
|
2021
|
|
Guide pour l’évaluation post-introduction du vaccin contre la COVID-19 (cPIE):
DIRECTIVES PROVISOIRES
|
2021
|
|
GUIDE PRATIQUE POUR LA CONCEPTION, L’UTILISATION ET LA PROMOTION DES FICHES CONSERVÉES À DOMICILE DANS LES PROGRAMMES DE VACCINATION
|
2015
|
|
Guide pratique pour l’élaboration et la conduite d’exercices de simulation destinés à tester et à valider les plans de préparation à la grippe pandémique
|
2019
|
|
Guide pratique pour les soins aux adolescents
|
2012
|
|
Guide pratique sur l’application du Règlement relatif au Transport des matières infectieuses 2013–2014
|
2012
|
|
Guide pratique sur l’application du Règlement relatif au Transport des matières infectieuses 2015-2016
|
2015
|
|
Guide pratique sur l’application du Règlement relatif au Transport des matières infectieuses 2019–2020
|
2019
|
|
Guide pratiquede l’OMS sur la tuberculose:
Module 1 : prévention Traitement préventif de la tuberculose
|
2021
|
|
Guide succinct des méthodes de dosage du plomb dans le sang
|
2013
|
|
Guide succinct des méthodes de dosage du plomb dans le sang:
Deuxième édition
|
2020
|
|
Guide technique pour la prise en charge des maladies cardiovasculaires dans le cadre des soins de santé primaires:
Protocoles thérapeutiques basés sur des données factuelles
|
2018
|
|
Guide technique pour la prise en charge des maladies cardiovasculaires dans le cadre des soins de santé primaires:
Accès aux médicaments essentiels et aux technologies de santé de base
|
2018
|
|
Guide technique pour la prise en charge des maladies cardiovasculaires dans le cadre des soins de santé primaires:
Systèmes de suivi
|
2018
|
|
Guide to applying the WHO Eye Care Competency Framework
|
2022
|
|
GUIDE TO CANCER EARLY DIAGNOSIS
|
2017
|
|
GUIDE TO CONDUCTING PROGRAMME REVIEWS FOR THE HEALTH SECTOR RESPONSE TO HIV/AIDS
|
2013
|
|
A guide to establishing a national haemovigilance system
|
2016
|
|
A guide to family planning:
for community health workers and their clients
|
2012
|
|
Guide to G6PD deficiency rapid diagnostic testing to support P. vivax radical cure
|
2018
|
|
A Guide to Introducing a Second Dose of Measles Vaccine into Routine Immunization Schedules
|
2013
|
|
Guide to INTRODUCING HPV VACCINE INTO NATIONAL IMMUNIZATION PROGRAMMES
|
2016
|
|
GUIDE TO INTRODUCING MENINGOCOCCAL A CONJUGATE VACCINE INTO THE ROUTINE IMMUNIZATION PROGRAMME
|
2019
|
|
Guideline::
Intermittent iron supplementation in preschool and school-age children
|
2011
|
|
Guideline:
Assessing and managing children at primary health-care facilities to prevent overweight and obesity in the context of the double burden of malnutrition
|
2017
|
|
GUIDELINE::
PREVENTIVE CHEMOTHERAPY TO CONTROL SOIL-TRANSMITTED HELMINTH INFECTIONS IN AT-RISK POPULATION GROUPS
|
2017
|
|
GUIDELINE::
FORTIFICATION OF RICE WITH VITAMINS AND MINERALS AS A PUBLIC HEALTH STRATEGY
|
2018
|
|
GUIDELINE:
Alternative mass drug administration regimens to eliminate lymphatic filariasis
|
2017
|
|
Guideline::
IRON SUPPLEMENTATION in postpartum women
|
2016
|
|
GUIDELINE::
Implementing effective actions for improving ADOLESCENT NUTRITION
|
2018
|
|
GUIDELINE:
Managing possible serious bacterial infection in young infants when referral is not feasible
|
2015
|
|
GUIDELINE:
DAILY IRON SUPPLEMENTATION in infants and children
|
2016
|
|
GUIDELINE:
DAILY IRON SUPPLEMENTATION in adult women and adolescent girls
|
2016
|
|
Guideline::
Intermittent iron and folic acid supplementation in menstruating women
|
2011
|
|
Guideline::
DAILY IRON SUPPLEMENTATION IN INFANTS AND CHILDREN
|
2016
|
|
GUIDELINE::
Fortification of food-grade salt with iodine for the prevention and control of iodine deficiency disorders
|
2014
|
|
GUIDELINE::
FORTIFICATION OF WHEAT FLOUR WITH VITAMINS AND MINERALS AS A PUBLIC HEALTH STRATEGY
|
2022
|
|
GUIDELINE::
OPTIMAL SERUM AND RED BLOOD CELL FOLATE CONCENTRATIONS IN WOMEN OF REPRODUCTIVE AGE FOR PREVENTION OF NEURAL TUBE DEFECTS
|
2015
|
|
Guideline::
Daily iron and folic acid supplementation in pregnant women
|
2012
|
|
Guideline::
Calcium supplementation in pregnant women
|
2013
|
|
Guideline::
Sugars intake for adults and children
|
2015
|
|
Guideline::
INFANT FEEDING IN AREAS OF ZIKA VIRUS TRANSMISSION
|
2021
|
|
GUIDELINE::
USE OF MULTIPLE MICRONUTRIENT POWDERS FOR POINT-OF-USE FORTIFICATION OF FOODS CONSUMED BY PREGNANT WOMEN
|
2016
|
|
GUIDELINE:
UPDATES ON HIV AND INFANT FEEDING
|
2016
|
|
Guideline::
INFANT FEEDING IN AREAS OF ZIKA VIRUS TRANSMISSION
|
2016
|
|
Guideline for the pharmacological treatment of hypertension in adults:
WEB ANNEX B Evidence-to-decision frameworks
|
2021
|
|
Guideline for the pharmacological treatment of hypertension in adults:
WEB ANNEX A Summary of evidence
|
2021
|
|
Guideline for the pharmacological treatment of hypertension in adults
|
2021
|
|
Guideline for the pharmacological treatment of hypertension in adults::
summary
|
2022
|
|
GUIDELINE ON HAND HYGIENE IN HEALTH CARE IN THE CONTEXT OF FILOVIRUS DISEASE OUTBREAK RESPONSE
|
2014
|
|
GUIDELINE ON THE USE OF DEVICES FOR ADULT MALE CIRCUMCISION FOR HIV PREVENTION
|
2013
|
|
Guidelines:
for revising ivermectin treatment boundaries within the context of onchocerciasis elimination
|
2015
|
|
GUIDELINES FOR CLINICAL RESEARCH ON ACUPUNCTURE
|
1995
|
|
GUIDELINES FOR DEVELOPING A NATIONAL IMMUNIZATION STRATEGY:
FREQUENTLY ASKED QUESTIONS, KEY CONCEPTS AND TERMS
|
2021
|
|
Guidelines for essential trauma care
|
2004
|
|
GUIDELINES FOR MALARIA VECTOR CONTROL
|
2019
|
|
GUIDELINES FOR MANAGING ADVANCED HIV DISEASE AND RAPID INITIATION OF ANTIRETROVIRAL THERAPY
|
2017
|
|
Guidelines for surveillance of drug resistance in tuberculosis:
5th Edition
|
2015
|
|
Guidelines for the clinical management of severe illness from influenza virus infections
|
2022
|
|
GUIDELINES FOR THE DEVELOPMENT OF NATIONAL PROGRAMMES FOR MONITORING BIRTH DEFECTS
|
1993
|
|
Guidelines for the diagnosis, treatment and prevention of leprosy
|
2018
|
|
Guidelines for the identification and management of substance use and substance use disorders in pregnancy
|
2014
|
|
Guidelines for the Management of Conditions Specifically Related to Stress
|
2013
|
|
GUIDELINES FOR THE MANAGEMENT OF SYMPTOMATIC SEXUALLY TRANSMITTED INFECTIONS:
WEB ANNEX F. SYSTEMATIC REVIEW FOR SYNDROMIC MANAGEMENT OF THE ANORECTAL SYNDROME
|
2021
|
|
GUIDELINES FOR THE MANAGEMENT OF SYMPTOMATIC SEXUALLY TRANSMITTED INFECTIONS:
WEB ANNEX D. SYSTEMATIC REVIEW FOR SYNDROMIC MANAGEMENT OF LOWER ABDOMINAL PAIN
|
2021
|
|
GUIDELINES FOR THE MANAGEMENT OF SYMPTOMATIC SEXUALLY TRANSMITTED INFECTIONS:
WEB ANNEX G. SYSTEMATIC REVIEW ON THE ROLE OF MYCOPLASMA GENITALIUM IN ACUTE AND PERSISTENT URETHRAL DISCHARGE AND PELVIC INFLAMMATORY DISEASE
|
2021
|
|
GUIDELINES FOR THE MANAGEMENT OF SYMPTOMATIC SEXUALLY TRANSMITTED INFECTIONS:
WEB ANNEX B. UPDATED SYSTEMATIC REVIEW OF THE PERFORMANCE OF THE VAGINAL DISCHARGE SYNDROMIC MANAGEMENT IN TREATING VAGINAL AND CERVICAL INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
2021
|
|
GUIDELINES FOR THE MANAGEMENT OF SYMPTOMATIC SEXUALLY TRANSMITTED INFECTIONS:
WEB ANNEX A. SYNDROMIC MANAGEMENT OR POINT OF CARE TESTS FOR URETHRAL DISCHARGE: SYSTEMATIC REVIEW AND MATHEMATICAL MODELLING
|
2021
|
|
GUIDELINES FOR THE MANAGEMENT OF SYMPTOMATIC SEXUALLY TRANSMITTED INFECTIONS:
WEB ANNEX E. SYSTEMATIC REVIEW FOR SYNDROMIC MANAGEMENT OF GENITAL ULCER DISEASE
|
2021
|
|
GUIDELINES FOR THE MANAGEMENT OF SYMPTOMATIC SEXUALLY TRANSMITTED INFECTIONS:
WEB ANNEX C. SYSTEMATIC REVIEW OF RISK FACTORS FOR CERVICAL INFECTIONS IN SYMPTOMATIC OR ASYMPTOMATIC WOMEN
|
2021
|
|
GUIDELINES FOR THE MANAGEMENT OF SYMPTOMATIC SEXUALLY TRANSMITTED INFECTIONS:
WEB ANNEX H. DETAILED METHODS FOR THE MODELLING OF THE COST AND EFFECTIVENESS OF APPROACHES FOR MANAGING WOMEN WITH VAGINAL DISCHARGE
|
2021
|
|
Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities
|
2017
|
|
GUIDELINES FOR THE PREVENTION OF DEFORMITIES IN POLIO
|
1995
|
|
Guidelines for trauma quality improvement programmes
|
2009
|
|
Guidelines on Core Components of Infection Prevention and Control Programmes:
at the National and Acute Health Care Facility Level
|
2016
|
|
Guidelines on food fortification with micronutrients
|
2006
|
|
GUIDELINES ON HIV SELF-TESTING AND PARTNER NOTIFICATION:
SUPPLEMENT TO CONSOLIDATED GUIDELINES ON HIV TESTING SERVICES
|
2016
|
|
GUIDELINES ON LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION:
WEB ANNEX D. PROJECTED POPULATION IMPACT OF EXPANDING PREP COVERAGE BY OFFERING LONG-ACTING INJECTABLE PREP IN DIFFERENT SETTINGS: MODEL COMPARISON ANALYSIS
|
2022
|
|
GUIDELINES ON LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION:
WEB ANNEX C. SYSTEMATIC REVIEW OF THE VALUES AND PREFERENCES REGARDING THE USE OF INJECTABLE PRE-EXPOSURE PROPHYLAXIS, INCLUDING LONG-ACTING INJECTABLE CABOTEGRAVIR, TO PREVENT HIV INFECTION
|
2022
|
|
GUIDELINES ON LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION:
WEB ANNEX B. SYSTEMATIC REVIEW, META-ANALYSIS AND GRADE EVIDENCE PROFILE ON SAFETY, EFFICACY, AND EFFECTIVENESS OF LONG-ACTING INJECTABLE CABOTEGRAVIR (CAB-LA) AS PRE-EXPOSURE PROPHYLAXIS (PREP) TO REDUCE THE RISK OF HIV ACQUISITION
|
2022
|
|
GUIDELINES ON LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION:
WEB ANNEX A. DECLARATIONS OF INTEREST FOR THE GUIDELINE DEVELOPMENT GROUP AND EXTERNAL PEER REVIEWERS
|
2022
|
|
GUIDELINES ON LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION:
WEB ANNEX F. PERSPECTIVES AND PREFERENCES REGARDING LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION AMONG PRE-EXPOSURE PROPHYLAXIS (PREP) PROVIDERS: A GLOBAL SURVEY AND IN-DEPTH INTERVIEWS
|
2022
|
|
GUIDELINES ON LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION:
WEB ANNEX G. EVIDENCE-TO-DECISION MAKING TABLE
|
2022
|
|
GUIDELINES ON LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION:
WEB ANNEX E. PREDICTED EFFECTS OF INTRODUCTION OF LONG-ACTING INJECTABLE CABOTEGRAVIR PRE-EXPOSURE PROPHYLAXIS IN SUB-SAHARAN AFRICA: A MODELLING STUDY
|
2022
|
|
Guidelines on mental health promotive and preventive interventions for adolescents
|
2020
|
|
Guidelines on mental health promotive and preventive interventions for adolescents:
EXECUTIVE SUMMARY
|
2021
|
|
Guidelines on mental health promotive and preventive interventions for adolescents: helping adolescents thrive:
Web Annex. GRADE evidence profiles and tables of included studies
|
2020
|
|
GUIDELINES ON PHYSICAL ACTIVITY, SEDENTARY BEHAVIOUR AND SLEEP FOR CHILDREN UNDER 5 YEARS OF AGE
|
2019
|
|
GUIDELINES ON PHYSICAL ACTIVITY, SEDENTARY BEHAVIOUR AND SLEEP FOR CHILDREN UNDER 5 YEARS OF AGE
|
2019
|
|
GUIDELINES ON RECREATIONAL WATER QUALITY:
Volume 1 Coastal and Fresh Waters
|
2021
|
|
GUIDELINES ON SANITATION AND HEALTH
|
2018
|
|
Guidelines on the management of chronic pain in children:
Executive Summary
|
2021
|
|
Guidelines on the management of chronic pain in children
|
2020
|
|
Guidelines on the management of chronic pain in children:
WEB ANNEXES A to K
|
2020
|
|
Guidelines on the management of chronic pain in children:
WEB ANNEXES A to K
|
2020
|
|
Guidelines on the management of chronic pain in children:
Executive Summary
|
2021
|
|
GUIDELINES ON THE PUBLIC HEALTH RESPONSE TO PRETREATMENT HIV DRUG RESISTANCE
|
2017
|
|
Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults
|
2014
|
|
Guidelines on Verification of Measles and Rubella Elimination in the Western Pacific Region
|
2019
|
|
Guiding principles on Ethical issues in HIV surveillance
|
2013
|
|
Guinea Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
GUINEA-WORM DISEASE::
COUNTDOWN TO ERADICATION
|
2012
|
|
HACER FRENTE A LA EPIDEMIA DE TABAQUISMO EN UNA NUEVA ERA DE LIBERALIZACIÓN DEL COMERCIO Y LA INVERSIÓN:
Encargado por la Iniciativa Liberarse del Tabaco de la Organización Mundial de la Salud
|
2014
|
|
Hacia cero lepra:
Estrategia mundial contra la lepra (enfermedad de Hansen) 2021–2030
|
2021
|
|
HACIA UN PLAN DE ACCIÓN MUNDIAL A FAVOR DE UNA VIDA SANAY BIENESTAR PARA TODOS:
Unidos para acelerar los progresos hacia los ODS relacionados con la salud
|
2018
|
|
Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity
|
2011
|
|
Haiti Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
HAND HYGIENE FOR ALL INITIATIVE:
Improving access and behaviour in health care facilities
|
2020
|
|
Hand Hygiene in Outpatient and Home-based Care and Long-term Care Facilities:
A Guide to the Application of the WHO Multimodal Hand Hygiene Improvement Strategy and the “My Five Moments for Hand Hygiene” Approach
|
2012
|
|
Handbook for clinical management of dengue
|
2012
|
|
Handbook for conducting an adolescent health services barriers assessment (AHSBA):
with a focus on disadvantaged adolescents
|
2019
|
|
Handbook for conducting an adolescent health services barriers assessment (AHSBA) with a focus on disadvantaged adolescents:
Knowing which adolescents are being left behind on the path to universal health coverage, and why
|
2019
|
|
HANDBOOK for integrated vector management
|
2012
|
|
Handbook for public health capacity-building at ground crossings and cross-border collaboration
|
2020
|
|
HANDBOOK FOR THE ASSESSMENT OF CAPACITIES AT THE HUMAN-ANIMAL INTERFACE
|
2017
|
|
Handbook for the Management of Public Health Events in Air Transport:
Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus
|
2015
|
|
Handbook on developing national action plans to prevent child maltreatment
|
2016
|
|
HANDS-ON TRAINING WORKSHOP ON CELL CULTURE TECHNIQUES FOR THE LABORATORY DIAGNOSIS OF POLIO/ENTEROVIRUSES AND MEASLES/RUBELLA VIRUSES IN THE WESTERN PACIFIC:
19-23 May 2014, Hong Kong Special Administrative Region
|
2015
|
|
Harm to Others from Drinking::
Patterns in Nine Societies
|
2019
|
|
Health accounts production tool (HAPT):
User guide
|
2022
|
|
Health and economic impacts of transport interventions in Accra, Ghana
|
2020
|
|
The health and social effects of nonmedical cannabis use
|
2016
|
|
Health and Sustainable Development Goals:
TEAM MEETING
|
2018
|
|
Health aspects of chemical safety: Strategic directions for action of the WHO Regional Office for Europe:
Report of the meeting in Bonn, Germany, 17-19 October 2012
|
2013
|
|
Health benefits of raising ambition in Colombia’s Nationally Determined Contribution (NDC)::
WHO technical report
|
2023
|
|
Health benefits of raising ambition in Pakistan’s nationally determined contribution::
WHO technical report
|
2021
|
|
Health care for women subjected to intimate partner violence or sexual violence:
A clinical handbook
|
2014
|
|
Health care without avoidable infections:
The critical role of infection prevention and control
|
2016
|
|
Health economic assessment tool (HEAT) for walking and for cycling:
Methods and user guide on physical activity, air pollution, injuries and carbon impact assessments
|
2017
|
|
Health, environment and climate change:
Human health and biodiversity Report by the Director-General
|
2018
|
|
HEALTH EQUITY AND ITS DETERMINANTS IN THE WESTERN PACIFIC REGION
|
2020
|
|
Health Evidence Network synthesis report 64:
What are the roles of intercultural mediators in health care and what is the evidence on their contributions and effectiveness in improving accessibility and quality of care for refugees and migrants in the WHO European Region?
|
2019
|
|
Health Evidence Network synthesis report 66:
What is the evidence on availability and integration of refugee and migrant health data in health information systems in the WHO European Region?
|
2019
|
|
HEALTH FINANCING IN FRAGILE AND CONFLICT-AFFECTED SITUATIONS::
A REVIEW OF THE EVIDENCE
|
2020
|
|
HEALTH FINANCING POLICY & IMPLEMENTATION IN FRAGILE & CONFLICT-AFFECTED SETTINGS::
A SYNTHESIS OF EVIDENCE AND POLICY RECOMMENDATIONS
|
2020
|
|
Health for the World’s Adolescents:
A second chance in the second decade
|
2014
|
|
HEALTH IN ALL POLICIES:
TRAINING MANUAL
|
2015
|
|
Health in All Policies as part of the primary health care agenda on:
multisectoral action
|
2018
|
|
Health in Prisons – COVID-19:
Minimum Dataset: Summary of data reported from May 2020 to October 2021
|
2022
|
|
Health in the green economy:
Health co-benefits of climate change mitigation Transport sector
|
2011
|
|
Health Inequality Monitoring
|
2013
|
|
HEALTH INEQUALITY MONITORING WORKBOOK:
EXERCISES TO GUIDE THE PROCESS OF HEALTH INEQUALITY MONITORING
|
2022
|
|
Health literacy development for the prevention and control of noncommunicable diseases:
Volume 3 Recommended actions
|
2022
|
|
Health literacy development for the prevention and control of noncommunicable diseases:
Volume 1 Overview
|
2022
|
|
Health literacy development for the prevention and control of noncommunicable diseases:
Volume 4 Case studies from WHO National Health Literacy Demonstration Projects
|
2022
|
|
Health literacy development for the prevention and control of noncommunicable diseases:
Volume 2 A globally relevant perspective
|
2022
|
|
Health of Adolescents in China
|
2011
|
|
The health of older people in selected countries of the Western Pacific Region
|
2014
|
|
Health of refugees and migrants:
Regional situation analysis, practices, experiences, lessons learned and ways forward
|
2018
|
|
HEALTH & PEACE INITIATIVE
|
2020
|
|
Health Product Research and Development Fund:
Operational Plan for Voluntary Pooled Funding Mechanism Includes two diseases case studies on priority health products for Leishmaniasis and Schistosomiasis
|
2017
|
|
HEALTH PRODUCT RESEARCH & DEVELOPMENT FUND::
A PROPOSAL FOR FINANCING AND OPERATION
|
2016
|
|
Health Promotion Glossary of Terms 2021
|
2021
|
|
Health risk assessment from the nuclear accident after the 2011 Great East Japan Earthquake and Tsunami based on a preliminary dose estimation
|
2013
|
|
Health Risk Assessment from the nuclear accident after the 2011 Great East Japan Earthquake and Tsunami based on a preliminary dose estimation
|
2013
|
|
HEALTH SECTOR INVOLVEMENT IN THE MINAMATA CONVENTION ON MERCURY::
Outcomes of World Health Organization regional workshops for ministries of health
|
2018
|
|
Health system responses to population ageing and noncommunicable diseases in Asia
|
2016
|
|
Health system review::
Achievements and challenges
|
2016
|
|
Health Systems Governance for Universal Health Coverage Action Plan:
Department of Health Systems Governance and Financing
|
2014
|
|
HEALTH TAXES::
A PRIMER
|
2019
|
|
HEALTH TAXES
|
2018
|
|
Health warning labels on alcoholic beverages::
opportunities for informed and healthier choices
|
2022
|
|
HEALTH WORKER COMMUNICATION FOR COVID-19 VACCINATION
|
2021
|
|
Health worker Ebola infections in Guinea, Liberia and Sierra Leone
|
2015
|
|
Health worker roles in providing safe abortion care and post-abortion contraception
|
2015
|
|
Health worker roles in providing safe abortion care and post-abortion contraception
|
2015
|
|
Health worker roles in providing safe abortion care and post-abortion contraception
|
2015
|
|
Health worker roles in providing safe abortion care and post-abortion contraception
|
2015
|
|
HEALTH WORKERS’ EDUCATION AND TRAINING ON ANTIMICROBIAL RESISTANCE:
CURRICULA GUIDE
|
2019
|
|
HEALTH WORKFORCE 2030:
Towards a global strategy on human resources for health
|
2015
|
|
HEALTH WORKFORCE AND LABOUR MARKET DYNAMICS IN OECD HIGH-INCOME COUNTRIES::
A SYNTHESIS OF RECENT ANALYSES AND SIMULATIONS OF FUTURE SUPPLY AND REQUIREMENTS
|
2017
|
|
Health workforce for ageing populations
|
2016
|
|
Health workforce governance and leadership capacity in the African Region:
Review of human resources for health units in the ministries of health
|
2012
|
|
Health workforce policy and management in the context of the COVID-19 pandemic response
|
2020
|
|
Healthier food and healthier food environments at sports events:
An action guide for sports event organizers
|
2023
|
|
Health-sector involvement in chemicals management at the national level::
review of current practice
|
2014
|
|
HEALTHY CITIES:
EFFECTIVE APPROACH TO A RAPIDLY CHANGING WORLD
|
2020
|
|
A healthy diet sustainably produced
|
2018
|
|
HEALTHY ENVIRONMENTS FOR HEALTHIER POPULATIONS::
WHY DO THEY MATTER, AND WHAT CAN WE DO?
|
2019
|
|
Healthy, prosperous lives for all::
the European Health Equity Status Report
|
2019
|
|
Hearing loss:
due to recreational exposure to loud sounds
|
2015
|
|
HEARING SCREENING:
CONSIDERATIONS FOR IMPLEMENTATION
|
2021
|
|
HeartCare:
A Primer for Policy-makers and Health-care Professionals
|
2018
|
|
HEARTS:
Technical package for cardiovascular disease management in primary health care
|
2016
|
|
HEARTS Technical package for cardiovascular disease management in primary health care:
Risk-based CVD management
|
2020
|
|
HEARTS Technical package for cardiovascular disease management in primary health care:
Implementation guide
|
2018
|
|
Helping people with developmental disorders:
Meeting report: Autism Spectrum Disorders and other developmental disorders, World Health Organization, Geneva, 16-18 September 2013
|
2014
|
|
Helping people with severe mental disorders live longer and healthier lives
|
2017
|
|
Hépatite A:
Dernière mise à jour le 5 septembre 2018
|
2020
|
|
Hépatite B
|
2018
|
|
Hepatitis A
|
2018
|
|
Hepatitis B
|
2018
|
|
HERRAMIENTA DE EVALUACIÓN DE RIESGOS PARA LA SALUD HUMANA DE LA OMS::
PELIGROS QUÍMICOS
|
2017
|
|
Herramienta de evaluación rápida de tecnología de asistencia (rATA)
|
2021
|
|
Herramienta de la OMS para el cálculo de costos y presupuestos de los planes de acción nacionales contra la resistencia a los antimicrobianos:
Guía del usuario
|
2022
|
|
High blood PRESSURE and PHYSICAL ACTIVITY
|
2013
|
|
High blood pressure and the role of primary health care
|
2013
|
|
High blood pressure - country experiences and effective interventions utilized across the European Region
|
2013
|
|
High burden to high impact:
A targeted malaria response
|
2019
|
|
HIGH-DOSE IRRADIATION::
WHOLESOMENESS OF FOOD IRRADIATED WITH DOSES ABOVE lOkGy
|
1999
|
|
HIV AND ADOLESCENTS::
GUIDANCE FOR HIV TESTING AND COUNSELLING AND CARE FOR ADOLESCENTS LIVING WITH HIV
|
2013
|
|
HIV AND ADOLESCENTS: HIV TESTING AND COUNSELLING, TREATMENT AND CARE FOR ADOLESCENTS LIVING WITH HIV:
SUMMARY OF KEY FEATURES AND RECOMMENDATIONS
|
2013
|
|
HIV AND INFANT FEEDING IN EMERGENCIES::
OPERATIONAL GUIDANCE
|
2018
|
|
HIV AND YOUNG MEN WHO HAVE SEX WITH MEN
|
2015
|
|
HIV AND YOUNG PEOPLE WHO INJECT DRUGS
|
2015
|
|
HIV AND YOUNG PEOPLE WHO SELL SEX
|
2015
|
|
HIV AND YOUNG TRANSGENDER PEOPLE
|
2015
|
|
HIV DRUG RESISTANCE REPORT 2017
|
2017
|
|
HIV DRUG RESISTANCE REPORT 2019
|
2019
|
|
HIV DRUG RESISTANCE REPORT 2021
|
2021
|
|
HIV DRUG RESISTANCE STRATEGY::
2021 UPDATE
|
2021
|
|
HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE::
2015 UPDATE
|
2015
|
|
HIV DRUG RESISTANCE SURVEILLANCE IN COUNTRIES SCALING UP PRE-EXPOSURE PROPHYLAXIS
|
2020
|
|
HIV DRUG RESISTANCE SURVEILLANCE IN COUNTRIES SCALING UP PRE-EXPOSURE PROPHYLAXIS
|
2020
|
|
HIV DRUG RESISTANCE SURVEYS::
TOOL FOR DATA ENTRY
|
2017
|
|
HIV OPERATIONAL PLAN 2012 – 2013:
WHO’s support to implement the Global Health Sector Strategy on HIV/AIDS
|
2012
|
|
HIV PROGRAMME: ACHIEVING OUR GOALS:
OPERATIONAL PLAN 2014–2015
|
2014
|
|
HIV SELF-TESTING STRATEGIC FRAMEWORK:
A GUIDE FOR PLANNING, INTRODUCING AND SCALING UP
|
2018
|
|
HIV STRATEGIC INFORMATION FOR IMPACT:
MODULE FOR ASSESSING AND STRENGTHENING THE QUALITY OF VIRAL LOAD TESTING DATA WITHIN HIV PROGRAMMES AND PATIENT MONITORING SYSTEMS
|
2020
|
|
HIV STRATEGIC INFORMATION FOR IMPACT:
CASCADE DATA USE MANUAL TO IDENTIFY GAPS IN HIV AND HEALTH SERVICES FOR PROGRAMME IMPROVEMENT
|
2018
|
|
HIV TESTING SERVICES 2019
|
2020
|
|
HIV TESTING SERVICES 2019
|
2020
|
|
HIV TESTING SERVICES 2019
|
2020
|
|
HIV TREATMENT AND CARE:
TREAT ALL: POLICY ADOPTION AND IMPLEMENTATION STATUS IN COUNTRIES
|
2017
|
|
HOJA DE RUTA DEL SAGE DE LA OMS PARA EL ESTABLECIMIENTO DE PRIORIDADES EN EL USO DE VACUNAS CONTRA LA COVID-19
|
2022
|
|
HOJA DE RUTA PARA LA RESPUESTA AL VIRUS DEL EBOLA
|
2014
|
|
Hoja de ruta sobre los productos químicos
|
2017
|
|
Hoja de ruta sobre los productos químicos Cuaderno de trabajo:
Hoja de ruta para fortalecer la participación del sector de la salud en el Enfoque Estratégico de la Gestión Internacional de los Productos Químicos de cara al objetivo fijado para 2020 y años posteriores
|
2018
|
|
Holding gatherings during the COVID-19 pandemic
|
2021
|
|
Home care for patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection presenting with mild symptoms and management of contacts:
Interim guidance
|
2018
|
|
Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts:
Interim guidance
|
2020
|
|
Home care for patients with suspected or confirmed COVID-19 and management of their contacts:
Interim guidance
|
2020
|
|
Hospital-based mental health services:
Promoting person-centred and rights-based approaches
|
2021
|
|
Household Energy Assessment Rapid Tool (HEART)::
A template for conducting a rapid situational assessment and stakeholder mapping
|
2022
|
|
Household Energy Assessment Rapid Tool (HEART)
|
2022
|
|
Household energy policy repository::
An overview
|
2022
|
|
Household transmission investigation protocol for coronavirus disease 2019 (COVID-19)
|
2020
|
|
Household transmission investigation protocol for coronavirus disease 2019 (COVID-19)
|
2020
|
|
How accurately do the WHO 2010 immunological or clinical criteria predict virological failure in adults and children receiving ART?
|
2013
|
|
HOW ALCOHOL HARMS YOUNG PEOPLE AND WHAT YOU CAN DO ABOUT IT
|
2015
|
|
HOW CAN THE CARDIOVASCULAR COMMUNITY IMPROVE TOBACCO CONTROL?
|
2018
|
|
HOW TO DEVELOP A REPAIR AND MAINTENANCE SYSTEM FOR COLD CHAIN EQUIPMENT
|
2017
|
|
HOW TO MONITOR TEMPERATURES IN THE VACCINE SUPPLY CHAIN
|
2015
|
|
HOW TO OBTAIN MEASURES OF POPULATION-LEVEL SODIUM INTAKE IN 24-HOUR URINE SAMPLES:
PROTOCOL
|
2021
|
|
How to plan and conduct telehealth consultations with children and adolescents and their families
|
2021
|
|
How to safely collect blood samples by phlebotomy from patients suspected to be infected with Ebola or Marburg
|
2017
|
|
How to safely collect oral swabs (saliva) from deceased patients suspected to be infected with Ebola or Marburg
|
2017
|
|
How to safely ship human blood samples from suspected Ebola or Marburg cases within a country by road, rail and sea
|
2017
|
|
How to temperature map cold chain equipment and storage areas
|
2022
|
|
HOW TO TEMPERATURE MAP COLD CHAIN EQUIPMENT AND STORAGE AREAS
|
2019
|
|
How to use a G6PD Rapid Diagnostic Test (for detecting glucose-6-phosphate dehydrogenase deficiency):
A guide for training at health facility level
|
2018
|
|
HRP ANNUAL REPORT 2016
|
2017
|
|
HRP ANNUAL REPORT 2017
|
2018
|
|
HRP ANNUAL REPORT 2018
|
2019
|
|
HRP ANNUAL REPORT 2019
|
2020
|
|
HRP ANNUAL REPORT 2020:
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), based in the WHO Department of Sexual and Reproductive Health and Research (SRH)
|
2021
|
|
HRP ANNUAL REPORT 2021:
UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), based in the WHO Department of Sexual and Reproductive Health and Research (SRH)
|
2022
|
|
HRP ANNUAL REPORT 2022
|
2023
|
|
Human African trypanosomiasis: update of the methodological framework for clinical trials:
Report of the first meeting of the Development of New Tools subgroup Geneva, 24 September 2014
|
2015
|
|
The Human and Financial Burden of Asbestos in the WHO European Region:
Meeting Report 5-6 November 2012, Bonn, Germany
|
2013
|
|
HUMAN GENOME EDITING::
RECOMMENDATIONS
|
2021
|
|
HUMAN GENOME EDITING::
A FRAMEWORK FOR GOVERNANCE
|
2021
|
|
HUMAN GENOME EDITING ::
A FRAMEWORK FOR GOVERNANCE
|
2021
|
|
HUMAN GENOME EDITING::
POSITION PAPER
|
2021
|
|
Human health effects of polycyclic aromatic hydrocarbons as ambient air pollutants:
Report of the Working Group on Polycyclic Aromatic Hydrocarbons of the Joint Task Force on the Health Aspects of Air Pollution
|
2021
|
|
Human papillomavirus (HPV) nucleic acid amplification tests (NAATs) to screen for cervical pre-cancer lesions and prevent cervical cancer:
Policy brief
|
2022
|
|
HUMAN RESOURCES FOR MEDICAL DEVICES:
The role of biomedical engineers
|
2017
|
|
HUMAN RESOURCES FOR MEDICAL DEVICES:
The role of biomedical engineers
|
2017
|
|
HUMAN T-LYMPHOTROPIC VIRUS TYPE 1::
TECHNICAL REPORT
|
2020
|
|
HYGIENE:
UN-WATER GLAAS FINDINGS ON NATIONAL POLICIES, PLANS, TARGETS AND FINANCE
|
2020
|
|
Hypertension and COVID-19
|
2021
|
|
HYPERTENSION INDICATORS FOR IMPROVING QUALITY AND COVERAGE OF SERVICES:
Virtual meeting, 1-2 March 2021: REPORT
|
2021
|
|
Identificación y tratamiento del síndrome de Guillain-Barré en el contexto del brote de virus de Zika:
Orientación provisional
|
2016
|
|
Identification et prise en charge du syndrome de Guillain-Barré dans le contexte du virus Zika:
Lignes directrices provisoires
|
2016
|
|
Identification of risks from exposure to ENDOCRINE-DISRUPTING CHEMICALS at the country level
|
2014
|
|
ILLEGAL TRADE OF TOBACCO PRODUCTS:
WHAT YOU SHOULD KNOW TO STOP IT
|
2015
|
|
IMAGING ULTRASOUND BEFORE 24 WEEKS OF PREGNANCY:
2022 update to the WHO antenatal care recommendations for a positive pregnancy experience Technical Brief
|
2022
|
|
IMAI District Clinician Manual::
Hospital Care for Adolescents and Adults
|
2011
|
|
IMAI District Clinician Manual::
Hospital Care for Adolescents and Adults
|
2011
|
|
IMAI One-day Orientation on Adolescents Living with HIV
|
2010
|
|
“Immunity passports” in the context of COVID-19:
Scientific brief
|
2020
|
|
Immunization as an essential health service::
guiding principles for immunization activities during the COVID-19 pandemic and other times of severe disruption
|
2020
|
|
IMMUNIZATION STRESS-RELATED RESPONSES:
A manual for program managers and health professionals to prevent, identify and respond to stress-related responses following immunization
|
2019
|
|
IMMUNIZATION STRESS-RELATED RESPONSES A Synopsis:
A synopsis of the manual for program managers and health professionals to prevent, identify and respond to stress-related responses following immunization
|
2019
|
|
The Immunological Basis for Immunization Series:
Module 15: Meningococcal disease Update 2020
|
2020
|
|
The impact of COVID-19 on health and care workers::
a closer look at deaths
|
2021
|
|
Impact of COVID-19 on human resources for health and policy response: the case of Plurinational State of Bolivia, Chile, Colombia, Ecuador and Peru:
Overview of findings from five Latin American countries
|
2021
|
|
The impact of COVID-19 on mental, neurological and substance use services::
results of a rapid assessment
|
2020
|
|
Impact of HRP research in medical (non-surgical) induced abortion::
a case-study
|
2008
|
|
Impacto de la COVID-19 en los recursos humanos para la salud y respuesta de política: el caso del Estado Plurinacional de Bolivia, Chile, Colombia, Ecuador y el Perú:
Síntesis de hallazgos en cinco países de América Latina
|
2021
|
|
IMPLEMENTATION BRIEF:
INTEGRATION OF HIV TESTING AND LINKAGE IN FAMILY PLANNING AND CONTRACEPTION SERVICES
|
2021
|
|
Implementation framework:
Guidance for systems and services
|
2019
|
|
IMPLEMENTATION GUIDANCE FOR ASSESSMENTS OF FRONTLINE SERVICE READINESS:
Strengthening real-time monitoring of health services in the context of the COVID-19 pandemic
|
2021
|
|
IMPLEMENTATION GUIDE FOR THE MEDICAL ELIGIBILITY CRITERIA FOR CONTRACEPTIVE USE AND SELECTED PRACTICE RECOMMENDATIONS FOR CONTRACEPTIVE USE GUIDELINES
|
2018
|
|
Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level:
Interim practical manual supporting implementation of the Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities
|
2019
|
|
IMPLEMENTATION OF NOVEL ORAL POLIO VACCINE TYPE 2 (nOPV2) FOR CIRCULATING VACCINE-DERIVED POLIOVIRUS TYPE 2 (cVDPV2) OUTBREAK RESPONSE::
TECHNICAL GUIDANCE FOR COUNTRIES
|
2020
|
|
Implementation of post-market surveillance in cervical cancer programmes
|
2021
|
|
Implementation of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property:
Global survey report 2020
|
2022
|
|
IMPLEMENTATION & SUSTAINABILITY OF HIV DRUG RESISTANCE SURVEILLANCE IN AFRICA ADDIS ABABA, ETHIOPIA:
25–27 JUNE 2013
|
2014
|
|
IMPLEMENTATION & SUSTAINABILITY OF HIV DRUG RESISTANCE SURVEILLANCE IN AFRICA CAPE TOWN, SOUTH AFRICA:
8–10 JULY 2013
|
2014
|
|
Implementation tools:
Package of Essential Noncommunicable (PEN) disease interventions for primary health care in low-resource settings
|
2013
|
|
Implementing child maltreatment prevention programmes::
what the experts say
|
2015
|
|
IMPLEMENTING FISCAL AND PRICING POLICIES TO PROMOTE HEALTHY DIETS:
A REVIEW OF CONTEXTUAL FACTORS
|
2021
|
|
Implementing quality management systems in national regulatory authorities::
Examples and practices
|
2021
|
|
IMPLEMENTING SCHOOL FOOD AND NUTRITION POLICIES:
A REVIEW OF CONTEXTUAL FACTORS
|
2021
|
|
IMPLEMENTING TUBERCULOSIS DIAGNOSTICS:
Policy framework
|
2015
|
|
Implicaciones para la salud pública de la aplicación del Protocolo de Nagoya:
Informe del Director General
|
2021
|
|
Implications of the COVID-19 pandemic for patient safety:
A rapid review
|
2022
|
|
The importance of sexual and reproductive health and rights to prevent HIV in adolescent girls and young women in eastern and southern Africa:
Evidence brief
|
2017
|
|
Improving access to safe blood products through local production and technology transfer in blood establishments:
Phase II
|
2016
|
|
Improving access to safe blood products through local production and technology transfer in blood establishments
|
2015
|
|
IMPROVING CARDIOVASCULAR RISK IN UZBEKISTAN::
Implementing a package of essential interventions to prevent and control noncommunicable diseases successfully involved nurses and found missing men
|
2018
|
|
IMPROVING CHILDREN’S HEALTH AND THE ENVIRONMENT:
EXAMPLES FROM THE WHO EUROPEAN REGION
|
2009
|
|
IMPROVING DATA FOR DECISION-MAKING:
A TOOLKIT FOR CERVICAL CANCER PREVENTION AND CONTROL PROGRAMMES
|
2018
|
|
IMPROVING EARLY CHILDHOOD DEVELOPMENT::
WHO Guideline
|
2020
|
|
Improving hypertension control in 3 million people:
Country experiences of programme development and implementation
|
2020
|
|
IMPROVING INFECTION PREVENTION AND CONTROL AT THE HEALTH FACILITY:
Interim practical manual supporting implementation of the WHO Guidelines on Core Components of Infection Prevention and Control Programmes
|
2018
|
|
IMPROVING MEN’S UPTAKE OF HIV TESTING AND LINKAGE TO SERVICES
|
2021
|
|
IMPROVING OUTCOMES FOR ACUTE CORONARY SYNDROME IN THE RUSSIAN FEDERATION::
An example of regionalization of services for improved quality and systems of care for acute coronary syndrome in Saint Petersburg
|
2018
|
|
Improving paediatric quality of care at first-level referral hospitals:
Final Meeting on the WHO-Russian Federation Paediatric Quality of Care Improvement Initiative Geneva, Switzerland 27–28 July 2015
|
2015
|
|
Improving preterm birth outcomes
|
2015
|
|
IMPROVING SURGICAL MALE CIRCUMCISION PRACTICE — URETHRAL FISTULA::
DIAGNOSIS, FIRST MANAGEMENT AND PREVENTION
|
2021
|
|
Improving the lives of people with epilepsy::
a technical brief
|
2022
|
|
Improving the quality of care in the public health system in Bangladesh::
building on new evidence and current policy levers
|
2017
|
|
IMPROVING THE QUALITY OF PAEDIATRIC CARE:
Operational guide for facility-based audit and review of paediatric mortality
|
2018
|
|
Improving the usability and impact of WHO guidelines:
Report of a WHO workshop
|
2022
|
|
INACTIVACIÓN DEL VIRUS DEL EBOLA DURANTE LA TINCIÓN DE EXTENSIONES DE SANGRE CON COLORANTE DE GIEMSA:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR — DMP-POE-07B
|
2016
|
|
INACTIVATION DU VIRUS EBOLA LORS DE LA COLORATION DES ÉTALEMENTS DE SANG AVEC LE GIEMSA:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-07B
|
2016
|
|
Incidences pour la santé publique de la mise en oeuvre du Protocole de Nagoya:
Rapport intérimaire du Directeur général
|
2019
|
|
Incidences pour la santé publique de la mise en oeuvre du Protocole de Nagoya:
Rapport du Directeur général
|
2021
|
|
INCORPORATING INTERSECTIONAL GENDER ANALYSIS INTO RESEARCH ON INFECTIOUS DISEASES OF POVERTY::
A toolkit for health researchers
|
2020
|
|
Increasing access to clean cooking through subsidies
|
2022
|
|
Increasing equity in health service access and financing::
Health strategy, policy achievements and new challenges
|
2016
|
|
Independent State of Papua New Guinea Health System Review
|
2019
|
|
INDIA
|
2018
|
|
India Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
India Health System Review
|
2022
|
|
India Health System Review
|
2022
|
|
Indonesia Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Induced abortion
|
1978
|
|
INDUCED ABORTION::
Guidelines for the Provision of Care and Services
|
1979
|
|
INEQUALITY MONITORING IN SEXUAL, REPRODUCTIVE, MATERNAL, NEWBORN, CHILD AND ADOLESCENT HEALTH:
A STEP-BY-STEP MANUAL
|
2022
|
|
INFECTION PREVENTION AND CONTROL ASSESSMENT FRAMEWORK AT THE FACILITY LEVEL
|
2018
|
|
Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection:
Interim guidance
|
2019
|
|
Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed
|
2021
|
|
Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed:
Interim guidance
|
2020
|
|
Infection prevention and control during health care when COVID-19 is suspected:
Interim guidance
|
2020
|
|
Infection prevention and control for the safe management of a dead body in the context of COVID-19:
Interim guidance
|
2020
|
|
Infection prevention and control guidance for long-term care facilities in the context of COVID-19:
Interim guidance
|
2021
|
|
Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19:
Interim guidance
|
2020
|
|
Infection prevention and control guideline for Ebola and Marburg disease
|
2023
|
|
Infection prevention and control health-care facility response for COVID-19:
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic
|
2019
|
|
Infection prevention and control in the context of coronavirus disease (COVID-19)::
A living guideline
|
2022
|
|
Infection prevention and control in the context of coronavirus disease (COVID-19)::
A living guideline
|
2022
|
|
Infection prevention and control (IPC) principles and procedures for COVID-19 vaccination activities
|
2021
|
|
Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care:
WHO Guidelines
|
2014
|
|
Infection tuberculeuse latente:
Lignes directrices unifiées et pouractualisées lapour la prise en charge programmatique
|
2018
|
|
INFLUER SUR LES DÉTERMINANTS SOCIAUX DE LA SANTÉ PAR L’ACTION INTERSECTORIELLE ::
CINQ EXEMPLES DE POLITIQUE PUBLIQUE AU MEXIQUE
|
2014
|
|
infodemic MANAGEMENT:
AN OVERVIEW OF INFODEMIC MANAGEMENT DURING COVID-19
|
2021
|
|
INFORMACIÓN GENERAL SOBRE LA HIPERTENSIÓN EN EL MUNDO:
Día Mundial de la Salud 2013
|
2013
|
|
INFORMAL CONSULTATION TO DEVELOP PRACTICAL RECOMMENDATIONS FOR ADDRESSING VIOLENCE AGAINST WOMEN AND CHILDREN:
Virtual meeting 15–16 March 2021
|
2021
|
|
Informal working group on the draft protocol to eliminate illicit trade in tobacco products:
Outcome of the two meetings of the working group
|
2011
|
|
Information note about intake of sugars recommended in the WHO guideline for adults and children
|
2015
|
|
INFORMATION SHEET ON CHILDREN’S ENVIRONMENTAL HEALTH FOR CHW:
Pollution-free environments for healthy generations – what every community health worker needs to know about children’s environmental health
|
2022
|
|
INFORMATION SHEET ON CHILDREN’S ENVIRONMENTAL HEALTH FOR CLINICIANS:
Pollution free environments for healthy generations – what every clinician needs to know about children’s environmental health
|
2022
|
|
INFORMATION SHEET ON CHILDREN’S ENVIRONMENTAL HEALTH FOR MED-SCHOOL FACULTY:
Pollution-free environments for healthy generations – what every medical-school faculty needs to know about children’s environmental health
|
2022
|
|
INFORMATION STRATEGIQUE VIH POUR IMPACT:
GUIDE D’UTILISATION DES DONNÉES DE LA CASCADE IDENTIFICATION DES LACUNES EN MATIÈRE DE SERVICES DE SOINS DU VIH ET DE SOINS DE SANTÉ DANS LE BUT D’AMÉLIORER LES PROGRAMMES
|
2019
|
|
Informe de una consulta de la OMS destinada a aumentar la participación de las comunidades y las organizaciones no gubernamentales y otras organizaciones de la sociedad civil en la aplicación de la Estrategia para poner fin a la tuberculosis
|
2015
|
|
INFORME MUNDIAL 2015 SOBRE EL PALUDISMO:
Resumen
|
2016
|
|
INFORME MUNDIAL SOBRE AHOGAMIENTOS:
PREVENIR UNA IMPORTANTE CAUSA DE MORTALIDAD
|
2016
|
|
INFORME MUNDIAL SOBRE EL PALUDISMO 2016:
RESUMEN
|
2017
|
|
INFORME MUNDIAL SOBRE LA AUDICIÓN:
RESUMEN EJECUTIVO
|
2021
|
|
INFORME MUNDIAL SOBRE LAS HEPATITIS, 2017
|
2017
|
|
INFORME MUNDIAL SOBRE LOS AHOGAMIENTOS POR SUMERSIÓN:
PREVENCIÓN DE UNA IMPORTANTE CAUSA DE MUERTE
|
2014
|
|
Informe mundial sobre prevención de las lesiones en los niños
|
2012
|
|
Informe mundial sobre prevención de las lesiones en los niños
|
2012
|
|
Informe sobre la ejecución del presupuesto y plan de trabajo para 2010-2011:
Informe de la Secretaría del Convenio
|
2012
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRE
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRE
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2017
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2017
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRE
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRE
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2017
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2017
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRE
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN:
VIRUS DE ZIKA MICROCEFALIA SÍNDROME DE GUILLAIN-BARRÉ
|
2016
|
|
INFORME SOBRE LA SITUACIÓN DEL VIRUS DE ZIKA:
SÍNDROME NEUROLÓGICO Y MALFORMACIONES CONGÉNITAS
|
2016
|
|
Informe sobre la situación mundial de la:
respuesta de la salud pública a la demencia
|
2021
|
|
Informe sobre las repercusiones financieras y administrativas para la Secretaría de las resoluciones cuya adopción se ha propuesto al Consejo Ejecutivo y la Asamblea de la Salud
|
2014
|
|
Informe sobre las repercusiones financieras y administrativas para la Secretaría de las resoluciones cuya adopción se ha propuesto al Consejo Ejecutivo y la Asamblea de la Salud
|
2014
|
|
Informe sobre las reuniones de comités de expertos y grupos de estudio:
Informe de la Secretaría
|
2013
|
|
Informe sobre las reuniones de los comités de expertos y los grupos de estudio:
Informe del Director General
|
2020
|
|
INFOSAN:
Integrando a las Autoridades Sanitarias para Reducir el Riesgo de los Alimentos
|
2015
|
|
INFOSAN:
Mise en contact des autorités de sécurité sanitaire des aliments afin de réduire les risques d’origine alimentaire
|
2015
|
|
INFOSAN:
Connecting Food Safety Authorities to Reduce Foodborne Risks
|
2015
|
|
INFOSAN Member Roles and Responsibilities
|
2015
|
|
Inhalateurs électroniques de nicotine, dont les cigarettes électroniques:
Rapport du Secrétariat de la Convention
|
2012
|
|
Inheriting a sustainable world?:
Atlas de la santé infantile et de l'environnement
|
2018
|
|
Inheriting a sustainable world?:
Atlas sobre salud infantil y medio ambiente
|
2018
|
|
Inheriting a sustainable world?:
Atlas on children’s health and the environment
|
2017
|
|
Iniciativa de la OMS sobre desechos eléctricos y electrónicos y salud infantil
|
2021
|
|
Initial clinical management of patients exposed to chemical weapons
|
2014
|
|
Initiative de l’OMS sur les déchets d’équipements électriques et électroniques et la santé des enfants
|
2021
|
|
INITIATIVE SANTÉ ET PAIX
|
2020
|
|
Injection safety in the context of coronavirus disease (COVID-19) vaccination:
Policy brief
|
2021
|
|
INJURIES and VIOLENCE:
THE FACTS 2014
|
2014
|
|
INJURIES and VIOLENCE:
THE FACTS
|
2010
|
|
INNOVATION IN DEINSTITUTIONALIZATION::
A WHO EXPERT SURVEY
|
2014
|
|
INNOVATIVE DELIVERY SYSTEMS FOR PAEDIATRIC MEDICINES::
TECHNOLOGY LANDSCAPE
|
2020
|
|
Insecticide-treated nets for malaria transmission control in areas with insecticide-resistant mosquito populations:
PREFERRED PRODUCT CHARACTERISTICS
|
2021
|
|
INSTITUTIONALIZING HEALTH TECHNOLOGY ASSESSMENT MECHANISMS::
A HOW TO GUIDE
|
2021
|
|
Instructions for the use of the WHO Training package for the health sector
|
2019
|
|
INSTRUMENTO DE EVALUACIÓN DEL SISTEMA DE CONTROL DE LOS ALIMENTOS:
DIMENSIÓN C INTERACCIONES CON LAS PARTES INTERESADAS
|
2019
|
|
INSTRUMENTO DE EVALUACIÓN DEL SISTEMA DE CONTROL DE LOS ALIMENTOS:
DOCUMENTO DE INTRODUCCIÓN
|
2021
|
|
INSTRUMENTO DE EVALUACIÓN DEL SISTEMA DE CONTROL DE LOS ALIMENTOS:
DIMENSIÓN A APORTACIONES Y RECURSOS
|
2019
|
|
INSTRUMENTO DE EVALUACIÓN DEL SISTEMA DE CONTROL DE LOS ALIMENTOS:
DIMENSIÓN D BASE CIENTÍFICA/DE CONOCIMIENTOS Y MEJORAMIENTO CONTINUO
|
2019
|
|
INSTRUMENTO DE EVALUACIÓN DEL SISTEMA DE CONTROL DE LOS ALIMENTOS:
DIMENSIÓN B FUNCIONES DE CONTROL
|
2019
|
|
INSTRUMENTO DE EVALUACIÓN DEL SISTEMA DE CONTROL DE LOS ALIMENTOS:
INTRODUCCIÓN Y GLOSARIO
|
2019
|
|
Instrumento de previsión de suministros esenciales para la COVID-19:
Panorama general de la estructura, metodología y supuestos en que se basa
|
2020
|
|
Instrumento de previsión de suministros esenciales para la COVID-19
|
2020
|
|
Integrated care for chronic diseases in Asia Pacific countries
|
2021
|
|
INTEGRATED CARE FOR OLDER PEOPLE:
Realigning primary health care to respond to population ageing
|
2018
|
|
Integrated care for older people:
Guidelines on community-level interventions to manage declines in intrinsic capacity
|
2017
|
|
Integrated care for older people (ICOPE):
Guidelines on community-level interventions to manage declines in intrinsic capacity
|
2017
|
|
Integrated care for tuberculosis (TB) and diabetes mellitus (DM) comorbidity in Asian countries::
health system challenges and opportunities
|
2022
|
|
INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS:
Global Survey Report
|
2017
|
|
INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS:
MANAGEMENT OF THE SICK YOUNG INFANT AGE UP TO 2 MONTHS Facilitator Guide
|
2019
|
|
INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS Global Survey Report
|
2017
|
|
Integrated Management of Pregnancy and Childbirth:
WHO Recommended Interventions for Improving Maternal and Newborn Health
|
2009
|
|
INTEGRATED PEOPLE-CENTRED EAR AND HEARING CARE:
POLICY BRIEF
|
2021
|
|
Integrated people-centred eye care, including preventable vision impairment and blindness:
Report by the Director-General
|
2020
|
|
Integrated sentinel surveillance of influenza and SARS-CoV-2 and the development of the Global Influenza Surveillance and Response System Plus:
Virtual meeting 12 — 14 October 2021
|
2022
|
|
Integrated Surveillance of Antimicrobial Resistance:
Guidance from a WHO Advisory Group
|
2013
|
|
Integrated Surveillance of Antimicrobial Resistance in Foodborne Bacteria::
Application of a One Health Approach
|
2017
|
|
Integrating a focus on anti-corruption, transparency and accountability in health systems assessments
|
2018
|
|
Integrating female genital mutilation content into nursing and midwifery curricula::
A PRACTICAL GUIDE
|
2022
|
|
Integrating national programmes to eliminate lymphatic filariasis and onchocerciasis:
Strategic and technical advisory group for neglected tropical diseases subgroup on disease-specific indicators
|
2016
|
|
Integrating palliative care and symptom relief into primary health care:
A WHO guide for planners, implementers and managers
|
2018
|
|
Integrating palliative care and symptom relief into the response to humanitarian emergencies and crises:
A WHO guide
|
2018
|
|
INTEGRATING SOCIAL SCIENCE INTERVENTIONS IN EPIDEMIC, PANDEMIC AND HEALTH EMERGENCY RESPONSE:
Report of an informal consultation London, United Kingdom 8 June 2017
|
2018
|
|
INTEGRATING STAKEHOLDER AND COMMUNITY ENGAGEMENT IN QUALITY OF CARE INITIATIVES FOR MATERNAL, NEWBORN AND CHILD HEALTH
|
2020
|
|
Integrating stroke services in health-care systems::
A practical approach
|
2020
|
|
INTEGRATING THE PREVENTION, TREATMENT AND CARE OF MENTAL HEALTH CONDITIONS AND OTHER NONCOMMUNICABLE DISEASES WITHIN HEALTH SYSTEMS:
WHO EUROPEAN HIGH-LEVEL CONFERENCE ON NONCOMMUNICABLE DISEASES Time to Deliver: meeting NCD targets to achieve Sustainable Development Goals in Europe 9-10 April 2019, Ashgabat, Turkmenistan
|
2019
|
|
Interagency list of priority medical devices for essential interventions for reproductive, maternal, newborn and child health
|
2016
|
|
Intercountry Workshop on School Health in the Prevention of Noncommunicable Diseases (NCDs):
Bishkek, Kyrgyzstan, 23-25 August 2016
|
2016
|
|
INTERIM GUIDANCE FOR COUNTRY VALIDATION OF VIRAL HEPATITIS ELIMINATION
|
2021
|
|
Interim guidance for the poliomyelitis (polio) surveillance network in the context of coronavirus disease (COVID-19)
|
2020
|
|
Interim guidance on the use of rapid Ebola antigen detection tests
|
2015
|
|
Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola
|
2014
|
|
Interim performance report for the 2012–2013 workplan and budget:
Report of the Convention Secretariat
|
2012
|
|
Interim Practical Manual:
supporting national implementation of the WHO Guidelines on Core Components of Infection Prevention and Control Programmes
|
2017
|
|
Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons:
Interim guidance
|
2021
|
|
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
|
2021
|
|
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
|
2022
|
|
Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
|
2022
|
|
Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19:
Interim guidance
|
2021
|
|
Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19
|
2022
|
|
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19:
(AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
|
2021
|
|
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
|
2022
|
|
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm
|
2022
|
|
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm:
Interim guidance
|
2021
|
|
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
|
2022
|
|
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac:
Interim guidance
|
2021
|
|
Interim recommendations for use of the Moderna mRNA 1273 vaccine against COVID-19
|
2022
|
|
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19:
Interim guidance
|
2021
|
|
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19:
Interim guidance
|
2021
|
|
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19:
Interim guidance
|
2021
|
|
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
|
2022
|
|
Interim recommendations for use of the Pfizer-BioNTech COVID-19 vaccine BNT162b2, under Emergency Use Listing
|
2022
|
|
Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing
|
2022
|
|
Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
|
2022
|
|
Interim recommendations on COVID-19 vaccination in autumn 2022 for the WHO European Region
|
2022
|
|
Internal reference pricing:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
THE INTERNATIONAL CODE OF MARKETING OF BREAST-MILK SUBSTITUTES
|
2017
|
|
The International Code of Marketing of Breast-milk Substitutes::
Frequently asked questions on the roles and responsibilities of health workers
|
2020
|
|
International Conference on Autism & Neurodevelopmental Disorders:
Thimphu, Bhutan, 19–21 April 2017
|
2017
|
|
International Coordinating Group (ICG) on Vaccine Provision for Cholera, Meningitis, and Yellow Fever::
Report of the Annual Meeting 23-24 September 2020
|
2021
|
|
International Coordinating Group on Vaccine Provision for Cholera Control:
Annual meeting 12 - 13 July 2016
|
2017
|
|
International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control:
Annual meeting 7-8 July 2016
|
2017
|
|
International Coordination Group for Oral Cholera Vaccine Provision:
Report of the Annual Meeting Geneva 11–12 July 2017
|
2017
|
|
International Coordination Group on Vaccine Provision for Cholera:
Report of the Annual Meeting Geneva 19 September 2018
|
2019
|
|
International Coordination Group on Vaccine Provision for Epidemic Meningitis:
Report of the Annual Meeting Geneva 10 September 2019
|
2020
|
|
International Coordination Group on Vaccine Provision for Epidemic Meningitis:
Report of the Annual Meeting Geneva 18 September 2018
|
2019
|
|
International Coordination Group on Vaccine Provision for Epidemic Meningitis Control:
Report of the Annual Meeting Geneva 13–14 July 2017
|
2017
|
|
International Health Regulations (2005) and chemical events
|
2015
|
|
International instruments on the use of antimicrobials across the human, animal and plant sectors
|
2020
|
|
International meeting on persistence of Ebola virus RNA in semen and implications for public health
|
2018
|
|
INTERNATIONAL MINIMUM REQUIREMENTS FOR HEALTH PROTECTION IN THE WORKPLACE
|
2017
|
|
International Standards for Clinical Trial Registries:
The registration of all interventional trials is a scientific, ethical and moral responsibility
|
2018
|
|
INTERNATIONAL TRAVEL AND HEALTH – 01 JULY 2019
|
2019
|
|
Interregional meeting on leishmaniasis among neighbouring endemic countries in the Eastern Mediterranean, African and European regions:
Amman, Jordan 23-25 September 2018
|
2019
|
|
Intersectoral factors influencing equity-oriented progress towards Universal Health Coverage::
results from a scoping review of literature
|
2017
|
|
Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031
|
2023
|
|
Intervencije u području upravljanja upotrebom antimikrobnih lijekova::
vodič kroz praksu
|
2022
|
|
Intervenciones para mejorar los resultados del parto prematuro
|
2015
|
|
Interventions de gestion des antimicrobiens ::
guide pratique
|
2022
|
|
Interventions de santé numérique axées sur la jeunesse:
Cadre pour la planification, l’élaboration et la mise en oeuvre de solutions avec et pour les jeunes
|
2021
|
|
Intrapartum care for a positive childbirth experience:
Transforming care of women and babies for improved health and well-being
|
2018
|
|
Introducing and scaling up testing for human papillomavirus as part of a comprehensive programme for prevention and control of cervical cancer:
A STEP-BY-STEP-GUIDE
|
2020
|
|
INTRODUCING RUBELLA VACCINE INTO NATIONAL IMMUNIZATION PROGRAMMES:
A STEP-BY-STEP GUIDE
|
2015
|
|
INTRODUCTION DU VACCIN ANTIRUBÉOLEUX DANS LES PROGRAMMES DE VACCINATION NATIONAUX:
GUIDE PAS-À-PAS
|
2015
|
|
Introduction to Crimean-Congo Haemorrhagic Fever:
Managing infectious hazards
|
2019
|
|
Investigation of cases of human infection with Middle East respiratory syndrome coronavirus (MERS-CoV):
Interim guidance
|
2018
|
|
Investing in and building longer-term health emergency preparedness during the COVID-19 pandemic:
Interim guidance for WHO Member States
|
2020
|
|
Investing in children::
the European child maltreatment prevention action plan 2015–2020
|
2014
|
|
Investing in children::
the European child maltreatment prevention action plan 2015–2020
|
2015
|
|
Investing in eye health::
securing the support of decision-makers
|
2012
|
|
Investing in health literacy:
What do we know about the co-benefits to the education sector of actions targeted at children and young people?
|
2016
|
|
Investing the Marginal Dollar for Maternal and Newborn Health::
Geographic Accessibility Analysis for Emergency Obstetric Care services in Burkina Faso
|
2016
|
|
Investing the Marginal Dollar for Maternal and Newborn Health::
Geographic Accessibility Analysis for Emergency Obstetric Care services in Cambodia
|
2016
|
|
Investing the Marginal Dollar for Maternal and Newborn Health::
Geographic Accessibility Analysis for Emergency Obstetric Care services in Malawi
|
2016
|
|
Investing the Marginal Dollar for Maternal and Newborn Health::
Geographic Accessibility Analysis for Emergency Obstetric Care services in Lao People's Democratic Republic
|
2016
|
|
Investissements marginaux pour la Santé Maternelle et Néonatale::
Analyse de l'accessibilité géographique aux soins obstétricaux et néonataux d'urgence, Burkina Faso
|
2016
|
|
Iodine in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2020
|
|
IRRADIACIÓN EN DOSIS ALTAS::
SALUBRIDAD DE LOS ALIMENTOS IRRADIADOS CON DOSIS MAYORES DE lOkGy
|
1999
|
|
iSupport For Dementia:
Training and support manual for carers of people with dementia
|
2019
|
|
iSupport For Dementia:
Training and support manual for carers of people with dementia
|
2019
|
|
Ivermectin Treatments in APOC Countries 1997–2013
|
2014
|
|
Japan Health System Review
|
2018
|
|
Jeu complet d’interventions en matière de soins oculaires
|
2022
|
|
JEUNE ET PHYSIQUEMENT ACTIF::
schéma d’orientation visant à rendre l’activité physique attrayante pour les jeunes
|
2013
|
|
Joint FAO/WHO Expert Meeting in collaboration with OIE on Foodborne Antimicrobial Resistance: Role of the Environment, Crops and Biocides:
MEETING REPORT
|
2019
|
|
JOINT REQUEST FOR SELECTED PREVENTIVE CHEMOTHERAPY MEDICINES AND JOINT REPORTING FORM:
A USER GUIDE
|
2013
|
|
Journée internationale de la sécurité sanitaire des aliments 2021:
Aperçu des festivités et des activités créatives
|
2021
|
|
JUNG UND KÖRPERLICH AKTIV::
wie körperliche Betätigung für Jugendliche attraktiv gemacht werden kann
|
2013
|
|
Kala-Azar Elimination Programme:
Report of a WHO consultation of partners Geneva, Switzerland 10–11 February 2015
|
2015
|
|
KEEPING THE VECTOR OUT:
Housing improvements for vector control and sustainable development
|
2017
|
|
KENYA
|
2018
|
|
Kenya Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Kenya national action plan on antimicrobial resistance:
Review of progress in the human health sector
|
2022
|
|
KEY CONSIDERATIONS FOR DIFFERENTIATED ANTIRETROVIRAL THERAPY DELIVERY FOR SPECIFIC POPULATIONS::
CHILDREN, ADOLESCENTS, PREGNANT AND BREASTFEEDING WOMEN AND KEY POPULATIONS
|
2017
|
|
Key criteria for the ethical acceptability of COVID-19 human challenge studies
|
2020
|
|
Key foodborne diseases and hazards
|
2015
|
|
Key planning recommendations for mass gatherings in the context of COVID-19:
Interim guidance
|
2021
|
|
Key planning recommendations for mass gatherings in the context of COVID-19:
Interim guidance
|
2020
|
|
Key points and Q&A:
A framework for malaria elimination (2017)
|
2017
|
|
KEY POPULATIONS STRATEGIC INFORMATION:
RECOMMENDED POPULATION SIZE ESTIMATES OF MEN WHO HAVE SEX WITH MEN
|
2020
|
|
A Killer NAILED:
A reconstruction of Maldives' triumph over measles
|
2017
|
|
The Kingdom of Bhutan Health System Review
|
2017
|
|
The Kingdom of Cambodia Health System Review
|
2015
|
|
The Kingdom of Thailand Health System Review
|
2015
|
|
The Kingdom of Tonga Health System Review
|
2015
|
|
Kit de herramientas de la OMS para la evaluación de riesgos que afectan a la salud humana:
PELIGROS QUÍMICOS
|
2022
|
|
Knowledge, Attitudes and Practice surveys Zika virus disease and potential complications:
Resource pack
|
2016
|
|
KYRGYZSTAN:
Early planning for strong COVID-19 preparedness and response actions
|
2020
|
|
Kyrgyzstan Republic Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
La atención ocular en los sistemas de salud:
guía de acción
|
2022
|
|
La carga de enfermedades de transmisión alimentaria (ETA) es considerable
|
2015
|
|
La COVID-19 chez les enfants et les adolescents:
Document d’information scientifique
|
2021
|
|
La COVID-19 en niños y adolescentes:
Reseña cientifica
|
2021
|
|
LA DESPARASITACIÓN DE LAS ADOLESCENTES Y LAS MUJERES EN EDAD REPRODUCTIVA:
INFORME DE POLÍTICA
|
2021
|
|
La estimación de la carga de morbilidad de transmisión alimentaria: Un manual práctico para paises:
Una guía para la planificación, implementación y presentación de informes sobre la carga a nivel de país de las enfermedades transmitidas por los alimentos
|
2021
|
|
LA FILARIOSE LYMPHATIQUE : ENTOMOLOGIE PRATIQUE ::
MANUEL À L’INTENTION DES PROGRAMMES NATIONAUX
|
2016
|
|
La función del sector de la salud en la gestión racional de las sustancias químicas:
Informe de la Secretaría
|
2015
|
|
La función del sector de la salud en la gestión racional de las sustancias químicas:
Informe de la Secretaría
|
2016
|
|
LA GESTIÓN DE RIESGOS ANTE UNA PANDEMIA DE GRIPE:
GUÍA DE LA OMS PARA FUNDAMENTAR Y ARMONIZAR LAS MEDIDAS NACIONALES E INTERNACIONALES DE PREPARACIÓN Y RESPUESTA ANTE UNA PANDEMIA
|
2017
|
|
La higiene de las manos en la asistencia ambulatoria y domiciliaria y en los cuidados de larga duración:
Guía de aplicación de la estrategia multimodal de la OMS para la mejora de la higiene de las manos y del modelo “Los cinco momentos para la higiene de las manos”
|
2013
|
|
La implementación de sistemas de gestión de la calidad en las autoridades regulatorias nacionales::
Ejemplos y prácticas
|
2021
|
|
LA INICIATIVA E-2020 PARA LOS 21 PAÍSES QUE ESTÁN EN VÍAS DE ELIMINACIÓN DEL PALUDISMO:
Informe sobre el progreso 2019
|
2019
|
|
La lucha contra la resistencia a los antimicrobianos, incluida la resistencia a los antibióticos
|
2014
|
|
La lucha contra la resistencia a los antimicrobianos, incluida la resistencia a los antibióticos
|
2014
|
|
LA LUTTE CONTRE LA PHARMACORÉSISTANCE DU VIH ::
TENDANCES, LIGNES DIRECTRICES ET ACTION MONDIALE
|
2017
|
|
LA MALADIE DU VER DE GUINÉE::
LE COMPTE À REBOURS VERS L’ÉRADICATION
|
2012
|
|
La minería aurífera artesanal:
o de pequeña escala y la salud
|
2017
|
|
LA NECESIDAD URGENTE DE PONER EN PRÁCTICA LA GESTIÓN DE LA SANGRE DEL PACIENTE
|
2022
|
|
LA PARTICIPACIÓN DEL SECTOR DE LA SALUD EN EL CONVENIO DE MINAMATA SOBRE EL MERCURIO::
Resultados de los talleres regionales de la Organización Mundial de la Salud para los ministerios de salud
|
2018
|
|
La prevención de la violencia::
Evaluación de los resultados de programas de educación para padres
|
2014
|
|
La prévention des traumatismes et de la violence:
GUIDE A L’INTENTION DES MINISTERES DE LA SANTE
|
2007
|
|
La prévention et l’élimination du manque de respect et des mauvais traitements lors de l’accouchement dans des établissements de soins
|
2014
|
|
LA QUALITÉ DES SOINS DE SANTÉ DANS LES ZONES FRAGILES, TOUCHÉES PAR DES CONFLITS OU VULNÉRABLES:
PASSER A L’ACTION
|
2021
|
|
LA RECHERCHE POUR UNE GÉNÉRATION SANS SIDA ::
UN PROGRAMME DE RECHERCHE MONDIAL POUR LES ADOLESCENTS VIVANT AVEC LE VIH
|
2017
|
|
LA RIPOSTE MONDIALE AU VIH/SIDA Le point sur l’épidémie et sur les progrès du secteur de santé vers un accès universel:
Rapport de situation 2011
|
2012
|
|
La santé pour les adolescents du monde:
une deuxième chance pour la deuxième décennie
|
2014
|
|
LA STRATÉGIE MONDIALE DU SECTEUR DE LA SANTÉ SUR LE VIH/SIDA 2011–2015::
INTÉRIMAIRE DES PROGRÈS
|
2014
|
|
LABELLING MALARIA BLOOD FILMS:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-06A
|
2016
|
|
Laboratory biosafety guidance related to coronavirus disease (COVID-19):
Interim guidance
|
2021
|
|
Laboratory biosafety guidance related to coronavirus disease (COVID-19):
Interim guidance
|
2020
|
|
LABORATORY BIOSAFETY MANUAL FOURTH EDITION AND ASSOCIATED MONOGRAPHS:
DECONTAMINATION AND WASTE MANAGEMENT
|
2020
|
|
LABORATORY DIAGNOSIS OF BURULI ULCER:
A MANUAL FOR HEALTH-CARE PROVIDERS
|
2014
|
|
Laboratory diagnosis of Ebola virus disease
|
2014
|
|
Laboratory Methods for the Diagnosis of Meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae:
WHO MANUAL, 2ND EDITION
|
2011
|
|
Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases:
Interim guidance
|
2020
|
|
Laboratory testing for coronavirus disease (COVID-19) in suspected human cases:
Interim guidance
|
2020
|
|
Laboratory Testing for Middle East Respiratory Syndrome Coronavirus:
Interim guidance (revised)
|
2018
|
|
Laboratory testing for severe acute hepatitis of unknown aetiology in children:
Interim guidance
|
2022
|
|
Laboratory testing strategy recommendations for COVID-19:
Interim guidance
|
2020
|
|
LABORATORY-BASED SURVEY OF ACQUIRED HIV DRUG RESISTANCE USING REMNANT VIRAL LOAD SPECIMENS
|
2021
|
|
Labour and delivery outcomes of pregnant women diagnosed with COVID-19:
Based on information as at 25 May 2020
|
2020
|
|
L’Afrique du Sud
|
2008
|
|
L’amiante chrysotile
|
2014
|
|
LANDSCAPE OF DIAGNOSTICS AGAINST ANTIBACTERIAL RESISTANCE, GAPS AND PRIORITIES
|
2019
|
|
Lao DPR Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
The Lao People’s Democratic Republic Health System Review
|
2014
|
|
Las enfermedades de transmisión alimentaria (ETA) en la Región de las Américas de la OMS
|
2015
|
|
Latent tuberculosis infection:
Updated and consolidated guidelines for programmatic management Annex 2. Evidence-to-Decision and GRADE tables
|
2018
|
|
Latent tuberculosis infection:
Updated and consolidated guidelines for programmatic management Annex 3. Values and preferences for the management of latent tuberculosis infection: survey of populations affected by the recommendations
|
2018
|
|
Latent tuberculosis infection:
Updated and consolidated guidelines for programmatic management
|
2018
|
|
L'avortement provoqué
|
1978
|
|
L’AVORTEMENT PROVOQUE::
Guide pratique des soins et services requis
|
1979
|
|
LAW AND HEALTH TAXES
|
2018
|
|
Le cadre de compétences en matière de soins oculaires
|
2022
|
|
Le modèle de cadre réglementaire mondial de l’OMS relatif aux dispositifs médicaux incluant les dispositifs médicaux de diagnostic in vitro
|
2019
|
|
Le module Soins aigus:
PRISE EN CHARGE INTÉGRÉE DES MALADIES DE L’ADOLESCENT ET DE L’ADULTE
|
2004
|
|
Le partage des tâches pour améliorer l’accès à la planification familiale/à la contraception
|
2018
|
|
LE POUVOIR DES VILLES ::
COMBATTRE LES MALADIES NON TRANSMISSIBLES ET LES ACCIDENTS DE LA ROUTE
|
2020
|
|
Le projet est terminé, mais nous pouvons encore en tirer des leçons!:
Orientations pratiques pour l’évaluation a posteriori des projets de santé sexuelle et reproductive des adolescentsDépartement
|
2020
|
|
Le retard de croissance chez l’enfant : défis et perspectives:
Rapport sur un colloque diffusé en ligne concernant les enjeux opérationnels relatifs à l’élaboration et à la mise en œuvre de programmes nationaux visant à réduire le retard de croissance 14 octobre 2013 – OMS, Genève
|
2014
|
|
Le rôle du secteur de la santé dans la gestion rationnelle des produits chimiques:
Rapport du Secrétariat
|
2015
|
|
Le rôle du secteur de la santé dans l’Approche stratégique de la gestion internationale des produits chimiques en vue de l’objectif de 2020 et au-delà:
Rapport du Secrétariat
|
2016
|
|
LE TABAC VOUS BRISE LE CŒUR:
Choisissez la santé, pas le tabac
|
2018
|
|
LEAD:
TRAINING FOR HEALTH CARE PROVIDERS SECOND EDITION
|
2023
|
|
LEADING THE REALIZATION OF HUMAN RIGHTS TO HEALTH AND THROUGH HEALTH:
Report of the High-Level Working Group on the Health and Human Rights of Women, Children and Adolescents
|
2017
|
|
Learning health systems: pathways to progress:
Flagship report of the Alliance for Health Policy and Systems Research
|
2021
|
|
LEARNING SESSION ON HIV-AFFECTED ADOLESCENT MOTHERS AND THEIR CHILDREN IN SUB-SAHARAN AFRICA:
13 DECEMBER 2019, GENEVA, SWITZERLAND
|
2020
|
|
Legal access rights to health care:
COUNTRY PROFILE JAPAN
|
2019
|
|
Legal access rights to health care:
COUNTRY PROFILE GERMANY
|
2019
|
|
Legal access rights to health care:
INTRODUCTION
|
2019
|
|
Legal access rights to health care:
COUNTRY PROFILE THAILAND
|
2019
|
|
Legal access rights to health care:
COUNTRY PROFILE KENYA
|
2019
|
|
Leishmaniasis: strengthening cross-border collaboration for control in central Asian and middle-eastern countries of the WHO European and Eastern Mediterranean Regions:
Report of a bi-regional meeting Awaza, Turkmenbashi, Turkmenistan 18–20 November 2014
|
2015
|
|
Leprosy/Hansen disease::
Contact tracing and post-exposure prophylaxis
|
2020
|
|
Leprosy/Hansen Disease::
Management of reactions and prevention of disabilities
|
2020
|
|
L’équipement de protection individuelle dans le cadre de la riposte à la flambée d’infections à filovirus
|
2014
|
|
Les enfants et les décharges numériques:
Exposition aux déchets d’équipements électriques et électroniques et santé des enfants
|
2022
|
|
Les enfants et les décharges numériques Exposition aux déchets d’équipements électriques et électroniques et santé des enfants:
RÉSUMÉ POUR LES DÉCIDEURS POLITIQUES
|
2021
|
|
Les maladies d’origine alimentaire dans la Région africaine de l’OMS
|
2015
|
|
Les maladies d’origine alimentaires représentent une charge non négligeable
|
2015
|
|
LES ORIENTATIONS DE L’OMS SUR LES ACTIVITÉS INTÉGRÉES DE GESTION DES ANTIMICROBIENS
|
2021
|
|
Les « passeports d’immunité » dans le cadre de la COVID-19:
Document d’information scientifique
|
2020
|
|
Les pratiques qui améliorent la couverture par la vaccination anti-hépatite B à la naissance
|
2014
|
|
Les premiers secours psychologiques:
pendant l’épidémie de la maladie à virus Ébola
|
2014
|
|
Les premiers secours psychologiques ::
Guide pour les acteurs de terrain
|
2012
|
|
Les questions de genre et la COVID-19:
Note de sensibilisation
|
2020
|
|
Les soins de santé oculaires dans les systèmes de santé — guide d’action
|
2022
|
|
Lessons learned from applying the Accelerated Action for the Health of Adolescents (AA-HA!) guidance for policy development in early adopter countries
|
2019
|
|
Lessons learned from applying the Accelerated Action for the Health of Adolescents (AA-HA!) guidance for policy development in early adopter countries
|
2019
|
|
Lessons learned on health adaptation to climate variability and change:
Experiences across low- and middle-income countries
|
2015
|
|
L’hygiène des mains au cours des soins dans le cadre de la réponse à une flambée de maladie à filovirus
|
2014
|
|
Liberia Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Life skills education school handbook:
Prevention of noncommunicable diseases
|
2020
|
|
Life skills education school handbook:
Prevention of noncommunicable diseases
|
2020
|
|
Ligne directrice unifiée sur la santé et les droits des femmes vivant avec le VIH en matière sexuelle et reproductive
|
2017
|
|
LIGNES DIRECTRICES ::
LA CHIMIOPRÉVENTION POUR COMBATTRE LES GÉOHELMINTHIASES DANS LES GROUPES DE POPULATION À RISQUE
|
2018
|
|
Lignes directrices consolidées sur les interventions d’autoprise en charge en matière de santé:
Santé sexuelle et reproductive et droits connexes
|
2019
|
|
LIGNES DIRECTRICES DE L’OMS POUR L’UTILISATION CHEZ LES ANIMAUX DE RENTE DESTINÉS À L’ALIMENTATION HUMAINE DES ANTIMICROBIENS IMPORTANTS POUR LA MÉDECINE HUMAINE:
Résumé d’orientation
|
2017
|
|
LIGNES DIRECTRICES DE L’OMS POUR L’UTILISATION CHEZ LES ANIMAUX DE RENTE DESTINÉS À L’ALIMENTATION HUMAINE DES ANTIMICROBIENS IMPORTANTS POUR LA MÉDECINE HUMAINE:
NOTE D’ORIENTATION
|
2017
|
|
LIGNES DIRECTRICES DE L’OMS RELATIVES AU LOGEMENT ET À LA SANTÉ:
RÉSUMÉ D’ORIENTATION
|
2018
|
|
Lignes directrices de l’OMS sur la prise en charge clinique de l’exposition au plomb:
Résumé analytique
|
2021
|
|
Lignes directrices de l’OMS sur la prise en charge clinique de l’exposition au plomb
|
2022
|
|
Lignes directrices de l’OMS sur la prise en charge des complications des mutilations sexuelles féminines
|
2018
|
|
Lignes directrices de l’OMS sur la santé mentale au travail:
Résumé d’orientation
|
2022
|
|
LIGNES DIRECTRICES DE L’OMS SUR L’ACTIVITÉ PHYSIQUE ET LA SÉDENTARITÉ:
EN UN COUP D’ŒIL
|
2020
|
|
Lignes directrices de l’OMS sur les interventions d’auto-prise en charge pour la santé et le bien-être, révision 2022:
Résumé d’orientation
|
2022
|
|
Lignes directrices OMS relatives à la qualité de l’air:
Particules (PM2,5 et PM10), ozone, dioxyde d’azote, dioxyde de soufre et monoxyde de carbone Résumé d’orientation
|
2021
|
|
Lignes directrices OMS relatives à la qualité de l’air intérieur ::
consommation domestique de combustibles
|
2014
|
|
Lignes directrices pour la gestion des questions éthiques lors des flambées de maladies infectieuses
|
2018
|
|
LIGNES DIRECTRICES POUR LA LUTTE CONTRE LES VECTEURS DU PALUDISME
|
2019
|
|
LIGNES DIRECTRICES POUR LA SURVEILLANCE POST COMMERCIALISATION DES DISPOSITIFS MÉDICAUX DE DIAGNOSTIC IN VITRO (DIV)
|
2017
|
|
Lignes directrices pour l’achat de dispositifs médicaux de diagnostic in vitro et articles et équipements de laboratoire connexes
|
2017
|
|
Lignes directrices relatives à la conduite d’interventions de promotion et de prévention auprès des adolescents : aider les adolescents à s’épanouir:
RÉSUMÉ
|
2021
|
|
LIGNES DIRECTRICES RELATIVES À L’ASSAINISSEMENT ET À LA SANTÉ
|
2019
|
|
Lignes directrices sur la prise en charge de la douleur chronique chez l’enfant:
RÉSUMÉ D’ORIENTATION
|
2021
|
|
LIGNES DIRECTRICES SUR L’AUTODÉPISTAGE DU VIH ET LA NOTIFICATION AUX PARTENAIRES:
SUPPLÉMENT AUX LIGNES DIRECTRICES UNIFIÉES SUR LES SERVICES DE DÉPISTAGE DU VIH
|
2016
|
|
Lignes directrices sur les soins liés à l’avortement::
Résumé d’orientation
|
2022
|
|
Lignes directrices unifiées de l’OMS sur la tuberculose:
Module 4 : Traitement Traitement de la tuberculose pharmacorésistante
|
2020
|
|
Lignes directrices unifiées de l’OMS sur la tuberculose:
Module 5 : prise en charge de la tuberculose chez les enfants et les adolescents
|
2022
|
|
LIGNES DIRECTRICES UNIFIÉES RELATIVES À L’UTILISATION DE MÉDICAMENTS ANTIRÉTROVIRAUX POUR LE TRAITEMENT ET LA PRÉVENTION DE L’INFECTION À VIH.:
DERNIÈRES INFORMATIONS
|
2015
|
|
LIGNES DIRECTRICES UNIFIÉES SUR LES INFORMATIONS STRATÉGIQUES:
RELATIVES À L’INFECTION À VIH DANS LE SECTEUR DE LA SANTÉ
|
2015
|
|
LIGNES DIRECTRICES UNIFIÉES SUR LES SERVICES DE DÉPISTAGE DU VIH:
5C : CONSENTEMENT, CONFIDENTIALITÉ, CONSEIL, RÉSULTATS CORRECTS ET CONNEXION
|
2015
|
|
LIGNES DIRECTRICES UNIFIÉES SUR LES SERVICES DE DÉPISTAGE DU VIH FACE À L’ÉVOLUTION DE L’ÉPIDÉMIE
|
2019
|
|
LIMPIEZA Y CONSERVACIÓN DE LOS PORTAOBJETOS PARA MICROSCOPIA:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-01
|
2016
|
|
L’importance des questions de genre dans le programme pour la vaccination à l’horizon 2030
|
2022
|
|
Line probe assays for detection of drug-resistant tuberculosis:
Interpretation and reporting manual for laboratory staff and clinicians
|
2022
|
|
Lista de Produtos Assistivos Prioritários:
Melhorando o acesso a tecnologias assistivas para todos, em todos os lugares
|
2017
|
|
LISTE 2018 DES FORMULATIONS OPTIMALES ET DES MÉDICAMENTS À USAGE LIMITÉ POUR LES ANTIRÉTROVIRAUX PÉDIATRIQUES
|
2018
|
|
Liste des produits et aides techniques prioritaires:
Rendre les technologies d’assistance plus accessibles à tous, partout
|
2016
|
|
LIVE LIFE::
Preventing suicide
|
2018
|
|
Living guidance for clinical management of COVID-19:
LIVING GUIDANCE
|
2021
|
|
Llamado a la Acción para Reforzar el Compromiso de las Organizaciones Comunitarias, las Organizaciones No Gubernamentales y otras Organizaciones de la Sociedad Civil en la Implementación de la Estrategia Fin de la TB:
Resultado de una reunión de consulta de la OMS, 11 a 13 de noviembre de 2015, Addis Abeba, Etiopía
|
2015
|
|
L’OMS RECOMMANDE L’AUTOTEST DU VIH
|
2016
|
|
L’OMS RECOMMANDE QU’UNE AIDE A LA NOTIFICATION DU PARTENAIRE SOIT APPORTEE AUX PERSONNES VIVANT AVEC LE VIH
|
2016
|
|
Looking back at a year that changed the world:
WHO’S RESPONSE TO COVID-19
|
2021
|
|
Los niños y los basureros digitales:
Exposición a los residuos electrónicos y salud infantil
|
2022
|
|
Los niños y los basureros digitales: exposición a los residuos electrónicos y salud infantil:
RESUMEN PARA LOS RESPONSABLES DE LAS POLÍTICAS
|
2021
|
|
LUCHA CONTRA LAS ENT:
«Mejores inversiones» y otras intervenciones recomendadas para la prevención y el control de las enfermedades no transmisibles
|
2017
|
|
L’utilisation de l’artésunate rectal comme traitement pré-transfert pour le paludisme grave à P. falciparum
|
2022
|
|
Lutte contre les maladies non transmissibles:
Résultats de la Réunion de haut niveau de l’Assemblée générale sur la prévention et la maîtrise des maladies non transmissibles et de la Première Conférence ministérielle mondiale sur les modes de vie sains et la lutte contre les maladies non transmissibles
|
2012
|
|
Lutter contre la maltraitance des personnes âgées:
Cinq priorités pour la Décennie des Nations Unies pour le vieillissement en bonne santé [2021-2030]
|
2022
|
|
Lutter contre la violence entre partenaires intimes et la violence sexuelle à l’encontre des femmes::
recommandations cliniques et politiques
|
2013
|
|
Lutter contre les maladies tropicales négligées pour atteindre les objectifs de développement durable:
Cadre pour le suivi et l’évaluation de l’évolution de la feuille de route pour les maladies tropicales négligées 2021-2030
|
2021
|
|
Lutter contre les maladies tropicales négligées pour atteindre les objectifs de développement durable:
Feuille de route pour les maladies tropicales négligées 2021-2030
|
2021
|
|
Lutter contre les maladies tropicales négligées pour atteindre les objectifs de développement durable ::
Un cadre de viabilité applicable à l’action contre les maladies tropicales négligées 2021-2030
|
2021
|
|
LYMPHATIC FILARIASIS:
A HANDBOOK FOR NATIONAL ELIMINATION PROGRAMMES
|
2013
|
|
LYMPHATIC FILARIASIS:
AN AIDE-MÉMOIRE FOR NATIONAL PROGRAMME MANAGERS
|
2013
|
|
LYMPHATIC FILARIASIS:
FACILITATORS’ GUIDE
|
2013
|
|
LYMPHATIC FILARIASIS:
LEARNERS’ GUIDE
|
2013
|
|
Lymphatic filariasis - managing morbidity and preventing disability::
An aide-mémoire for national programme managers, Second edition
|
2021
|
|
Lymphatic filariasis - managing morbidity and preventing disability: An aide-mémoire for national programme managers, second edition:
WEB ANNEX B: Lymphatic filariasis: Situation analysis tool for morbidity management and disability prevention
|
2021
|
|
Lymphatic filariasis - managing morbidity and preventing disability: An aide-mémoire for national programme managers, Second edition:
WEB ANNEX A: Protocol for evaluating minimum package of care of morbidity management and disability prevention for lymphoedema management in designated health facilities
|
2021
|
|
Madagascar Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Mainstreaming gender within the WHO Health Emergencies Programme::
2022–2026 strategy
|
2022
|
|
Maintaining a safe and adequate blood supply and collecting convalescent plasma in the context of the COVID-19 pandemic:
Interim guidance
|
2021
|
|
Maintaining a safe and adequate blood supply during Zika virus outbreaks:
Interim guidance
|
2016
|
|
Maintaining essential health services::
operational guidance for the COVID-19 context
|
2020
|
|
Maintaining infection prevention and control measures for COVID-19 in health care facilities
|
2022
|
|
Maintaining surveillance of influenza and monitoring SARS-CoV-2:
adapting Global Influenza Surveillance and Response System (GISRS) and sentinel systems during the COVID-19 pandemic
|
2020
|
|
Maintien des mesures de lutte anti-infectieuse contre la COVID-19 dans les établissements de santé
|
2022
|
|
Make Listening Safe
|
2015
|
|
Making every school a health-promoting school:
Country case studies
|
2021
|
|
Making every school a health-promoting school:
Global standards and indicators
|
2021
|
|
Making every school a health-promoting school:
Implementation guidance
|
2021
|
|
Making health services adolescent friendly:
Developing national quality standards for adolescent friendly health services
|
2012
|
|
Making South-East Asia SAFER from alcohol related harm::
Current status and way forward
|
2019
|
|
Maladie à virus Ebola::
Principales questions-réponses concernant les déchets des activités de soins
|
2014
|
|
Maladie à virus Ebola::
Principales questions-réponses concernant l’eau, l’assainissement et l’hygiène
|
2014
|
|
Maladie à virus Ebola et animaux de compagnie
|
2014
|
|
Maladie à virus Ebola Sécurité et santé au travail
|
2014
|
|
Malaria elimination:
GUIDE FOR PARTICIPANTS
|
2016
|
|
Malaria Elimination Oversight Committee (MEOC) focused review meeting:
MEETING REPORT
|
2019
|
|
Malaria eradication: benefits, future scenarios and feasibility:
Executive summary
|
2019
|
|
Malaria eradication: benefits, future scenarios & feasibility:
A report of the Strategic Advisory Group on Malaria Eradication
|
2020
|
|
Malaria eradication: benefits, future scenarios & feasibility:
A report of the Strategic Advisory Group on Malaria Eradication
|
2020
|
|
MALARIA PARASITE COUNTING:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE — MM-SOP-09
|
2016
|
|
Malaria Prevention and Control::
An important responsibility of a Health-Promoting School
|
2007
|
|
Malaria Rapid Diagnostic Test Performance:
Summary results of WHO product testing of malaria RDTs: round 1-8 (2008–2018)
|
2018
|
|
MALARIA SURVEILLANCE, MONITORING & EVALUATION::
A REFERENCE MANUAL
|
2018
|
|
Malawi Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Malawi national action plan on antimicrobial resistance Review of progress in the human health sector:
Antimicrobial resistance policy information and action brief series
|
2022
|
|
MALAYSIA:
Strong Preparedness and Leadership for a successful COVID-19 Response
|
2020
|
|
Malaysia Health System Review
|
2013
|
|
MALE CIRCUMCISION FOR HIV PREVENTION:
WHO INFORMAL CONSULTATION ON TETANUS AND VOLUNTARY MEDICAL MALE CIRCUMCISION 9 – 10 MARCH 2015, GENEVA, SWITZERLAND
|
2015
|
|
MALE CIRCUMCISION FOR HIV PREVENTION:
WHO TECHNICAL ADVISORY GROUP ON INNOVATIONS IN MALE CIRCUMCISION: EVALUATION OF TWO ADULT DEVICES
|
2013
|
|
MALE CIRCUMCISION FOR HIV PREVENTION:
IMPLEMENTING THE 2017–2021 FRAMEWORK FOR VOLUNTARY MEDICAL MALE CIRCUMCISION
|
2017
|
|
MALE CIRCUMCISION FOR HIV PREVENTION:
WHO TECHNICAL ADVISORY GROUP ON INNOVATIONS IN MALE CIRCUMCISION 30 SEPTEMBER – 2 OCTOBER 2014, GENEVA, SWITZERLAND
|
2015
|
|
MALE CIRCUMCISION FOR HIV PREVENTION:
MANUAL FOR MALE CIRCUMCISION UNDER LOCAL ANAESTHESIA AND HIV PREVENTION SERVICES FOR ADOLESCENT BOYS AND MEN
|
2018
|
|
MALE CIRCUMCISION FOR HIV PREVENTION:
IMPROVING SURGICAL MALE CIRCUMCISION PRACTICE THROUGH EXPERIENCE: PREVENTING URETHRAL FISTULA
|
2019
|
|
MALE CIRCUMCISION FOR HIV PREVENTION:
USE OF DEVICES FOR ADULT MALE CIRCUMCISION FOR HIV PREVENTION IN EAST AND SOUTHERN AFRICA 13–14 NOVEMBER 2013, ENTEBBE, UGANDA
|
2014
|
|
Mali Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Management of asymptomatic persons who are RT-PCR positive for Middle East respiratory syndrome coronavirus (MERS-CoV):
Interim guidance
|
2018
|
|
MANAGEMENT OF BIRTH DEFECTS AND HAEMOGLOBIN DISORDERS:
REPORT OF A JOINT WHO-MARCH OF DIMES MEETING Geneva, Switzerland, 17-19 May 2006
|
2006
|
|
Management of Buruli ulcer–HIV coinfection:
Technical update
|
2020
|
|
Management of Buruli ulcer–HIV coinfection:
Technical update
|
2015
|
|
Management of ill travellers at Points of Entry (international airports, seaports, and ground crossings) in the context of COVID-19:
Interim guidance
|
2020
|
|
Management of physical health conditions in adults with severe mental disorders:
WHO GUIDELINES
|
2018
|
|
Management of pregnancy, childbirth and the postpartum period in the presence of female genital mutilation:
Report of a WHO Technical Consultation Geneva, 15-17 October 1997
|
2001
|
|
MANAGEMENT OF WASTES GENERATED FROM MALARIA DIAGNOSTIC TESTS:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-13
|
2016
|
|
Managing epidemics:
Key facts about major deadly diseases
|
2018
|
|
Managing meningitis epidemics in Africa:
A quick reference guide for health authorities and health-care workers
|
2010
|
|
Managing possible serious bacterial infection in young infants 0–59 days old when referral is not feasible
|
2017
|
|
Managing the COVID-19 infodemic:
CALL FOR ACTION
|
2020
|
|
Manejo clínico de la COVID-19:
Orientaciones evolutivas
|
2021
|
|
Manejo clínico de la COVID-19:
Orientaciones provisionales
|
2020
|
|
Manejo clínico de la infección respiratoria aguda grave (IRAG) en caso de sospecha de COVID-19:
Orientaciones provisionales
|
2020
|
|
Manejo clínico de la infección respiratoria aguda grave presuntamente causada por el nuevo coronavirus (2019-nCoV):
Orientaciones provisionales
|
2020
|
|
Manejo clínico de la infección respiratoria aguda grave presuntamente causada por el nuevo coronavirus (nCoV):
Orientaciones provisionales
|
2020
|
|
Manejo clínico de las personas sobrevivientes de violación y de violencia de pareja:
Elaboración de protocolos para situaciones de crisis humanitaria
|
2022
|
|
Manganese in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2021
|
|
Mantenimiento de la vigilancia de la gripe y seguimiento del SARS-CoV-2:
Adaptación del Sistema Mundial de Vigilancia y Respuesta a la Gripe (SMVRG) y de los sistemas centinela durante la pandemia de COVID-19 ORIENTACIONES PROVISIONALES REVISADAS
|
2022
|
|
Mantenimiento de las medidas de prevención y control de las infecciones por el virus de la COVID-19 en los establecimientos de salud
|
2022
|
|
MANUAL BÁSICO DE CUIDADO DEL OÍDO Y LA AUDICIÓN
|
2020
|
|
MANUAL DE BIOSSEGURANÇA PARA LABORATÓRIOS DA TUBERCULOSE
|
2013
|
|
MANUAL DE ENCUESTAS:
SOBRE EL CUIDADO DEL OÍDO Y LA AUDICIÓN DE LA OMS
|
2023
|
|
Manual de la OMS para la aplicación de los planes de acción nacionales sobre la resistencia a los antimicrobianos:
Guía para el sector de la salud humana
|
2022
|
|
MANUAL DE LA OMS SOBRE EL RADÓN EN INTERIORES:
UNA PERSPECTIVA DE SALUD PÚBLICA
|
2015
|
|
Manual de práctica clínica para un:
Aborto seguro
|
2014
|
|
MANUAL DE USO DE DATOS EN CASCADA:
PARA DETECTAR DEFICIENCIAS EN LOS SERVICIOS DE VIH Y DE SALUD Y MEJORAR LOS PROGRAMAS
|
2019
|
|
Manual for investigating suspected outbreaks of illnesses of possible chemical etiology:
Guidance for investigation and control
|
2021
|
|
A manual for public procurement of assistive products, accessories, spare parts and related services
|
2020
|
|
Manual for selection of molecular WHO-recommended rapid diagnostic tests:
for detection of tuberculosis and drug-resistant tuberculosis
|
2022
|
|
Manual for the Laboratory Identification and Antimicrobial Susceptibility Testing of Bacterial Pathogens of Public Health Importance in the Developing World:
Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, Neisseria gonorrhoeae, Salmonella serotype Typhi, Shigella, and Vibrio cholerae
|
2003
|
|
MANUAL for the Public Health Management of Chemical Incidents
|
2009
|
|
Manual para la elaboración de directrices:
2a edición
|
2015
|
|
Manual para la gestión de eventos de salud pública en el transporte aéreo:
Actualizado con información sobre la enfermedad por el virus del Ebola y el síndrome respiratorio de Oriente Medio por coronavirus
|
2017
|
|
MANUAL para la gestión de salud pública de los incidentes químicos
|
2016
|
|
MANUAL PARA LA INSPECCIÓN DE BUQUES Y EMISIÓN DE CERTIFICADOS DE SANIDAD A BORDO
|
2012
|
|
Manual para la investigación de presuntos brotes de enfermedades que podrían ser de origen químico:
Orientación para la investigación y la contención
|
2022
|
|
Manuel de gestion des évènements de santé publique dans le transport aérien:
Mis à jour en intégrant les informations sur la maladie à virus Ébola et le coronavirus du syndrome respiratoire du Moyen-Orient
|
2016
|
|
MANUEL DE L’OMS:
POUR LES ENQUÊTES SUR LA SANTÉ DE L’OREILLE ET DE L’AUDITION
|
2023
|
|
Manuel de l’OMS pour la mise en œuvre des plans d’action nationaux de lutte contre la résistance aux antimicrobiens:
Recommandations pour le secteur de la santé humaine
|
2022
|
|
MANUEL DE PLANIFICATION ET DE SUIVI DES STRATÉGIES NATIONALES:
POUR LES SOINS DE L’OREILLE ET DE L’AUDITION.
|
2016
|
|
Manuel destiné à l’animateur:
Premiers secours psychologiques pendant l’épidémie de la maladie à virus Ébola.
|
2014
|
|
Manuel d’évaluation des obstacles relatifs aux services de santé destinés aux adolescents,:
en particulier aux adolescents défavorisés
|
2019
|
|
Manuel d’investigation des flambées épidémiques d’étiologie chimique présumée:
Orientation pour l’investigation et la régulation
|
2022
|
|
Manuel GLASS de gestion des données de consommation des antimicrobiens
|
2021
|
|
Manuel opérationnel de l’OMS sur la tuberculose:
Module 4 : Traitement Traitement de la tuberculose pharmacorésistante
|
2021
|
|
Manuel opérationnel de l’OMS sur la tuberculose:
Module 5 : prise en charge de la tuberculose chez les enfants et les adolescents
|
2022
|
|
MANUEL pour la gestion de l’aspect santé publique des accidents chimiques
|
2016
|
|
Mapping opportunities for training in air pollution and health for the health workforce
|
2021
|
|
The MAPS Toolkit:
mHealth Assessment and Planning for Scale
|
2015
|
|
Marco de Aplicación de la Iniciativa Mundial contra el Cáncer de Mama Evaluación, fortalecimiento y expansión de los servicios de detección precoz y tratamiento del cáncer de mama:
Resumen ejecutivo
|
2023
|
|
Marco de competencias para la atención ocular
|
2022
|
|
MARCO DE COMPETENCIAS PARA LA Rehabilitación
|
2021
|
|
MARCO DE GOBERNANZA:
SOBRE LA EDICIÓN DEL GENOMA HUMANO
|
2022
|
|
Marco operacional para el desarrollo de sistemas de salud resilientes al clima
|
2017
|
|
Marco para el Fortalecimiento de la Preparación ante Emergencias Sanitarias en las Ciudades y los Entornos Urbanos
|
2022
|
|
Marco para la toma de decisiones: puesta en práctica de campañas de vacunación masiva durante la COVID-19:
Orientaciones provisionales
|
2020
|
|
MARKETING OF BREAST-MILK SUBSTITUTES::
NATIONAL IMPLEMENTATION OF THE INTERNATIONAL CODE
|
2016
|
|
MARKETING OF BREAST-MILK SUBSTITUTES::
NATIONAL IMPLEMENTATION OF THE INTERNATIONAL CODE STATUS REPORT 2018
|
2018
|
|
Marketing of Breast‑milk Substitutes::
National Implementation of the International Code
|
2020
|
|
Mark-up regulation across the pharmaceutical supply and distribution chain:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
MASS CASUALTY MANAGEMENT SYSTEMS:
Strategies and guidelines for building health sector capacity
|
2007
|
|
Mass drug administration for falciparum malaria:
A practical field manual
|
2017
|
|
Master protocol for surveillance of pfhrp2/3 deletions and biobanking to support future research
|
2020
|
|
Matériel biomédical pour la prise en charge des cas de COVID-19 – Outil de recensement:
Modules harmonisés pour l’évaluation des établissements de santé dans le contexte de la pandémie de COVID-19
|
2020
|
|
Maternal, infant and young child nutrition in East and Southern African countries::
moving to national implementation
|
2013
|
|
Mauritania Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
MAXIMIZING THE TREATMENT AND PREVENTION POTENTIAL OF ANTIRETROVIRAL DRUGS::
EARLY COUNTRY EXPERIENCES TOWARDS IMPLEMENTING A TREAT-ALL POLICY
|
2015
|
|
Meaningful engagement of adolescents and young people in national and local HIV programming
|
2019
|
|
MEASLES AND RUBELLA STRATEGIC FRAMEWORK 2021–2030
|
2020
|
|
Measuring and monitoring national prevalence of child maltreatment::
a practical handbook
|
2016
|
|
Measuring health inequalities in the context of sustainable development goals
|
2021
|
|
Measuring primary health care expenditure under SHA 2011:
Technical note, December 2021
|
2022
|
|
Measuring sexual health::
Conceptual and practical considerations and related indicators
|
2010
|
|
MEASURING THE CLIMATE RESILIENCE OF HEALTH SYSTEMS
|
2022
|
|
Medical certification, ICD mortality coding, and reporting mortality associated with COVID-19:
Technical note
|
2020
|
|
Medical eligibility criteria for contraceptive use:
Fifth edition 2015
|
2015
|
|
Medical eligibility criteria for contraceptive use Fifth edition 2015
|
2014
|
|
Medical Gas Piping System Safety
|
2023
|
|
Medical management of abortion
|
2018
|
|
Medical Oxygen Fire Risk:
Mitigation Measures
|
2023
|
|
Medición del gasto en atención primaria de salud según SHA 2011:
Nota técnica, diciembre de 2021
|
2022
|
|
Medico-legal policy note
|
2015
|
|
Medidas integrales y coordinadas para gestionar los trastornos del espectro autista:
Informe de la Secretaría
|
2013
|
|
Medidas integrales y coordinadas para gestionar los trastornos del espectro autista:
Informe de la Secretaría
|
2014
|
|
Medidas integrales y coordinadas para gestionar los trastornos del espectro autista
|
2013
|
|
Meeting of the Expanded Bangladesh, Bhutan, India, Nepal and Sri Lanka (BBINS) Malaria Drug Resistance Monitoring Network (including Indonesia, Maldives and Timor-Leste)
|
2020
|
|
Meeting of the International Task Force for Disease Eradication, April 2018
|
2019
|
|
Meeting of the WHO Informal Working Group on Echinococcosis on the occasion of the XXV World Congress of Echinococcosis Khartoum, Sudan, 25 November 2013:
Summary report
|
2014
|
|
MEETING OF THE WHO INFORMAL WORKING GROUP ON ECHINOCOCCOSIS (WHO-IWGE):
WHO Headquarters, Geneva, Switzerland 15–16 December 2016
|
2017
|
|
Meeting on enteric and diarrhoeal diseases surveillance, prevention and control with a focus on cholera, typhoid and rotavirus in the Eastern Mediterranean Region
|
2020
|
|
Meeting on the implementation of the global action plan on the public health response to dementia:
Meeting report: 11-12 December 2017, World Health Organization, Geneva, Switzerland
|
2018
|
|
MEETING REPORT:
Operationalizing Nurturing Care
|
2018
|
|
MEETING REPORT:
World Conference on Social Determinants of Health
|
2012
|
|
MEETING REPORT:
TRAINING FOR LEADERSHIP AND ADVOCACY TEAMS TO REDUCE ALCOHOL HARM IN YOUNG PEOPLE IN SELECTED COUNTRIES IN THE WESTERN PACIFIC REGION (MODULE 3)
|
2019
|
|
MEETING REPORT:
REGIONAL FORUM ON PROTECTING YOUNG PEOPLE FROM THE HARMFUL USE OF ALCOHOL
|
2016
|
|
MEETING REPORT:
TRAINING FOR LEADERSHIP AND ADVOCACY TEAMS TO REDUCE ALCOHOL HARM IN YOUNG PEOPLE IN SELECTED COUNTRIES IN THE WESTERN PACIFIC REGION (MODULE 2)
|
2018
|
|
MEETING REPORT:
Nurturing human capital along the life course: Investing in early child development
|
2013
|
|
MEETING REPORT:
BIREGIONAL WORKSHOP ON HEALTH FINANCING FOR UNIVERSAL HEALTH COVERAGE IN ASIA AND THE PACIFIC BEYOND COVID-19
|
2021
|
|
Meeting report:
First meeting of the Global Network of WHO national counterparts for implementation of the Global strategy to reduce the harmful use of alcohol
|
2011
|
|
Meeting report:
Consultation on the Development of Guidance on How to Incorporate the Results of Modelling into WHO Guidelines, Geneva, Switzerland, 27-29 April 2016
|
2017
|
|
MEETING REPORT:
COMMUNICATION FOR HEALTH (C4H): BUILDING ON EXPERIENCES IN THE CONTEXT OF COVID-19 TO STRENGTHEN USE OF STRATEGIC COMMUNICATIONS IN THE WESTERN PACIFIC REGION
|
2021
|
|
Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions:
17-19 November 2020
|
2021
|
|
Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis,:
27-29 October 2020
|
2021
|
|
MEETING REPORT ON ASSESSMENT OF WORLD HEALTH ORGANIZATION HIV DRUG RESISTANCE EARLY WARNING INDICATORS:
Report of the Early Warning Indicator Advisory Panel Meeting
|
2012
|
|
MEETING REPORT ON WHO RESNET ANNUAL MEETING
|
2012
|
|
MEETING SUMMARY OF THE WHO CONSULTATION ON POTENTIAL EBOLA THERAPIES AND VACCINES
|
2014
|
|
Meeting to Develop a Global Consensus on Preconception Care to Reduce Maternal and Childhood Mortality and Morbidity:
World Health Organization Headquarters, Geneva 6–7 February 2012 Meeting report
|
2013
|
|
Meetings of the Malaria Elimination Certification Panel (MECP):
Report of two virtual meetings, 3–4 February 2021 and 17 July 2021
|
2022
|
|
Mejorar la calidad de la asistencia sanitaria prestada a los adolescentes mediante un enfoque basado en normas
|
2015
|
|
Mekong Malaria Elimination:
Epidemiology summary
|
2020
|
|
Mekong Malaria Elimination (MME) Programme Partners’ Forum
|
2018
|
|
THE MEKONG MALARIA ELIMINATION PROGRAMME:
ACCELERATING MALARIA ELIMINATION IN THE GREATER MEKONG
|
2022
|
|
Meningitis outbreak response in sub-Saharan Africa:
WHO guideline
|
2014
|
|
Men’s and women’s perceptions of the relationship between female genital mutilation and women’s sexuality in three communities in Egypt
|
2010
|
|
MENTAL HEALTH ACTION PLAN 2013-2020
|
2013
|
|
MENTAL HEALTH AND CLIMATE CHANGE::
POLICY BRIEF
|
2022
|
|
Mental Health and COVID-19::
Early evidence of the pandemic’s impact
|
2022
|
|
Mental health and psychosocial considerations during the COVID-19 outbreak
|
2020
|
|
Mental health and psychosocial support for conflict-related sexual violence::
10 myths
|
2012
|
|
Mental health and psychosocial support for conflict-related sexual violence::
principles and interventions
|
2012
|
|
MENTAL HEALTH ATLAS 2017
|
2018
|
|
MENTAL HEALTH ATLAS 2017
|
2018
|
|
MENTAL HEALTH ATLAS 2020
|
2021
|
|
Mental health crisis services:
Promoting person-centred and rights-based approaches
|
2021
|
|
Mental health of people with neglected tropical diseases:
Towards a person-centred approach
|
2020
|
|
Mental health promotion and mental health care in refugees and migrants:
Technical guidance
|
2018
|
|
Mental health promotion and mental health care in refugees and migrants::
policy brief
|
2018
|
|
Mental health, resilience and inequalities
|
2009
|
|
Mental Health Status of Adolescents in South-East Asia::
Evidence for Action
|
2017
|
|
Menú de indicadores de atención ocular (ECIM):
Una herramienta para monitorear estrategias y acciones para la atención ocular
|
2022
|
|
MENÚ DE INDICADORES DE REHABILITACION:
Una herramienta complementaria al Marco para el Monitoreo y la Evaluación de la Rehabilitación
|
2020
|
|
MENU DES INDICATEURS DE LA RÉADAPTATION:
Outil pour accompagner le Cadre de suivi et d’évaluation de la réadaptation (FRAME)
|
2020
|
|
Menu d‘indicateur de soins oculaires (ECIM):
Un outil de suivi des stratégies et des actions en matière de soins oculaires
|
2022
|
|
MERCURIO EN PRODUCTOS QUE ACLARAN LA PIEL
|
2019
|
|
MERCURY IN SKIN LIGHTENING PRODUCTS
|
2019
|
|
MESSAGES CLÉS DE L’EXPOSÉ DE LA POSITION DE L’OMS:
Renforcer la résilience des systèmes de santé pour instaurer la couverture sanitaire universelle et la sécurité sanitaire pendant et après la pandémie de COVID-19
|
2021
|
|
Mesurer les dépenses de soins de santé primaires dans le cadre du Système de comptes de la santé 2011:
Note technique, décembre 2021
|
2022
|
|
Mesures globales et coordonnées pour la prise en charge des troubles du spectre autistique
|
2013
|
|
Mesures globales et coordonnées pour la prise en charge des troubles du spectre autistique:
Rapport du Secrétariat
|
2014
|
|
Mesures globales et coordonnées pour la prise en charge des troubles du spectre autistique:
Rapport du Secrétariat
|
2013
|
|
Metas mundiales de nutrición 2025:
Documento normativo sobre retraso del crecimiento
|
2017
|
|
Metas mundiales de nutrición 2025:
Documento normativo sobre anemia
|
2017
|
|
Méthodologie GLASS pour la surveillance de la consommation des antimicrobiens au niveau national
|
2021
|
|
Methods and operating procedures for aircraft disinsection:
Report of a WHO consultation Geneva, 3–4 July 2018
|
2018
|
|
Methods to analyse medicine utilization and expenditure to support pharmaceutical policy implementation
|
2018
|
|
mhGAP Community Toolkit:
Mental Health Gap Action Programme (mhGAP)
|
2019
|
|
mhGAP Intervention Guide:
for mental, neurological and substance use disorders in non-specialized health settings
|
2016
|
|
mhGAP operations manual
|
2018
|
|
mhGAP training manuals:
for the mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
|
2017
|
|
MICROSCOPY EXAMINATION OF THICK AND THIN BLOOD FILMS FOR IDENTIFICATION OF MALARIA PARASITES:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE — MM-SOP-08
|
2016
|
|
Middle East respiratory syndrome coronavirus (MERS-CoV):
Summary of Current Situation, Literature Update and Risk Assessment
|
2015
|
|
Mid-level health-care providers are a safe alternative to doctors for first-trimester abortions in developing countries
|
2008
|
|
Milk fluoridation for the prevention of dental caries
|
2009
|
|
Minamata Convention on Mercury:
Annotated bibliography of WHO information
|
2021
|
|
MINIMUM TECHNICAL STANDARDS AND RECOMMENDATIONS FOR REHABILITATION:
Emergency Medical Teams
|
2016
|
|
Mise en oeuvre de systèmes de gestion de la qualité dans les autorités nationales de réglementation ::
Exemples et pratiques
|
2021
|
|
Mise en place de programmes d’évaluation externe de la qualité appliqués au dépistage des infections transmissibles par transfusion dans les dons de sang
|
2016
|
|
MISE EN ŒUVRE DU NOUVEAU VACCIN ANTIPOLIOMYÉLITIQUE ORAL DE TYPE 2 (nVPO2) POUR LA RIPOSTE AUX FLAMBÉES DUES À DES POLIOVIRUS CIRCULANTS DÉRIVÉS DE SOUCHES VACCINALES DE TYPE 2 (PVDVc2)::
ORIENTATION TECHNIQUE POUR LES PAYS
|
2020
|
|
Mobiliser le secteur privé de la prestation de services de santé grâce à la gouvernance des systèmes de santé mixtes:
stratégie du Groupe consultatif de l’OMS sur la gouvernance du secteur privé pour la couverture sanitaire universelle
|
2021
|
|
MOBILIZING AMBITIOUS AND IMPACTFUL COMMITMENTS FOR MAINSTREAMING NUTRITION IN HEALTH SYSTEMS:
Nutrition in universal health coverage Global nutrition summit
|
2020
|
|
Model Disability Survey (MDS):
SURVEY MANUAL
|
2017
|
|
Modelling the health impacts of disruptions to essential health services during COVID-19:
Module 1: Understanding modelling approaches for sexual, reproductive, maternal, newborn, child and adolescent health, and nutrition
|
2021
|
|
MODELS TO INFORM FAST TRACKING VOLUNTARY MEDICAL MALE CIRCUMCISION IN HIV COMBINATION PREVENTION:
23–24 MARCH 2016
|
2017
|
|
Modern food biotechnology, human health and development::
an evidence-based study
|
2005
|
|
Modes Opératoires Normalisés pour Déterminer la Teneur en Nicotine, Glycérol et Propylèneglycol des E-Liquides
|
2022
|
|
MODULE FOR ASSESSING AND STRENGTHENING THE QUALITY OF VIRAL LOAD TESTING DATA WITHIN HIV PROGRAMMES AND PATIENT MONITORING SYSTEMS
|
2020
|
|
MODULE POUR L’ÉVALUATION ET LE RENFORCEMENT DE LA QUALITÉ DES DONNÉES SUR LA MESURE DE LA CHARGE VIRALE DANS LE CADRE DES PROGRAMMES DE LUTTE CONTRE LE VIH ET DES SYSTÈMES DE SUIVI DES PATIENTS:
OUTIL DE MISE EN OEUVRE
|
2021
|
|
MOLECULAR DIAGNOSTICS INTEGRATION GLOBAL MEETING REPORT
|
2019
|
|
Mongolia Health System Review
|
2013
|
|
MONITOREO DE AVANCES:
EN MATERIA DE LAS ENFERMEDADES NO TRANSMISIBLES 2017
|
2017
|
|
MONITOREO DE AVANCES EN MATERIA DE LAS ENFERMEDADES NO TRANSMISIBLES 2020
|
2020
|
|
MONITOREO DE LAS DESIGUALDADES EN LA SALUD SEXUAL, REPRODUCTIVA, MATERNA, NEONATAL, INFANTIL Y ADOLESCENTE:
MANUAL PASO A PASO
|
2022
|
|
MONITOREO DE LOS AVANCES EN RELACIÓN CON:
LAS ENFERMEDADES NO TRANSMISIBLES 2022
|
2022
|
|
MONITORING AND EVALUATION OF THE GLOBAL ACTION PLAN ON ANTIMICROBIAL RESISTANCE:
Framework and recommended indicators
|
2019
|
|
MONITORING AND RESTRICTING DIGITAL MARKETING OF UNHEALTHY PRODUCTS TO CHILDREN AND ADOLESCENTS
|
2019
|
|
Monitoring children’s development in primary care services::
moving from a focus on child deficits to family-centred participatory support
|
2020
|
|
Monitoring COVID-19 vaccination:
Considerations for the collection and use of vaccination data
|
2021
|
|
MONITORING FLOUR FORTIFICATION TO MAXIMIZE HEALTH BENEFITS::
A MANUAL FOR MILLERS, REGULATORS, AND PROGRAMME MANAGERS
|
2021
|
|
Monitoring human rights in contraceptive services and programmes
|
2017
|
|
Monkeypox:
Current status in West and Central Africa
|
2018
|
|
Moving towards culturally competent, migrant-inclusive health systems::
a comparative study of Malaysia and Thailand
|
2021
|
|
MOZAMBIQUE – A comprehensive community-based service delivery intervention for TB
|
2020
|
|
Mozambique Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
mRNA-1273 vaccine (Moderna) against COVID-19 Background document:
DRAFT
|
2021
|
|
MULTI-COUNTRY ASSESSMENT OF NATIONAL CAPACITY TO PROVIDE HEARING CARE
|
2013
|
|
A multi-country study on gender, sexuality and vaginal practices::
Implications for sexual health
|
2012
|
|
Multisystem inflammatory syndrome in children and adolescents with COVID-19:
Scientific brief
|
2020
|
|
Mutilations génitales féminines et devenir obstétrical::
étude prospective concertée dans six pays africains*
|
2006
|
|
Myanmar Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Nairobi 2006::
Trust and the Future of Adaptation Funding
|
2007
|
|
National Action for Global Change on Antimicrobial Resistance
|
2016
|
|
National antimicrobial resistance surveillance systems and participation in the Global Antimicrobial Resistance Surveillance System (GLASS):
Core components checklist and questionnaire
|
2016
|
|
National antimicrobial resistance surveillance systems and participation in the Global Antimicrobial Resistance Surveillance System (GLASS):
A guide to planning, implementation, and monitoring and evaluation
|
2016
|
|
National programmes for age-friendly cities and communities A guide
|
2023
|
|
National survey for noncommunicable disease risk factors and mental health using WHO STEPS approach in Bhutan – 2014
|
2015
|
|
NCDprime:
Modelling the impact of national policies on noncommunicable disease (NCD) mortality using PRIME: a policy scenario modelling tool
|
2019
|
|
Ne polluez pas mon avenir !:
L'IMPACT ENVIRONNEMENTAL SUR LA SANTÉ INFANTILE
|
2017
|
|
Necesidades de rehabilitación de las personas que se recuperan de COVID-19
|
2021
|
|
Neglected tropical diseases and One Health:
Gearing up against antimicrobial resistance to secure the safety of future generations
|
2021
|
|
Nepal Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
NETTOYAGE ET STOCKAGE DES LAMES DE MICROSCOPIE:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-01
|
2016
|
|
Neurology and COVID-19
|
2021
|
|
Neutralizing monoclonal antibody cocktail REGN-EB3 for Ebola virus disease (EVD)
|
2022
|
|
Neutralizing monoclonal antibody mAb114 for Ebola virus disease (EVD)
|
2022
|
|
NEW MANDATE, STRONGER SUPPORT, UNPRECEDENTED OPPORTUNITIES:
Neglected Tropical Diseases
|
2013
|
|
NEW RECOMMENDATIONS IN THE UPDATED WHO GUIDELINES FOR THE SCREENING, CARE AND TREATMENT OF PERSONS WITH CHRONIC HEPATITIS C INFECTION
|
2016
|
|
New WHO recommendations on screening and treatment to prevent cervical cancer among women living with HIV:
Policy brief
|
2021
|
|
New Zealand Health System Review
|
2014
|
|
Nickel in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2021
|
|
Niger Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Nigeria Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
NIGERIA - Improving TB detection among nomadic communities through innovative community-based interventions
|
2020
|
|
Ninth meeting:
of the Working Group on Monitoring of Neglected Tropical Diseases Drug Efficacy Geneva, 12 March 2020
|
2020
|
|
¡No contamines mi futuro!:
EL IMPACTO DE LOS FACTORES MEDIOAMBIENTALES EN LA SALUD INFANTIL
|
2017
|
|
NONCOMMUNICABLE DISEASES:
PROGRESS MONITOR 2020
|
2020
|
|
NONCOMMUNICABLE DISEASES:
PROGRESS MONITOR 2017
|
2017
|
|
Noncommunicable diseases:
Fact sheet on Sustainable Development Goals (SDGs): health targets
|
2017
|
|
NONCOMMUNICABLE DISEASES:
PROGRESS MONITOR 2022
|
2022
|
|
NON-COMMUNICABLE DISEASES AND MENTAL HEALTH:
CASE STUDIES FROM ACROSS THE UNITED NATIONS SYSTEM
|
2019
|
|
Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza:
Annex: Report of systematic literature reviews
|
2019
|
|
Norma mundial de la OMS y la UIT sobre dispositivos y sistemas de audición sin riesgos
|
2019
|
|
Norma mundial para la escucha sin riesgos en locales y eventos musicales
|
2022
|
|
Normas básicas de higiene del entorno en la atención sanitaria
|
2016
|
|
Normas sobre agua, saneamiento e higiene para escuelas en contextos de escasos recursos
|
2010
|
|
Norme mondiale de l’OMS pour une écoute sans risque dans les lieux et les manifestations de divertissement
|
2022
|
|
Normes de notification relatives au Programme:
pour la santé sexuelle, reproductive, de la mère, du nouveau-né, de l’enfant et de l’adolescent
|
2017
|
|
NORMES MONDIALES POUR LA QUALITÉ DES SERVICES DE SANTÉ DESTINÉS AUX ADOLESCENTS:
GUIDE POUR LA MISE EN OEUVRE D’UNE STRATÉGIE FONDÉE SUR DES NORMES AFIN D’AMÉLIORER LA QUALITÉ DES SERVICES DE SANTÉ POUR LES ADOLESCENTS
|
2016
|
|
NORMES POUR L’ALIMENTATION SAINE, L’ACTIVITÉ PHYSIQUE, LA SÉDENTARITÉ ET LE SOMMEIL DANS LES STRUCTURES D’ÉDUCATION ET DE PRISE EN CHARGE DE LA PETITE ENFANCE ::
OUTIL
|
2021
|
|
Normes relatives à l’eau, l’assainissement et l’hygiène en milieu scolaire dans les environnements pauvres en ressources
|
2010
|
|
Norms, standards and processes underpinning WHO vector control policy development
|
2020
|
|
Nota informativa sobre la ingesta de azúcares recomendada en la directriz de la OMS para adultos y niños
|
2015
|
|
Note d’information sur l’apport de sucres recommandé pour les adultes et les enfants dans la directive de l’OMS
|
2015
|
|
Note d’orientation ::
Accès aux technologies d’assistance
|
2020
|
|
Note d’orientation de l’OMS ::
Prise en charge clinique de la COVID-19
|
2022
|
|
Note Technique:
Suppléments alimentaires pour la prise en charge de la malnutrition aiguë modérée chez les nourrissons et les enfants âgés de 6 à 59 mois
|
2012
|
|
NOTES D’ORIENTATION DU BUREAU RÉGIONAL DE L’OMS POUR L’AFRIQUE SUR LA COVID-19:
VOLUME 2 : PRISE EN CHARGE DES CAS DE COVID-19 - LES MESURES D'INTERVENTION
|
2020
|
|
NOUVELLES RECOMMANDATIONS DE L’OMS LIGNES DIRECTRICES POUR LE DEPISTAGE, LES SOINS ET LE TRAITEMENT DES PERSONNES AYANT UNE INFECTION CHRONIQUE AVEC LE VIRUS DE L’HEPATITE C
|
2016
|
|
NUMÉRATION DES PARASITES:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS — DMP-MON-09
|
2016
|
|
NÚMERO 004-01::
resultados de investigação sobre o trabalho de parto e o próprio parto de mulheres grávidas diagnosticadas com Covid-19
|
2020
|
|
NUMÉRO 011-02 ::
Capacité de riposte à la COVID-19 avec les systèmes de santé - Systèmes d’information sanitaire
|
2021
|
|
NÚMERO 011-02::
Capacidade de Resposta dos Sistemas de Saúde à COVID-19 – Sistemas de Informação Sanitária
|
2021
|
|
Nurturing care for children living in humanitarian settings
|
2020
|
|
NUTRITION ACTION IN SCHOOLS::
A REVIEW OF THE EVIDENCE RELATED TO THE NUTRITION-FRIENDLY SCHOOLS INITIATIVE
|
2020
|
|
NUTRITION IN UNIVERSAL HEALTH COVERAGE
|
2019
|
|
Nutrition Landscape Information System (NLiS):
Country profile indicators interpretation guide
|
2019
|
|
Nutrition Landscape Information System (NLiS):
Results of a user survey
|
2019
|
|
NUTRITIONAL ANAEMIAS::
TOOLS FOR EFFECTIVE PREVENTION AND CONTROL
|
2017
|
|
Nutritional rickets:
A REVIEW OF DISEASE BURDEN, CAUSES, DIAGNOSIS, PREVENTION AND TREATMENT
|
2019
|
|
OBTENCIÓN DE MUESTRAS DE SANGRE POR PUNCIÓN DACTILAR Y PREPARACIÓN DE EXTENSIONES DE SANGRE GRUESAS Y FINAS:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-05A
|
2016
|
|
OBTENCIÓN DE MUESTRAS DE SANGRE POR VENOPUNCIÓN Y PREPARACIÓN DE EXTENSIONES DE SANGRE A PARTIR DE SANGRE VENOSA RECOLECTADA EN TUBOS CON ANTICOAGULANTE:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-05B
|
2016
|
|
Off-label use of medicines for COVID-19:
Scientific brief
|
2020
|
|
OMS ::
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, RAPPORT DE SITUATION N° 3
|
2014
|
|
OMS ::
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, MISE À JOUR
|
2014
|
|
OMS ::
Feuille de route pour la riposte à Ebola, rapport de situation N° 1
|
2014
|
|
OMS ::
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, MISE À JOUR
|
2014
|
|
OMS ::
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, MISE À JOUR
|
2014
|
|
OMS ::
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, POINT SUR L’ÉVOLUTION RÉCENTE
|
2014
|
|
OMS ::
Feuille de route pour la riposte au virus Ebola, rapport de situation N° 5
|
2014
|
|
OMS::
FEUILLE DE ROUTE POUR LA RIPOSTE AU VIRUS EBOLA, POINT SUR L'ÉVOLUTION RÉCENTE
|
2014
|
|
OMS ::
Feuille de route pour la riposte au virus Ebola, rapport de situation N° 4
|
2014
|
|
OMS ::
Feuille de route de la riposte au virus Ebola, rapport de situation, 5 septembre 2014
|
2014
|
|
ONCHOCERCIASIS: DIAGNOSTIC TARGET PRODUCT PROFILE:
to support preventive chemotherapy
|
2021
|
|
ONCHOCERCOSE – PROFILS DE PRODUITS CIBLES (TPP) DE DIAGNOSTIC:
pour soutenir la chimiothérapie préventive
|
2021
|
|
ONLINE GLOBAL CONSULTATION ON CONTACT TRACING FOR COVID-19
|
2021
|
|
Opciones Terapéuticas y COVID-19:
ORIENTACIÓN EVOLUTIVA
|
2020
|
|
Opciones terapéuticas y COVID-19
|
2022
|
|
Opciones terapéuticas y COVID-19
|
2021
|
|
Operational considerations for COVID-19 surveillance using GISRS:
Interim guidance
|
2020
|
|
Operational considerations for managing COVID-19 cases or outbreak in aviation:
Interim guidance
|
2020
|
|
Operational considerations for managing COVID-19 cases or outbreaks on board ships:
Interim guidance
|
2020
|
|
Operational considerations to expedite genomic sequencing component of GISRS surveillance of SARS-CoV-2
|
2021
|
|
Operational framework for building climate resilient health systems
|
2015
|
|
Operational Guidance on Sharing Influenza Viruses with Human Pandemic Potential (IVPP) under the Pandemic Influenza Preparedness (PIP) Framework
|
2017
|
|
Operational guidelines on HIV testing and counselling of infants, children and adolescents for service providers in the African Region
|
2014
|
|
Operational plan to take forward the Global Strategy for Women’s, Children’s and Adolescents’ Health:
Committing to implementation Report by the Secretariat
|
2016
|
|
Operationalizing management of sick young infants with possible serious bacterial infection (PSBI) when referral is not feasible in the context of existing maternal, newborn, and child health programmes
|
2017
|
|
Operationalizing Nurturing Care for Early Childhood Development:
The role of the health sector alongside other sectors and actors
|
2019
|
|
Opportunities for transition to clean household energy in Ethiopia:
Application of the WHO Household Energy Assessment Rapid Tool (HEART)
|
2018
|
|
Optimized Supportive Care for Ebola Virus Disease:
CLINICAL MANAGEMENT STANDARD OPERATING PROCEDURES
|
2019
|
|
Optimizing brain health across the life course::
WHO position paper
|
2022
|
|
Oral Health Surveys:
Basic Methods
|
2013
|
|
Organización Mundial de la Salud Alianza para la eliminación mundial del tracoma para 2020:
Segunda reunión científica mundial sobre triquiasis tracomatosa Ciudad del Cabo, 4 a 6 de noviembre de 2015
|
2016
|
|
Organotins in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2020
|
|
Orientação sobre como conduzir avaliações à eficácia da vacina no contexto das novas variantes do SARS-CoV-2
|
2021
|
|
Orientación sobre microplanificación operativa para la inmunización contra la COVID-19
|
2021
|
|
Orientaciones de la OMS para proteger la salud frente al cambio climático mediante la planificación de la adaptación de la salud
|
2019
|
|
Orientaciones estratégicas mundiales sobre ENFERMERÍA Y PARTERÍA 2021-2025
|
2021
|
|
Orientaciones evolutivas para el manejo clínico de la COVID-19:
ORIENTACIONES EVOLUTIVAS
|
2021
|
|
ORIENTACIONES NORMATIVAS DE LA OMS SOBRE LAS ACTIVIDADES INTEGRALES PARA LA OPTIMIZACIÓN DE LOS ANTIMICROBIANOS
|
2021
|
|
Orientaciones para el manejo clínico de casos de síndrome de trombosis con trombocitopenia (STT) tras la vacunación contra la COVID-19
|
2021
|
|
Orientaciones para la vigilancia poscomercialización y la vigilancia del mercado de los dispositivos médicos, incluidos los de diagnóstico in vitro
|
2021
|
|
Orientações estratégicas mundiais para:
ENFERMEIROS E PARTEIRAS 2021-2025
|
2022
|
|
Orientations évolutives concernant la prise en charge clinique de la COVID-19:
ORIENTATIONS ÉVOLUTIVES
|
2021
|
|
Orientations opérationnelles pour l’échange de virus grippaux susceptibles de donner lieu à une pandémie humaine (IVPP*), conformément aux Cadre de préparation en cas de grippe pandémique (PIP)
|
2017
|
|
Orientations stratégiques mondiales de l’OMS POUR LES SOINS INFIRMIERS ET OBSTÉTRICAUX 2021-2025
|
2021
|
|
Orientations sur la prise en charge clinique du syndrome de thrombose-thrombocytopénie (TTS) après la vaccination contre la maladie à coronavirus 2019 (COVID-19):
Orientations provisoires
|
2021
|
|
Orientations sur les aspects éthiques à prendre en considération pour planifier et examiner des recherches sur la santé sexuelle et reproductive des adolescents
|
2019
|
|
Origin of SARS-CoV-2
|
2020
|
|
OUTIL DE COLLECTE DE DONNÉES SOCIALES ET COMPORTEMENTALES SUR LA COVID-19 EN AFRIQUE
|
2021
|
|
Outil de l’OMS pour le calcul des coûts et la budgétisation d’un plan d’action national pour combattre la résistance aux antimicrobiens:
Guide de l’utilisateur
|
2022
|
|
Outil de prévision des fournitures essentielles dans le cadre de la COVID-19:
Foire aux questions (FAQ)
|
2020
|
|
Outil de prévision des fournitures essentielles dans le cadre de la COVID-19:
Vue d’ensemble de la structure, de la méthodologie et des hypothèses utilisées
|
2020
|
|
Outil d’évaluation des services des soins oculaires
|
2015
|
|
OUTIL D'ÉVALUATION DES SYSTÈMES DE CONTRÔLE DES ALIMENTS:
DIMENSION B FONCTIONS DE CONTRÔLE
|
2020
|
|
OUTIL D'ÉVALUATION DES SYSTÈMES DE CONTRÔLE DES ALIMENTS:
INTRODUCTION ET GLOSSAIRE
|
2020
|
|
OUTIL D’ÉVALUATION DES SYSTÈMES DE CONTRÔLE DES ALIMENTS:
BROCHURE D’INTRODUCTION
|
2021
|
|
OUTIL D'ÉVALUATION DES SYSTÈMES DE CONTRÔLE DES ALIMENTS:
DIMENSION D FONDEMENT SCIENTIFIQUE, BASE DE CONNAISSANCES ET AMÉLIORATION CONTINUE
|
2020
|
|
OUTIL D'ÉVALUATION DES SYSTÈMES DE CONTRÔLE DES ALIMENTS:
DIMENSION A INTRANTS ET RESSOURCES
|
2020
|
|
OUTIL D'ÉVALUATION DES SYSTÈMES DE CONTRÔLE DES ALIMENTS:
DIMENSION C INTERACTIONS AVEC LES PARTIES PRENANTES
|
2020
|
|
Outil d’évaluation rapide sur la Technologie d’Assistance (rATA)
|
2021
|
|
Outline for the Development of National Programmes for Elimination of Asbestos-Related Diseases
|
2007
|
|
Overseas medical referral::
the health system challenges for Pacific Island Countries
|
2020
|
|
An overview of infodemic management during COVID-19:
January 2020–July 2022
|
2023
|
|
Overview of methods to assess population exposure to ambient air pollution
|
2023
|
|
Overview of public health and social measures in the context of COVID-19:
Interim guidance
|
2020
|
|
OVERVIEW OF THE WHO PREQUALIFICATION OF IN VITRO DIAGNOSTICS ASSESSMENT
|
2018
|
|
OVERVIEW OF THE WHO PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT:
WHO Prequalification of Male Circumcision Devices
|
2019
|
|
Oxygen Cylinder Safety
|
2023
|
|
Oxygen sources and distribution for COVID-19 treatment centres:
Interim guidance
|
2020
|
|
Oxygen therapy for children
|
2016
|
|
PACKAGE OF CARE FOR CHILDREN AND ADOLESCENTS WITH ADVANCED HIV DISEASE::
STOP AIDS
|
2020
|
|
Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care:
in Low-Resource Settings
|
2010
|
|
Package of eye care interventions
|
2022
|
|
Package of interventions for rehabilitation:
Module 4 Cardiopulmonary conditions
|
2023
|
|
Package of interventions for rehabilitation:
Module 2 Musculoskele tal conditions
|
2023
|
|
Package of interventions for rehabilitation:
Module 2 Musculoskeletal conditions
|
2023
|
|
Package of interventions for Rehabilitation. Module. 4 Cardiopulmonary conditions.
|
2023
|
|
Packages of Interventions for Family Planning, Safe Abortion care, Maternal, Newborn and Child Health
|
2010
|
|
Pacote técnico SAFER UM MUNDO LIVRE DOS DANOS RELACIONADOS AO ÁLCOOL:
Cinco áreas de intervenção em âmbito nacional e estadual
|
2020
|
|
PAediatric Drug Optimization standard procedure
|
2021
|
|
THE PAEDIATRIC ENVIRONMENTAL HISTORY::
A tool for health care providers TRAINING FOR HEALTH CARE PROVIDERS SECOND EDITION
|
2019
|
|
THE PAEDIATRIC ENVIRONMENTAL HISTORY: A tool for health care providers:
TRAINING FOR HEALTH CARE PROVIDERS THIRD EDITION
|
2023
|
|
Pakistan Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
PAKISTAN – Harnessing the Government Lady Health Worker Programme to increase community-based active TB case-finding
|
2020
|
|
Palliative Care::
symptom management and end-of-life care
|
2003
|
|
PALLIATIVE CARE FOR NONCOMMUNICABLE DISEASES A global snapshot
|
2019
|
|
PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE
|
2009
|
|
Pandemic Influenza Preparedness Framework:
Partnership Contribution High-Level Implementation Plan I. Final Report 2014–2017
|
2018
|
|
Pandemic Influenza Preparedness Framework:
ANNUAL PROGRESS REPORT 1 January – 31 December 2018
|
2019
|
|
Pandemic influenza preparedness Framework:
for the sharing of influenza viruses and access to vaccines and other benefits
|
2021
|
|
Pandemic Influenza Preparedness Framework:
High-Level Implementation Plan 2018-2023
|
2018
|
|
Pandemic influenza preparedness Framework:
for the sharing of influenza viruses and access to vaccines and other benefits
|
2011
|
|
Pandemic Influenza Preparedness Framework:
A SUMMARY Partnership Contribution (PC) Preparedness High-Level Implementation Plan 2018-2023
|
2018
|
|
Pandemic influenza preparedness framework::
Partnership Contribution High-Level Implementation Plan III 2024–2030
|
2018
|
|
Pandemic Influenza Preparedness Framework:
BIENNIAL PROGRESS REPORT 1 January 2018 - 31 December 2019
|
2020
|
|
Pandemic Influenza Preparedness Framework:
Partnership Contribution High-Level Implementation Plan III 2024-2030
|
2023
|
|
PANDEMIC INFLUENZA PREPAREDNESS FRAMEWORK:
PROGRESS REPORT
|
2020
|
|
Pandemic influenza preparedness in WHO Member States:
REPORT OF A MEMBER STATES SURVEY
|
2019
|
|
Pandemic Influenza Preparedness (PIP) Framework:
Partnership Contribution (PC) Preparedness High-Level Implementation Plan II 2018-2023
|
2018
|
|
Pandemic Influenza Preparedness (PIP) Framework:
Partnership Contribution (PC) Preparedness High-Level Implementation Plan II 2018-2023
|
2019
|
|
Pandemic Influenza Preparedness (PIP) Framework:
Partnership Contribution (PC) Preparedness High-Level Implementation Plan II 2018-2023
|
2021
|
|
Pandemic Influenza Risk Management:
A WHO guide to inform and harmonize national and international pandemic preparedness and response
|
2017
|
|
PANORAMA MONDIAL DE L’HYPERTENSION:
Journée mondiale de la santé 2013
|
2013
|
|
Paquete de intervenciones de atención ocular
|
2022
|
|
Parasitoses d’origine alimentaire:
CLONORCHIASE et OPISTHORCHIASE
|
2021
|
|
Parasitosis de transmisión alimentaria:
CLONORQUIASIS y OPISTORQUIASIS
|
2021
|
|
PARTICIPACIÓN PÚBLICA Y FINANCIACIÓN COLECTIVA DE LA INVESTIGACIÓN EN SALUD:
Una guía práctica
|
2022
|
|
Participant Manual:
MANAGEMENT OF THE SICK YOUNG INFANT AGE UP TO 2 MONTHS
|
2019
|
|
PARTICIPATION DU SECTEUR DE LA SANTÉ DANS LA CONVENTION DE MINAMATA SUR LE MERCURE ::
Résultats des ateliers régionaux de l’Organisation mondiale de la Santé pour les ministres de la santé
|
2018
|
|
PARTNERS AT THE FRONTLINE:
WHO and the Global Fund making impact in countries
|
2019
|
|
«Pasaportes de inmunidad» en el contexto de la COVID-19:
Nota científica
|
2020
|
|
PAUTAS DE ALIMENTACIÓN SALUDABLE, ACTIVIDAD FÍSICA, COMPORTAMIENTO SEDENTARIO Y SUEÑO PARA LA EDUCACIÓN Y ATENCIÓN A LA PRIMERA INFANCIA::
CONJUNTO DE HERRAMIENTAS
|
2021
|
|
Pautas de información de los programas:
de salud sexual, reproductiva, materna, neonatal, infantil y adolescente
|
2017
|
|
Pautas de la OMS sobre la ética en la vigilancia de la salud pública
|
2017
|
|
Pautas y orientación operativa para la revisión ética de la investigación en salud con seres humanos
|
2012
|
|
Peer support mental health services:
Promoting person-centred and rights-based approaches
|
2021
|
|
People-centred framework for tuberculosis programme planning and prioritization:
User guide
|
2019
|
|
People’s Republic of China Health System Review
|
2015
|
|
PÉRDIDA DE AUDICIÓN EN LA NIÑEZ:
¡QUÉ HACER PARA ACTUAR DE INMEDIATO!
|
2016
|
|
PERFORMANCE INCENTIVES FOR HEALTH CARE PROVIDERS
|
2010
|
|
Performance report for the 2010–2011 workplan and budget:
Report of the Convention Secretariat
|
2012
|
|
Personal Interventions and Risk Communication on Air Pollution
|
2020
|
|
Personal protective equipment in the context of filovirus disease outbreak response
|
2014
|
|
PERSON-CENTRED COMMUNICATION FOR FEMALE GENITAL MUTILATION PREVENTION:
A FACILITATOR’S GUIDE FOR TRAINING HEALTH-CARE PROVIDERS
|
2022
|
|
PERSON-CENTRED HIV STRATEGIC INFORMATION:
STRENGTHENING ROUTINE DATA FOR IMPACT
|
2022
|
|
PERSON-CENTRED HIV STRATEGIC INFORMATION:
STRENGTHENING ROUTINE DATA FOR IMPACT
|
2022
|
|
PERSON-CENTRED HIV STRATEGIC INFORMATION:
STRENGTHENING ROUTINE DATA FOR IMPACT
|
2022
|
|
PERSON-CENTRED HIV STRATEGIC INFORMATION:
STRENGTHENING ROUTINE DATA FOR IMPACT
|
2022
|
|
PERSON-CENTRED HIV STRATEGIC INFORMATION:
STRENGTHENING ROUTINE DATA FOR IMPACT
|
2022
|
|
PERSON-CENTRED HIV STRATEGIC INFORMATION:
STRENGTHENING ROUTINE DATA FOR IMPACT
|
2022
|
|
PERSON-CENTRED HIV STRATEGIC INFORMATION:
STRENGTHENING ROUTINE DATA FOR IMPACT
|
2022
|
|
Person-centred recovery planning for mental health and well-being:
WHO Quality Rights self-help tool
|
2019
|
|
PERSPECTIVAS SOCIAIS E COMPORTAMENTAIS:
FERRAMENTA DE RECOLHA DE DADOS SOBRE COVID-19 EM ÁFRICA
|
2021
|
|
Pesticide residues in food — 2011:
Toxicological evaluations
|
2012
|
|
Pesticide residues in food — 2012:
Toxicological evaluations
|
2013
|
|
Pesticide residues in food — 2013:
Toxicological evaluations
|
2014
|
|
Pesticide residues in food — 2014:
Toxicological evaluations
|
2015
|
|
Pesticide residues in food — 2015:
Toxicological evaluations
|
2016
|
|
Philippines Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
The Philippines Health System Review
|
2011
|
|
The Philippines Health System Review
|
2018
|
|
PHYSICAL ACTIVITY, SEDENTARY BEHAVIOUR AND SLEEP:
FOR CHILDREN UNDER 5 YEARS OF AGE
|
2019
|
|
PLAN D'ACTION GLOBAL POUR LA SANTÉ MENTALE 2013-2020
|
2013
|
|
Plan d'action global pour la santé mentale 2013-2030
|
2022
|
|
PLAN D’ACTION GLOBAL POUR PERMETTRE À TOUS DE VIVRE EN BONNE SANTÉ ET PROMOUVOIR LE BIEN-ÊTRE DE TOUS:
Unir nos efforts pour accélérer les progrès en vue des objectifs de développement durable liés à la santé
|
2018
|
|
PLAN D’ACTION MONDIAL:
visant à renforcer le rôle du système de santé dans une riposte nationale multisectorielle à la violence interpersonnelle, en particulier à l’égard des femmes et des filles et à l’égard des enfants
|
2017
|
|
PLAN D’ACTION MONDIAL CONTRE LA RÉSISTANCE DU VIH AUX MÉDICAMENTS, 2016-2021
|
2016
|
|
Plan d’action mondial de l’OMS visant à réduire au minimum le risque d’exposition au poliovirus associé aux établissements après l’éradication par type des poliovirus sauvages et l’arrêt progressif de l’utilisation du vaccin antipoliomyélitique oral
|
2015
|
|
Plan d’action mondial pour combattre la résistance aux antimicrobiens:
Rapport du Secrétariat
|
2016
|
|
Plan d’action mondial pour combattre la résistance aux antimicrobiens
|
2015
|
|
Plan d’action mondial pour combattre la résistance aux antimicrobiens:
Projet de résolution avec les amendements résultant de consultations informelles
|
2015
|
|
Plan d’action mondial pour combattre la résistance aux antimicrobiens:
Options pour instituer un cadre mondial de développement et de gestion qui facilite la mise au point, le contrôle, la distribution et l’usage approprié de nouveaux médicaments antimicrobiens, outils de diagnostic, vaccins et autres interventions Rapport du Secrétariat
|
2016
|
|
PLAN D’ACTION MONDIAL POUR COMBATTRE LA RÉSISTANCE AUX ANTIMICROBIENS
|
2016
|
|
Plan d’action mondial pour combattre la résistance aux antimicrobiens:
Options pour organiser une réunion de haut niveau en 2016, en marge de l’Assemblée générale des Nations Unies, et résultats potentiels Rapport du Secrétariat
|
2015
|
|
Plan de acción integral sobre salud mental 2013-2030
|
2022
|
|
PLAN DE ACCIÓN MUNDIAL:
SOBRE LA RESISTENCIA A LOS ANTIMICROBIANOS
|
2016
|
|
Plan de acción mundial de la OMS para minimizar el riesgo asociado a las instalaciones de almacenamiento de poliovirus después de la erradicación de poliovirus salvajes por tipos específicos y la suspensión secuencial del uso sistemático de la vacuna antipoliomielítica oral
|
2015
|
|
Plan de acción mundial sobre la resistencia a los antimicrobianos:
Informe de la Secretaría
|
2016
|
|
Plan de acción mundial sobre la resistencia a los antimicrobianos:
Opciones para establecer un marco mundial de desarrollo y rectoría a fin de respaldar el desarrollo, el control, la distribución y el uso adecuado de nuevos antimicrobianos, instrumentos diagnósticos, vacunas y otras intervenciones Informe de la Secretaría
|
2016
|
|
Plan de acción mundial sobre la resistencia a los antimicrobianos
|
2015
|
|
Plan de acción mundial sobre la resistencia a los antimicrobianos:
Opciones, incluidos los posibles productos entregables, para la celebración de una reunión de alto nivel en 2016 paralela a la Asamblea General de las Naciones Unidas Informe de la Secretaría
|
2015
|
|
Plan de acción mundial sobre la resistencia a los antimicrobianos:
Proyecto de resolución con enmiendas derivadas de las consultas oficiosas
|
2015
|
|
PLAN DE ACCIÓN SOBRE SALUD MENTAL 2013-2020
|
2013
|
|
Plan operacional para llevar adelante la Estrategia Mundial para la Salud de la Mujer, el Niño y el Adolescente:
Compromiso con la aplicación Informe de la Secretaría
|
2016
|
|
Plan opérationnel pour faire avancer la Stratégie mondiale pour la santé de la femme, de l’enfant et de l’adolescent:
Engagement pour la mise en œuvre Rapport du Secrétariat
|
2016
|
|
Plan pluriannuel complet (PPAc):
Guide d'utilisation de l'Outil de calcul des coûts et du financement pour la création d'un Plan pluriannuel complet de (PPAc)
|
2014
|
|
Plan stratégique 2003–2005:
Les défis de l’élargissement
|
2004
|
|
Plan stratégique de l’OMS sur six ans visant à réduire l’impact des situations d’urgence et des catastrophes:
2014-2019
|
2015
|
|
Planches pour le diagnostic des parasites intestinaux
|
2021
|
|
Planificación estratégica para la aplicación de los artículos sanitarios del Convenio de Minamata sobre el Mercurio
|
2019
|
|
Planification et mise en oeuvre d’activités de vaccination supplémentaires de haute qualité avec des vaccins injectables Exemple des vaccins contre la rougeole et la rubéole:
Guide pratique
|
2017
|
|
Planification stratégique pour la mise en œuvre des articles liés à la santé de la Convention de Minamata sur le mercure
|
2019
|
|
Planning and costing nutrition actions::
the OneHealth Tool
|
2014
|
|
Planning and Implementing High-Quality Supplementary Immunization Activities for Injectable Vaccines:
Using an Example of Measles and Rubella Vaccines
|
2016
|
|
Planning and Implementing palliative care services::
a guide for programme managers
|
2016
|
|
Planning meeting for operational research on malaria elimination:
17–18 October 2013, Geneva, Switzerland Meeting Report| Global Malaria Programme
|
2014
|
|
PLANNING & MONITORING OF NATIONAL STRATEGIES A MANUAL
|
2015
|
|
Plataforma clínica mundial sobre la COVID-19:
MÓDULO RELATIVO AL EMBARAZO (FRC-E)
|
2020
|
|
Plataforma Mundial de Datos Clínicos:
Hepatitis aguda grave de causa desconocida en niños
|
2022
|
|
Plateforme clinique mondiale COVID-19 AVEC MODULE GROSSESSE - CRF-P
|
2020
|
|
Plateforme de données cliniques mondiale:
Hépatite aiguë sévère d’étiologie inconnue chez l’enfant
|
2022
|
|
Plateforme mondiale de données cliniques sur la COVID-19 ::
cahier d’observation pour les cas suspects de syndrome inflammatoire multisystémique présentant un lien temporel avec la COVID-19 chez les enfants et les adolescents
|
2020
|
|
POCKET GUIDE::
Medical management of abortion
|
2018
|
|
POINT-OF-CARE TESTS FOR DIAGNOSING HIV INFECTION AMONG CHILDREN YOUNGER THAN 18 MONTHS
|
2020
|
|
Point-of-care tests for sexually transmitted infections:
Target product profiles
|
2023
|
|
Points clés et questions-réponses:
Situation et tendances de la résistance aux insecticides chez les vecteurs du paludisme (2018)
|
2018
|
|
Policies, programme and services for comprehensive abortion care in South-East Asia Region
|
2021
|
|
POLICIES, REGULATIONS & LEGISLATION PROMOTING HEALTHY HOUSING::
A REVIEW
|
2021
|
|
Policies to reduce air pollution from household heating
|
2022
|
|
POLICY BRIEF:
THE 2021 OPTIMAL FORMULARY AND LIMITED-USE LIST FOR ANTIRETROVIRAL DRUGS FOR CHILDREN
|
2021
|
|
Policy brief::
Access to assistive technology
|
2020
|
|
Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19
|
2021
|
|
POLICY IMPLEMENTATION PACKAGE:
FOR NEW TB DRUG INTRODUCTION
|
2014
|
|
POLICY OPTIONS ON MENTAL HEALTH:
A WHO-GULBENKIAN MENTAL HEALTH PLATFORM COLLABORATION
|
2017
|
|
Policy paper on traceability of medical products
|
2021
|
|
POLIO ENVIRONMENTAL SURVEILLANCE EXPANSION PLAN:
Global Expansion Plan under the Endgame Strategy 2013-2018
|
2015
|
|
Polio Eradication Strategy 2022–2026:
Executive summary
|
2021
|
|
Polluants cancérogènes et analyse des risques sur AirQ+
|
2020
|
|
POLLUTION DE L'AIR ET SANTÉ DE L'ENFANT:
Prescrire un air sain RÉSUMÉ
|
2018
|
|
Pollution de l’air intérieur des ménages au Burkina Faso ::
Profil pays et éléments clés pour l’élaboration d’une stratégie nationale
|
2021
|
|
Polyunsaturated fatty acids intake and risk of all-cause mortality, cardiovascular disease, breast cancer, mental health, and type 2 diabetes:
A systematic review and meta-analysis of prospective cohort studies
|
2022
|
|
Poner fin a la desatención para alcanzar los Objetivos de Desarrollo Sostenible::
marco de seguimiento y evaluación de los progresos realizados en relación con la hoja de ruta para las enfermedades tropicales desatendidas 2021-2030
|
2021
|
|
Poner fin a la desatención para alcanzar los Objetivos de Desarrollo Sostenible:
Un marco de sostenibilidad para la acción contra las enfermedades tropicales desatendidas 2021-2030
|
2021
|
|
Poner fin a la desatención para alcanzar los Objetivos de Desarrollo Sostenible:
Hoja de ruta sobre enfermedades tropicales desatendidas 2021-2030
|
2021
|
|
Pooled procurement:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection
|
2020
|
|
Population-based approaches to:
CHILDHOOD OBESITY PREVENTION
|
2012
|
|
Population-wide interventions for reducing alcohol consumption::
what does the per capita consumption indicator say?
|
2022
|
|
Portable digital radiography system:
Technical specifications
|
2021
|
|
POSITION PAPER ON ECONOMIC ARGUMENTS FOR INTERSECTORAL INTERVENTIONS THAT IMPROVE THE SOCIAL DETERMINANTS OF HEALTH::
MEXICO
|
2013
|
|
Possible developmental early effects of endocrine disrupters on child health
|
2012
|
|
POST-CRASH RESPONSE:
Supporting those affected by road traffic crashes
|
2016
|
|
Postępowanie kliniczne w ostrym zakażeniu dróg oddechowych o ciężkim przebiegu (SARI) w przypadku podejrzenia choroby COVID-19:
Wytyczne tymczasowe
|
2020
|
|
Post-market surveillance – how to detect problems for HIV self-testing test kits
|
2018
|
|
POST-MARKET SURVEILLANCE OF IN VITRO DIAGNOSTICS
|
2015
|
|
POTABLE REUSE:
GUIDANCE FOR PRODUCING SAFE DRINKING-WATER
|
2017
|
|
Potential corruption risks in health financing arrangements:
Report of a rapid review of the literature
|
2020
|
|
Potential Ebola therapies and vaccines
|
2014
|
|
The potential impact of health service disruptions on the burden of malaria::
a modelling analysis for countries in sub-Saharan Africa
|
2020
|
|
THE POWER OF CITIES::
TACKLING NONCOMMUNICABLE DISEASES AND ROAD TRAFFIC INJURIES
|
2019
|
|
Practical actions in cities to strengthen preparedness for the COVID-19 pandemic and beyond:
An interim checklist for local authorities
|
2020
|
|
Practical considerations and recommendations for religious leaders and faith-based communities in the context of COVID-19:
Interim guidance
|
2020
|
|
Practical guidance for national influenza centres establishing or implementing neuraminidase inhibitor susceptibility surveillance:
Updated 2018
|
2019
|
|
Practical guidance for national influenza centres establishing or implementing neuraminidase inhibitor susceptibility surveillance
|
2016
|
|
A practical guide for developing and conducting simulation exercises to test and validate pandemic influenza preparedness plans
|
2018
|
|
A Practical Guide for Health Researchers
|
2004
|
|
PRACTICAL GUIDE FOR THE DESIGN,USE AND PROMOTION OF HOME-BASED RECORDS IN IMMUNIZATION PROGRAMMES
|
2015
|
|
A practical guide to the implementation of a computerized information management system for blood transfusion services
|
2019
|
|
Practices in addressing the health needs of refugees and migrants:
WHO Region of the Americas
|
2018
|
|
Practices in addressing the health needs of refugees and migrants:
WHO South-East Asia Region
|
2018
|
|
Practices in addressing the health needs of refugees and migrants:
WHO Eastern Mediterranean Region
|
2018
|
|
Practices to improve coverage of the hepatitis B birth dose vaccine
|
2012
|
|
Pratiques sûres lors de l’Eïd al-Adha dans le cadre de la COVID-19:
Orientations provisoires
|
2021
|
|
Pre-exposure prophylaxis for men who have sex with men::
A systematic review
|
2014
|
|
Pregnancy management in the context of Zika virus infection:
Interim guidance update
|
2016
|
|
PRÉLÈVEMENT D’ÉCHANTILLONS SANGUINS PAR PONCTION VEINEUSE ET PRÉPARATION D’ÉTALEMENTS DE SANG À PARTIR DE SANG VEINEUX COLLECTÉ DANS DES TUBES CONTENANT UN ANTICOAGULANT:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-05B
|
2016
|
|
Preliminary dose estimation from the nuclear accident after the 2011 Great East Japan Earthquake and Tsunami
|
2012
|
|
Preliminary evaluation of the WHO global coordination mechanism on the prevention and control of noncommunicable diseases
|
2018
|
|
Preliminary evaluation of the WHO global coordination mechanism on the prevention and control of noncommunicable diseases
|
2018
|
|
Premier rapport de la Commission B
|
2021
|
|
PREPARACIÓN DE LA SOLUCIÓN AMORTIGUADORA DE pH 7,2:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-03A
|
2016
|
|
PREPARACIÓN DE LA SOLUCIÓN AMORTIGUADORA DE pH 7,2 CON PASTILLAS DE AMORTIGUADOR:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-03B
|
2016
|
|
PREPARACIÓN DE LA SOLUCIÓN DE TRABAJO DE COLORANTE DE GIEMSA:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-04
|
2016
|
|
PREPARACIÓN DE LA SOLUCIÓN MADRE DE COLORANTE DE GIEMSA:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-02
|
2016
|
|
PREPARACIÓN DE MUESTRAS DE SANGRE SECA EN PAPEL DE FILTRO:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR — DMP-POE-10
|
2016
|
|
Preparación para la tercera Reunión de Alto Nivel de la Asamblea General sobre la Prevención y el Control de las Enfermedades No Transmisibles, que se celebrará en 2018:
Informe del Director General
|
2017
|
|
Preparación para una gripe pandémica:
Marco para el intercambio de virus gripales y el acceso a las vacunas y otros beneficios
|
2012
|
|
Preparación para una gripe pandémica Marco para el intercambio de virus gripales y el acceso a las vacunas y otros beneficios
|
2021
|
|
Préparation à la certification de l’élimination du paludisme
|
2021
|
|
Preparation and administration of mAb114 for Ebola virus disease (EVD)
|
2022
|
|
Preparation and administration of REGN-EB3 for Ebola virus disease (EVD)
|
2022
|
|
PRÉPARATION DE LA SOLUTION MÈRE DE GIEMSA:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-02
|
2016
|
|
Préparation de la Troisième Réunion de haut niveau de l’Assemblée générale sur la prévention et la maîtrise des maladies non transmissibles, qui doit avoir lieu en 2018:
Rapport du Directeur général
|
2017
|
|
PRÉPARATION DE SOLUTION (EAU) TAMPONNÉE À pH 7,2 À PARTIR DE COMPRIMÉS TAMPONS:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-03B
|
2016
|
|
PRÉPARATION DE SOLUTION TAMPONNÉE À pH 7,2:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-03A
|
2016
|
|
PRÉPARATION DE TACHES DE SANG SUR DU PAPIER FILTRE:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS — DMP-MON-10
|
2016
|
|
PRÉPARATION D’UNE SOLUTION DE TRAVAIL GIEMSA:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-04
|
2016
|
|
Préparation et administration de mAb114 contre la maladie à virus Ebola (MVE)
|
2022
|
|
Préparation et administration de REGN-EB3 contre la maladie à virus Ebola (MVE)
|
2022
|
|
Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018:
Report by the Director-General
|
2017
|
|
PREPARATION OF BLOOD SPOTS ON FILTER PAPER:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE — MM-SOP-10
|
2016
|
|
PREPARATION OF GIEMSA WORKING SOLUTION:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-04
|
2016
|
|
PREPARATION OF WATER BUFFERED TO pH 7.2:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-03A
|
2016
|
|
PREPARATION OF WATER BUFFERED TO pH 7.2 WITH BUFFER TABLETS:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-03B
|
2016
|
|
Preparedness Checklist for Long-Term Care Facilities
|
2020
|
|
Preparedness for cyclones, tropical storms, tornadoes, floods and earthquakes during the COVID-19 pandemic:
Health advisory
|
2020
|
|
Preparedness, prevention and control of coronavirus disease (COVID-19) for refugees and migrants in non-camp settings:
Interim guidance
|
2020
|
|
Preparing for certification of malaria elimination
|
2020
|
|
Preparing for large-scale community transmission of COVID-19:
Guidance for countries and areas in the WHO Western Pacific Region
|
2020
|
|
Pre-referral artesunate treatment of childhood malaria in the community:
Training Manual for community health workers to assess danger signs, provide emergency pre-referral treatment and refer treated children to a health facility.
|
2012
|
|
Prevencija povreda i nasilja
|
2007
|
|
PREVENCIÓN DE ENFERMEDADES A TRAVÉS DE AMBIENTES SALUDABLES:
EXPOSICIÓN AL MERCURIO: UN ASUNTO IMPORTANTE PARA LA SALUD PÚBLICA
|
2021
|
|
Prevención y control de las enfermedades no transmisibles:
Resultados de la Reunión de Alto Nivel de la Asamblea General sobre la Prevención y el Control de las Enfermedades No Transmisibles y de la Primera Conferencia Ministerial Mundial sobre Modos de Vida Sanos y Control de las Enfermedades No Transmisibles
|
2012
|
|
Prevención y control de las enfermedades no transmisibles::
Directrices para la atención primaria en entornos con pocos recursos
|
2013
|
|
Prevención y control de las hepatitis virales::
Marco para la acción mundial
|
2012
|
|
Prevención y erradicación de la falta de respeto y el maltrato durante la atención del parto en centros de salud
|
2014
|
|
Prevenindo a violência juvenil::
um panorama das evidências
|
2015
|
|
Prévenir la violence exercée par des partenaires intimes et la violence sexuelle contre les femmes:
Intervenir et produire des données
|
2012
|
|
PRÉVENIR LES MALADIES GRÂCE À DES ENVIRONNEMENTS SAINS:
EXPOSITION AU MERCURE : UN PROBLÈME MAJEUR DE SANTÉ PUBLIQUE
|
2021
|
|
Prevenir los ahogamientos::
guía práctica
|
2017
|
|
PREVENTABLE EPILEPSY: TAENIA SOLIUM INFECTION BURDENS ECONOMIES, SOCIETIES AND INDIVIDUALS:
A RATIONALE FOR INVESTMENT AND ACTION
|
2016
|
|
Preventing and addressing intimate partner violence against migrant and ethnic minority women::
the role of the health sector
|
2014
|
|
Preventing and managing COVID-19 across long-term care services:
Web annex
|
2020
|
|
Preventing and managing COVID-19 across long-term care services
|
2020
|
|
Preventing and mitigating COVID-19 at work:
Policy brief
|
2021
|
|
PREVENTING DIARRHOEA THROUGH BETTER WATER, SANITATION AND HYGIENE:
Exposures and impacts in low- and middle-income countries
|
2014
|
|
PREVENTING DISEASE THROUGH HEALTHY ENVIRONMENTS:
EXPOSURE TO MERCURY: A MAJOR PUBLIC HEALTH CONCERN
|
2021
|
|
Preventing drowning:
Practical guidance for the provision of day-care, basic swimming and water safety skills, and safe rescue and resuscitation training
|
2022
|
|
Preventing drowning::
an implementation guide
|
2017
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED EPIDEMICS::
RECOMMENDATIONS AND KEY CONSIDERATIONS
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
WEB ANNEX 2.2 MALE CIRCUMCISION AND THE RISK OF HIV INFECTION IN WOMEN: SYSTEMATIC REVIEW AND META-ANALYSIS
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
ENHANCING UPTAKE OF VMMC AMONG ADOLESCENT BOYS AND MEN AT HIGHER RISK FOR HIV - EVIDENCE AND CASE STUDIES. TECHNICAL BRIEF
|
2021
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
WEB ANNEX 5.2 CASE STUDIES ON ENHANCING UPTAKE OF VOLUNTARY MEDICAL MALE CIRCUMCISION SERVICES
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
WEB ANNEX 4.1 GRADE TABLES, SUMMARY OF STUDIES AND EVIDENCE-TO-DECISION TABLE ON SAFETY AND ACCEPTABILITY OF MALE CIRCUMCISION DEVICES: COLLAR CLAMP, ELASTIC COLLAR COMPRESSION AND SURGICAL ASSIST DEVICES
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
WEB ANNEX 2.1 GRADE AND EVIDENCE-TO-DECISION TABLES ON VOLUNTARY MEDICAL MALE CIRCUMCISION FOR HIV PREVENTION AMONG ADOLESCENTS AND MEN
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
RECOMMENDATIONS AND KEY CONSIDERATIONS
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
WEB ANNEX 1.1 GUIDELINE DEVELOPMENT PROCESS AND GROUPS; DECLARATIONS OF INTERESTS
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
WEB ANNEX 2.3 PART 2 SYNTHESIS OF LITERATURE ON VOLUNTARY MEDICAL MALE CIRCUMCISION: FACILITATORS AND BARRIERS, BY COUNTRY
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
WEB ANNEX 6.1 SUSTAINING VOLUNTARY MEDICAL MALE CIRCUMCISION SERVICES AND LINKAGES WITH ADOLESCENT SEXUAL AND REPRODUCTIVE HEALTH: THE ZIMBABWE SMART-LYNCAGES PROJECT
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
WEB ANNEX 2.3 PART 1 WHO GUIDANCE ON VOLUNTARY MEDICAL MALE CIRCUMCISION FOR HIV PREVENTION AMONG ADOLESCENT BOYS AND MEN: LITERATURE REVIEWS FOR PICO QUESTIONS 1–3
|
2020
|
|
PREVENTING HIV THROUGH SAFE VOLUNTARY MEDICAL MALE CIRCUMCISION FOR ADOLESCENT BOYS AND MEN IN GENERALIZED HIV EPIDEMICS:
WEB ANNEX 5.1 GRADE AND EVIDENCE-TO-DECISION TABLES ON ENHANCING UPTAKE OF VOLUNTARY MEDICAL MALE CIRCUMCISION AMONG MEN
|
2020
|
|
Preventing injuries and violence:
A GUIDE FOR MINISTRIES OF HEALTH
|
2007
|
|
Preventing maltreatment and other adverse childhood experiences
|
2013
|
|
PREVENTING NONCOMMUNICABLE DISEASES (NCDs) BY REDUCING ENVIRONMENTAL RISK FACTORS
|
2017
|
|
PREVENTING SUICIDE:
A resource for filmmakers and others working on stage and screen
|
2019
|
|
Preventing unsafe abortion
|
2014
|
|
Preventing unsafe abortion
|
2019
|
|
Preventing violence::
Evaluating outcomes of parenting programmes
|
2013
|
|
Preventing violence against children 2020:
Status report for the WHO Eastern Mediterranean Region
|
2021
|
|
PREVENTING VIOLENCE AGAINST CHILDREN 2020::
STATUS REPORT FOR THE WHO AFRICAN REGION
|
2022
|
|
Preventing violence against children in the WHO Eastern Mediterranean Region:
Facts from the Global status report on preventing violence against children 2020
|
2021
|
|
Preventing youth violence::
an overview of the evidence
|
2015
|
|
Prevention and control of noncommunicable diseases:
Outcomes of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and the First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control
|
2012
|
|
Prevention and Control of Noncommunicable Diseases::
Guidelines for primary health care in low-resource settings
|
2012
|
|
Prevention and control of noncommunicable diseases in refugees and migrants:
Technical guidance
|
2019
|
|
Prevention and Control of Severe Acute Respiratory Syndrome(SARS)
|
2003
|
|
The prevention and elimination of disrespect and abuse during facility-based childbirth
|
2015
|
|
Prevention & Control of Viral Hepatitis Infection::
Framework for Global Action
|
2012
|
|
Prévention de la noyade ::
Guide pratique
|
2017
|
|
Prévention de la violence ::
évaluation des résultats de programmes parentaux
|
2014
|
|
PRÉVENTION DE LA VIOLENCE À L’ÉGARD DES ENFANTS 2020::
RAPPORT DE SITUATION DANS LA RÉGION AFRICAINE DE L’OMS
|
2022
|
|
Prévention et lutte contre les maladies non transmissibles ::
Directive relative aux soins de santé primaires dans les contextes de faibles ressources
|
2013
|
|
Prévention et lutte contre l’hépatite virale ::
Cadre pour l’action mondiale
|
2012
|
|
Prevention, identification and management of health worker infection in the context of COVID-19:
Interim guidance
|
2020
|
|
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS:
GUIDELINES ON ANTIVIRAL PROPHYLAXIS IN PREGNANCY
|
2020
|
|
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS: Guidelines on antiviral prophylaxis in pregnancy:
Annex D. Acceptability, feasibility, values and preferences of antiviral prophylaxis for HBV-infected pregnant women in addition to timely birth dose vaccination
|
2020
|
|
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS: Guidelines on antiviral prophylaxis in pregnancy:
Web Annex C: Impact and cost–effectiveness of HBV peripartum antiviral therapy
|
2020
|
|
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS: Guidelines on antiviral prophylaxis in pregnancy:
Web Annex F. Summary of declared interests of Guideline Development Group members
|
2020
|
|
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS: Guidelines on antiviral prophylaxis in pregnancy:
Web Annex A. Systematic review of the efficacy and safety of antiviral therapy during pregnancy
|
2020
|
|
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS: Guidelines on antiviral prophylaxis in pregnancy:
Web Annex B: Systematic review of the performance of hepatitis B e antigen test, as an alternative to HBV DNA, to assess eligibility for initiating antiviral therapy during pregnancy
|
2020
|
|
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS: Guidelines on antiviral prophylaxis in pregnancy:
Annex E. Framework for regional verification of the global control goal for hepatitis B surface antigen prevalence in children by 2020
|
2020
|
|
Prevention of Suicidal Behaviours::
Feasibility Demonstration Projects on Community Interventions for Safer Access to Pesticides
|
2008
|
|
PRICE SETTING AND REGULATION IN HEALTH SERVICES
|
2020
|
|
Pricing approaches sensitive to health systems’ ability to pay and the need for accelerating towards Health Sustainable Development Goal
|
2021
|
|
PRIMARY EAR AND HEARING CARE:
TRAINER’S HANDBOOK
|
2023
|
|
PRIMARY EAR AND HEARING CARE TRAINER’S HANDBOOK
|
2023
|
|
PRIMARY EAR AND HEARING CARE: TRAINING MANUAL:
WEB ANNEX. DEVELOPMENT OF THE PRIMARY EAR AND HEARING CARE TRAINING MANUAL, INFORMATION SOURCES AND DECLARATION OF INTERESTS
|
2023
|
|
PRIMARY EAR AND HEARING CARE TRAINING MANUAL
|
2023
|
|
Primary Health Care on the Road to Universal Health Coverage:
2019 GLOBAL MONITORING REPORT
|
2019
|
|
A Primer for Media:
Antimicrobial Resistance in the Western Pacific Region
|
2016
|
|
Primer informe de la Comisión B
|
2021
|
|
Primera ayuda psicológica::
Guía para trabajadores de campo
|
2012
|
|
PRIMUL AJUTOR PSIHOLOGIC::
Ghid pentru asistenţii comunitari
|
2011
|
|
Principales agentes etiológicos de las enfermedades de transmisión alimentaria
|
2015
|
|
PRINCIPALES CONSIDÉRATIONS CONCERNANT LA DÉLIVRANCE DIFFÉRENCIÉE DE TRAITEMENTS ANTIRÉTROVIRAUX À DES POPULATIONS PARTICULIÈRES ::
ENFANTS, ADOLESCENTS, FEMMES ENCEINTES OU ALLAITANTES ET POPULATIONS CLÉS
|
2017
|
|
Principales étapes pour l’élaboration ou la mise à jour d’un plan national de préparation en cas de grippe pandémique
|
2018
|
|
Principales maladies d’origine alimentaire et principaux risques
|
2015
|
|
Principes destinés à faire l’objet d’un consensus mondial sur le don et la gestion du sang, de ses constituants et des produits médicaux d’origine humaine:
Rapport du Secrétariat
|
2016
|
|
Principes directeurs applicables aux questions éthiques concernant la surveillance du VIH
|
2013
|
|
Principes directeurs pour la formation de base et la sécurité dans la pratique de l'acupuncture
|
2001
|
|
Principes généraux de bonnes pratiques pour les soins chroniques:
PRISE EN CHARGE INTÉGRÉE DE LA MALADIE CHEZ L’ADOLESCENT ET L’ADULTE
|
2004
|
|
Principes sur le don et la gestion du sang, de ses constituants et des autres produits médicaux d’origine humaine:
Rapport du Secrétariat
|
2017
|
|
Principios para un consenso mundial sobre la donación y la gestión de sangre, componentes sanguíneos y otros productos médicos de origen humano:
Informe de la Secretaría
|
2016
|
|
Principios sobre la donación y la gestión de sangre, componentes sanguíneos y otros productos médicos de origen humano:
Informe de la Secretaría
|
2017
|
|
Principles for global consensus on the donation and management of blood, blood components and medical products of human origin:
Report by the Secretariat
|
2016
|
|
PRINCIPLES OF HEALTH BENEFIT PACKAGES
|
2021
|
|
Principles on the donation and management of blood, blood components and other medical products of human origin:
Report by the Secretariat
|
2017
|
|
Prioridades estratégicas de la OMS en materia de resistencia a los antimicrobianos:
Preservar los antimicrobianos para hoy y para mañana
|
2022
|
|
Priorités stratégiques de l’OMS pour lutter contre la résistance aux antimicrobiens:
Préserver les antimicrobiens pour aujourd’hui et pour demain
|
2022
|
|
PRIORITIZATION OF PATHOGENS TO GUIDE DISCOVERY, RESEARCH AND DEVELOPMENT OF NEW ANTIBIOTICS FOR DRUG-RESISTANT BACTERIAL INFECTIONS, INCLUDING TUBERCULOSIS
|
2017
|
|
Prioritizing areas for action in the field of population-based prevention of CHILDHOOD OBESITY:
A SET OF TOOLS FOR MEMBER STATES to determine and identify priority areas for action
|
2012
|
|
Priority Assistive Products List:
Improving access to assistive technology for everyone, everywhere
|
2016
|
|
Priority medical devices list for the COVID-19 response and associated technical specifications:
INTERIM GUIDANCE
|
2020
|
|
Prise en charge clinique de la COVID-19:
Orientations provisoires
|
2020
|
|
Prise en charge clinique de l’infection respiratoire aiguë sévère (IRAS) en cas de suspicion de maladie à coronavirus 2019 (COVID-19):
Lignes directrices provisoires
|
2020
|
|
Prise en charge clinique de l’infection respiratoire aiguë sévère lorsqu’une infection par le nouveau coronavirus (2019-nCoV) est soupçonnée:
Lignes directrices provisoires
|
2020
|
|
Prise en charge clinique de l’infection respiratoire aiguë sévère lorsqu’une infection par un nouveau coronavirus (nCoV) est soupçonnée:
Lignes directrices provisoires
|
2020
|
|
Prise en charge clinique des cas de fièvre hémorragique virale Guide de poche pour l’agent de santé de première ligne:
Guide d’urgence provisoire à adapter aux conditions d’exercice dans les différents pays
|
2016
|
|
Prise en charge clinique des infections respiratoires aiguës sévères lorsqu’une infection par le coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) est soupçonnée:
Lignes directrices provisoires
|
2015
|
|
Prise en charge clinique des survivantes de viol et de violence exercée par un partenaire intime:
Élaboration de protocoles à adopter dans les situations de crise humanitaire
|
2022
|
|
PRISE EN CHARGE CLINIQUE, PRÉVENTION ET MAÎTRISE DE L’ORTHOPOXVIROSE SIMIENNE (VARIOLE DU SINGE):
Orientations provisoires pour une intervention rapide
|
2022
|
|
Prise en charge des sujets asymptomatiques avec un résultat positif au test RT-PCR de dépistage du coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV):
Lignes directrices provisoires
|
2015
|
|
Prise en charge d’une infection bactérienne potentiellement grave chez le jeune nourrisson âgé de 0 à 59 jours lorsqu’un transfert vers une structure hospitalière est impossible
|
2017
|
|
Prise en charge intégrée de la grossesse et de l’accouchement:
Interventions recommandées par l’OMS pour améliorer la santé de la mère et du nouveau-né
|
2007
|
|
Prise en compte de la santé dans l’élaboration de plans d’action nationaux concernant l’extraction minière et à petite échelle d’or en vertu de la Convention de Minamata sur le mercure
|
2019
|
|
The private sector,:
universal health coverage and primary health care
|
2016
|
|
Private sector engagement to deliver maternal, newborn, child health and family planning services during COVID-19 in Pakistan
|
2023
|
|
PROBLEM MANAGEMENT PLUS (PM+):
PM+: Individualna psihološka pomoć odraslima u nevolji uzrokovanoj nepovoljnom situacijom u zajednici
|
2016
|
|
PROBLEM MANAGEMENT PLUS (PM+):
Individual psychological help for adults impaired by distress in communities exposed to adversity
|
2016
|
|
PROBLEM MANAGEMENT PLUS (PM+):
Individual psychological help for adults impaired by distress in communities exposed to adversity
|
2016
|
|
PROBLEM MANAGEMENT PLUS (PM+):
Psychological help for adults in communities exposed to adversity
|
2016
|
|
Procedimiento Operativo Normalizado para Determinar el Contenido en Nicotina, Glicerol y Propilenglicol en Líquidos para Sistemas Electrónicos de Administración
|
2022
|
|
PROCEDIMIENTOS GENERALES DE SEGURIDAD EN EL LABORATORIO DE DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-11
|
2016
|
|
PROCÉDURES GÉNÉRALES DE SÉCURITÉ DANS LE LABORATOIRE DE DIAGNOSTIC MICROSCOPIQUE DU PALUDISME:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-11
|
2016
|
|
Productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación:
Informe de la Directora General
|
2016
|
|
Productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación:
Informe de la Directora General
|
2015
|
|
Produits médicaux de qualité inférieure et falsifiés:
Rapport du Directeur général
|
2020
|
|
Produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits:
Rapport du Directeur général
|
2016
|
|
Produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits:
Rapport du Directeur général
|
2015
|
|
Produits sanguins et autres produits médicaux d’origine humaine:
Rapport du Secrétariat
|
2014
|
|
Progess in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa January - December 2012
|
2013
|
|
Programa de Certificación del Confinamiento en apoyo del Plan de acción mundial de la OMS para el confinamiento de poliovirus:
GAPIII−PCC
|
2017
|
|
PROGRAMA OMS DE INVESTIGACIÓN EN MATERIA DE SALUD PÚBLICA PARA LA GESTIÓN DE INFODEMIAS
|
2021
|
|
PROGRAMA SOBRE EL VIH: ALCANZAR NUESTROS OBJETIVOS:
PLAN OPERATIVO 2014-2015
|
2014
|
|
PROGRAMME DE RECHERCHE EN SANTÉ PUBLIQUE DE L’OMS SUR LA GESTION DES INFODÉMIES
|
2021
|
|
Programme reporting standards for sexual, reproductive, maternal, newborn, child and adolescent health
|
2017
|
|
PROGRAMME VIH/SIDA : PARVENIR AU BUT:
PLAN OPÉRATIONNEL 2014-2015
|
2014
|
|
PROGRAMMING IN ACCESS-CONSTRAINED ENVIRONMENTS:
PRACTICAL GUIDANCE
|
2018
|
|
PROGRÈS ACCOMPLIS DANS LA MISE EN OEUVRE DES QUATRE ENGAGEMENTS ASSORTIS D’ÉCHÉANCES EN MATIÈRE DE LUTTE CONTRE LES MALADIES NON TRANSMISSIBLES DANS LA RÉGION AFRICAINE
|
2018
|
|
Progress report on HIV, viral hepatitis and sexually transmitted infections, 2019:
Accountability for the global health sector strategies, 2016–2021
|
2019
|
|
Progress report on implementation of the regional strategic framework for blood safety and availability 2016–2025
|
2020
|
|
Progress reports:
Report by the Director-General
|
2018
|
|
Progress reports on Investing in Children::
the European Child and Adolescent Health Strategy 2015–2020 and the European Child Maltreatment Prevention Action Plan 2015–2020
|
2018
|
|
The project has ended but we can still learn from it!:
Practical guidance for conducting post-project evaluations of adolescent sexual and reproductive health projects
|
2019
|
|
Projet de directives pour l’application de l’article 6 de la Convention-cadre de l’OMS:
Rapport du groupe de travail
|
2012
|
|
Projet de directives pour l’application de l’article 6 de la Convention-cadre de l’OMS:
Rapport du groupe de rédaction intersessions à composition non limitée
|
2014
|
|
Projet de plan d’action mondial contre la résistance aux antimicrobiens:
Rapport du Secrétariat
|
2014
|
|
PROJET DE PLAN D’ACTION MONDIAL DE L’OMS RELATIF AU HANDICAP 2014-2021 ::
Un meilleur état de santé pour toutes les personnes handicapées
|
2016
|
|
Projet de plan mondial d’action de santé publique contre la démence:
Rapport du Directeur général
|
2017
|
|
Projet de protocole pour éliminer le commerce illicite des produits du tabac
|
2012
|
|
Projet de protocole pour éliminer le commerce illicite des produits du tabac:
Note du Secrétariat de la Convention
|
2011
|
|
Projet de protocole pour éliminer le commerce illicite des produits du tabac
|
2012
|
|
Projet pour l’élaboration de programmes nationaux pour l’élimination des maladies liées à l’amiante
|
2007
|
|
Promoting adolescent sexual and reproductive health through schools in low income countries::
an information brief
|
2009
|
|
Promoting price transparency:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
Promoting public health measures in response to COVID-19 on cargo ships and fishing vessels:
Interim guidance
|
2020
|
|
PROMOTING RIGHTS AND COMMUNITY LIVING FOR CHILDREN WITH PSYCHOSOCIAL DISABILITIES
|
2015
|
|
PROMOTING RIGHTSAND COMMUNITY LIVING FOR CHILDREN WITH PSYCHOSOCIAL DISABILITIES
|
2015
|
|
Promoting the health of refugees and migrants
|
2019
|
|
Promoting the health of refugees and migrants:
Draft global action plan, 2019–2023
|
2019
|
|
Promoting the use of quality-assured generic and biosimilar medicines:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
Proof-of-Principle routine diagnostic project for antimicrobial resistance surveillance:
GEORGIA
|
2017
|
|
Protecting Health from Climate Change:
Vulnerability and Adaptation Assessment
|
2013
|
|
Protecting the Blood Supply During Infectious Disease Outbreaks:
Guidance for National Blood Services
|
2019
|
|
Protéger la santé face au changement climatique:
Évaluation de la vulnérabilité et de l’adaptation
|
2015
|
|
PROTOCOL:
TO ELIMINATE ILLICIT TRADE IN TOBACCO PRODUCTS
|
2013
|
|
Protocol for assessment of potential risk factors for coronavirus disease 2019 (COVID-19) among health workers in a health care setting
|
2020
|
|
PROTOCOL TEMPLATE TO BE USED AS A TEMPLATE FOR OBSERVATIONAL STUDY PROTOCOLS:
SENTINEL SURVEILLANCE OF ADVERSE EVENTS OF SPECIAL INTEREST (AESIS) AFTER VACCINATION WITH COVID-19 VACCINES
|
2021
|
|
Protocol to INVESTIGATE non-seasonal influenza and other emerging acute respiratory diseases
|
2018
|
|
PROTOCOLE:
POUR ÉLIMINER LE COMMERCE ILLICITE DES PRODUITS DU TABAC
|
2013
|
|
Protocole de recherche sur la transmission dans les familles de l’infection par la maladie à coronavirus 2019 (COVID-19)
|
2020
|
|
Protocole d’enquête sur la maladie à coronavirus 2019 (COVID-19) – Les X premiers cas et contacts (FFX)
|
2020
|
|
Protocole original pour la surveillance des délétions des gènes pfhrp2/3 et la mise en banque de matériel biologique en vue de recherches ultérieures
|
2020
|
|
Protocole type pour la surveillance des délétions des gènes pfhrp2/pfhrp3
|
2020
|
|
PROTOCOLO:
PARA LA ELIMINACIÓN DEL COMERCIO ILÍCITO DE PRODUCTOS DE TABACO
|
2013
|
|
Protocolo de investigación de la transmisión en los hogares de la enfermedad por el coronavirus de 2019 (COVID-19)
|
2020
|
|
Protocolo de investigación de los primeros casos y sus contactos directos (FFX) de la enfermedad por el coronavirus de 2019 (COVID-19)
|
2020
|
|
Providing differentiated delivery to children and adolescents
|
2019
|
|
Providing peer support for adolescents and young people living with HIV
|
2019
|
|
PROVISIONAL STRATEGY FOR INTERRUPTING LYMPHATIC FILARIASIS TRANSMISSION IN LOIASIS-ENDEMIC COUNTRIES:
Report of the meeting on lymphatic filariasis, malaria and integrated vector management Accra, Ghana, 5–9 March 2012
|
2012
|
|
Proyecto de directrices para la aplicación del artículo 6 del Convenio Marco de la OMS para el Control del Tabaco:
Informe del grupo de trabajo
|
2012
|
|
Proyecto de directrices para la aplicación del artículo 6 del Convenio Marco de la OMS para el Control del Tabaco:
Informe del grupo de redacción de composición abierta entre reuniones
|
2014
|
|
Proyecto de plan de acción mundial sobre la respuesta de salud pública a la demencia:
Informe de la Directora General
|
2017
|
|
Proyecto de plan de acción mundial sobre resistencia a los fármacos antimicrobianos:
Informe de la Secretaría
|
2014
|
|
Proyecto de protocolo para la eliminación del comercio ilícito de productos de tabaco
|
2012
|
|
Proyecto de protocolo para la eliminación del comercio ilícito de productos de tabaco
|
2012
|
|
Proyecto de protocolo para la eliminación del comercio ilícito de productos de tabaco:
Nota de la Secretaría del Convenio
|
2011
|
|
Pruebas de laboratorio para la hepatitis aguda grave de causa desconocida en niños:
Orientaciones provisionales
|
2022
|
|
Pruebas diagnósticas para el SARS-CoV-2:
Orientaciones provisionales
|
2020
|
|
Psühholoogiline esmaabi::
otseste abistajate juhendamise käsiraamat
|
2013
|
|
Psychological first aid:
during Ebola virus disease outbreaks
|
2014
|
|
Psychological first aid::
Facilitator’s manual for orienting field workers
|
2013
|
|
Psychological first aid:
during Ebola Disease Outbreaks
|
2014
|
|
Psychological first aid::
Guide for field workers
|
2011
|
|
PUBLIC ENGAGEMENT AND CROWDFUNDING IN HEALTH RESEARCH:
A Practical Guide
|
2021
|
|
PUBLIC HEALTH ACTION FOR THE PREVENTION OF SUICIDE:
A FRAMEWORK
|
2012
|
|
Public Health Emergency Operations Centre Network (EOC-NET)
|
2013
|
|
PUBLIC HEALTH IMPACT AND IMPLICATIONS FOR FUTURE ACTIONS: WHO GLOBAL CONSULTATION ON THE HUMAN T-LYMPHOTROPIC VIRUS TYPE 1:
TOKYO, JAPAN, 13-15 NOVEMBER 2019
|
2021
|
|
THE PUBLIC HEALTH IMPACT OF CHEMICALS::
KNOWNS AND UNKNOWNS
|
2016
|
|
THE PUBLIC HEALTH IMPACT OF CHEMICALS: KNOWNS AND UNKNOWNS:
Data addendum for 2019
|
2021
|
|
THE PUBLIC HEALTH IMPACT OF CHEMICALS: KNOWNS AND UNKNOWNS:
Data addendum for 2016
|
2018
|
|
Public Health Implications of Excessive Use of the Internet, Computers, Smartphones and Similar Electronic Devices:
Meeting report
|
2014
|
|
Public Health Implications of Excessive Use of the Internet, Computers, Smartphones and Similar Electronic Devices Meeting report:
Main Meeting Hall, Foundation for Promotion of Cancer Research National Cancer Research Centre, Tokyo, Japan 27-29 August 2014
|
2015
|
|
The public health implications of implementation of the Nagoya Protocol:
Report by the Director-General
|
2021
|
|
The public health implications of implementation of the Nagoya Protocol:
Interim report by the Director-General
|
2019
|
|
Public Health Research Agenda for Influenza:
Report of a regional meeting New Delhi, India, 18–20 August 2010
|
2011
|
|
Public Health Research Agenda for Influenza in the South-East Asia Region::
A review of current status and needs
|
2011
|
|
Public health surveillance for COVID-19:
Interim guidance
|
2020
|
|
Public Hospital Governance in Asia and the Pacific
|
2015
|
|
Pulse survey on continuity of essential health services during the COVID-19 pandemic
|
2020
|
|
Puntos clave y preguntas/respuestas:
Estado y tendencias de la resistencia a insecticidas en vectores de malaria (2018)
|
2018
|
|
Purchasing arrangements with the private sector to provide primary health care in underserved areas
|
2014
|
|
The Pursuit of Responsible Use of Medicines::
Sharing and Learning from Country Experiences
|
2012
|
|
QUADRO DE IMPLEMENTAÇÃO DA ESTRATÉGIA MUNDIAL PARA ACELERAR A ELIMINAÇÃO DO CANCRO DO COLO DO ÚTERO ENQUANTO PROBLEMA DE SAÚDE PÚBLICA NA REGIÃO AFRICANA DA OMS
|
2021
|
|
Quadro de indicadores e metas para fortalecimento dos laboratórios no âmbito da Estratégia Fim da TB
|
2016
|
|
Quality assurance of pharmaceuticals::
MEETING A MAJOR PUBLIC HEALTH CHALLENGE
|
2014
|
|
QUALITY CONTROL OF GIEMSA STOCK SOLUTION AND BUFFERED WATER:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-03C
|
2016
|
|
QUALITY CRITERIA FOR HEALTH NATIONAL ADAPTATION PLANS
|
2021
|
|
QUALITY CRITERIA FOR THE EVALUATION OF CLIMATE-INFORMED EARLY WARNING SYSTEMS FOR INFECTIOUS DISEASES
|
2021
|
|
Quality, Equity, Dignity:
The network to improve quality of care for maternal, newborn and child health STRATEGIC OBJECTIVES
|
2018
|
|
QUALITY HEALTH SERVICES AND PALLIATIVE CARE:
Practical approaches and resources to support policy, strategy and practice
|
2021
|
|
Quality of Care:
What are effective policy options for governments in low- and middle-income countries to improve and regulate the quality of ambulatory care?
|
2015
|
|
Quality of care in contraceptive information and services, based on human rights standards::
A checklist for health care providers
|
2017
|
|
QUALITY OF CARE IN FRAGILE, CONFLICT-AFFECTED AND VULNERABLE SETTINGS:
TOOLS AND RESOURCES COMPENDIUM
|
2020
|
|
QUALITY OF CARE IN FRAGILE, CONFLICT-AFFECTED AND VULNERABLE SETTINGS:
TAKING ACTION
|
2020
|
|
Quantitative risk assessment of the effects of climate change on selected causes of death, 2030s and 2050s
|
2014
|
|
Quatrième rapport de la Commission A
|
2016
|
|
QUÉ NECESITA SABER ANTES Y DESPUÉS DE UNA INTERVENCIÓN QUIRÚURGICA
|
2016
|
|
Quelques conseils pour écouter sans risque
|
2019
|
|
Questionário da Avaliação Rápida de Tecnologia Assistiva (rATA)
|
2021
|
|
Questions touchant au commerce et à l'investissement en relation avec la mise en œuvre de la Conventioncadre de l’OMS:
Rapport du Secrétariat de la Convention
|
2014
|
|
RABIES:
RATIONALE FOR INVESTING IN THE GLOBAL ELIMINATION OF DOG-MEDIATED HUMAN RABIES
|
2015
|
|
A Rapid Assessment in Relation to Alcohol and Other Substance Use and Sexual Behaviour in Zimbabwe:
FINAL REPORT
|
2001
|
|
rapid Assistive Technology Assessment tool (rATA)
|
2021
|
|
Rapid communication::
Key changes to the treatment of drug-resistant tuberculosis
|
2022
|
|
Rapid Guidance on the Decommissioning of Ebola Care Facilities
|
2015
|
|
Rapid hospital readiness checklist:
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic
|
2020
|
|
A Rapid Review of Evidence-Based Information, Best Practices and Lessons Learned in Addressing the Health Needs of Refugees and Migrants:
Report to the World Health Organization
|
2018
|
|
A Rapid Situation Assessment of Alcohol in Relation to Sexual Behaviour in Lagos, Nigeria
|
2012
|
|
Rapport de la réunion sur l’administration du vaccin contre le VPH:
Détermination des besoins relatifs à la mise en œuvre et à la recherche Genève, 17-19 Avril 2012
|
2011
|
|
RAPPORT DE LA SEIZIÈME RÉUNION DE L’ALLIANCE OMS POUR L’ÉLIMINATION DU TRACHOME CÉCITANT D’ICI 2020
|
2012
|
|
RAPPORT DE LA VISIOCONFÉRENCE SUR LA MISE EN OEUVRE ET LA PÉRENNITÉ DE LA MISE EN PLACE DE LA STRATÉGIE DE L’OMS POUR LA RÉSISTANCE DU VIH AUX ANTIRÉTROVIRAUX EN AFRIQUE
|
2014
|
|
RAPPORT DE SITUATION 2001–2011 ET PLAN STRATÉGIQUE 2012–2020
|
2013
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBÉE DE MALADIE À VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA:
INCORPORANT LE RAPPORT D'ACTIVITE DE L'OMS
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
RAPPORT DE SITUATION SUR LA FLAMBEE DE MALADIE A VIRUS EBOLA
|
2015
|
|
Rapport de situation sur la mise en oeuvre du cadre stratégique régional pour la sécurité transfusionnelle et la disponibilité des produits sanguins 2016-2025
|
2020
|
|
RAPPORT DE SITUATION SUR LA MISE EN ŒUVRE DE LA DÉCENNIE D’ACTION POUR LA SÉCURITÉ ROUTIÈRE DANS LA RÉGION AFRICAINE:
Rapport du Secrétariat
|
2017
|
|
Rapport de synthèse du Directeur général
|
2021
|
|
Rapport d’une consultation de l’OMS visant à renforcer la participation des communautés et des organisations non gouvernementales et autres organisations de la société civile à la mise en œuvre de la Stratégie Mettre fin à la tuberculose
|
2015
|
|
Rapport européen sur la prévention de la maltraitance des enfants:
Résumé
|
2013
|
|
Rapport mondial de situation sur l’action de:
santé publique contre la démence
|
2021
|
|
RAPPORT MONDIAL SUR LA NOYADE:
COMMENT PRÉVENIR UNE CAUSE MAJEURE DE DÉCÈS
|
2014
|
|
RAPPORT MONDIAL SUR LA NOYADE:
COMMENT PRÉVENIR UNE CAUSE MAJEURE DE DÉCÈS
|
2015
|
|
Rapport mondial sur la prévention des traumatismes chez l’enfant
|
2008
|
|
Rapport mondial sur la prévention des traumatismes chez l’enfant
|
2008
|
|
RAPPORT MONDIAL SUR L’AUDITION:
RÉSUMÉ ANALYTIQUE
|
2021
|
|
RAPPORT MONDIAL SUR L’HÉPATITE, 2017
|
2017
|
|
RAPPORT OMS 2012 SUR LA RÉSISTANCE DU VIH AUX ANTIRÉTROVIRAUX
|
2014
|
|
RAPPORT SUR LE PALUDISME DANS LE MONDE 2015:
Résumé
|
2016
|
|
RAPPORT SUR LE PALUDISME DANS LE MONDE 2016:
RÉSUMÉ
|
2017
|
|
Rapport sur les incidences financières et administratives qu’auront pour le Secrétariat les résolutions proposées au Conseil exécutif ou à l’Assemblée de la Santé pour adoption
|
2014
|
|
Rapport sur les incidences financières et administratives qu’auront pour le Secrétariat les résolutions proposées au Conseil exécutif ou à l’Assemblée de la Santé pour adoption
|
2014
|
|
Rapport sur les réunions de comités d’experts et de groupes d’étude:
Rapport du Directeur général
|
2020
|
|
Rapport sur l’exécution du plan de travail et du budget 2010-2011:
Rapport du Secrétariat de la Convention
|
2012
|
|
RAPPORTS DE SITUATION SUR LES PROGRAMMES TECHNIQUES
|
2019
|
|
RAPPORTS DE SITUATION SUR LES PROGRAMMES TECHNIQUES
|
2016
|
|
RAPPORTS DE SITUATION SUR LES PROGRAMMES TECHNIQUES
|
2021
|
|
Rastreo de contactos y cuarentena en el contexto de la variante ómicron del SARS-CoV-2:
Orientaciones provisionales
|
2022
|
|
RATIFICATION DU PROTOCOLE POUR ÉLIMINER LE COMMERCE ILLICITE DES PRODUITS DU TABAC
|
2018
|
|
Rational use of personal protective equipment for COVID-19 and considerations during severe shortages:
Interim guidance
|
2020
|
|
Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19):
Interim guidance
|
2020
|
|
Réadaptation DANS LES SYSTÈMES DE SANTÉ:
GUIDE D’ACTION
|
2020
|
|
Readiness for influenza during the COVID-19 pandemic:
Policy brief
|
2020
|
|
Recherche des contacts et placement en quarantaine dans le contexte du variant Omicron du SARS-CoV-2:
Orientations provisoires
|
2022
|
|
Reciclaje de baterías de plomo-ácido usadas::
consideraciones sanitarias
|
2017
|
|
Reciclaje de baterías de plomo-ácido usadas:
Breve reseña para el sector sanitario
|
2017
|
|
RECOGNIZING NEGLECTED TROPICAL DISEASES THROUGH CHANGES ON THE SKIN:
A TRAINING GUIDE FOR FRONT-LINE HEALTH WORKERS
|
2018
|
|
Recomendaciones a los Estados Miembros para mejorar las prácticas de higiene de manos con el fin de ayudar a prevenir la transmisión del virus de la COVID-19
|
2020
|
|
Recomendaciones de la OMS Para los cuidados durante el parto, para una experiencia de parto positiva:
Transformar la atención a mujeres y neonatos para mejorar su salud y bienestar
|
2018
|
|
Recomendaciones de la OMS sobre cuidados maternos y neonatales para una experiencia posnatal positiva:
Resumen ejecutivo
|
2022
|
|
Recomendaciones de la OMS sobre la prevención y la gestión del consumo de tabaco y la exposición al humo ajeno durante el embarazo
|
2014
|
|
Recomendaciones provisionales para el uso de la vacuna BBV152 COVAXIN® de Bharat Biotech contra la COVID-19
|
2022
|
|
Recomendaciones provisionales para el uso de la vacuna ChAdOx1-S [recombinante] contra la COVID-19 (vacuna de AstraZeneca contra la COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™)
|
2022
|
|
Recomendaciones provisionales para el uso de la vacuna inactivada contra la COVID-19 BIBP desarrollada por China National Biotec Group (CNBG), Sinopharm
|
2022
|
|
Recomendaciones provisionales para el uso de la vacuna inactivada contra la COVID-19 CoronaVac, desarrollada por Sinovac
|
2022
|
|
Recomendaciones provisionales sobre el uso de la vacuna BNT162b2 de Pfizer y BioNTech contra la COVID-19 en el marco de la Lista de Uso en Emergencias
|
2021
|
|
Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19
|
2022
|
|
Recomendaciones provisionales sobre el uso de la vacuna mRNA-1273 de Moderna contra la COVID-19
|
2021
|
|
Recomendaciones provisionales sobre el uso de la vacuna mRNA-1273 de Moderna contra la COVID-19
|
2022
|
|
Recomendaciones provisionales sobre el uso de la vacuna Novavax NVX-CoV2373 contra la COVID-19
|
2021
|
|
Recomendaciones sobre la ética de la prevención, atención y control de la tuberculosis
|
2013
|
|
Recomendaciones sobre la fortificación de las harinas de trigo y de maíz Informe de reunión::
Declaración de consenso provisional
|
2009
|
|
Recomendaciones sobre prácticas seleccionadas para el uso de anticonceptivos:
Tercera edición, 2018
|
2018
|
|
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva:
Sumário executivo
|
2022
|
|
Recomendações sobre o uso de máscaras no contexto da COVID-19:
Orientações provisórias
|
2020
|
|
Recommandation de l’OMS relative à la mobilisation communautaire pour la santé de la mère et du nouveau-né au moyen de cycles d’apprentissage et d’action participatifs avec les associations féminines sous la conduite d’animateurs
|
2014
|
|
Recommandations aux États Membres pour améliorer les pratiques d’hygiène des mains par un accès universel à des postes publics d’hygiène des mains afin d’aider à prévenir la transmission du virus de la COVID-19 ::
Orientations provisoires
|
2020
|
|
Recommandations de l’OMS concernant les soins maternels et néonataux pour une expérience positive de la période postnatale:
Résumé analytique
|
2022
|
|
Recommandations de l’OMS pour la prévention et la prise en charge de la consommation de tabac et de l’exposition à la fumée secondaire pendant la grossesse
|
2015
|
|
Recommandations pour la surveillance après mise sur le marché des dispositifs médicaux y compris des dispositifs de diagnostic in vitro et pour la surveillance du marché de ces dispositifs
|
2021
|
|
Recommandations provisoires concernant l’utilisation du vaccin ChAdOx1-S [recombinant] contre la COVID-19 (vaccin anti-COVID-19 d’AstraZeneca AZD1222 Vaxzevria™, SII COVISHIELD™)
|
2022
|
|
Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 Ad26.COV2.S de Janssen
|
2022
|
|
Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 BBV152 COVAXIN® de Bharat Biotech
|
2022
|
|
Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 inactivé BIBP développé par China National Biotec Group (CNBG), Sinopharm
|
2022
|
|
Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 inactivé, CoronaVac, développé par Sinovac
|
2022
|
|
Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 Pfizer-BioNTech, BNT162b2, en vertu du protocole OMS d’autorisation d’utilisation d’urgence
|
2022
|
|
Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 Pfizer-BioNTech, BNT162b2, en vertu du protocole OMS d’autorisation d’utilisation d’urgence
|
2021
|
|
Recommandations provisoires pour l’utilisation du vaccin Moderna (mRNA-1273) contre la COVID-19
|
2022
|
|
Recommandations provisoires pour l’utilisation du vaccin Moderna (mRNA-1273) contre la COVID-19
|
2022
|
|
Recommandations provisoires pour l’utilisation du vaccin Novavax NVX-CoV2373 contre la COVID-19
|
2021
|
|
Recommandations relatives aux soins de soutien aux patients atteints de maladie à virus Ebola
|
2018
|
|
Recommandations sur l’enrichissement des farines de blé et de maïs Rapport de réunion ::
déclaration de consensus provisoire
|
2009
|
|
Recommandations temporaires de l’OMS pour les réunions internationales auxquelles assistent des personnes en provenance de pays touchés par la maladie à virus Ebola
|
2014
|
|
RECOMMANDATIONS TRANSITOIRES:
Utilisation de sang total ou de plasma de convalescent recueilli chez des patients rétablis après une maladie à virus Ebola pour la transfusion, comme traitement empirique pendant les épidémies
|
2014
|
|
RECOMMENDATIONS AND GUIDANCE ON HEPATITIS C VIRUS SELF-TESTING:
Web Annex F. Cost-effectiveness of hepatitis C virus self-testing
|
2021
|
|
RECOMMENDATIONS AND GUIDANCE ON HEPATITIS C VIRUS SELF-TESTING:
Web Annex D. Values and preferences on hepatitis C virus self-testing
|
2021
|
|
RECOMMENDATIONS AND GUIDANCE ON HEPATITIS C VIRUS SELF-TESTING:
Web Annex B. Declaration of interests for the Guideline Development Group, Observers and Peer Reviewers
|
2021
|
|
RECOMMENDATIONS AND GUIDANCE ON HEPATITIS C VIRUS SELF-TESTING:
Web Annex E. Hepatitis C virus self-testing: multi-country evidence on usability and acceptability
|
2021
|
|
RECOMMENDATIONS AND GUIDANCE ON HEPATITIS C VIRUS SELF-TESTING:
Web Annex C. Hepatitis C virus self-testing: systematic review report
|
2021
|
|
RECOMMENDATIONS AND GUIDANCE ON HEPATITIS C VIRUS SELF-TESTING:
Web Annex A. Process for guidelines development
|
2021
|
|
Recommendations for management of common childhood conditions:
Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care
|
2012
|
|
Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities
|
2021
|
|
RECOMMENDATIONS ON DIGITAL INTERVENTIONS FOR HEALTH SYSTEM STRENGTHENING:
EXECUTIVE SUMMARY
|
2019
|
|
RECOMMENDATIONS ON DIGITAL INTERVENTIONS FOR HEALTH SYSTEM STRENGTHENING:
RESEARCH CONSIDERATIONS
|
2019
|
|
Recommendations on Wheat and Maize Flour Fortification Meeting Report::
Interim Consensus Statement
|
2009
|
|
Recommendations to Member States to improve hand hygiene practices to help prevent the transmission of the COVID-19 virus:
Interim guidance
|
2020
|
|
Recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season
|
2021
|
|
Recommended package of interventions for HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for people in prisons and other closed settings:
Policy brief
|
2023
|
|
Recommended package of interventions for HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for people who inject drugs:
Policy brief
|
2023
|
|
RECOMMENDED POPULATION SIZE ESTIMATES OF MEN WHO HAVE SEX WITH MEN
|
2020
|
|
Recommended selection criteria for procurement of malaria rapid diagnostic tests
|
2018
|
|
RECORDING AND REPORTING MICROSCOPY RESULTS:
MALARIA MICROSCOPY STANDARD OPERATING PROCEDURE – MM-SOP-06B
|
2016
|
|
Recovering from health emergency, Sierra Leone makes measured progress:
Case Study
|
2021
|
|
Rectal artesunate for pre-referral treatment of severe malaria
|
2017
|
|
Recueil de lignes directrices de l’OMS et de normes associées ::
assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux Deuxième édition
|
2018
|
|
RECUENTO DE PARÁSITOS PALÚDICOS:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR — DMP-POE-09
|
2016
|
|
Recyclage des batteries au plomb usagées:
Note d’information pour le secteur de la santé
|
2017
|
|
Recyclage des batteries au plomb usagées ::
considérations sanitaires
|
2017
|
|
Recycling used lead-acid batteries::
health considerations
|
2017
|
|
Recycling used lead-acid batteries::
Brief information for the health sector
|
2017
|
|
Red and processed meat in the context of health and the environment::
many shades of red and green Information brief
|
2023
|
|
Redesigning child and adolescent health programmes:
MEETING REPORT 23-25 January 2019
|
2019
|
|
REDUCING GLOBAL HEALTH RISKS:
Through mitigation of short-lived climate pollutants
|
2015
|
|
Reducing inequities in health across the life-course:
Transition to independent living – young adults
|
2019
|
|
REDUCING STUNTING IN CHILDREN:
Equity considerations for achieving the Global Nutrition Targets 2025
|
2018
|
|
Regional Action Framework for Control and Elimination of Neglected Tropical Diseases in the Western Pacific
|
2020
|
|
Regional Action Plan on Healthy Ageing in the Western Pacific
|
2020
|
|
Regional framework for action on ageing and health in the Western Pacific (2014–2019)
|
2014
|
|
REGIONAL MEETING TO REVIEW AND ACCELERATE COUNTRY PROGRESS IN PREVENTION OF AVOIDABLE VISUAL IMPAIRMENT
|
2016
|
|
Regional Plan of Action for SIDS in the African and South East Asian Regions
|
2019
|
|
Regional situation analysis, practices, experiences, lessons learned and ways forward:
WHO Western Pacific Region
|
2018
|
|
Regional situation analysis, practices, experiences, lessons learned and ways forward:
WHO Region of Americas
|
2018
|
|
Regional situation analysis, practices, experiences, lessons learned and ways forward:
WHO African Region
|
2018
|
|
Regional situation analysis, practices, experiences, lessons learned and ways forward:
WHO European Region
|
2018
|
|
Regional Status Report on Blood Safety and Availability 2016
|
2017
|
|
Regional Strategic Directions for strengthening midwifery in the South-East Asia Region 2020-2024
|
2020
|
|
Regional Strategic Framework on Community-Based Rehabilitation (CBR) in the South-East Asia Region 2012–2017
|
2012
|
|
Regional Strategy and Plan of Action for Measles and Rubella Elimination in the Western Pacific
|
2018
|
|
Regional workshop on child and adolescent Tuberculosis in the WHO European Region:
4-5 December 2017, Copenhagen, Denmark
|
2018
|
|
REGISTRO Y NOTIFICACIÓN DE LOS RESULTADOS DEL EXAMEN MICROSCÓPICO:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-06B
|
2016
|
|
REGULATORY GUIDANCE FOR ASSESSMENT AND MANAGEMENT OF APPLICATIONS:
FOR MARKETING AUTHORIZATION OF OXYTOCIN
|
2021
|
|
Rehabilitación EN LOS SISTEMAS DE SALUD:
GUÍA DE ACCIÓN
|
2020
|
|
REHABILITATION AND DISABILITY IN THE WESTERN PACIFIC
|
2017
|
|
Rehabilitation COMPETENCY FRAMEWORK
|
2020
|
|
REHABILITATION in health systems
|
2017
|
|
Rehabilitation IN HEALTH SYSTEMS:
GUIDE FOR ACTION
|
2019
|
|
REHABILITATION INDICATOR MENU:
A tool accompanying the Framework for Rehabilitation Monitoring and Evaluation (FRAME)
|
2019
|
|
Reinforcing the focus on anti-corruption, transparency and accountability in national health policies, strategies and plans
|
2019
|
|
REJETS CHIMIQUES ASSOCIÉS À DES CYCLONES
|
2018
|
|
REJETS CHIMIQUES ASSOCIÉS À DES INONDATIONS
|
2018
|
|
REJETS CHIMIQUES ASSOCIÉS À DES SÉISMES
|
2018
|
|
REJETS CHIMIQUES CAUSÉS PAR DES PHÉNOMÈNES ET CATASTROPHES NATURELS:
INFORMATIONS POUR LES AUTORITÉS DE SANTÉ PUBLIQUE
|
2019
|
|
RENFORCER LA PRÉPARATION AUX SITUATIONS D’URGENCE SANITAIRE DANS LES VILLES ET LES MILIEUX URBAINS ::
ORIENTATIONS À L’INTENTION DES AUTORITÉS NATIONALES ET LOCALES
|
2022
|
|
Renforcer la résilience du système de santé pour instaurer la couverture sanitaire universelle et la sécurité sanitaire pendant et après la COVID-19:
EXPOSÉ DE LA POSITION DE L'OMS
|
2021
|
|
Renforcer le système de santé afin de répondre aux femmes qui subissent de la violence exercée par un partenaire intime et de la violence sexuelle:
Manuel destiné aux gestionnaires de santé
|
2021
|
|
REPLACE TRANS FAT:
AN ACTION PACKAGE TO ELIMINATE INDUSTRIALLY PRODUCED TRANS-FATTY ACIDS
|
2021
|
|
REPLACE TRANS FAT::
UN CONJUNTO DE MEDIDAS PARA ELIMINAR DEL SUMINISTRO MUNDIAL DE ALIMENTOS LAS GRASAS TRANS DE PRODUCCIÓN INDUSTRIAL
|
2021
|
|
REPLACE TRANS FAT:
FREQUENTLY ASKED QUESTIONS
|
2018
|
|
REPLACE TRANS FAT:
POLICIES TO ELIMINATE INDUSTRIALLY PRODUCED TRANS FAT
|
2019
|
|
REPLACE TRANS FAT ::
UN PROGRAMME D’ACTION POUR ÉLIMINER LES ACIDES GRAS TRANS (AGT) INDUSTRIELS
|
2021
|
|
REPLACE TRANS FAT:
AN ACTION PACKAGE TO ELIMINATE INDUSTRIALLY-PRODUCED TRANS FAT FROM THE GLOBAL FOOD SUPPLY TRANS FAT FREE BY 2023
|
2018
|
|
REPLACE TRANS FAT: AN ACTION PACKAGE TO ELIMINATE INDUSTRIALLY PRODUCED TRANS-FATTY ACIDS MODULE 1: REVIEW:
How-to guide for landscape assessment and roadmap development for elimination of trans fats
|
2020
|
|
REPLACE TRANS FAT: AN ACTION PACKAGE TO ELIMINATE INDUSTRIALLY PRODUCED TRANS-FATTY ACIDS MODULE 2: PROMOTE:
How-to guide for determining the best replacement oils and interventions to promote their use
|
2020
|
|
REPLACE TRANS FAT: AN ACTION PACKAGE TO ELIMINATE INDUSTRIALLY PRODUCED TRANS-FATTY ACIDS MODULE 3: LEGISLATE OR REGULATE:
How-to guide for trans fat policy action
|
2020
|
|
REPLACE TRANS FAT: AN ACTION PACKAGE TO ELIMINATE INDUSTRIALLY PRODUCED TRANS-FATTY ACIDS MODULE 4: ASSESS:
How-to guide for trans fat surveillance
|
2020
|
|
REPLACE TRANS FAT: AN ACTION PACKAGE TO ELIMINATE INDUSTRIALLY PRODUCED TRANS-FATTY ACIDS MODULE 5: CREATE:
How-to guide for creating trans fat awareness
|
2020
|
|
REPLACE TRANS FAT: AN ACTION PACKAGE TO ELIMINATE INDUSTRIALLY PRODUCED TRANS-FATTY ACIDS MODULE 6: ENFORCE:
How-to guide for trans fat policies and enforcement of regulations
|
2020
|
|
REPORT:
EXPERT CONSULTATION ON ADOLESCENTS AND SUBSTANCE USE IN THE WESTERN PACIFIC REGION
|
2011
|
|
REPORT:
WORKING GROUP ON CLINICAL RESEARCH METHODOLOGY FOR ACUPUNCTURE
|
1994
|
|
REPORT:
REGIONAL MEETING ON THE HARMUL USE OF ALCOHOL BY YOUNG PEOPLE
|
2014
|
|
REPORT:
MEETING ON THE REVISION OF GUIDELINES FOR CLINICAL RESEARCH ON ACUPUNCTURE
|
2006
|
|
REPORT FROM THE SCOPING CONSULTATION ON SEVERE BACTERIAL INFECTIONS AMONG PEOPLE WITH ADVANCED HIV DISEASE:
VIRTUAL MEETING 23 NOVEMBER 2021
|
2022
|
|
Report from WHO Sessions on the WHO Chemicals Road Map at SAICM Regional Meetings:
January - February 2018
|
2018
|
|
REPORT INFORMAL CONSULTATION ON CHAGAS DISEASE IN THE WESTERN PACIFIC
|
2011
|
|
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation:
Geneva, 29–30 January 2018
|
2018
|
|
Report of a joint mission to review the neglected tropical disease programme and supply chain management for donated preventive chemotherapy medicines:
Mozambique, 10–17 December 2019
|
2020
|
|
Report of a WHO consultation meeting to enhance the engagement of communities, nongovernmental and other civil society organizations in implementing the End TB Strategy
|
2015
|
|
Report of a WHO expert consultation on dosing to enable implementation of treatment recommendations in the WHO consolidated guidelines on the management of TB in children and adolescents
|
2022
|
|
Report of a WHO meeting on elimination of African trypanosomiasis (Trypanosoma brucei gambiense):
Geneva, 3–5 December 2012
|
2013
|
|
Report of a WHO–FIND consultative meeting on diagnostics for Buruli ulcer:
Geneva, Switzerland, 21 November 2013
|
2014
|
|
Report of a WHO–FIND meeting on diagnostics for Buruli ulcer:
Geneva, 26–27 March 2018
|
2018
|
|
REPORT Of ADOLESCENT HEALTH SERVICES BARRIERS ASSESSMENT IN ETHIOPIA
|
2021
|
|
Report of an adolescent health services barriers assessment (AHSBA) in the United Republic of Tanzania
|
2019
|
|
Report of an extended meeting of the Biosafety Advisory Group:
WHO headquarters, Geneva, Switzerland, 13–15 December 2016
|
2018
|
|
Report of Informal Consultation on Treatment of Reactions and Prevention of Disabilities:
11-13 December 2018, Chennai, India
|
2019
|
|
Report of the 12th Country Support Unit Network Meeting:
Manila, the Phillipines, 6 – 8 May 2013
|
2013
|
|
Report of the 13th Country Support Unit Network Meeting:
Chateau du Bossey Bogis-Bossey, Switzerland Saturday, 23 November 2013
|
2014
|
|
Report of the 14th Country Support Network Meeting with the presence of the UN Collaboration Network:
Planning of the “improvement of the delivery model (country focus) and UN collaboration” outputs of the WHO Reform Implementation Plan Château de Penthes, Geneva, Switzerland 27 - 28 May 2014
|
2014
|
|
REPORT OF THE 17th MEETING OF THE WHO ALLIANCE FOR THE GLOBAL ELIMINATION OF BLINDING TRACHOMA:
GENEVA, 22-24 APRIL 2013
|
2013
|
|
REPORT OF THE 18TH MEETING OF THE WHO ALLIANCE FOR THE GLOBAL ELIMINATION OF TRACHOMA BY 2020
|
2014
|
|
REPORT OF THE 19TH MEETING OF THE WHO ALLIANCE FOR THE GLOBAL ELIMINATION OF TRACHOMA BY 2020
|
2015
|
|
Report of the 1st Meeting of the WHO Onchocerciasis Technical Advisory Subgroup:
Varembé Conference Centre Geneva, Switzerland 10-12 October 2017
|
2018
|
|
REPORT OF THE 20TH MEETING OF THE WHO ALLIANCE FOR THE GLOBAL ELIMINATION OF TRACHOMA BY 2020:
SYDNEY, AUSTRALIA, 26–28 APRIL 2016
|
2019
|
|
REPORT OF THE 21ST MEETING OF THE WHO ALLIANCE FOR THE GLOBAL ELIMINATION OF TRACHOMA BY 2020:
GENEVA, SWITZERLAND, 20–22 APRIL 2017
|
2019
|
|
REPORT OF THE 23RD MEETING OF THE WHO ALLIANCE FOR THE GLOBAL ELIMINATION OF TRACHOMA BY 2020:
30 NOVEMBER–1 DECEMBER 2020
|
2021
|
|
Report of the 3rd meeting of the WHO advisory group on integrated surveillance of antimicrobial resistance:
14-17 June 2011, Oslo, Norway
|
2012
|
|
Report of the 6th Meeting WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance with AGISAR 5-year Strategic Framework to Support Implementation of the Global Action Plan on Antimicrobial Resistance (2015-2019):
10-12 June 2015 Seoul, Republic of Korea
|
2015
|
|
Report of the 7th Meeting WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR):
17-20 October 2016 Raleigh, North Carolina, United States of America (USA)
|
2018
|
|
Report of the Annual meeting of the Child and Adolescent TB Working Group
|
2017
|
|
Report of the consultative meetings on Strategic Options and Alternative Treatment Strategies for Accelerating Onchocerciasis Elimination in Africa
|
2015
|
|
REPORT OF THE FIFTEENTH WHOPES WORKING GROUP MEETING:
WHO/HQ, GENEVA 18–22 JUNE 2012
|
2012
|
|
REPORT OF THE First meeting OF THE Technical Advisory Group on Food Safety::
Safer Food for Better Health Virtual meeting 8–10 February 2021
|
2021
|
|
Report of the first meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases:
Geneva, 30–31 October 2019
|
2020
|
|
Report of the first WHO stakeholders meeting on gambiense human African trypanosomiasis elimination Geneva, 25-27 March 2014
|
2014
|
|
Report of the first WHO stakeholders meeting on rhodesiense human African trypanosomiasis:
Geneva, 20–22 October 2014
|
2015
|
|
Report of the fourth meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases:
Virtual meeting, 26–27 October 2021
|
2022
|
|
Report of the fourth WHO stakeholders meeting on gambiense and rhodesiense human African trypanosomiasis elimination:
Virtual meeting, 1−3 June 2021
|
2022
|
|
Report of the Global Conference on Primary Health Care::
From Alma-Ata towards Universal Health Coverage and the Sustainable Development Goals
|
2019
|
|
Report of the Global Consultation on the Programmatic Management of Latent Tuberculosis Infection
|
2016
|
|
Report of the HPV Vaccine Delivery Meeting:
Identifying Needs for Implementation & Research Geneva, 17-19 April 2012
|
2012
|
|
Report of the Informal Consultation on Stopping Discrimination and Promoting Inclusion of Persons Affected by Leprosy:
New Delhi 14-16 November 2017
|
2018
|
|
Report of the meeting to review the latest scientific evidence on the impact of cigarette ventilation on cigarette use:
18–19 November 2019
|
2022
|
|
Report of the second Global Forum of malaria-eliminating countries:
MEETING REPORT
|
2018
|
|
REPORT OF THE Second meeting OF THE Technical Advisory Group on Food Safety::
Safer Food for Better Health Virtual meeting 19 and 22–23 April 2021
|
2021
|
|
Report of the Second Meeting of the WHO Onchocerciasis Technical Advisory Subgroup:
UNAIDS BUILDING, ROOM 46025 Geneva, Switzerland 12-14 February 2018
|
2018
|
|
Report of the second WHO stakeholders meeting on gambiense human African trypanosomiasis elimination:
Geneva, 21–23 March 2016
|
2016
|
|
Report of the second WHO stakeholders meeting on rhodesiense human African trypanosomiasis:
Geneva, 26–28 April 2017
|
2017
|
|
Report of the Technical Consultation on the Programmatic Management of Latent Tuberculosis Infection
|
2017
|
|
Report of the third Global Forum of malaria-eliminating countries
|
2019
|
|
Report of the third meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases:
Virtual meeting, 3 June 2021
|
2022
|
|
Report of the Third Meeting of the WHO Onchocerciasis Technical Advisory Subgroup:
Geneva, 26-28 February 2019
|
2020
|
|
Report of the third WHO stakeholders meeting on gambiense human African trypanosomiasis elimination:
Geneva, Switzerland 18-20 April 2018
|
2020
|
|
Report of the third WHO stakeholders meeting on rhodesiense human African trypanosomiasis:
Geneva, Switzerland, 10–11 April 2019
|
2020
|
|
Report of the WHO Ad-hoc Advisory Group on aircraft disinsection for controlling the international spread of vectorborne diseases:
Geneva, Switzerland 21-22 April 2016
|
2016
|
|
Report of the WHO expert consultation on the WHO protocol for measuring trans-fatty acids in foods held virtually on 27 and 30 June 2022
|
2023
|
|
REPORT OF THE WHO GLOBAL PARTNERS’ MEETING ON HEPATITIS ELIMINATION:
CHÂTEAU DE PENTHES, PREGNY-CHAMBÉSY (GENEVA, SWITZERLAND) 27–28 FEBRUARY 2019
|
2019
|
|
Report of the WHO global technical consultation on public health and social measures during health emergencies:
Online meeting 31 August to 2 September 2021
|
2022
|
|
Report of the WHO Informal Working Group on cystic and alveolar echinococcosis surveillance, prevention and control, with the participation of the Food and Agriculture Organization of the United Nations and the World Organisation for Animal Health
|
2011
|
|
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)
|
2020
|
|
REPORT OF THE WORLD OF WORK DIALOGUE
|
2021
|
|
Report on a Collaborative Study for Proposed 1st International Standard for TNF receptor II Fc fusion protein (Etanercept)
|
2015
|
|
A REPORT on activities during the Fifth International Lead Poisoning Prevention Week, 22–28 October 2017
|
2018
|
|
Report on activities during the ninth International Lead Poisoning Prevention Week:
24–30 October 2021
|
2023
|
|
Report on antimalarial drug efficacy, resistance and response:
10 years of surveillance (2010-2019)
|
2020
|
|
Report on Bhutan Global School-Based Student Health Survey 2016
|
2017
|
|
Report on financial and administrative implications for the Secretariat of resolutions proposed for adoption by the Executive Board or Health Assembly
|
2014
|
|
Report on meetings of expert committees and study groups:
Report by the Director-General
|
2020
|
|
Report on the first international symposium on self-testing for HIV:
The legal, ethical, gender, human rights and public health implications of HIV self-testing scale-Up 8-9 April 2013 Brocher Foundation Geneva, Switzerland
|
2013
|
|
Report on the fourth meeting of the WHO Onchocerciasis Technical Advisory Subgroup:
Virtual meeting, 28−29 October 2020
|
2021
|
|
Report on the health of refugees and migrants in the WHO European Region:
No PUBLIC HEALTH without REFUGEE and MIGRANT HEALTH
|
2018
|
|
Report on the Intercountry workshop on promoting urban health equity assessment and response:
Cairo, Egypt 2–4 September 2012
|
2012
|
|
Report on the meeting on indicators for monitoring alcohol, drugs and other psychoactive substance use, substance-attributable harm and societal responses:
VALENCIA, SPAIN, 19–21 OCTOBER 2009
|
2010
|
|
Report on the WHO collaborative study to establish the 1st International Standard for anti-EV71 serum (Human)
|
2015
|
|
REPORTABLE CHANGES TO A WHO PREQUALIFIED MALE CIRCUMCISION DEVICE
|
2019
|
|
REPORTING ON ROAD SAFETY:
A GUIDE FOR JOURNALISTS
|
2015
|
|
Reports on meetings of expert committees and study groups:
Report by the Secretariat
|
2013
|
|
Reproductive health:
Draft strategy to accelerate progress towards the attainment of international development goals and targets
|
2003
|
|
Reproductive health:
Report by the Secretariat
|
2004
|
|
The Republic of Indonesia Health System Review
|
2017
|
|
Republic of Korea Health System Review
|
2015
|
|
The Republic of the Union of Myanmar Health System Review
|
2014
|
|
RÉPUBLIQUE DÉMOCRATIQUE DU CONGO - Intégration du dépistage de la tuberculose aux activités communautaires de riposte au VIH
|
2020
|
|
RESEARCH FOR AN AIDS FREE GENERATION::
A GLOBAL RESEARCH AGENDA FOR ADOLESCENTS LIVING WITH HIV
|
2017
|
|
Research on reproductive health at WHO:
Biennial Report 2000–2001
|
2002
|
|
Research Priorities for Chagas Disease, Human African Trypanosomiasis and Leishmaniasis
|
2012
|
|
Research Priorities for Helminth Infections:
Technical Report of the TDR Disease Reference Group on Helminth Infections
|
2012
|
|
Research Priorities for the Environment, Agriculture and Infectious Diseases of Poverty:
Technical Report of the TDR Thematic Reference Group on Environment, Agriculture and Infectious Diseases of Poverty
|
2013
|
|
Reseña normativa::
el acceso a la tecnología de apoyo
|
2020
|
|
Resilient and people-centred health systems::
Progress, challenges and future directions in Asia
|
2018
|
|
RÉSISTANCE AUX ANTIMICROBIENS
|
2019
|
|
Résistance aux antimicrobiens
|
2019
|
|
Résistance aux antimicrobiens:
Rapport du Directeur général
|
2020
|
|
Résistance aux antimicrobiens:
Rapport récapitulant les progrès accomplis dans l’application de la résolution WHA67.25 sur la résistance aux antimicrobiens Rapport du Secrétariat
|
2015
|
|
Résistance aux antimicrobiens
|
2014
|
|
Résistance aux antimicrobiens:
Projet de résolution proposé par l’Afrique du Sud, l’Argentine, l’Australie, le Canada, le Chili, la Chine, les États-Unis d’Amérique, la Fédération de Russie, Israël, le Kenya, Oman, le Panama, le Sri Lanka, la Suisse et les États Membres de l’Union européenne
|
2019
|
|
Résistance aux antimicrobiens:
Rapport récapitulant les progrès accomplis dans l’application de la résolution WHA67.25 sur la résistance aux antimicrobiens Rapport du Secrétariat
|
2014
|
|
Résistance aux antimicrobiens:
Projet de plan d’action mondial pour combattre la résistance aux antimicrobiens Rapport du Secrétariat
|
2014
|
|
Résistance aux antimicrobiens:
Rapport du Secrétaire général
|
2014
|
|
Résistance aux antimicrobiens
|
2019
|
|
Résistance aux antimicrobiens:
Rapport du Secrétariat
|
2017
|
|
Résistance aux antimicrobiens:
Projet de plan d’action mondial pour combattre la résistance aux antimicrobiens Rapport du Secrétariat
|
2015
|
|
Résistance aux antimicrobiens:
Rapport du Secrétariat
|
2013
|
|
RESISTANCE AUX ANTIMICROBIENS
|
2019
|
|
Resistencia a los antimicrobianos:
Proyecto de resolución presentado por la Argentina, Australia, el Canadá, Chile, China, los Estados Unidos de América, la Federación de Rusia, Israel, Kenya, Omán, Panamá, Sri Lanka, Sudáfrica, Suiza y los Estados Miembros de la Unión Europea
|
2019
|
|
Resistencia a los antimicrobianos:
Informe de la Secretaría
|
2016
|
|
Resistencia a los antimicrobianos
|
2019
|
|
Resistencia a los antimicrobianos:
Informe resumido sobre los progresos realizados en la aplicación de la resolución WHA67.25, relativa a la resistencia a los antimicrobianos Informe de la Secretaría
|
2014
|
|
Resistencia a los antimicrobianos
|
2019
|
|
Resistencia a los antimicrobianos:
Informe del Director General
|
2020
|
|
Resistencia a los antimicrobianos
|
2014
|
|
Resistencia a los antimicrobianos:
Informe resumido sobre los progresos realizados en la aplicación de la resolución WHA67.25, relativa a la resistencia a los antimicrobianos Informe de la Secretaría
|
2015
|
|
Resistencia a los antimicrobianos:
Proyecto de plan de acción mundial sobre la resistencia a los antimicrobianos Informe de la Secretaría
|
2015
|
|
Resistencia a los antimicrobianos:
Informe de la Secretaría
|
2017
|
|
Resistencia a los fármacos antimicrobianos:
Informe de la Secretaría
|
2014
|
|
Resistencia a los fármacos antimicrobianos:
Informe de la Secretaría
|
2013
|
|
RÉSOLUTION:
STRATÉGIE RÉGIONALE SUR LA RÉGLEMENTATION DES PRODUITS MÉDICAUX DANS LA RÉGION AFRICAINE, 2016-2025 (document AFR/RC66/13)
|
2016
|
|
RESOURCE CONSIDERATIONS FOR INVESTING IN HAND HYGIENE IMPROVEMENT IN HEALTH CARE FACILITIES
|
2021
|
|
Resource package for strengthening countries’ health systems response to violence against women
|
2021
|
|
Resource tool on alcohol taxation and pricing policies
|
2017
|
|
Responding to child maltreatment::
a clinical handbook for health professionals
|
2022
|
|
RESPONDING TO CHILDREN AND ADOLESCENTS WHO HAVE BEEN SEXUALLY ABUSED:
WHO CLINICAL GUIDELINES
|
2017
|
|
RESPONDING TO CHILDREN AND ADOLESCENTS WHO HAVE BEEN SEXUALLY ABUSED:
WHO CLINICAL GUIDELINES
|
2017
|
|
RESPONDING TO CHILDREN AND ADOLESCENTS WHO HAVE BEEN SEXUALLY ABUSED:
WHO CLINICAL GUIDELINES
|
2017
|
|
RESPONDING TO CHILDREN AND ADOLESCENTS WHO HAVE BEEN SEXUALLY ABUSED:
WHO CLINICAL GUIDELINES
|
2017
|
|
RESPONDING TO CHILDREN AND ADOLESCENTS WHO HAVE BEEN SEXUALLY ABUSED:
WHO CLINICAL GUIDELINES
|
2017
|
|
RESPONDING TO CHILDREN AND ADOLESCENTS WHO HAVE BEEN SEXUALLY ABUSED:
WHO CLINICAL GUIDELINES
|
2017
|
|
RESPONDING TO CHILDREN AND ADOLESCENTS WHO HAVE BEEN SEXUALLY ABUSED:
WHO CLINICAL GUIDELINES
|
2017
|
|
RESPONDING TO CHILDREN AND ADOLESCENTS WHO HAVE BEEN SEXUALLY ABUSED:
WHO CLINICAL GUIDELINES
|
2017
|
|
RESPONDING TO CHILDREN AND ADOLESCENTS WHO HAVE BEEN SEXUALLY ABUSED:
WHO CLINICAL GUIDELINES
|
2017
|
|
Responding to community spread of COVID-19:
Interim guidance
|
2020
|
|
RESPONDING TO FAILED TRANSMISSION ASSESSMENT SURVEYS REPORT OF AN AD HOC MEETING:
STRATEGIC AND TECHNICAL ADVISORY GROUP FOR NEGLECTED TROPICAL DISEASES SUBGROUP ON DISEASE-SPECIFIC INDICATORS
|
2016
|
|
Responding to intimate partner violence and sexual violence against women:
WHO clinical and policy guidelines
|
2013
|
|
Responding to intimate partner violence and sexual violence against women::
clinical and policy recommendations
|
2013
|
|
Responding to the global mpox outbreak:
Ethics issues and considerations A policy brief
|
2023
|
|
Responding to violence against women and children during COVID - 1 9:
Impact on service provision, strategies and actions in the WHO European Region
|
2021
|
|
Response plan to pfhrp2 gene deletions
|
2019
|
|
Respuesta a la COVID-19:
Informe principal del Grupo Independiente de Preparación y Respuesta frente a las Pandemias
|
2021
|
|
RESSOURCE DE BASE POUR LES SOINS DE L’OREILLE ET AUDITIFS
|
2020
|
|
RESTRICTIONS IN USE AND AVAILABILITY OF PHARMACEUTICALS:
2010 - 2018
|
2020
|
|
Résultats liés à l’activité utérine et aux conditions d’accouchement des femmes enceintes infectées par la COVID-19
|
2020
|
|
RÉSUMÉ D’ORIENTATION:
Orientations et dossiers techniques relatifs aux services de santé mentale communautaires
|
2021
|
|
RESUMEN:
Orientaciones y módulos técnicos sobre los servicios comunitarios de salud mental
|
2021
|
|
RESUMEN SOBRE LA POSICIÓN DE LA OMS:
Generación de resiliencia en los sistemas de salud en pro de la cobertura sanitaria universal y la seguridad sanitaria durante y después de la pandemia de COVID-19
|
2021
|
|
RETENTION OF THE HEALTH WORKFORCE IN RURAL AND REMOTE AREAS: A SYSTEMATIC REVIEW:
Web Annex B. Descriptive evidence profiles
|
2020
|
|
RETENTION OF THE HEALTH WORKFORCE IN RURAL AND REMOTE AREAS: A SYSTEMATIC REVIEW:
Web Annex A. GRADE evidence profiles
|
2020
|
|
Retraso del crecimiento en la niñez: Retos y oportunidades:
Informe de un coloquio difundido por internet sobre cuestiones operativas relacionadas con el establecimiento y la ejecución de las agendas nacionales para la reducción del retraso del crecimiento, 14 de octubre del 2013 – OMS Ginebra
|
2014
|
|
Réunion de l’OMS sur l’ulcère de Buruli ::
lutte et recherche
|
2013
|
|
Review and reorientation of the “Programme for active health protection of mothers and children” for greater health equity in the former Yugoslav Republic of Macedonia
|
2015
|
|
Review meeting for special projects as part of global leprosy control:
18-20 June 2018, New Delhi, India
|
2018
|
|
Review of acute care and rehabilitation services for heart attack and stroke in Belarus
|
2017
|
|
Review of acute care and rehabilitation services for heart attack and stroke in Kyrgyzstan
|
2017
|
|
Review of contextual factors to inform the development of the WHO guideline on the use of low-sodium salt substitutes
|
2022
|
|
REVIEW OF MINAMATA CONVENTION INITIAL ASSESSMENT REPORTS:
Key findings for health
|
2021
|
|
Review of national treatment guidelines for sexually transmitted infections in the Western Pacific Region
|
2018
|
|
Review of product information for selected antiretroviral medicines circulating in five African countries
|
2022
|
|
REVIEW OF THE INTERNATIONAL COORDINATING GROUP ON VACCINE PROVISION (2006-2016)
|
2016
|
|
Review of the International Coorinating Group on Vaccine Provision (2006-2016)
|
2016
|
|
Revised case report form for Confirmed Novel Coronavirus COVID-19 (report to WHO within 48 hours of case identification)
|
2020
|
|
Riposte à la COVID-19:
Rapport principal du Groupe indépendant sur la préparation et la riposte à la pandémie
|
2021
|
|
RIPOSTE MONDIALE DU SECTEUR DE LA SANTÉ AU VIH, 2000–2015:
PRIORITÉ AUX INNOVATIONS EN AFRIQUE
|
2015
|
|
Risk assessment and management of exposure of health care workers in the context of COVID-19:
Interim guidance
|
2020
|
|
Risk Communication and Community Engagement (RCCE) Considerations::
Ebola Response in the Democratic Republic of the Congo
|
2018
|
|
Risk communication and community engagement readiness and response to coronavirus disease (COVID-19):
Interim guidance
|
2020
|
|
RISK COMMUNICATION SAVES LIVES & LIVELIHOODS:
Pandemic Influenza Preparedness Framework
|
2015
|
|
RISK REDUCTION OF COGNITIVE DECLINE AND DEMENTIA:
WHO GUIDELINES
|
2019
|
|
The road to 2030
|
2022
|
|
Roadmap to improve and ensure good indoor ventilation in the context of COVID-19
|
2021
|
|
Roadmap towards ending TB in children and adolescents
|
2018
|
|
Rôle du secteur de la santé dans la gestion rationnelle des produits chimiques:
Rapport du Secrétariat
|
2016
|
|
Rôle du secteur de la santé dans l’approche stratégique de la gestion internationale des produits chimiques, dans la perspective de l’objectif fixé pour 2020 et au-delà:
Projet de résolution proposé par les délégations de l’Argentine, du Canada, des États-Unis d’Amérique, de Monaco, du Panama, de la Thaïlande et de l’Uruguay, et les États Membres de l’Union européenne
|
2016
|
|
Rôle du secteur de la santé dans l’Approche stratégique de la gestion internationale des produits chimiques, dans la perspective de l’objectif fixé pour 2020 et au-delà:
Rapport du Secrétariat
|
2017
|
|
Rôle du secteur de la santé dans l’approche stratégique de la gestion internationale des produits chimiques, dans la perspective de l’objectif fixé pour 2020 et au-delà
|
2016
|
|
Rôle du secteur de la santé dans l’Approche stratégique de la gestion internationale des produits chimiques, dans la perspective de l’objectif fixé pour 2020 et au-delà:
Rapport du Directeur général
|
2021
|
|
Role of the health sector in the sound management of chemicals:
Report by the Secretariat
|
2015
|
|
Role of the health sector in the sound management of chemicals:
Report by the Secretariat
|
2016
|
|
The role of the health sector in the Strategic Approach to International Chemicals Management towards the 2020 goal and beyond:
Draft resolution proposed by the delegations of Argentina, Canada, Monaco, Panama, Thailand, United States of America, Uruguay, and European Union Member States
|
2016
|
|
The role of the health sector in the Strategic Approach to International Chemicals Management towards the 2020 goal and beyond:
Report by the Director General
|
2021
|
|
The role of the health sector in the Strategic Approach to International Chemicals Management towards the 2020 goal and beyond:
Report by the Secretariat
|
2017
|
|
The role of the health sector in the Strategic Approach to International Chemicals Management towards the 2020 goal and beyond
|
2017
|
|
The role of the health sector in the Strategic Approach to International Chemicals Management towards the 2020 goal and beyond:
Report by the Secretariat
|
2016
|
|
The role of the health sector in the Strategic Approach to International Chemicals Management towards the 2020 goal and beyond
|
2016
|
|
Role of the polio network in COVID-19 vaccine delivery and essential immunization:
Lessons learned for successful transition
|
2022
|
|
ROLE OF WHO IN SOUTH AFRICA SSB TAX INITIATIVE
|
2018
|
|
Rôles des agents de santé dans la dispensation des:
soins liés à l’avortement sécurisé et de la contraception post-avortement
|
2016
|
|
Rôles et responsabilités des membres d'INFOSAN
|
2015
|
|
ROTULADO DE LAS EXTENSIONES DE SANGRE PARA EL DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-06A
|
2016
|
|
Roundtable on noncommunicable diseases - strengthening the role and contribution of the food and non-alcoholic beverage industry to respond to the 2011 Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of NCDs
|
2018
|
|
RUEDA CON LOS CRITERIOS MÉDICOS DE ELEGIBILIDAD PARA EL USO DE ANTICONCEPTIVOS 2015
|
2016
|
|
Rumo à zero hanseníase:
Estratégia Global de Hanseníase 2021–2030
|
2021
|
|
Rwanda Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
¿SABÍA QUE PUEDE HABER "SUPERBACTERIAS" EN LOS ALIMENTOS?
|
2017
|
|
Safe abortion::
Technical & policy guidance for health systems
|
2015
|
|
Safe abortion::
technical and policy guidance for health systems
|
2012
|
|
Safe and unsafe induced abortion:
Global and regional levels in 2008, and trends during 1995–2008
|
2012
|
|
Safe Eid al Adha practices in the context of COVID-19:
Interim guidance
|
2021
|
|
Safe Eid al Adha practices in the context of COVID-19:
Interim guidance
|
2020
|
|
Safe Ramadan practices in the context of the COVID-19:
Interim guidance
|
2020
|
|
SAFEGUARDING THE FUTURE::
GIVING PRIORITY TO THE NEEDS OF ADOLESCENT AND YOUNG MOTHERS LIVING WITH HIV
|
2021
|
|
Safety aspects of genetically modified foods of plant origin:
Report of a Joint FAO/WHO Expert Consultation on Foods Derived from Biotechnology
|
2000
|
|
Safety evaluation of certain food additives and contaminants:
Prepared by the Seventy-seventh meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA)
|
2013
|
|
Safety evaluation of certain food additives and contaminants
|
2015
|
|
Safety evaluation of certain food additives and contaminants:
Supplement 1: Non-dioxin-like polychlorinated biphenyls
|
2016
|
|
Safety in administering medicines for neglected tropical diseases
|
2021
|
|
Safety monitoring of molnupiravir for treatment of mild to moderate COVID-19 infection in low and middle-income countries using cohort event monitoring::
a WHO study
|
2022
|
|
Salt reduction and iodine fortification strategies in public health:
Report of a joint technical meeting convened by World Health Organization and The George Institute for Global Health in collaboration with the International Council for the Control of Iodine Deficiency Disorders Global Network, Australia, March 2013
|
2014
|
|
Salud del adolescente:
Informe de la Secretaría
|
2015
|
|
Salud, medio ambiente y cambio climático:
Salud humana y biodiversidad Informe del Director General
|
2018
|
|
Salud mental y COVID-19::
datos iniciales sobre las repercusiones de la pandemia
|
2022
|
|
Salud ocular universal:
Un plan de acción mundial para 2014-2019
|
2013
|
|
Salud para los adolescentes del mundo:
Una segunda oportunidad en la segunda década
|
2014
|
|
Salud reproductiva:
Informe de la Secretaría
|
2004
|
|
Sangre y otros productos médicos de origen humano:
Informe de la Secretaría
|
2014
|
|
Santé, environnement et changement climatique:
Santé humaine et diversité biologique Rapport du Directeur général
|
2018
|
|
Santé et extraction minière:
artisanale et à petite échelle de l'or
|
2017
|
|
Santé génésique:
Projet de stratégie pour accélérer les projets en vue de la réalisation des objectifs et cibles du devéloppement international
|
2003
|
|
Santé génésique:
Rapport du Secrétariat
|
2004
|
|
Santé mentale et soutien psychosocial pour les victimes de violence sexuelle liée au conflit ::
dix mythes
|
2012
|
|
Santé oculaire universelle:
Plan d’action mondial 2014-2019
|
2013
|
|
Santé sexuelle et reproductive:
Compétences de base en soins primaires
|
2012
|
|
SARS:
How a global epidemic was stopped
|
2006
|
|
SARS-CoV-2 genomic sequencing for public health goals:
Interim guidance
|
2021
|
|
Saturated fat and trans-fat intakes and their replacement with other macronutrients:
A systematic review and meta-analysis of prospective observational studies
|
2022
|
|
Saturated fatty acid and trans-fatty acid intake for adults and children:
WHO guideline
|
2023
|
|
SAVIEZ-VOUS QU'ON POUVAIT TROUVER DES «SUPERBACTÉRIES» DANS LA NOURRITURE ?
|
2017
|
|
Saving the lives of mothers and children::
how mobiles help to make malaria monitoring more effective – the Ma Santé programme
|
2013
|
|
Scalable psychological interventions for people in communities affected by adversity:
A new area of mental health and psychosocial work at WHO
|
2017
|
|
SCHISTOSOMIASIS:
PROGRESS REPORT 2001–2011 AND STRATEGIC PLAN 2012–2020
|
2013
|
|
SCHOOL-BASED VIOLENCE PREVENTION:
A practical handbook
|
2019
|
|
Schools and other educational institutions transmission investigation protocol for coronavirus disease 2019 (COVID-19)
|
2020
|
|
Scoping review of interventions to maintain essential services for maternal, newborn, child and adolescent health and older people during disruptive events
|
2021
|
|
Screening, assessment and management of neonates and infants with complications associated with Zika virus exposure in utero
|
2016
|
|
Second focused review meeting by the Malaria Elimination Oversight Committee (MEOC):
Report of a virtual meeting, 28 June–1 July 2021
|
2021
|
|
Second formal meeting of the Foodborne Disease Burden Epidemiology Reference Group (FERG):
Appraising the Evidence and Reviewing Initial Results
|
2009
|
|
Second Meeting of the Global Task Force on Cholera Control:
15-16 June 2015 – Geneva, Switzerland
|
2016
|
|
Second meeting of the Malaria Elimination Oversight Committee (MEOC):
MEETING REPORT
|
2018
|
|
Second meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases:
13 October 2020
|
2021
|
|
Second WHO high-level meeting on Ebola vaccines access and financing
|
2015
|
|
Second WHO Model List of Essential In Vitro Diagnostics
|
2019
|
|
Seguimiento de las reuniones de alto nivel de la Asamblea General de las Naciones Unidas sobre temas relacionados con la salud:
Resistencia a los antimicrobianos Informe del Director General
|
2019
|
|
Seguimiento de las reuniones de alto nivel de la Asamblea General de las Naciones Unidas sobre temas relacionados con la salud:
Resistencia a los antimicrobianos Informe del Director General
|
2018
|
|
Selected practice recommendations for contraceptive use:
Third edition 2016
|
2016
|
|
The selection and use of essential in vitro diagnostics:
Report of the second meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2019 (including the second WHO model list of essential in vitro diagnostics)
|
2022
|
|
The selection and use of essential in vitro diagnostics:
Report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (including the third WHO model list of essential in vitro diagnostics)
|
2021
|
|
Sélection et utilisation des dispositifs de diagnostic in vitro essentiels:
Compte rendu de la deuxième réunion du Groupe stratégique consultatif d’experts de l’OMS sur les dispositifs de diagnostic in vitro, 2019 (incluant la deuxième Liste modèle OMS des dispositifs de diagnostic in vitro essentiels)
|
2021
|
|
Selection of Essential In Vitro Diagnostics at Country Level:
Using the WHO Model List of Essential In Vitro Diagnostics to develop and update a national list of essential in vitro diagnostics
|
2021
|
|
Self-care competency framework:
Volume 2. Knowledge guide for health and care workers to support people’s self-care
|
2023
|
|
Self-care competency framework:
Volume 3. Curriculum guide for health and care workers to support people’s self-care
|
2023
|
|
Self-care competency framework:
Volume 1. Global competency standards for health and care workers to support people’s self-care
|
2023
|
|
SEMI-ANNUAL STATUS UPDATES JANUARY-JUNE & JULY-DECEMBER 2020
|
2021
|
|
Senegal Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Sensitizing health workers to providing responsive care for adolescents and young people living with HIV
|
2019
|
|
Serie de documentos técnicos:
sobre la adaptación a las consecuencias para la salud sensibles al clima: desnutrición
|
2022
|
|
Série de publications techniques sur:
l’adaptation aux répercussions du climat sur la santé: dénutrition
|
2022
|
|
Série técnica sobre a:
adaptação aos impactos na saúde sensíveis ao clima: subnutrição
|
2022
|
|
Serious childhood problems in countries with limited resources:
Background book on Management of the Child with a Serious Infection or Severe Malnutrition
|
2004
|
|
Serum and red blood cell folate concentrations for assessing folate status in populations
|
2012
|
|
Serum and red blood cell folate concentrations for assessing folate status in populations
|
2015
|
|
SERUM FERRITIN CONCENTRATIONS FOR THE ASSESSMENT OF IRON STATUS IN INDIVIDUALS AND POPULATIONS::
TECHNICAL BRIEF
|
2020
|
|
SERVICII PENTRU UTILIZATORII DE SCAUN RULANT:
MANUALUL FORMATORULUI
|
2015
|
|
SET OF COMPLETED CARDS, REGISTERS AND REPORTS:
A COMPANION FOR THE EXERCISE BOOKLET OF THE THREE INTERLINKED PATIENT MONITORING SYSTEM
|
2013
|
|
Setting global research:
priorities for urban health
|
2022
|
|
Seventh meeting of the Working Group on Monitoring of Neglected Tropical Diseases Drug Efficacy:
Geneva, 26-27 February 2018
|
2018
|
|
Severe Acute Respiratory Infections Treatment Centre:
Practical manual to set up and manage a SARI treatment centre and a SARI screening facility in health care facilities
|
2020
|
|
Severe acute respiratory syndrome (SARS)
|
2004
|
|
Severity of disease associated with Omicron variant as compared with Delta variant in hospitalized patients with suspected or confirmed SARS-CoV-2 infection
|
2022
|
|
SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS INFOGRAPHIC SNAPSHOT:
ESWATINI 2021
|
2021
|
|
Sexual and reproductive health of women living with HIV/AIDS:
Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings
|
2006
|
|
Sexual health, human rights and the law
|
2015
|
|
SEXUAL, REPRODUCTIVE, MATERNAL, NEWBORN, CHILD AND ADOLESCENT HEALTH POLICY SURVEY, 2018—2019::
summary report
|
2020
|
|
Sexually transmitted infections
|
2019
|
|
SHAKE:
THE SALT HABIT
|
2016
|
|
SHAKE:
LE SEL : UNE HABITUDE À PERDRE
|
2017
|
|
SHAKE:
LE SEL : UNE HABITUDE À PERDRE
|
2017
|
|
SHAKE:
THE SALT HABIT
|
2016
|
|
SHAKE THE SALT HABIT
|
2016
|
|
A short guide to cancer screening:
Increase effectiveness, maximize benefits and minimize harm
|
2022
|
|
Sierra Leone Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Silver in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2021
|
|
Simplified protocol for measuring trans-fatty acids content as a percentage of total fatty acids in food products:
WHO laboratory protocol
|
2023
|
|
Síndrome inflamatorio multisistémico en niños y adolescentes con COVID-19:
Informe científico
|
2020
|
|
Síntese de evidências para políticas::
Acesso à tecnologia assistiva
|
2020
|
|
Sistema de vigilancia y monitoreo mundiales de la OMS para los productos médicos de calidad subestándar y falsificados
|
2018
|
|
Sistema Mundial de Vigilancia de la Resistencia a los Antimicrobianos:
Protocolo de implementación temprana para la inclusión de Candida spp.
|
2019
|
|
Sistemas alimentarios para una mejor salud:
Resumen ejecutivo
|
2021
|
|
Sistemas electrónicos de administración de nicotina, incluidos los cigarrillos electrónicos:
Informe de la Secretaría del Convenio
|
2012
|
|
SITUAÇÃO ACTUAL DA SEGURANÇA E DISPONIBILIDADE DE SANGUE NA REGIÃO AFRICANA DA OMS:
RELATÓRIO DO INQUÉRITO DE 2013
|
2017
|
|
SITUAÇÃO DA IMPLEMENTAÇÃO DOS QUATRO COMPROMISSOS CALENDARIZADOS SOBRE AS DOENÇAS NÃO TRANSMISSÍVEIS NA REGIÃO AFRICANA
|
2018
|
|
Situación del Protocolo para la eliminación del comercio ilícito de productos de tabaco
|
2014
|
|
SITUATION ACTUELLE DE LA SÉCURITÉ TRANSFUSIONNELLE ET APPROVISIONNEMENT EN SANG DANS LA RÉGION AFRICAINE DE L’OMS:
RAPPORT DE L’ENQUÊTE 2013
|
2017
|
|
Situation analysis and practices in addressing the health needs of refugees and migrants: Examples of public health interventions and practices:
WHO Eastern Mediterranean Region
|
2018
|
|
SITUATION DE la production et du commerce du tabac en Afrique
|
2021
|
|
Situation of child and adolescent health in Europe
|
2018
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2017
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2017
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2017
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS DISEASE YELLOW FEVER EBOLA VIRUS DISEASE
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2017
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
SITUATION REPORT:
ZIKA VIRUS MICROCEPHALY GUILLAIN-BARRÉ SYNDROME
|
2016
|
|
Sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases:
Hybrid meeting, 27–28 September 2022
|
2022
|
|
SMOKING AND CARDIOVASCULAR DISEASE IN THE EASTERN MEDITERRANEAN REGION
|
2018
|
|
Smoking and Cardiovascular health
|
2018
|
|
Smoking and COVID-19:
Scientific brief
|
2020
|
|
Sobre el terreno::
cómo recoger sin riesgo hisopados bucales (saliva) de cadáveres de personas presuntamente infectadas por el virus del Ebola
|
2014
|
|
SOCIAL AND BEHAVIOURAL INSIGHTS:
COVID-19 DATA COLLECTION TOOL FOR AFRICA
|
2021
|
|
Social determinants of sexual and reproductive health:
Informing future research and programme implementation
|
2010
|
|
Sociocultural motivations for female genital mutilation::
matrimonial strategies, family motivations and religious justifications among the Al Pulaar and the Soninké in the River Senegal Valley
|
2011
|
|
Soins chroniques du VIH par Traitement Antirétroviral:
PRISE EN CHARGE INTÉGRÉE DE LA MALADIE CHEZ L’ADOLESCENT ET L’ADULTE
|
2004
|
|
Soins cliniques pour les survivants de la maladie à virus Ebola
|
2016
|
|
SOINS DE L’OREILLE ET DE L’AUDITION:
INDICATEURS DE SUIVI DE LA PRESTATION DE SERVICES
|
2023
|
|
SOINS DE L’OREILLE ET DE L’AUDITION ::
OUTIL D’ANALYSE DE LA SITUATION
|
2016
|
|
Soins de santé pour les femmes victimes d’actes de violence commis par un partenaire intime ou d’actes de violence sexuelle:
Manuel clinique
|
2022
|
|
Soins de supports optimisés pour la maladie à virus Ebola:
PROCÉDURES DE GESTION CLINIQUE STANDARD
|
2019
|
|
Soins intégrés pour les personnes âgées (SIPA):
Directives applicables aux interventions communautaires liées au déclin des capacités intrinsèques
|
2017
|
|
Soins oculaires intégrés centrés sur la personne, cécité et déficience visuelle évitables comprises:
Rapport du Directeur général
|
2020
|
|
Soins palliatifs ::
Gestion des symptômes et soins de fin de vie
|
2004
|
|
SOINS POUR LES FILLES ET LES FEMMES VIVANT AVEC DES MUTILATIONS SEXUELLES FÉMININES:
MANUEL CLINIQUE
|
2020
|
|
Solid waste management and health in Accra, Ghana
|
2021
|
|
Solomon Islands Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Solomon Islands Health System Review
|
2015
|
|
SOMALIA:
WHO Somalia: working with an expanded network of national and international partners to address COVID-19
|
2020
|
|
Somalia Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
SOUTH AFRICA:
Implementation of reforms under the National Drug Policy
|
2015
|
|
South Sudan Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
South–South and triangular cooperation for implementation of the WHO Framework Convention on Tobacco Control:
Report by the Convention Secretariat
|
2012
|
|
Soyez malin : buvez de l'eau!:
Un guide destiné aux directeurs des établissements scolaires pour limiter la vente et la commercialisation des boissons sucrées en milieu scolaire
|
2018
|
|
Spain::
assessing health system capacity to manage sudden large influxes of migrants
|
2018
|
|
SPECIFICATIONS AND QUANTITIES FOR EFFICIENT PROCUREMENT OF ESSENTIAL EQUIPMENT AND LABORATORY COMMODITIES FOR HIV
|
2015
|
|
SPONTANEOUS AND INDUCED ABORTION
|
1970
|
|
Sport for Health Conference Doha, Qatar, 4–6 October 2022:
Summary report
|
2023
|
|
Sri Lanka Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Sri Lanka Health System Review
|
2021
|
|
Standard Operating Procedure for Determination of Benzo[a]pyrene in Mainstream Cigarette Smoke Under ISO and Intense Smoking conditions
|
2015
|
|
Standard Operating Procedure for Determination of Humectants in Cigarette Tobacco Filler
|
2016
|
|
Standard Operating Procedure for Determination of Nicotine, Glycerol and Propylene Glycol Content in the Tobacco of Heated Tobacco Products
|
2023
|
|
Standard Operating Procedure for Determination of Nicotine, Glycerol and Propylene Glycol in e-Liquids
|
2021
|
|
Standard operating procedures for surveillance of meningitis preparedness and response to epidemics in Africa
|
2018
|
|
Standard protocol to assess the prevalence of gonorrhoea and chlamydia among pregnant women in antenatal care clinics
|
2018
|
|
Standard terminology and principles for vaccine delivery costs
|
2022
|
|
Standards for cookstove performance::
guidance and resources
|
2022
|
|
STANDARDS FOR HEALTHY EATING, PHYSICAL ACTIVITY, SEDENTARY BEHAVIOUR AND SLEEP IN EARLY CHILDHOOD EDUCATION AND CARE SETTINGS::
A TOOLKIT
|
2021
|
|
STANDARDS FOR HEALTHY EATING, PHYSICAL ACTIVITY, SEDENTARY BEHAVIOUR AND SLEEP IN EARLY CHILDHOOD EDUCATION AND CARE SETTINGS: A TOOLKIT:
WEB ANNEX Development of the standards and global survey questionnaire
|
2021
|
|
Standards for improving the quality of care for children and young adolescents in health facilities
|
2018
|
|
STANDARDS FOR PROSTHETICS AND ORTHOTICS:
Part 1: STANDARDS
|
2017
|
|
A standards-driven approach to improve the quality of health-care services for adolescents
|
2015
|
|
STATE OF HEALTH INEQUALITY:
Indonesia
|
2017
|
|
STATE OF INEQUALITY:
HIV, tuberculosis and malaria
|
2021
|
|
STATE OF THE WORLD'S NURSING 2020:
Investing in education, jobs and leadership
|
2020
|
|
STATE OF THE WORLD'S NURSING 2020:
investing in education, jobs and leadership
|
2020
|
|
Statement of Action to enhance the engagement of communities, non-governmental and other civil society organisations in the implementation of the End TB Strategy:
Outcome of a WHO consultation meeting, November 11-13, 2015, Addis Ababa, Ethiopia
|
2015
|
|
Statement of the WHO Working Group on COVID-19 Animal Models (WHO-COM) about the UK and South African SARS-CoV-2 new variants.
|
2020
|
|
STATUS OF BLOOD SAFETY IN THE WHO AFRICAN REGION:
Report of the 2010 Survey
|
2014
|
|
Status of environmental surveillance for SARS-CoV-2 virus:
Scientific brief
|
2020
|
|
STATUS OF IMPLEMENTATION OF THE FOUR TIME-BOUND COMMITMENTS ON NONCOMMUNICABLE DISEASES IN THE AFRICAN REGION
|
2018
|
|
Status of the Protocol to Eliminate Illicit Trade in Tobacco Products
|
2014
|
|
STATUS OF Tobacco Production and Trade in Africa
|
2021
|
|
Status report on artemisinin resistance
|
2014
|
|
Status report on artemisinin resistance
|
2014
|
|
STATUS REPORT ON THE IMPLEMENTATION OF THE DECADE OF ACTION FOR ROAD SAFETY IN THE AFRICAN REGION:
Report of the Secretariat
|
2017
|
|
Step safely::
strategies for preventing and managing falls across the life-course
|
2021
|
|
Step-by-step guide for developing a public health strategy for artisanal and small-scale gold mining in the context of the Minamata Convention on Mercury
|
2021
|
|
STEPS PREVALENCE OF NONCOMMUNICABLE DISEASE RISK FACTORS IN UKRAINE _ 2019
|
2020
|
|
STIMULUS PACKAGE FOR ELIMINATING DOG-MEDIATED HUMAN RABIES:
A CONCEPT
|
2016
|
|
Strategic and Technical Advisory Group for neglected tropical diseases:
Report of a meeting of the subworking group on monitoring and evaluation of disease-specific indicators – lymphatic filariasis Task Force for Global Health, Atlanta, GA 1 October 2012
|
2013
|
|
Strategic and Technical Advisory Group on antimicrobial resistance (STAG-AMR):
Report of Seventh Meeting 2-3 November 2016 WHO Headquarters, Geneva
|
2017
|
|
Strategic and Technical Advisory Group on antimicrobial resistance (STAG-AMR):
Report of Fifth Meeting
|
2015
|
|
Strategic and Technical Advisory Group on Antimicrobial Resistance (STAG-AMR):
Report of Second Meeting 14-16 April 2014 WHO Headquarters, Geneva
|
2014
|
|
Strategic Approach to International Chemicals Management: implementation and priorities in the health sector:
Bonn, Germany 22–23 June 2015
|
2015
|
|
Strategic framework for blood safety and availability 2016–2025
|
2017
|
|
Strategic framework for blood safety and availability 2016-2025
|
2016
|
|
Strategic mapping of institutional frameworks and their approach to equity
|
2019
|
|
Strategic Plan 2003–2005 Challenges of scaling up
|
2004
|
|
Strategic Plan for Enhancing Chemical Risk Assessment Capacity in Network Participants:
Strategic Plan: 2018-2020
|
2017
|
|
Strategic plan for measles and rubella elimination in WHO South-East Asia Region::
2020–2024
|
2019
|
|
Strategic planning for implementation of the health-related articles of the Minamata Convention on Mercury
|
2019
|
|
Strategic planning for implementation of the health-related articles of the Minamata Convention on Mercury
|
2019
|
|
Strategic Preparedness, Readiness and Response Plan to END THE GLOBAL COVID-19 EMERGENCY IN 2022
|
2022
|
|
Strategic Purchasing in China, Indonesia and the Philippines
|
2016
|
|
Strategic Toolkit for Assessing Risks:
A comprehensive toolkit for all-hazards health emergency risk assessment
|
2021
|
|
Stratégie de l’OMS pour la médecine traditionnelle pour:
2014-2023
|
2013
|
|
Stratégie de riposte face à la résistance aux antipaludiques en Afrique
|
2023
|
|
STRATÉGIE MONDIALE DE RECHERCHE ET D’INNOVATION POUR LA TUBERCULOSE
|
2020
|
|
STRATÉGIE MONDIALE DU SECTEUR DE LA SANTÉ CONTRE LE VIH 2016–2021:
VERS L’ÉLIMINATION DU SIDA
|
2016
|
|
STRATÉGIE MONDIALE DU SECTEUR DE LA SANTÉ CONTRE LES INFECTIONS SEXUELLEMENT TRANSMISSIBLES 2016-2021:
VERS L’ÉLIMINATION DES IST
|
2016
|
|
STRATÉGIE MONDIALE DU SECTEUR DE LA SANTÉ CONTRE L’HÉPATITE VIRALE 2016–2021:
VERS L’ÉLIMINATION DE L’HÉPATITE VIRALE
|
2016
|
|
Stratégie mondiale visant à réduire l’usage nocif de l’alcool
|
2010
|
|
STRATEGIE POUR L’EGALITE DES GENRES:
2019-2023
|
2019
|
|
STRATÉGIE TECHNIQUE MONDIALE DE LUTTE CONTRE LE PALUDISME 2016–2030
|
2021
|
|
STRATÉGIE TECHNIQUE MONDIALE DE LUTTE CONTRE LE PALUDISME 2016–2030
|
2015
|
|
Stratégies mondiales du secteur de la santé contre, respectivement, le VIH, l’hépatite virale et les infections sexuellement transmissibles pour la période 2022-2030
|
2022
|
|
Stratégies nationales en santé au XXIe siècle - Guide pratique
|
2022
|
|
Stratégies OMS de coopération avec les pays
|
2016
|
|
Strategies to end seclusion and restraint:
WHO QualityRights Specialized training
|
2019
|
|
Strategies to prevent anaemia: Recommendations from an Expert Group Consultation:
New Delhi, India, 5-6 December 2016
|
2016
|
|
Strategies to strengthen referral from primary care to secondary care in low- and middle-income countries
|
2019
|
|
Strategizing national health in the 21st century::
a handbook
|
2016
|
|
Strategy to respond to antimalarial drug resistance in Africa
|
2022
|
|
Strengthening care for the injured::
Success stories and lessons learned from around the world
|
2010
|
|
Strengthening COVID-19 vaccine demand and uptake in refugees and migrants:
An operational guide
|
2022
|
|
STRENGTHENING HEALTH EMERGENCY PREPAREDNESS IN CITIES AND URBAN SETTINGS::
GUIDANCE FOR NATIONAL AND LOCAL AUTHORITIES
|
2021
|
|
Strengthening Health Resilience to Climate Change:
Technical Briefing for the World Health Organization Conference on Health and Climate
|
2015
|
|
Strengthening health systems to respond to women subjected to intimate partner violence or sexual violence:
A manual for health managers
|
2017
|
|
Strengthening intersectoral collaboration for adolescent health
|
2015
|
|
Strengthening intersectoral collaboration for the prevention of violence against children:
Tallinn, Estonia 14-15 January 2020
|
2020
|
|
Strengthening pandemic preparedness planning for respiratory pathogens
|
2022
|
|
Strengthening Preparedness for COVID-19 in Cities and Urban Settings:
Interim Guidance for Local Authorities
|
2020
|
|
Strengthening primary health care for the prevention and management of cardiometabolic disease in low- and middle-income countries
|
2019
|
|
Strengthening surveillance of and response to foodborne diseases:
Stage Two Booklet Strengthening indicator-based surveillance
|
2017
|
|
Strengthening surveillance of and response to foodborne diseases:
Introductory module
|
2017
|
|
Strengthening surveillance of and response to foodborne diseases:
Stage One Booklet Investigating foodborne disease outbreaks
|
2017
|
|
Strengthening surveillance of and response to foodborne diseases:
Stage Three Booklet Integrating surveillance data to better understand risks across the food chain
|
2017
|
|
Strengthening surveillance of and response to foodborne diseases:
Stage One Booklet Using indicator- and event-based surveillance to detect foodborne events
|
2017
|
|
Strengthening the assessment of lymphatic filariasis transmission and documenting the achievement of elimination:
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators GENEVA, SWITZERLAND, 27–29 AUGUST 2014
|
2016
|
|
Strengthening the capacity of community health workers to deliver care for sexual, reproductive, maternal, newborn, child and adolescent health:
Technical brief by the H4+ (UNAIDS, UNFPA, UNICEF, UN Women, WHO and the World Bank)
|
2015
|
|
Strengthening the health system response to violence against women in Uganda:
Lessons learned from adapting and implementing WHO guidelines and tools
|
2020
|
|
Strengthening vital statistics systems:
What are the practical interventions necessary to reduce ignorance and uncertainty about causes of death and disease burden in the Asia Pacific region?
|
2014
|
|
Stresli Anlarda Ne Yapmalı?::
Resimli Rehber
|
2020
|
|
Stressz idején tegyük azt, ami számít:
Illusztrációkat tartalmazó útmutató
|
2020
|
|
Studying unsafe abortion::
a practical guide
|
1995
|
|
SUB-REGIONAL WORKSHOP ON ENHANCED SURVEILLANCE OF ACUTE FLACCID PARALYSIS AND POLIOMYELITIS:
Report on a WHO Meeting Ljubljana, Slovenia 5–6 July 2001
|
2001
|
|
Subsanar las desigualdades en una generación:
Alcanzar la equidad sanitaria actuando sobre los determinantes sociales de la salud
|
2008
|
|
Substandard and falsified medical products:
Report by the Director-General
|
2020
|
|
Substandard/spurious/falsely labelled/falsified/counterfeit medical products:
Report by the Director General
|
2015
|
|
Substandard/spurious/falsely-labelled/falsified/counterfeit medical products:
Report by the Director-General
|
2012
|
|
Substandard/spurious/falsely-labelled/falsified/counterfeit medical products:
Report by the Director-General
|
2016
|
|
Suite of health service capacity assessments in the context of the COVID-19 pandemic:
Interim guidance
|
2020
|
|
SUIVI DES INÉGALITÉS EN MATIÈRE DE SANTÉ SEXUELLE ET REPRODUCTIVE ET DE SANTÉ DE LA MÈRE, DU NOUVEAU-NÉ, DE L'ENFANT ET DE L'ADOLESCENT:
MANUEL PRATIQUE
|
2022
|
|
SUIVI DES PROGRÈS 2017:
DANS LA LUTTE CONTRE LES MALADIES NON TRANSMISSIBLES
|
2017
|
|
SUIVI DES PROGRÈS DANS LA LUTTE CONTRE:
LES MALADIES NON TRANSMISSIBLES 2022
|
2022
|
|
SUIVI DES PROGRÈS DANS LA LUTTE CONTRE LES MALADIES NON TRANSMISSIBLES 2020
|
2020
|
|
Suivi des réunions de haut niveau de l’Assemblée générale des Nations Unies sur des questions relatives à la santé:
Résistance aux antimicrobiens Rapport du Directeur général
|
2018
|
|
Suivi des réunions de haut niveau de l’Assemblée générale des Nations Unies sur des questions relatives à la santé:
Résistance aux antimicrobiens Rapport du Directeur général
|
2019
|
|
SUIVI ET ÉVALUATION ÉPIDÉMIOLOGIQUE DU TRAITEMENT MÉDICAMENTEUX DE MASSE:
ORGANISATION MONDIALE DE LA SANTÉ PROGRAMME MONDIAL POUR L’ÉLIMINATION DE LA FILARIOSE LYMPHATIQUE
|
2013
|
|
SUMMARY OF KEY INFORMATION:
PRACTICAL TO COUNTRIES EXPERIENCING OUTBREAKS OF A(H5N1) AND OTHER SUBTYPES OF AVIAN INFLUENZA
|
2016
|
|
Summary on environment, climate change and health for WHO representatives and other country staff
|
2023
|
|
Summary Report::
Hand Hygiene Self-Assessment Framework Survey 2015/2016
|
2016
|
|
Summary report on the:
Meeting on prevention and control of Crimean–Congo haemorrhagic fever in the Eastern Mediterranean Region Muscat, Oman 7–9 December 2015
|
2016
|
|
Summary report on the Consultative meeting on early detection and screening of priority cancers in the Eastern Mediterranean Region:
Cairo, Egypt 14–15 January 2016
|
2016
|
|
Summary report on the Expert consultation to scale up cancer care in the Eastern Mediterranean Region:
Cairo, Egypt 27–28 November 2016
|
2016
|
|
Summary report on the Experts’ consultative meeting to develop the regional strategy on blood safety and self-sufficiency (2014–2018):
Amman, Jordan 18–20 June 2014
|
2015
|
|
Summary report on the First coordination meeting on the regional comparative breast cancer research programme:
Sharm El-Sheikh, Egypt 21–22 January 2012
|
2012
|
|
Summary report on the Meeting on autism spectrum disorders:
Rome, Italy 16–18 November 2015
|
2016
|
|
Summary report on the Regional consultation on haemovigilance:
Amman, Jordan 4–5 December 2016
|
2017
|
|
Summary report on the Regional consultation on the availability and safety of blood transfusion during humanitarian emergencies:
Tunis, Tunisia 15–16 May 2016
|
2016
|
|
Summary report on the Regional consultation to review the draft global plan of action to strengthen the role of health system in addressing interpersonal violence, in particular against women and girls, and against children:
Cairo, Egypt 27–28 April 2015
|
2015
|
|
Summary report on the Regional meeting of directors of national blood transfusion services:
Casablanca, Morocco 17–19 May 2016
|
2016
|
|
Summary report on the Regional workshop on health sector involvement in the implementation of the Minamata Convention on Mercury:
Amman, Jordan 30 November–1 December 2016
|
2016
|
|
Supported decision-making and advance planning:
WHO QualityRights Specialized training
|
2019
|
|
Supported living services for mental health:
Promoting person-centred and rights-based approaches
|
2021
|
|
Sur les soins intrapartum pour une expérience positive de l’accouchement:
Transformer le soins des femmes et des nourrissons pour améliorer leur santé et leur bien-être
|
2018
|
|
Surface sampling of coronavirus disease (COVID-19)::
A practical “how to” protocol for health care and public health professionals
|
2020
|
|
SURGICAL APPROACHES TO THE UROGENITAL MANIFESTATIONS OF LYMPHATIC FILARIASIS:
REPORT FROM AN INFORMAL CONSULTATION AMONG EXPERTS
|
2019
|
|
Surgical Care at the District Hospital
|
2003
|
|
SURVEILLANCE DE LA RÉSISTANCE DU VIH AUX ANTIRÉTROVIRAUX CHEZ LES ADULTES QUI COMMENCENT UN TRAITEMENT ANTIRÉTROVIRAL (RÉSISTANCE DU VIH AUX ARV PRÉTRAITEMENT)
|
2014
|
|
SURVEILLANCE DE LA RÉSISTANCE DU VIH AUX ANTIRÉTROVIRAUX CHEZ LES ADULTES SOUS TRAITEMENT ANTIRÉTROVIRAL (RÉSISTANCE DU VIH AUX ANTIRÉTROVIRAUX ACQUISE)
|
2014
|
|
Surveillance de la santé publique dans le contexte de la COVID-19:
Orientations provisoires
|
2020
|
|
Surveillance de la santé publique dans le contexte de la COVID-19
|
2022
|
|
Surveillance de l’infection à virus Zika, de la microcéphalie et du syndrome de Guillain-Barré:
Orientations provisoires
|
2016
|
|
Surveillance d’Ebola dans les pays n’ayant pas notifié de cas de maladie à virus Ebola
|
2014
|
|
Surveillance for human infection with Middle East respiratory syndrome coronavirus (MERS-CoV):
Interim guidance
|
2018
|
|
Surveillance for Zika virus infection, microcephaly and Guillain-Barré syndrome:
Interim guidance
|
2016
|
|
SURVEILLANCE OF HIV DRUG RESISTANCE IN ADULTS INITIATING ANTIRETROVIRAL THERAPY (PRETREATMENT HIV DRUG RESISTANCE)
|
2014
|
|
SURVEILLANCE OF HIV DRUG RESISTANCE IN ADULTS RECEIVING ART (ACQUIRED HIV DRUG RESISTANCE)
|
2014
|
|
SURVEILLANCE OF HIV DRUG RESISTANCE IN CHILDREN NEWLY DIAGNOSED WITH HIV BY EARLY INFANT DIAGNOSIS
|
2017
|
|
Surveillance protocol for SARS-CoV-2 infection among health workers
|
2020
|
|
Surveillance Standards for:
Vaccine-Preventable Diseases
|
2018
|
|
Surveillance template protocol for pfhrp2/pfhrp3 gene deletions
|
2020
|
|
Survey of Adverse Childhood Experiences among Romanian university students:
Study Report from the 2012 Survey
|
2013
|
|
SURVEY OF ADVERSE CHILDHOOD EXPERIENCES AMONG YOUNG PEOPLE IN THE FORMER YUGOSLAV REPUBLIC OF MACEDONIA
|
2013
|
|
SURVEY OF ADVERSE CHILDHOOD EXPERIENCES AND ASSOCIATED HEALTH-HARMING BEHAVIOURS AMONG POLISH STUDENTS
|
2018
|
|
Survey of the quality of selected antiretrovial medicines circulating in five African countries
|
2019
|
|
SURVEY ON THE PREVALENCE OF ADVERSE CHILDHOOD EXPERIENCES AMONG YOUNG PEOPLE IN THE RUSSIAN FEDERATION:
REPORT
|
2014
|
|
SURVEYS OF DRINKING PATTERNS AND PROBLEMS IN SEVEN DEVELOPING COUNTRIES
|
2001
|
|
SURVIVE and THRIVE:
Transforming care for every small and sick newborn
|
2019
|
|
Sustainable preparedness for health security and resilience::
Adopting a whole-of-society approach and breaking the “panic-then-forget” cycle
|
2020
|
|
Sustaining lives and livelihoods::
a decision framework for calibrating social and movement measures during the COVID-19 pandemic
|
2020
|
|
Sustaining the drive to overcome the global impact of neglected tropical diseases:
Second WHO report on neglected tropical diseases
|
2013
|
|
Swaziland, Lesotho & RSA a step closer to polio eradication
|
2017
|
|
SYSTEMATIC EVIDENCE REVIEW FOR DEVELOPING WHO GUIDELINES ON PROTECTING WORKERS FROM POTENTIAL RISKS OF MANUFACTURED NANOMATERIALS:
Which hazard category should specific nanomaterials or groups of nanomaterials be assigned to and how?
|
2017
|
|
Systematic review of needs for medical devices for ageing populations:
Commissioned to the Australian Safety and Efficacy Register of New Interventional Procedures – Surgical (ASERNIP-S) by the World Health Organization (WHO)
|
2015
|
|
A Systematic Review of the Health Complications of Female Genital Mutilation:
including Sequelae in Childbirth
|
2000
|
|
Systematic reviews for the update of the WHO Guideline on country pharmaceutical pricing policies
|
2020
|
|
Système de classification des pays concernés par le virus Zika:
Orientations provisoires
|
2017
|
|
Système mondial de surveillance de la résistance aux antimicrobiens:
Manuel de mise en œuvre initiale
|
2016
|
|
Système mondial de surveillance et de suivi de l'OMS pour les produits médicaux de qualité inférieure et falsifiés (GSMS)
|
2018
|
|
Systems for health: everyone has a role:
Flagship report of the Alliance for Health Policy and Systems Research
|
2022
|
|
TABAC & CARDIOPATHIES CORONARIENNES
|
2020
|
|
TABAC & CARDIOPATHIES CORONARIENNES
|
2020
|
|
TABACO Y CARDIOPATÍA CORONARIA
|
2020
|
|
TABACO Y CARDIOPATÍA CORONARIA
|
2020
|
|
Tackling abuse of older people:
Five priorities for the United Nations Decade of Healthy Ageing (2021–2030)
|
2022
|
|
TACKLING ANTIMICROBIAL RESISTANCE (AMR) TOGETHER:
Working Paper 5.0: Enhancing the focus on gender and equity
|
2018
|
|
TACKLING ANTIMICROBIAL RESISTANCE (AMR) TOGETHER:
Working Paper 1.0: Multisectoral coordination
|
2018
|
|
TACKLING ANTIMICROBIAL RESISTANCE (AMR) TOGETHER:
Working Paper 5.0: Enhancing the focus on gender and equity
|
2018
|
|
TACKLING HIV DRUG RESISTANCE::
TRENDS, GUIDELINES AND GLOBAL ACTION
|
2017
|
|
TACKLING NCDs:
‘Best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases
|
2017
|
|
Tackling noncommunicable diseases in Ukraine 2015 – 2019
|
2020
|
|
TADDs:
Instrumento para la evaluación de los sistemas de atención a la diabetes y a la retinopatía diabética
|
2015
|
|
TADDS:
Tool for the assessment of diabetic retinopathy and diabetes management systems
|
2015
|
|
TaDDs*:
Outil d’appréciation des systèmes de prise en charge de la rétinopathie diabétique et du diabète
|
2016
|
|
Tailoring malaria interventions in the COVID-19 response
|
2020
|
|
TARGET PRODUCT PROFILE:
for a test for rhodesiense human African trypanosomiasis diagnosis usable in peripheral health facilities
|
2021
|
|
Target product profile for therapy of diagnosed uncomplicated gonorrhoea
|
2020
|
|
Target product profile for therapy of neonatal sepsis in high resistance settings
|
2020
|
|
Target product profile for therapy of uncomplicated enteric fever
|
2020
|
|
TARGET PRODUCT PROFILES FOR ANTIBACTERIAL RESISTANCE DIAGNOSTICS
|
2020
|
|
TARGET PRODUCT PROFILES FOR NEEDED ANTIBACTERIAL AGENTS::
enteric fever, gonorrhoea, neonatal sepsis, urinary tract infections and meeting report
|
2020
|
|
TARGET PRODUCT PROFILES FOR NEEDED ANTIBACTERIAL AGENTS::
enteric fever, gonorrhoea, neonatal sepsis, urinary tract infections and meeting report
|
2020
|
|
TARGET PRODUCT PROFILES FOR ORAL THERAPY OF URINARY TRACT INFECTIONS
|
2020
|
|
Target product profiles for oral therapy of urinary tract infections
|
2020
|
|
Target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0
|
2020
|
|
Task Force on definitions, criteria and indicators for interruption of transmission and elimination of leprosy:
Report of the final meeting Chengalpattu, India, 24-26 March 2021
|
2021
|
|
Task sharing to improve access to Family Planning/Contraception
|
2017
|
|
Tax exemptions or reductions for pharmaceutical products:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
TDR INTERSECTIONAL GENDER RESEARCH STRATEGY:
Building the science of solutions FOR ALL
|
2020
|
|
TECHNICAL BRIEF::
GENDER
|
2018
|
|
Technical considerations for implementing a risk-based approach to international travel in the context of COVID-19:
Interim guidance
|
2021
|
|
Technical consultation::
Strategies for global surveillance of antimicrobial resistance 8-19 December 2012 World Health Organization Headquarters, Geneva Meeting report
|
2013
|
|
Technical consultation o n the s election of h ealth p roducts
|
2019
|
|
TECHNICAL CONSULTATION ON IN VITRO DIAGNOSTICS FOR AMR:
27–28 March 2019, WHO headquarters, Geneva
|
2019
|
|
Technical consultation on indicators of adolescent health WHO, Geneva, Switzerland 30 September – 1 October 2014:
GLOBAL REFERENCE LIST OF HEALTH INDICATORS FOR ADOLESCENTS (AGED 10–19 YEARS)
|
2015
|
|
Technical consultation on setting global sodium benchmarks for different food categories:
Report of a virtual meeting, 21–23 October 2020
|
2022
|
|
Technical Consultation on the Development of National Health Laboratory Policies:
Meeting Report
|
2016
|
|
TECHNICAL CONSULTATION ON THE PREVENTION CONTROL AND RESPONSE TO INJURIES AND VIOLENCE IN THE WESTERN PACIFIC REGION:
Manila, Philippines 28-31 October 2013
|
2014
|
|
Technical Expert Group Meeting Report:
Commercial products for preserving clinical specimens for the diagnosis of tuberculosis
|
2017
|
|
TECHNICAL FOCUS::
COVID-19 Early Epidemiologic and Clinical investigations for public health response
|
2020
|
|
Technical Guidance Series (TGS) for WHO Prequalification – Diagnostic Assessment:
Guidance on test method validation for in vitro diagnostic medical devices TGS-4
|
2017
|
|
TECHNICAL MEETING ON THE REGIONAL ADAPTATION OF THE WHO NUTRIENT PROFILE MODEL TO THE WESTERN PACIFIC REGION:
Manila, Philippines 19 - 21 October 2015
|
2016
|
|
Technical note::
Supplementary foods for the management of moderate acute malnutrition in infants and children 6–59 months of age
|
2012
|
|
TECHNICAL NOTE:
QUALITY AND REGULATORY CONSIDERATIONS FOR THE USE OF VITAMIN A SUPPLEMENTS IN PUBLIC HEALTH PROGRAMMES FOR INFANTS AND CHILDREN AGED 6–59 MONTHS
|
2019
|
|
Technical package for cardiovascular disease management in primary health care:
Access to essential medicines and technology
|
2018
|
|
Technical package for cardiovascular disease management in primary health care:
Risk-based CVD management
|
2020
|
|
Technical package for cardiovascular disease management in primary health care:
Systems for monitoring
|
2018
|
|
Technical package for cardiovascular disease management in primary health care:
Healthy-lifestyle counselling
|
2018
|
|
Technical package for cardiovascular disease management in primary health care:
Evidence-based treatment protocols
|
2018
|
|
Technical package for cardiovascular disease management in primary health care:
Team-based care
|
2018
|
|
Technical package for cardiovascular diseasemanagement in primary health care:
Implementation guide
|
2018
|
|
The technical package SAFER A WORLD FREE FROM ALCOHOL RELATED HARMS:
Five areas of intervention at national and subnational levels
|
2019
|
|
Technical report on ::
Taxation for Sugar Sweetened Beverages in Sri Lanka
|
2018
|
|
Technical Report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine)
|
2021
|
|
TECHNICAL SERIES ON ADAPTING TO CLIMATE-SENSITIVE HEALTH IMPACTS:
DIARRHOEAL DISEASES
|
2022
|
|
Technical specifications for invasive and non-invasive ventilators for COVID-19:
Interim guidance
|
2020
|
|
TECHNICAL SPECIFICATIONS FOR OXYGEN CONCENTRATORS
|
2015
|
|
Technical specifications for pre-market assessment of blood pressure measuring device with cuff, automated and semi-automated
|
2023
|
|
Technical specifications for Pressure Swing Adsorption (PSA) Oxygen Plants:
Interim guidance
|
2020
|
|
TECHNICAL SPECIFICATIONS FOR SELECTION OF ESSENTIAL IN VITRO DIAGNOSTICS FOR SARS-COV-2
|
2021
|
|
Technical specifications of personal protective equipment for COVID-19:
INTERIM GUIDANCE
|
2020
|
|
Technical specifications of radiotherapy equipment for cancer treatment
|
2021
|
|
Technical Specifications Series for submission to WHO Prequalification — Diagnostic Assessment
|
2018
|
|
Technical Specifications Series for submission to WHO Prequalification — Diagnostic Assessment
|
2018
|
|
TECHNICAL UPDATE ON TREATMENT OPTIMIZATION:
USE OF TENOFOVIR IN HIV-INFECTED CHILDREN AND ADOLESCENTS: A PUBLIC HEALTH PERSPECTIVE
|
2012
|
|
TECHNICAL UPDATE ON TREATMENT OPTIMIZATION:
USE OF EFAVIRENZ DURING PREGNANCY: A PUBLIC HEALTH PERSPECTIVE
|
2012
|
|
TECHNICAL WORKSHOP ON TAXING SUGAR-SWEETENED BEVERAGES:
Manila, Philippines 21–22 September 2016
|
2017
|
|
TEMPLATE FOR REHABILITATION INFORMATION COLLECTION:
A tool accompanying the Systematic Assessment of Rehabilitation Situation (STARS)
|
2019
|
|
TEN STRATEGIES FOR KEEPING CHILDREN SAFE ON THE ROAD
|
2015
|
|
TEN YEARS IN PUBLIC HEALTH 2007-2017
|
2017
|
|
Tendering and negotiation:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
Tenth meeting of the WHO Vector Control Advisory Group
|
2019
|
|
Tercer informe de la Comisión B:
(Proyecto)
|
2017
|
|
Terrorist Threats to Food:
Guidance for Establishing and Strengthening Prevention and Response Systems
|
2002
|
|
Tests diagnostiques pour le dépistage du SARS-CoV-2:
Orientations provisoires
|
2020
|
|
Tetanus and voluntary medical male circumcision: risk according to circumcision method and risk mitigation:
Report of the WHO Technical Advisory Group on Innovations in Male Circumcision – consultative review of additional information, 12 August 2016
|
2016
|
|
Tetrachloroethene in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2020
|
|
THAILAND:
How a Strong Health System Fights a Pandemic
|
2020
|
|
Therapeutics and COVID-19:
LIVING GUIDELINE
|
2020
|
|
Therapeutics and COVID-19
|
2022
|
|
Therapeutics and COVID-19
|
2021
|
|
Therapeutics and COVID-19
|
2022
|
|
Therapeutics and COVID-19:
LIVING GUIDELINE
|
2021
|
|
Therapeutics and COVID-19
|
2022
|
|
Therapeutics and COVID-19
|
2022
|
|
Therapeutics for Ebola virus disease:
19 August 2022
|
2022
|
|
THERAPIE INTERPERSONNELLE (TIP) DE GROUPE POUR LA DEPRESSION
|
2016
|
|
Thimphu Declaration:
Autism and Neurodevelopmental Disorders
|
2017
|
|
THINKING HEALTHY:
A manual for psychosocial management of perinatal depression
|
2015
|
|
THIRD INTERCOUNTRY TRAINING WORKSHOP ON SUBNATIONAL INITIATIVES FOR CARDIOVASCULAR DISEASE PREVENTION, CONTROL AND MANAGEMENT IN THE MEKONG COUNTRIES:
Pakse, Lao People’s Democratic Republic 18–20 June 2018
|
2018
|
|
Third Meeting of the Global Task Force on Cholera Control:
14-15 June 2016 – Amman, Jordan
|
2016
|
|
Third round of the global pulse survey on continuity of essential health services during the COVID-19 pandemic::
November–December 2021
|
2022
|
|
Thirteenth General Programme of Work (GPW13):
Methods for impact measurement
|
2020
|
|
Thirteenth meeting of the WHO Vector Control Advisory Group
|
2021
|
|
TINCIÓN DE GIEMSA DE EXTENSIONES DE SANGRE PARA EL DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-07A
|
2016
|
|
Tips for safe listening
|
2019
|
|
TOBACCO::
POISONING OUR PLANET
|
2022
|
|
TOBACCO BREAKS HEARTS:
Choose health, not tobacco
|
2018
|
|
Tobacco control to improve child health and development
|
2021
|
|
TOBACCO & CORONARY HEART DISEASE
|
2020
|
|
TOBACCO & CORONARY HEART DISEASE
|
2020
|
|
TOBACCO & DEMENTIA
|
2014
|
|
Tõenduspõhisuse ülevaade:
Suhkruga magustatud jookide tarbimise ja sellest põhjustatud tervisekahjude vähendamine Eestis
|
2016
|
|
Togo Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
A tool for strengthening gender-sensitive national HIV and Sexual and Reproductive Health (SRH) monitoring and evaluation systems
|
2016
|
|
Toolkit for developing a multisectoral action plan for noncommunicable diseases:
Module 1. Conducting a comprehensive assessment
|
2022
|
|
A toolkit for integrated vector management in sub-Saharan Africa
|
2016
|
|
A TOOLKIT FOR NATIONAL DENGUE BURDEN ESTIMATION
|
2018
|
|
TOOLKIT FOR ORAL HEALTH PROFESSIONALS TO DELIVER BRIEF TOBACCO INTERVENTIONS
|
2017
|
|
TOOLKIT FOR RESEARCH AND DEVELOPMENT OF PAEDIATRIC ANTIRETROVIRAL DRUGS AND FORMULATIONS
|
2018
|
|
Total fat intake for the prevention of unhealthy weight gain in adults and children:
WHO guideline
|
2023
|
|
TOWARDS A BEATING CARDIOVASCULAR DISEASE PLAN FOR EUROPE
|
2022
|
|
Towards a dementia inclusive society:
WHO toolkit for dementia-friendly initiatives (DFIs)
|
2021
|
|
Towards a dementia plan::
a WHO guide
|
2018
|
|
Towards a Grand Convergence for Child Survival and Health:
A strategic review of options for the future building on lessons learnt from IMNCI
|
2016
|
|
Towards improving access to medical devices through local production:
Phase II Report of a case study in four sub-Saharan countries
|
2016
|
|
Towards long-term care systems in sub-Saharan Africa
|
2017
|
|
Towards the elimination of asbestos-related diseases in the WHO European Region
|
2015
|
|
Towards tuberculosis elimination::
an action framework for low-incidence countries
|
2014
|
|
Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015:
WHO PROGRESS REPORT 2011
|
2011
|
|
Towards universal coverage for preventive chemotherapy for Neglected Tropical Diseases: guidance for assessing “who is being left behind and why”:
WORKING DRAFT FOR FURTHER PILOTING DURING 2018 – 2019
|
2017
|
|
Towards Universal Eye Health::
A Regional Action Plan for the Western Pacific (2014–2019)
|
2014
|
|
Towards zero leprosy:
Global Leprosy (Hansen’s disease) Strategy 2021–2030
|
2021
|
|
Toxicological evaluation of certain veterinary drug residues in food:
Prepared by the Seventy-eighth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA)
|
2014
|
|
Toxicological evaluation of certain veterinary drug residues in food
|
2016
|
|
Toxicological evaluation of certain veterinary drug residues in food
|
2012
|
|
Tracking health expenditure on COVID-19 within the System of Health Accounts Framework:
Technical note, June 2022
|
2022
|
|
Trade and Health::
Towards building a National Strategy
|
2015
|
|
Trade and investment issues relevant to implementation of the WHO FCTC:
Report by the Convention Secretariat
|
2014
|
|
TRADITIONAL AND COMPLEMENTARY MEDICINE
|
2021
|
|
TRADITIONAL AND COMPLEMENTARY MEDICINE IN PRIMARY HEALTH CARE
|
2018
|
|
Training course on the inpatient management of severe acute malnutrition: Module 2. Principles of care:
Web Annex A. Weight-for-height reference card
|
2021
|
|
Training course on the inpatient management of severe acute malnutrition: Module 4. Feeding:
Web Annex B. Ready-to-use therapeutic food reference table
|
2021
|
|
Training course on the inpatient management of severe acute malnutrition: Module 4. Feeding:
Web Annex D. Daily ward feeds chart
|
2021
|
|
Training course on the inpatient management of severe acute malnutrition: Module 4. Feeding:
Web Annex C. F-100 reference card
|
2021
|
|
Training course on the inpatient management of severe acute malnutrition: Module 4. Feeding:
Web Annex A. F-75 reference card
|
2021
|
|
Training course on the inpatient management of severe acute malnutrition: Module 5. Daily care:
Web Annex. Monitoring danger signs during inpatient management of severe acute malnutrition
|
2021
|
|
Training course on the inpatient management of severe acute malnutrition: Module 6. Monitoring and problem solving:
Web Annex B. Monitoring checklists
|
2021
|
|
TRAINING FOR TOBACCO QUIT LINE COUNSELLORS::
TELEPHONE COUNSELLING
|
2014
|
|
Training on GLASS methodology for national surveillance of antimicrobial consumption
|
2022
|
|
Training on Operational Microplanning for COVID-19 Vaccination:
Facilitator’s Guide
|
2023
|
|
Training package for the health sector:
Improving the capacity to diagnose, prevent and manage paediatric diseases linked to the environment
|
2019
|
|
TRAINING REPORT:
SUBREGIONAL TRAINING FOR LEADERSHIP AND ADVOCACY TEAMS TO REDUCE ALCOHOL HARM IN YOUNG PEOPLE, MODULE 1
|
2018
|
|
Traitement de pré transfert du paludisme grave avec de l’artésunate par voie rectale
|
2017
|
|
Traitement pré-transfert par l’artésunate rectal dans le paludisme infantile
|
2012
|
|
Traitements contre la COVID-19
|
2022
|
|
Traitements contre la COVID-19:
ORIENTATIONS ÉVOLUTIVES
|
2020
|
|
Traitements contre la maladie à virus Ebola
|
2022
|
|
Traitements et vaccins potentiels contre le virus Ebola
|
2014
|
|
TRANSITION TO NEW ANTIRETROVIRAL DRUGS IN HIV PROGRAMMES::
CLINICAL AND PROGRAMMATIC CONSIDERATIONS
|
2017
|
|
TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES
|
2017
|
|
TRANSITIONING TO AN OPTIMAL PAEDIATRIC ARV FORMULARY::
IMPLEMENTATION CONSIDERATIONS
|
2018
|
|
Translating community research into global policy reform for national action:
A checklist for community engagement to implement the WHO Consolidated guideline on sexual and reproductive health and rights of women living with HIV
|
2019
|
|
Transmission of SARS-CoV-2: implications for infection prevention precautions:
Scientific brief
|
2020
|
|
Tratamiento de soporte optimizado para la enfermedad por el virus del Ébola:
Protocolos de soporte individualizado y optimizado
|
2023
|
|
Tratamiento médico del aborto
|
2019
|
|
TRAUMATISMES et VIOLENCE:
LES FAITS 2014
|
2014
|
|
TRAUMATISMES et VIOLENCE LES FAITS
|
2010
|
|
TRAUMATISMOS y VIOLENCIA:
DATOS
|
2010
|
|
Travailler ensemble:
un guide de ressources pour l’intégration des services de vaccination tout au long de la vie
|
2019
|
|
Travaux en cours concernant les articles 9 et 10 de la Convention-cadre de l’OMS pour la lutte antitabac:
Rapport de l’Initiative de l’OMS pour un monde sans tabac
|
2012
|
|
TREATMENT OF MYCOBACTERIUM ULCERANS DISEASE (BURULI ULCER):
GUIDANCE FOR HEALTH WORKERS
|
2012
|
|
Treizième programme général de travail (treizième PGT):
Méthodes de mesure de l’impact
|
2021
|
|
Trichiasis surgery for trachoma
|
2015
|
|
Trichloroethene in drinking-water:
Background document for development of WHO Guidelines for drinking-water quality
|
2020
|
|
Troisième rapport de la Commission B:
(Projet)
|
2017
|
|
Tuberculose : lignes directrices relatives à la surveillance de la pharmacorésistance:
Cinquième édition
|
2015
|
|
TUBERCULOSIS:
LABORATORY BIOSAFETY MANUAL
|
2012
|
|
Tuberculosis, HIV, malaria and neglected tropical diseases:
Strengthening collaboration to prevent and manage antimicrobial resistance
|
2019
|
|
TURNING PLANS INTO ACTION FOR ANTIMICROBIAL RESISTANCE (AMR):
Working Paper 2.0: Implementation and coordination
|
2019
|
|
Twentieth Session of the Joint Action Forum Addis Ababa, Ethiopia, 08 - 09 December 2014:
FINAL COMMUNIQUE
|
2014
|
|
Uganda Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
UN Initiative on Greening Procurement in the Health Sector::
From Products to Services
|
2013
|
|
Un Sistema de Cuentas de Salud 2011:
EDICIÓN REVISADA Versión resumida
|
2022
|
|
Un Sistema de Cuentas de Salud 2011:
EDICIÓN REVISADA
|
2022
|
|
Understanding and addressing violence against women:
Human trafficking
|
2012
|
|
Understanding and addressing violence against women
|
2012
|
|
Understanding and addressing violence against women
|
2012
|
|
Understanding and addressing violence against women:
Femicide
|
2012
|
|
Une définition de cas clinique pour l’affection post-COVID-19 établie par un consensus Delphi
|
2021
|
|
Une sélection de recommandations pratiques relatives à l’utilisation de méthodes contraceptives:
Troisième édition 2017
|
2017
|
|
United Nations Inter-Agency Task Force on the Prevention and Control of Non-communicable Diseases:
2022-2025 strategy
|
2022
|
|
United Republic of Tanzania Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
UNITED REPUBLIC OF TANZANIA – TB Community Network: a platform for a stronger community response to tuberculosis:
CASE STUDY
|
2020
|
|
Universal eye health:
A global action plan 2014–2019
|
2013
|
|
Universal health coverage:
for sexual and reproductive health
|
2020
|
|
Unrecorded alcohol::
what the evidence tells us
|
2022
|
|
Unsafe abortion:
Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2003
|
2007
|
|
Unsafe abortion:
Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008
|
2011
|
|
Unsafe abortion:
Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2000 Fourth edition
|
2004
|
|
Unsafe abortion:
Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008
|
2011
|
|
Unsafe abortion incidence and mortality:
Global and regional levels in 2008 and trends during 1990 –2008
|
2012
|
|
Update of antibacterial agents in clinical development
|
2018
|
|
Update on artemisinin resistance - April 2012
|
2012
|
|
UPDATE ON THE E-2020 INITIATIVE OF 21 MALARIA-ELIMINATING COUNTRIES:
REPORT AND COUNTRY BRIEFS
|
2018
|
|
An update on WHO’s work on female genital mutilation (FGM)
|
2011
|
|
UPDATED GUIDELINE:
Paediatric emergency triage, assessment and treatment Care of critically ill children
|
2016
|
|
UPDATED RECOMMENDATIONS ON HIV PREVENTION, INFANT DIAGNOSIS, ANTIRETROVIRAL INITIATION AND MONITORING
|
2021
|
|
UPDATED RECOMMENDATIONS ON TREATMENT OF ADOLESCENTS AND CHILDREN WITH CHRONIC HCV INFECTION, AND HCV SIMPLIFIED SERVICE DELIVERY AND DIAGNOSTICS:
WEB ANNEX D: VALUES AND PREFERENCES SURVEY REPORTS
|
2022
|
|
UPDATED RECOMMENDATIONS ON TREATMENT OF ADOLESCENTS AND CHILDREN WITH CHRONIC HCV INFECTION, AND HCV SIMPLIFIED SERVICE DELIVERY AND DIAGNOSTICS:
WEB ANNEX B: EVIDENCE-TO-DECISION-MAKING TABLES AND GRADE TABLES
|
2022
|
|
UPDATED RECOMMENDATIONS ON TREATMENT OF ADOLESCENTS AND CHILDREN WITH CHRONIC HCV INFECTION, AND HCV SIMPLIFIED SERVICE DELIVERY AND DIAGNOSTICS:
WEB ANNEX A: SUMMARY OF DECLARATIONS OF CONFLICTS OF INTEREST
|
2022
|
|
UPDATED RECOMMENDATIONS ON TREATMENT OF ADOLESCENTS AND CHILDREN WITH CHRONIC HCV INFECTION, AND HCV SIMPLIFIED SERVICE DELIVERY AND DIAGNOSTICS:
WEB ANNEX C: SYSTEMATIC REVIEW REPORTS
|
2022
|
|
Updated WHO Recommendation on Tranexamic Acid for the Treatment of Postpartum Haemorrhage:
Highlights and Key Messages from the World Health Organization’s 2017 Global Recommendation
|
2017
|
|
Urban HEART:
Urban Health Equity Assessment and Response Tool USER MANUAL
|
2010
|
|
THE URGENT NEED TO IMPLEMENT PATIENT BLOOD MANAGEMENT
|
2021
|
|
Use and procurement of additional lubricants for male and female condoms: WHO/UNFPA/FHI:
Advisory note - Key points
|
2012
|
|
Use and procurement of additional lubricants for male and female condoms: WHO/UNFPA/FHI360:
Advisory note
|
2012
|
|
The use of artesunate-pyronaridine for the treatment of uncomplicated malaria
|
2019
|
|
USE OF CELL CULTURE IN VIROLOGY FOR DEVELOPING COUNTRIES:
IN THE SOUTH-EAST ASIA REGION
|
2017
|
|
Use of community health workers to manage and prevent noncommunicable diseases
|
2019
|
|
Use of Convalescent Whole Blood or Plasma Collected from Patients Recovered from Ebola Virus Disease for Transfusion, as an Empirical Treatment during Outbreaks:
Interim Guidance for National Health Authorities and Blood Transfusion Services
|
2014
|
|
The use of delamanid in the treatment of multidrug-resistant tuberculosis:
Interim policy guidance
|
2014
|
|
The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents:
Interim policy guidance
|
2016
|
|
Use of devices for adult male circumcision in public health HIV prevention programmes:
Conclusions of the WHO Technical Advisory Group on Innovations in Male Circumcision EXECUTIVE SUMMARY
|
2012
|
|
Use of e-health programmes to deliver urban primary health-care services for noncommunicable diseases in middle-income countries
|
2021
|
|
USE OF MALATHION FOR VECTOR CONTROL:
REPORT OF A WHO MEETING GENEVA, 16–17 MAY 2016
|
2016
|
|
Use of medical and non-medical/fabric masks for community outreach activities during the COVID-19 pandemic, based on current WHO guidance
|
2021
|
|
THE USE OF MOLECULAR LINE PROBE ASSAY FOR THE DETECTION OF RESISTANCE TO SECOND-LINE ANTI-TUBERCULOSIS DRUGS:
EXPERT GROUP MEETING REPORT GENEVA: FEBRUARY 2013
|
2013
|
|
The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin:
Policy update
|
2016
|
|
The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs:
Policy guidance
|
2016
|
|
The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex::
technical guide
|
2018
|
|
The use of non-pharmaceutical forms of Artemisia
|
2019
|
|
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19:
Scientific brief
|
2020
|
|
The use of rectal artesunate as a pre-referral treatment for severe P. falciparum malaria
|
2022
|
|
Use of SARS-CoV-2 antigen rapid diagnostic tests for COVID-19 self-testing:
INTERIM GUIDANCE
|
2022
|
|
Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing:
INTERIM GUIDANCE
|
2022
|
|
Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing:
Interim guidance
|
2022
|
|
Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing:
INTERIM GUIDANCE
|
2022
|
|
Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing:
INTERIM GUIDANCE
|
2022
|
|
Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing:
INTERIM GUIDANCE
|
2022
|
|
Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing:
INTERIM GUIDANCE
|
2022
|
|
Use of systematic reviews of the evidence in public health nutrition:
Proceedings of an informal consultation held 8 October 2011 in Geneva, Switzerland
|
2013
|
|
USER GUIDE FOR NAVIGATING RESOURCES ON STEPWISE IMPLEMENTATION OF HAEMOVIGILANCE SYSTEMS
|
2022
|
|
Using a contextualized competency framework to develop rehabilitation programmes and their curricula:
A stepwise guide for programme and curriculum developers
|
2020
|
|
Using multidimensional poverty and vulnerability indices to inform equitable policies and interventions in health emergencies
|
2021
|
|
USO, CUIDADO Y MANTENIMIENTO DE LOS MICROSCOPIOS:
DIAGNÓSTICO MICROSCÓPICO DEL PALUDISMO PROCEDIMIENTO OPERATIVO ESTANDAR – DMP-POE-12
|
2016
|
|
Uso de mascarillas médicas y no médicas/de tela para actividades comunitarias de salud durante la pandemia de COVID-19, sobre la base de las orientaciones actuales de la OMS
|
2021
|
|
Uso de pruebas de diagnóstico rápido de detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19:
ORIENTACIONES PROVISIONALES
|
2022
|
|
Uso de pruebas de diagnóstico rápido de detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19:
Orientaciones provisionales
|
2022
|
|
Uso de pruebas de diagnóstico rápido de detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19:
ORIENTACIONES PROVISIONALES
|
2022
|
|
Uso de pruebas de diagnóstico rápido de detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19:
ORIENTACIONES PROVISIONALES
|
2022
|
|
Uso de pruebas de diagnóstico rápido de detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19:
ORIENTACIONES PROVISIONALES
|
2022
|
|
Uso de pruebas de diagnóstico rápido de detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19:
ORIENTACIONES PROVISIONALES
|
2022
|
|
Uso de pruebas de diagnóstico rápido por detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19:
ORIENTACIONES PROVISIONALES
|
2022
|
|
Utilisation des masques médicaux et non médicaux/en tissu dans le cadre des activités de santé à base communautaire pendant la pandémie de COVID-19, sur la base des orientations actuelles de l’OMS
|
2021
|
|
Utilisation des tests de diagnostic rapide antigéniques du SARS-CoV-2 pour l’autodépistage de la COVID-19:
ORIENTATIONS PROVISOIRES
|
2022
|
|
Utilisation des tests de diagnostic rapide antigéniques du SARS-CoV-2 pour l’autodépistage de la COVID-19:
Orientations provisoires
|
2022
|
|
Utilisation des tests de diagnostic rapide antigéniques du SARS-CoV-2 pour l’autodépistage de la COVID-19:
ORIENTATIONS PROVISOIRES
|
2022
|
|
Utilisation des tests de diagnostic rapide antigéniques du SARS-CoV-2 pour l’autodépistage de la COVID-19:
ORIENTATIONS PROVISOIRES
|
2022
|
|
Utilisation des tests de diagnostic rapide antigéniques du SARS-CoV-2 pour l’autodépistage de la COVID-19:
ORIENTATIONS PROVISOIRES
|
2022
|
|
Utilisation des tests de diagnostic rapide antigéniques du SARS-CoV-2 pour l’autodépistage de la COVID-19:
ORIENTATIONS PROVISOIRES
|
2022
|
|
Utilisation des tests de diagnostic rapide antigéniques du SARS-CoV-2 pour l’autodépistage de la COVID-19:
ORIENTATIONS PROVISOIRES
|
2022
|
|
UTILISATION, SOIN D’USAGE ET ENTRETIEN DES MICROSCOPES:
DIAGNOSTIC MICROSCOPIQUE DU PALUDISME MODES OPÉRATOIRES NORMALISÉS – DMP-MON-12
|
2016
|
|
VACCINE SAFETY COMMUNICATION IN THE DIGITAL AGE:
2018 MEETING REPORT 4-5 June 2018 Les Pensieres Center for Global Health 4-5 June 2018
|
2019
|
|
VALIDATION DE L’ÉLIMINATION DU TRACHOME EN TANT QUE PROBLÈME DE SANTÉ PUBLIQUE
|
2016
|
|
VALIDATION OF ELIMINATION OF LYMPHATIC FILARIASIS AS A PUBLIC HEALTH PROBLEM
|
2017
|
|
VALIDATION OF ELIMINATION OF TRACHOMA AS A PUBLIC HEALTH PROBLEM
|
2016
|
|
Value-based pricing:
WHO Guideline on Country Pharmaceutical Pricing Policies A plain language summary
|
2021
|
|
Values & preferences of MSM::
the Use of Antiretroviral Therapy as Prevention
|
2014
|
|
Vector alert: Anopheles stephensi invasion and spread:
Horn of Africa, the Republic of the Sudan and surrounding geographical areas, and Sri Lanka
|
2019
|
|
Vector control interventions designed for malaria transmission control in complex emergencies and in response to natural disasters:
PREFERRED PRODUCT CHARACTERISTICS
|
2021
|
|
Vers zéro lèpre:
Stratégie mondiale de Lutte contre la Lèpre (maladie de Hansen) 2021–2030
|
2021
|
|
Viet Nam Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Vigilancia de la infección por el virus de Zika, la microcefalia y el síndrome de Guillain-Barré:
Orientación provisional
|
2016
|
|
Vigilância global, prevenção e controlo das DOENÇAS RESPIRATÓRIAS CRÓNICAS:
Uma abordagem integradora
|
2007
|
|
VIOLENCE À L’ÉGARD DES FEMMES ESTIMATIONS DE LA PRÉVALENCE, 2018
|
2021
|
|
Violence à l’égard des femmes, estimations pour 2018:
Résumé d’orientation
|
2021
|
|
Violence à l’encontre des femmes:
L’action du secteur de la santé
|
2013
|
|
Violence against women:
Intimate partner and sexual violence against women
|
2019
|
|
Violence against women:
Intimate partner and sexual violence against women
|
2014
|
|
Violence against Women:
The Health Sector Responds
|
2013
|
|
VIOLENCE AGAINST WOMEN PREVALENCE ESTIMATES, 2018
|
2021
|
|
VIOLENCE AGAINST WOMEN PREVALENCE ESTIMATES, 2018
|
2021
|
|
Violence Against Women Prevalence Estimates, 2018:
Global, regional and national prevalence estimates for intimate partner violence against women and global and regional prevalence estimates for non-partner sexual violence against women
|
2021
|
|
Violence Against Women Prevalence Estimates, 2018:
Executive summary
|
2021
|
|
VIOLENCE AGAINST WOMEN PREVALENCE ESTIMATES, 2018
|
2021
|
|
VIOLENCE AGAINST WOMEN PREVALENCE ESTIMATES, 2018
|
2021
|
|
VIOLENCE AGAINST WOMEN PREVALENCE ESTIMATES, 2018
|
2021
|
|
VIOLENCE AGAINST WOMEN PREVALENCE ESTIMATES, 2018
|
2021
|
|
VIOLENCE AGAINST WOMEN PREVALENCE ESTIMATES, 2018
|
2021
|
|
VIOLENCE AGAINST WOMEN PREVALENCE ESTIMATES, 2018
|
2021
|
|
Violence, health and sustainable development:
Factsheet - Sustainable Development Goals (SDGs): health targets
|
2020
|
|
VIOLENCE IN THE WESTERN PACIFIC REGION:
CHILD MALTREATMENT
|
2016
|
|
VIOLENCE IN THE WESTERN PACIFIC REGION 2014
|
2015
|
|
Violencia contra la mujer:
Respuesta del sector de la salud
|
2013
|
|
Violencia contra las mujeres: estimaciones para 2018:
Resumen
|
2021
|
|
VIRUS DEL ZIKA MICROCEFALIA Y SÍNDROME DE GUILLAIN-BARRÉ:
INFORME SOBRE LA SITUACIÓN
|
2016
|
|
VIRUS DEL ZIKA MICROCEFALIA Y SÍNDROME DE GUILLAIN-BARRÉ:
INFORME SOBRE LA SITUACIÓN
|
2016
|
|
VIRUS DEL ZIKA, MICROCEFALIA Y SÍNDROME DE GUILLAIN-BARRÉ:
INFORME SOBRE LA SITUACIÓN
|
2016
|
|
VIRUS DEL ZIKA, MICROCEFALIA Y SÍNDROME DE GUILLAIN-BARRÉ:
INFORME SOBRE LA SITUACIÓN
|
2016
|
|
VIRUS DEL ZIKA, MICROCEFALIA Y SÍNDROME DE GUILLAIN-BARRÉ:
INFORME SOBRE LA SITUACIÓN
|
2016
|
|
VIRUS DEL ZIKA MICROCEFALIA y SÍNDROME DE GUILLAIN-BARRÉ:
INFORME DE LA SITUACIÓN
|
2016
|
|
VIRUS DEL ZIKA, MICROCEFALIA Y SÍNDROME DE GUILLAIN-BARRÉ:
INFORME SOBRE LA SITUACIÓN
|
2016
|
|
VIRUS DEL ZIKA, MICROCEFALIA Y SÍNDROME DE GUILLAIN-BARRÉ:
INFORME SOBRE LA SITUACIÓN
|
2016
|
|
Visceral leishmaniasis: control strategies and epidemiological situation update in East Africa:
Report of a WHO bi-regional consultation Addis Ababa, Ethiopia 9–11 March 2015
|
2015
|
|
Vivre sans sida ::
Cadre pour l’accélération du traitement du VIH chez les enfants et les adolescents
|
2018
|
|
Voice of the children:
Alcohol in the eyes of the young
|
2019
|
|
VOLUNTARY MEDICAL MALE CIRCUMCISION FOR HIV PREVENTION IN 14 PRIORITY COUNTRIES IN EAST AND SOUTHERN AFRICA
|
2016
|
|
VOLUNTARY MEDICAL MALE CIRCUMCISION FOR HIV PREVENTION IN 14 PRIORITY COUNTRIES IN EASTERN AND SOUTHERN AFRICA
|
2017
|
|
WANT A FRIEND? BE A FRIEND!:
THE GUIDE TO PET CARE AND BITE PREVENTION
|
2015
|
|
Water, Sanitation and Hygiene Standards for Schools in Low-cost Settings
|
2009
|
|
Web Annex 1.:
Standard operating procedures (SOPs) for enhanced reporting of cases of acute hepatitis
|
2019
|
|
Web Annex 1. Decision-making table, PICO question on when to treat:
In: Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
|
2018
|
|
Web Annex 2.:
Template protocol for surveys to estimate the prevalence of biomarkers of infection with the hepatitis viruses
|
2019
|
|
Web Annex 2. Decision-making table, PICO question on how to treat:
In: Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
|
2018
|
|
Web Annex 3.:
Protocol for surveillance of the fraction of cirrhosis and hepatocellular carcinoma attributable to viral hepatitis in clinical centres of excellence
|
2019
|
|
Web Annex 3.1.:
Adult hepatitis C virus treatment systematic review
|
2018
|
|
Web Annex 3.2.:
Adult hepatitis C virus treatment systematic review; supporting evidence
|
2018
|
|
Web Annex 4.:
Modelling analyses
|
2018
|
|
Web Annex 5. Summary of available non-pangenotypic regimens:
In: Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
|
2018
|
|
Web Annex 6.:
Decision-making table, PICO question on children and adolescents
|
2018
|
|
Web Annex 7.:
Values and preferences surveys
|
2018
|
|
Web Annex 8.:
Summary of findings tables
|
2018
|
|
WEB ANNEX A.:
DECLARATION OF INTERESTS OF GUIDELINE DEVELOPMENT GROUP AND EXTERNAL REVIEW GROUP
|
2018
|
|
Web Annex A:
Report of the systematic review on the effect of household crowding on health
|
2018
|
|
Web Annex B:
Report of the systematic review on the effect of indoor cold on health
|
2018
|
|
WEB ANNEX B.:
SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS ASSESSING FIRST-LINE ART TREATMENTS
|
2018
|
|
Web Annex C:
Report of the systematic review on the effect of insulation against cold on health
|
2018
|
|
WEB ANNEX C.:
SAFETY OF DOLUTEGRAVIR IN PREGNANCY AND BREAST FEEDING
|
2018
|
|
WEB ANNEX D.:
SURVEYS OF VALUES AND PREFERENCES
|
2018
|
|
Web Annex D:
Report of the systematic review on the effect of indoor heat on health
|
2018
|
|
Web Annex E:
Report of the systematic review on the relationship between hazards in the home and injuries
|
2018
|
|
WEB ANNEX E.:
RECOMMENDATIONS FOR USE OF HORMONAL CONTRACEPTION FOR WOMEN LIVING WITH HIV USING ANTIRETROVIRAL THERAPY (ART)
|
2018
|
|
WEB ANNEX F.:
SYSTEMATIC REVIEW: WHICH ART REGIMEN TO SWITCH TO WHEN FAILING FIRST-LINE TREATMENT
|
2018
|
|
Web Annex F:
Report of the systematic review on potential benefits of accessible home environments for people with functional impairments
|
2018
|
|
WEB ANNEX G.:
SAFETY AND EFFICACY OF ANTIRETROVIRAL DRUGS FOR POST-EXPOSURE PROPHYLAXIS
|
2018
|
|
Web Annex G:
Estimation of minimal risk and maximum acceptable temperatures for selected cities
|
2018
|
|
WEB ANNEX H.:
INDETERMINATE RESULTS DURING HIV EARLY INFANT DIAGNOSIS TESTING: A META-ANALYSIS AND REVIEW OF THE LITERATURE
|
2018
|
|
WEB ANNEX I.:
REPORT ON COST-EFFECTIVENESS OF IMPLEMENTING AN INDETERMINATE RANGE FOR EARLY INFANT DIAGNOSIS OF HIV
|
2018
|
|
WEB ANNEX J.:
TABLE OF DRUG INTERACTIONS WITH ANTIRETROVIRAL DRUGS
|
2018
|
|
Web annexes::
Medical management of abortion: evidence summary
|
2018
|
|
Web annexes::
Medical management of abortion: evidence summary
|
2018
|
|
Web annexes::
Medical management of abortion: evidence summary
|
2018
|
|
Web annexes: Medical management of abortion: evidence summary:
4. Timing of post-abortion contraception
|
2018
|
|
Weekly epidemiological record
|
2016
|
|
Weekly epidemiological record
|
2018
|
|
Weekly epidemiological record
|
2019
|
|
Weekly epidemiological record
|
2020
|
|
WEEKLY IRON AND FOLIC ACID SUPPLEMENTATION AS AN ANAEMIA-PREVENTION STRATEGY IN WOMEN AND ADOLESCENT GIRLS:
LESSONS LEARNT FROM IMPLEMENTATION OF PROGRAMMES AMONG NON-PREGNANT WOMEN OF REPRODUCTIVE AGE
|
2018
|
|
Weekly Operational Update on COVID
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
Weekly Operational Update on COVID-19
|
2021
|
|
well-being:
Towards developing WHO's agenda on well-being
|
2021
|
|
WESTERN PACIFIC REGIONAL ACTION PLAN:
for Dengue Prevention and Control (2016)
|
2017
|
|
Western Pacific Regional Framework on Rehabilitation
|
2019
|
|
What are the challenges facing Myanmar in progressing towards Universal Health Coverage?
|
2015
|
|
What constitutes an effective and efficient package of services for the prevention, diagnosis, treatment and care of tuberculosis among refugees and migrants in the WHO European Region?:
Themed issues on migration and health, VIII
|
2018
|
|
WHAT COUNTS IN ECONOMIC EVALUATIONS IN HEALTH?:
BENEFIT-COST ANALYSIS COMPARED TO OTHER FORMS OF ECONOMIC EVALUATIONS
|
2020
|
|
WHAT DO WE KNOW ABOUT COMMUNITY HEALTH WORKERS?:
A SYSTEMATIC REVIEW OF EXISTING REVIEWS
|
2020
|
|
What health-care providers say on providing abortion care in Cape Town, South Africa::
findings from a qualitative study
|
2010
|
|
What strategies to address communication barriers for refugees and migrants in health care settings have been implemented and evaluated across the WHO European Region?:
Themed issues on migration and health, IX
|
2018
|
|
What worked? What didn’t? What’s next?
|
2023
|
|
WHAT YOU NEED TO KNOW BEFORE AND AFTER SURGERY
|
2015
|
|
WHAT’S NEW IN ADOLESCENT TREATMENT AND CARE
|
2015
|
|
WHAT’S NEW IN MONITORING
|
2015
|
|
WHEEL CHAIR SERVICE TRAINING OF TRAINERS PACKAGE:
ToT Handbook
|
2017
|
|
Wheelchair provision guidelines:
Web Annex B Systematic review data tables and appendices
|
2023
|
|
Wheelchair provision guidelines:
Web Annex A Summary of evidence
|
2023
|
|
WHEELCHAIR SERVICE TRAINING OF TRAINERS PACKAGE:
ToT Handbook BASIC LEVEL
|
2017
|
|
WHEELCHAIR SERVICE TRAINING PACKAGE:
Reference Manual for Participants
|
2012
|
|
WHEELCHAIR SERVICE TRAINING PACKAGE:
Participant's Workbook
|
2013
|
|
WHEELCHAIR SERVICE TRAINING PACKAGE:
For Managers Trainer’s Manual
|
2015
|
|
WHO::
EBOLA RESPONSE ROADMAP UPDATE
|
2014
|
|
WHO::
EBOLA RESPONSE ROADMAP UPDATE
|
2014
|
|
WHO::
EBOLA RESPONSE ROADMAP UPDATE
|
2014
|
|
WHO::
Ebola Response Roadmap Situation Report
|
2014
|
|
WHO::
EBOLA RESPONSE ROADMAP UPDATE
|
2014
|
|
WHO::
Ebola Response Roadmap Situation Report 3
|
2014
|
|
WHO::
Ebola Response Roadmap Situation Report
|
2014
|
|
WHO::
EBOLA RESPONSE ROADMAP UPDATE
|
2014
|
|
WHO::
Ebola Response Roadmap Situation Report 2
|
2014
|
|
WHO::
EBOLA RESPONSE ROADMAP UPDATE
|
2014
|
|
WHO::
EBOLA RESPONSE ROADMAP UPDATE
|
2014
|
|
WHO::
Ebola Response Roadmap Situation Report
|
2014
|
|
WHO::
Ebola Response Roadmap Situation Report
|
2014
|
|
WHO::
Ebola Response Roadmap Situation Report 1
|
2014
|
|
WHO::
Ebola Response Roadmap Situation Report
|
2014
|
|
WHO: Addressing Violence Against Women:
Key achievements and priorities
|
2018
|
|
WHO Advisory Committee on Variola Virus Research:
Report of the Seventeenth Meeting Geneva, Switzerland 12 and 13 January 2016
|
2016
|
|
WHO ADVISORY COMMITTEE ON VARIOLA VIRUS RESEARCH:
REPORT OF THE TWENTY-SECOND MEETING, GENEVA, 4–5 NOVEMBER 2020
|
2021
|
|
WHO Advisory Committee on Variola Virus Research:
Report of the Eighteenth Meeting Geneva, Switzerland 2 and 3 November 2016
|
2017
|
|
WHO Advisory Committee on Variola Virus Research:
Report of the twenty-first meeting, Geneva, 30 October-1 November 2019
|
2020
|
|
WHO Advisory Committee on Variola Virus Research:
Report of the Twentieth Meeting Geneva, Switzerland 26 – 27 September 2018
|
2019
|
|
The WHO African Programme for Onchocerciasis Control Progress Report 2015:
1st September 2014 - 31st August 2015
|
2015
|
|
WHO aircraft disinsection methods and procedures
|
2021
|
|
WHO ambient air quality database, 2022 update:
Status report
|
2023
|
|
WHO and the Global Fund:
ACHIEVING IMPACT TOGETHER
|
2017
|
|
WHO ANNUAL MEETING ON BURULI ULCER 28–30 MARCH 2011:
ABSTRACTS
|
2011
|
|
WHO antenatal care recommendations for a positive pregnancy experience Nutritional interventions update::
Multiple micronutrient supplements during pregnancy
|
2020
|
|
WHO BENCHMARKS FOR THE PRACTICE OF ACUPUNCTURE
|
2020
|
|
WHO BENCHMARKS FOR THE PRACTICE OF AYURVEDA
|
2022
|
|
WHO BENCHMARKS FOR THE PRACTICE OF UNANI MEDICINE
|
2022
|
|
WHO BENCHMARKS FOR THE TRAINING OF ACUPUNCTURE
|
2020
|
|
WHO BENCHMARKS FOR THE TRAINING OF UNANI MEDICINE
|
2022
|
|
WHO BI-REGIONAL CONSULTATION ON THE STATUS OF IMPLEMENTATION OF LEISHMANIASIS CONTROL STRATEGIES AND EPIDEMIOLOGICAL SITUATIONS IN EASTERN AFRICA
|
2018
|
|
WHO Chemical Safety - Activity Report 2018
|
2019
|
|
WHO CIVIL SOCIETY TASK FORCE ON TB:
Engagement with civil society as the driver for change
|
2020
|
|
WHO Clinical Consortium on Healthy Ageing:
Topic focus: frailty and intrinsic capacity
|
2017
|
|
WHO Clinical Consortium on Healthy Ageing 2017:
Focus: Development of comprehensive assessments and care plans Report of consortium meeting, 21–22 November 2017 in Geneva, Switzerland
|
2018
|
|
WHO Clinical Consortium on Healthy Ageing 2018:
Report of Consortium meeting held 11–12 December 2018 in Geneva, Switzerland
|
2019
|
|
WHO Clinical Consortium on Healthy Ageing 2019:
Report of Consortium meeting, held 21–22 November 2019, in Geneva, Switzerland
|
2020
|
|
WHO collaborative study to assess the suitability of a WHO International Reference Panel for Ebola virus VP40 antigen
|
2016
|
|
WHO collaborative study to assess the suitability of an interim standard for antibodies to Ebola virus
|
2015
|
|
WHO collaborative study to assess the suitability of interim standards for Ebola virus NAT assays
|
2015
|
|
WHO collaborative study to assess the suitability of the 1st International Standard and the 1st International Reference Panel for antibodies to Ebola virus
|
2017
|
|
WHO COLLABORATNE PROJECT ON IDENTIFICATION AND MANAGEMENT OF ALCOHOL-RELATED PROBLEMS IN PRIMARY HEALTH CARE:
Report on Phase IV
|
2006
|
|
WHO COMMUNITY ENGAGEMENT FRAMEWORK FOR QUALITY, PEOPLE-CENTRED AND RESILIENT HEALTH SERVICES
|
2017
|
|
WHO competency framework:
Building a response workforce to manage infodemics
|
2021
|
|
WHO COMPETENCY FRAMEWORK:
FOR HEALTH WORKERS’ EDUCATION AND TRAINING ON ANTIMICROBIAL RESISTANCE
|
2018
|
|
WHO Consolidated Guideline on Self-Care Interventions for Health:
Sexual and Reproductive Health and Rights
|
2019
|
|
WHO Consolidated Guideline on Self-Care Interventions for Health:
Sexual and Reproductive Health and Rights
|
2019
|
|
WHO consolidated guidelines on drug-resistant tuberculosis treatment:
Annexes 3–9
|
2019
|
|
WHO consolidated guidelines on tuberculosis:
Module 5: Management of tuberculosis in children and adolescents
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 5: Management of tuberculosis in children and adolescents
|
2022
|
|
WHO consolidated guidelines on tuberculosis.:
Module 3: diagnosis. Tests for TB infection Web Annex E Modelling for economic evidence for the use of Mycobacterium tuberculosis antigen-based skin tests
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 5: Management of tuberculosis in children and adolescents
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 1: Prevention Infection prevention and control
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 3: Diagnosis Rapid diagnostics for tuberculosis detection
|
2020
|
|
WHO consolidated guidelines on tuberculosis:
Module 3: Diagnosis Rapid diagnostics for tuberculosis detection
|
2021
|
|
WHO consolidated guidelines on tuberculosis:
Module 5: Management of tuberculosis in children and adolescents
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 4: Treatment Drug-resistant tuberculosis treatment
|
2020
|
|
WHO consolidated guidelines on tuberculosis:
Module 5: Management of tuberculosis in children and adolescents
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 1: Prevention Tuberculosis preventive treatment
|
2020
|
|
WHO consolidated guidelines on tuberculosis:
Module 3: diagnosis. Tests for TB infection Web Annex A Accuracy of Mycobacterium tuberculosis antigen-based skin tests: a systematic review and meta-analysis
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 4: Drug-resistant tuberculosis treatment Online annexes
|
2020
|
|
WHO consolidated guidelines on tuberculosis:
Module 3: Diagnosis Tests for tuberculosis infection
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 1: Prevention Infection prevention and control Web Annex D. Systematic reviews
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 4: Treatment Drug-resistant tuberculosis treatment 2022 update Web Annexes
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 4: Treatment Tuberculosis care and support Web annexes
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 4: Treatment Drug-resistant tuberculosis treatment 2022 update
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 5: Management of tuberculosis in children and adolescents
|
2022
|
|
WHO consolidated guidelines on tuberculosis:
Module 4: Treatment Drug-susceptible tuberculosis treatment
|
2022
|
|
WHO consolidated guidelines on tuberculosis Module 1: Prevention Infection prevention and control:
Web Annex B. GRADE evidence summary tables
|
2022
|
|
WHO consolidated guidelines on tuberculosis Module 1: Prevention Infection prevention and control:
Web Annex A. Methods and expert panels
|
2022
|
|
WHO consolidated guidelines on tuberculosis Module 1: Prevention Infection prevention and control:
Web Annex C. GRADE evidence-to-decision tables
|
2022
|
|
WHO consolidated guidelines on tuberculosis Module 2: Screening Systematic screening for tuberculosis disease:
Web Annex C. GRADE Evidence to Decision Tables
|
2021
|
|
WHO consolidated guidelines on tuberculosis Module 2: screening systematic screening for tuberculosis disease:
Web Annex A. Methods and expert panels
|
2021
|
|
WHO consolidated guidelines on tuberculosis Module 2: screening systematic screening for tuberculosis disease:
Web Annex B. GRADE summary of findings tables
|
2021
|
|
WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection:
Web Annex 2. GRADE profiles
|
2021
|
|
WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection:
Web Annex 4. Evidence synthesis and analysis
|
2021
|
|
WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection:
Web Annex 1. List of studies included in systematic reviews
|
2020
|
|
WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection:
Web Annex 2. GRADE profiles
|
2020
|
|
WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection:
Web Annex 1. List of studies included in systematic reviews
|
2021
|
|
WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection:
Web Annex 3. Evidence-to-decision tables
|
2021
|
|
WHO consolidated guidelines on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection:
Web Annex 4. Evidence synthesis and analysis
|
2020
|
|
WHO consolidated guidelines on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection:
Web Annex 3. Evidence-to-decision tables
|
2020
|
|
WHO consolidated guidelines on tuberculosis Module 3: diagnosis. Tests for TB infection:
Web Annex B Safety of Mycobacterium tuberculosis antigen-based skin tests: a systematic review and meta-analysis
|
2022
|
|
WHO consolidated guidelines on tuberculosis Module 3: diagnosis. Tests for TB infection:
Web Annex D Cost–effectiveness of Mycobacterium tuberculosis antigen-based skin tests: a systematic review
|
2022
|
|
WHO consolidated guidelines on tuberculosis Module 3: diagnosis. Tests for TB infection:
Web Annex F Qualitative evidence for the use of Mycobacterium tuberculosis antigen-based skin tests
|
2022
|
|
WHO consolidated guidelines on tuberculosis Module 3: diagnosis. Tests for TB infection:
Web Annex C GRADE profiles of Mycobacterium tuberculosis antigen-based skin tests
|
2022
|
|
WHO consolidated guidelines on tuberculosis Module 3: diagnosis. Tests for TB infection:
Web Annex G Mycobacterium tuberculosis antigen-based skin tests: evidence-to-decision table
|
2022
|
|
WHO consolidated guidelines on tuberculosis Module 3: diagnosis. Tests for TB infection:
Web Annex I Diagnostic accuracy of interferon gamma release assays for evaluation of patients with pulmonary TB
|
2022
|
|
WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment:
ANNEX 2 GRADE summary of evidence tables (for new recommendations in 2018 & 2019 guidelines updates)
|
2020
|
|
WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment:
ANNEX 3 GRADE evidence-to-decision tables
|
2020
|
|
WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment:
ANNEX 1. Methods and Expert Panels
|
2020
|
|
WHO consultation to adapt influenza sentinel surveillance systems to include COVID-19 virological surveillance:
Virtual meeting 6 — 8 October 2020
|
2022
|
|
WHO Consultation to Develop a Strategy to Estimate the Global Burden of Foodborne Diseases:
Taking Stock and Charting the Way Forward Geneva, 25–27 September 2006
|
2007
|
|
WHO Consultation Towards the Development of guidance on ethics and governance of artificial intelligence for health:
Meeting report Geneva, Switzerland, 2–4 October 2019
|
2021
|
|
WHO Costing and Budgeting Tool for National Action Plans on Antimicrobial Resistance:
User guide
|
2021
|
|
WHO Country Cooperation Strategy
|
2016
|
|
WHO Country Office Swaziland Newsflash
|
2016
|
|
WHO country presence in small island developing states (SIDS)
|
2021
|
|
WHO country presence in small island developing states (SIDS), 2021
|
2021
|
|
WHO COVID-19: Case Definitions:
Updated in Public health surveillance for COVID-19
|
2020
|
|
WHO COVID-19 Essential Supplies Forecasting Tool (COVID-19-ESFT):
Frequently Asked Questions (FAQ)
|
2020
|
|
WHO COVID-19 preparedness and response progress report 1 FEBRUARY TO 30 JUNE 2020
|
2020
|
|
WHO Ebola Research and Development Summit
|
2015
|
|
WHO ENGAGEMENT WITH MEMBER STATES ON TOBACCO TAXATION
|
2014
|
|
WHO ESTIMATES OF THE GLOBAL BURDEN OF FOODBORNE DISEASES:
FOODBORNE DISEASE BURDEN EPIDEMIOLOGY REFERENCE GROUP 2007-2015
|
2015
|
|
WHO ESTIMATES OF THE GLOBAL BURDEN OF FOODBORNE DISEASES
|
2015
|
|
WHO ESTIMATES OF THE GLOBAL BURDEN OF FOODBORNE DISEASES:
FOODBORNE DISEASE BURDEN EPIDEMIOLOGY REFERENCE GROUP 2007-2015
|
2015
|
|
WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing:
Report of the fifth meeting 23–24 November 2020
|
2021
|
|
WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing:
Report of the third meeting Cape Town, South Africa, 25–26 February 2020
|
2021
|
|
WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing:
Report of the sixth meeting 25–26 March 2021
|
2021
|
|
WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing:
Report of the fourth meeting 2–4 September 2020
|
2021
|
|
WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing:
REPORT OF THE SECOND MEETING Geneva, Switzerland, 26—28 August 2019
|
2019
|
|
WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing:
Report of the first online consultation 15 January–7 February 2020
|
2021
|
|
WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing:
REPORT OF THE FIRST MEETING Geneva, Switzerland, 18–19 March 2019
|
2019
|
|
WHO Expert Committee on Biological Standardization:
Sixty-second report
|
2013
|
|
WHO Expert Committee on Biological Standardization:
Sixty-fifth report
|
2015
|
|
WHO Expert Committee on Biological Standardization:
Sixty-seventh report
|
2017
|
|
WHO Expert Committee on Biological Standardization
|
2018
|
|
WHO Expert Committee on Biological Standardization:
Sixty-third report
|
2014
|
|
WHO Expert Committee on Biological Standardization:
Seventieth report
|
2020
|
|
WHO Expert Committee on Biological Standardization
|
2016
|
|
WHO Expert Committee on Biological Standardization:
Report of the seventy-second and seventy-third meetings
|
2021
|
|
WHO Expert Committee on Biological Standardization:
Sixty-fourth report
|
2014
|
|
WHO Expert Committee on Biological Standardization:
Sixty-eighth report
|
2018
|
|
WHO Expert Committee on Biological Standardization
|
2017
|
|
WHO Expert Committee on Biological Standardization:
Seventy-first report
|
2021
|
|
WHO Expert Committee on Biological Standardization
|
2022
|
|
WHO Expert Committee on Biological Standardization:
Sixty-ninth report
|
2019
|
|
WHO Expert Committee on Biological Standardization
|
2015
|
|
WHO Expert Committee on Biological Standardization:
Report of the seventy-second and seventy-third meetings
|
2021
|
|
WHO Expert Committee on Biological Standardization:
Seventy-first report
|
2021
|
|
WHO Expert Committee on Biological Standardization:
Sixty-sixth report
|
2016
|
|
WHO Expert Committee on Drug Dependence
|
2016
|
|
WHO Expert Committee on Drug Dependence:
Thirty-sixth report
|
2015
|
|
WHO Expert Committee on Drug Dependence
|
2022
|
|
WHO Expert Committee on Drug Dependence:
Forty-third report
|
2021
|
|
Who Expert Committee on Drug Dependence:
Thirty-fifth Report
|
2012
|
|
WHO Expert Committee on Drug Dependence:
Forty-second report
|
2020
|
|
WHO Expert Committee on Drug Dependence
|
2018
|
|
WHO Expert Committee on Drug Dependence:
Forty-first report
|
2019
|
|
WHO Expert Committeeon Drug Dependence:
Forty-fourth report
|
2022
|
|
WHO Expert Committeeon Drug Dependence:
Thirty-eighth report
|
2017
|
|
WHO Expert Committeeon Drug Dependence:
Thirty-ninth report
|
2018
|
|
WHO Expert Committeeon Drug Dependence:
Fortieth report
|
2018
|
|
WHO Expert Consultation on Public Health Intervention against Early Childhood Caries:
REPORT OF A MEETING Bangkok, Thailand, 26–28 January 2016
|
2017
|
|
WHO Expert Meeting on the Economic and Commercial Determinants of Health 6–7 May 2021
|
2022
|
|
WHO EXPERT MEETING REPORT ON:
SHORT, MEDIUM AND LONGER TERM PRODUCT DEVELOPMENT PRIORITIES IN HIV-RELATED DIAGNOSTICS 6-7 JUNE 2012 GENEVA, SWITZERLAND
|
2012
|
|
WHO external quality assurance scheme for malaria nucleic acid amplification testing:
Operational Manual
|
2017
|
|
WHO Framework for strengthening and scaling-up services for the management of invasive cervical cancer
|
2020
|
|
WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use:
GAPIII
|
2015
|
|
WHO global air quality guidelines:
Particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide
|
2021
|
|
WHO global air quality guidelines:
Particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide Executive summary
|
2021
|
|
WHO Global Benchmarking Tool (GBT) for Evaluation of National Regulatory System of Medical Products
|
2021
|
|
WHO Global Clinical Data Platform for the clinical characterization of Ebola:
Statistical analysis plan
|
2023
|
|
WHO Global Clinical Platform for the Clinical Characterization of COVID-19:
Statistical Analysis Plan
|
2021
|
|
WHO Global Consultative Meeting on the Safe Shipment of Infectious Substances:
WHO headquarters, Geneva, Switzerland, 15–16 March 2018
|
2018
|
|
WHO GLOBAL DISABILITY ACTION PLAN 2014-2021:
BETTER HEALTH FOR ALL PEOPLE WITH DISABILITY
|
2015
|
|
WHO Global Initiative for Emergency and Essential Surgical Care Sixth Biennial and Tenth Anniversary Meeting:
14-15 December, 2015 WHO Headquarters Geneva, Switzerland
|
2016
|
|
WHO Global Plan of Action on Workers' Health (2008-2017)::
Baseline for Implementation
|
2013
|
|
WHO Global Plan of Action on Workers’ Health (2008-2017): Baseline for Implementation:
Global Country Survey 2008/2009 Executive Summary and Survey Findings
|
2013
|
|
WHO GLOBAL REPORT ON TRADITIONAL AND COMPLEMENTARY MEDICINE 2019
|
2019
|
|
WHO global sodium benchmarks for different food categories
|
2021
|
|
WHO Global standard for safe listening venues & events
|
2022
|
|
WHO Global Strategy for Containment of Antimicrobial Resistance
|
2001
|
|
WHO GLOBAL STRATEGY FOR FOOD SAFETY 2022-2030:
Towards stronger food safety systems and global cooperation
|
2022
|
|
WHO GLOBAL STRATEGY FOR FOOD SAFETY 2022-2030:
Towards stronger food safety systems and global cooperation Executive summary
|
2022
|
|
WHO Global Strategy on Health, Environment and Climate Change:
The transformation needed to improve lives and wellbeing sustainably through healthy environments
|
2020
|
|
WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products
|
2017
|
|
WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products
|
2017
|
|
WHO GUIDANCE FOR CLIMATE-RESILIENT AND ENVIRONMENTALLY SUSTAINABLE HEALTH CARE FACILITIES
|
2020
|
|
WHO guidance on post-market surveillance for manufacturers of in vitro diagnostics (IVDs) and their economic operators
|
2019
|
|
WHO guidance to protect health from climate change through health adaptation planning
|
2014
|
|
WHO guideline::
USE OF MULTIPLE MICRONUTRIENT POWDERS FOR POINT-OF-USE FORTIFICATION OF FOODS CONSUMED BY INFANTS AND YOUNG CHILDREN AGED 6–23 MONTHS AND CHILDREN AGED 2–12 YEARS
|
2016
|
|
WHO GUIDELINE::
FORTIFICATION OF MAIZE FLOUR AND CORN MEAL WITH VITAMINS AND MINERALS
|
2016
|
|
WHO guideline for clinical management of exposure to lead
|
2021
|
|
WHO guideline for clinical management of exposure to lead:
Executive summary
|
2021
|
|
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV):
Web Annex. Evidence-to-decision framework for mRNA testing for HPV
|
2021
|
|
WHO GUIDELINE for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia:
WEB ANNEX B. Evidence-to-decision tables
|
2022
|
|
WHO GUIDELINE for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia:
WEB ANNEX A. A systematic review on the treatment of visceral leishmaniasis in HIV-Leishmania co-infected persons in East Africa and South-East Asia
|
2022
|
|
WHO Guideline on Country Pharmaceutical Pricing Policies:
Web Annex B EVIDENCE TO DECISION (EtD) TABLES
|
2020
|
|
WHO guideline on country pharmaceutical pricing policies
|
2020
|
|
WHO GUIDELINE ON HEALTH POLICY AND SYSTEM SUPPORT TO OPTIMIZE COMMUNITY HEALTH WORKER PROGRAMMES:
Selected highlights
|
2018
|
|
WHO guideline on health workforce development, attraction, recruitment and retention in rural and remote areas::
a summary
|
2021
|
|
WHO guideline on health workforce development, attraction, recruitment and retention in rural and remote areas:
Web Annexes
|
2021
|
|
WHO GUIDELINE ON MASS DRUG ADMINISTRATION OF AZITHROMYCIN TO CHILDREN UNDER FIVE YEARS OF AGE TO PROMOTE CHILD SURVIVAL
|
2020
|
|
WHO guideline on school health services:
Web Annex E. Systematic reviews of the effectiveness and acceptability of comprehensive school health services: evidence summaries
|
2021
|
|
WHO guideline on school health services:
Web Annex F. Systematic reviews of the effectiveness and acceptability of comprehensive school health services: GRADE evidence profiles and evidence-to-decision table
|
2021
|
|
WHO guideline on school health services
|
2021
|
|
WHO guideline on school health services:
Web Annex C. Systematic overview of systematic reviews of comprehensive school health services: methodology and select findings
|
2021
|
|
WHO guideline on school health services:
Web Annex G. Survey of expert opinion on school health services: methodology and select findings
|
2021
|
|
WHO guideline on school health services:
Web Annex H. Menu of interventions with WHO resources
|
2021
|
|
WHO guideline on school health services:
Web Annex D. Systematic reviews of the effectiveness and acceptability of comprehensive school health services: methodology
|
2021
|
|
WHO guideline on school health services:
Web Annex A. Compendium
|
2021
|
|
WHO guideline on school health services:
Web Annex B. Brief exploratory review of school health services globally: methodology and select findings
|
2021
|
|
WHO Guideline on Self-Care Interventions for Health and Well-Being:
Web Annex. GRADE Tables
|
2021
|
|
WHO Guideline on Self-Care Interventions for Health and Well-Being
|
2021
|
|
WHO guideline on self-care interventions for health and well-being, 2022 revision:
Web Annex A. Global values and preferences survey report
|
2022
|
|
WHO guideline on self-care interventions for health and well-being, 2022 revision:
Web Annex B. GRADE tables
|
2022
|
|
WHO guideline on self-care interventions for health and well-being, 2022 revision::
executive summary
|
2022
|
|
WHO GUIDELINE ON Syphilis screening and treatment for pregnant women
|
2017
|
|
WHO Guideline on the prevention of drowning through provision of day-care, and basic swimming and water safety skills
|
2021
|
|
WHO GUIDELINE ON USE OF FERRITIN CONCENTRATIONS TO ASSESS IRON STATUS IN INDIVIDUALS AND POPULATIONS
|
2020
|
|
WHO GUIDELINE RECOMMENDATIONS ON DIGITAL INTERVENTIONS FOR HEALTH SYSTEM STRENGTHENING
|
2019
|
|
WHO GUIDELINE RECOMMENDATIONS ON DIGITAL INTERVENTIONS FOR HEALTH SYSTEM STRENGTHENING
|
2019
|
|
WHO guideline RECOMMENDATIONS ON DIGITAL INTERVENTIONS FOR HEALTH SYSTEM STRENGTHENING:
Evidence and Recommendations
|
2019
|
|
WHO GUIDELINES:
for malaria
|
2021
|
|
WHO guidelines for indoor air quality::
household fuel combustion
|
2014
|
|
WHO guidelines for indoor air quality::
household fuel combustion
|
2014
|
|
WHO guidelines for plague management: revised recommendations for the use of rapid diagnostic tests, fluoroquinolones for case management and personal protective equipment for prevention of post-mortem transmission:
Web Annex A. Antibiotics for treating plague: a systematic review (executive summary) Background document for the WHO Plague Guidelines meeting, Madagascar, 20–21 September 2019
|
2021
|
|
WHO guidelines for plague management: revised recommendations for the use of rapid diagnostic tests, fluoroquinolones for case management and personal protective equipment for prevention of post-mortem transmission:
Web Annex B. Evidence-to-decision tables
|
2021
|
|
WHO guidelines for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition:
Web Annex A: Syntheses of evidence
|
2021
|
|
WHO guidelines for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition:
Web Annex B: Evidence to Decision Tables
|
2021
|
|
WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS):
Updated recommendations
|
2004
|
|
WHO GUIDELINES FOR THE PHARMACOLOGICAL AND RADIOTHERAPEUTIC MANAGEMENT OF CANCER PAIN IN ADULTS AND ADOLESCENTS
|
2018
|
|
WHO guidelines for the prevention of sexual transmission of Zika virus::
executive summary
|
2019
|
|
WHO GUIDELINES FOR THE Treatment of Chlamydia trachomatis
|
2016
|
|
WHO GUIDELINES FOR THE Treatment of Genital Herpes Simplex Virus
|
2016
|
|
WHO GUIDELINES FOR THE Treatment of Neisseria gonorrhoeae
|
2016
|
|
WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions
|
2019
|
|
WHO Guidelines on Ethical Issues in Public Health Surveillance
|
2017
|
|
WHO Guidelines on Hand Hygiene in Health Care:
First Global Patient Safety Challenge Clean Care is Safer Care
|
2009
|
|
WHO Guidelines on Hand Hygiene in Health Care: a Summary:
First Global Patient Safety Challenge Clean Care is Safer Care
|
2009
|
|
WHO guidelines on mental health at work:
Web Annex. Evidence profiles and supporting evidence
|
2022
|
|
WHO guidelines on mental health at work:
Executive summary
|
2022
|
|
WHO guidelines on parenting interventions to prevent maltreatment and enhance parent–child relationships with children aged 0–17 years:
Web Annex. GRADE evidence profiles and evidence to decision tables
|
2022
|
|
WHO GUIDELINES ON PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOUR:
AT A GLANCE
|
2020
|
|
WHO GUIDELINES ON PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOUR:
WEB ANNEX Evidence Profiles
|
2020
|
|
WHO guidelines on the management of health complications from female genital mutilation
|
2016
|
|
WHO guidelines on the management of health complications from female genital mutilation
|
2016
|
|
WHO guidelines on the use of chest imaging in COVID-19:
Web Annex B. GRADE evidence-to-decision tables
|
2022
|
|
WHO guidelines on the use of chest imaging in COVID-19:
Web Annex A. Systematic review reports
|
2022
|
|
WHO guidelines on the use of chest imaging in COVID-19
|
2022
|
|
WHO guidelines on tuberculosis infection prevention and control:
2019 update
|
2019
|
|
WHO GUIDELINES ON USE OF MEDICALLY IMPORTANT ANTIMICROBIALS IN FOOD-PRODUCING ANIMALS:
Web Annex B. From evidence to recommendations
|
2017
|
|
WHO GUIDELINES ON USE OF MEDICALLY IMPORTANT ANTIMICROBIALS IN FOOD-PRODUCING ANIMALS:
Executive summary
|
2017
|
|
WHO GUIDELINES ON USE OF MEDICALLY IMPORTANT ANTIMICROBIALS IN FOOD-PRODUCING ANIMALS
|
2017
|
|
WHO GUIDELINES ON USE OF MEDICALLY IMPORTANT ANTIMICROBIALS IN FOOD-PRODUCING ANIMALS:
Policy brief
|
2017
|
|
WHO GUIDELINES ON USE OF MEDICALLY IMPORTANT ANTIMICROBIALS IN FOOD-PRODUCING ANIMALS:
Web Annex A. Evidence base
|
2017
|
|
WHO guiding principles for pathogen genome data sharing
|
2022
|
|
WHO Handbook for Guideline Development:
2nd edition
|
2014
|
|
WHO HEALTH AND CLIMATE CHANGE SURVEY REPORT:
TRACKING GLOBAL PROGRESS
|
2019
|
|
WHO High-level meeting on Ebola vaccines access and financing
|
2014
|
|
WHO HIV DRUG RESISTANCE NETWORK STEERING GROUP MEETING REPORT
|
2021
|
|
WHO HIV DRUG RESISTANCE REPORT 2012
|
2012
|
|
WHO HIV DRUG RESISTANCE STEERING GROUP MEETING
|
2013
|
|
WHO HIV POLICY ADOPTION AND IMPLEMENTATION STATUS IN COUNTRIES
|
2018
|
|
WHO HIVResNet HIV DRUG RESISTANCE:
LABORATORY OPERATIONAL FRAMEWORK
|
2020
|
|
WHO HIVRESNET MEETING REPORT
|
2019
|
|
WHO HIVResNet MEETING REPORT
|
2018
|
|
WHO HIVRESNET MEETING REPORT:
JOHANNESBURG, SOUTH AFRICA, 11–12 NOVEMBER 2017
|
2018
|
|
WHO HOUSING AND HEALTH GUIDELINES:
EXECUTIVE SUMMARY
|
2018
|
|
WHO Human Health Risk Assessment Toolkit:
CHEMICAL HAZARDS Second Edition
|
2021
|
|
WHO HUMAN HEALTH RISK ASSESSMENT TOOLKIT::
CHEMICAL HAZARDS
|
2010
|
|
WHO Immunological Basis for Immunization Series:
Module 7: Measles
|
2020
|
|
WHO implementation handbook for national action plans on antimicrobial resistance:
Guidance for the human health sector
|
2022
|
|
WHO IMPLEMENTATION TOOL FOR PRE-EXPOSURE PROPHYLAXIS (PREP) OF HIV INFECTION:
MODULE 2 COMMUNITY EDUCATORS AND ADVOCATES
|
2017
|
|
WHO IMPLEMENTATION TOOL FOR PRE-EXPOSURE PROPHYLAXIS (PrEP) OF HIV INFECTION:
MODULE 1 CLINICAL
|
2017
|
|
WHO IMPLEMENTATION TOOL FOR PRE-EXPOSURE PROPHYLAXIS (PrEP) OF HIV INFECTIONADOLESCENTS:
MODULE 12 ADOLESCENTS AND YOUNG ADULTS
|
2018
|
|
WHO Information Kit on Epilepsy:
What you can do
|
2015
|
|
WHO Information Note on developing policy guidance for drug-resistant tuberculosis
|
2018
|
|
WHO Initiative on E-waste and Child Health
|
2021
|
|
WHO Initiative to Estimate the Global Burden of Foodborne Diseases:
Fourth formal meeting of the Foodborne Disease Burden Epidemiology Reference Group (FERG) Sharing New Results, Making Future Plans, and Preparing Ground for the Countries Geneva, 8–12 November 2010
|
2014
|
|
WHO Initiative to Estimate the Global Burden of Foodborne Diseases:
Fifth formal meeting of the Foodborne Disease Burden Epidemiology Reference Group (FERG)
|
2014
|
|
WHO integrated global surveillance on ESBL-producing E. coli using a “One Health” approach::
Implementation and opportunities
|
2021
|
|
WHO integrated global surveillance on ESBL-producing E. coli using a “One Health” approach::
Implementation and opportunities
|
2021
|
|
WHO Interim Guidance for International Meetings Attended by Individuals from Ebola Virus Disease-affected countries
|
2014
|
|
WHO international standard terminologies on traditional Chinese medicine
|
2022
|
|
WHO list of priority medical devices for cancer management
|
2017
|
|
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
|
2021
|
|
WHO Living guideline::
Drugs to prevent COVID-19
|
2021
|
|
WHO Malaria Elimination Oversight Committee (MEOC) meeting:
MEETING REPORT
|
2018
|
|
WHO Malaria Policy Advisory Committee (MPAC) meeting:
MEETING REPORT
|
2016
|
|
WHO Malaria Policy Advisory Committee (MPAC) meeting
|
2018
|
|
WHO Malaria Policy Advisory Committee (MPAC) meeting
|
2019
|
|
WHO Malaria Policy Advisory Committee (MPAC) meeting:
MEETING REPORT
|
2017
|
|
WHO Malaria Policy Advisory Committee (MPAC) meeting
|
2018
|
|
WHO Malaria Policy Advisory Committee (MPAC) meeting:
MEETING REPORT
|
2017
|
|
WHO Malaria Policy Advisory Committee (MPAC) meeting:
MEETING REPORT
|
2016
|
|
WHO Malaria Policy Advisory Group (MPAG) meeting
|
2020
|
|
WHO Malaria Policy Advisory Group (MPAG) meeting:
MEETING REPORT
|
2021
|
|
WHO Malaria Policy Advisory Group (MPAG) meeting:
MEETING REPORT
|
2021
|
|
WHO Malaria Policy Advisory Group (MPAG) meeting:
MEETING REPORT
|
2022
|
|
WHO MANIFESTO FOR A HEALTHY RECOVERY FROM COVID-19:
Prescriptions and Actionables for a Healthy and Green Recovery
|
2020
|
|
WHO MANUAL FOR HIV DRUG RESISTANCE TESTING USING DRIED BLOOD SPOT SPECIMENS
|
2020
|
|
WHO MANUAL FOR HIV DRUG RESISTANCE TESTING USING DRIED BLOOD SPOT SPECIMENS
|
2012
|
|
WHO manual for organizing a national external quality assessment programme for health laboratories and other testing sites
|
2016
|
|
WHO manual for the establishment of national and other secondary standards for vaccines
|
2011
|
|
WHO Mass Gathering COVID-19 Risk Assessment Tool — Generic Events
|
2022
|
|
WHO MEDICAL ELIGIBILITY CRITERIA WHEEL FOR CONTRACEPTIVE USE 2015
|
2015
|
|
WHO Meeting on Buruli ulcer and other skin NTDs:
Final report 25-27 March 2019 WHO Headquarters Geneva, Switzerland
|
2019
|
|
WHO MEETING ON SURVIVORS OF EBOLA VIRUS DISEASE: CLINICAL CARE OF SURVIVORS:
Meeting report Freetown, Sierra Leone, 3-4 August 2015
|
2015
|
|
WHO MENU OF COST–EFFECTIVE INTERVENTIONS FOR MENTAL HEALTH
|
2021
|
|
WHO MERS Global Summary and Assessment of Risk
|
2019
|
|
WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals
|
2018
|
|
WHO Monograph on Tobacco cessation and oral health integration
|
2017
|
|
WHO operational handbook on tuberculosis:
Module 4: Treatment Drug-resistant tuberculosis treatment 2022 update Web Annexes
|
2022
|
|
WHO operational handbook on tuberculosis:
Module 4: Treatment Drug-resistant tuberculosis treatment 2022 update
|
2022
|
|
WHO operational handbook on tuberculosis:
Module 3: Diagnosis Rapid diagnostics for tuberculosis detection
|
2021
|
|
WHO operational handbook on tuberculosis:
Module 3: Diagnosis Rapid diagnostics for tuberculosis detection
|
2020
|
|
WHO operational handbook on tuberculosis:
Module 5: Management of tuberculosis in children and adolescents
|
2022
|
|
WHO operational handbook on tuberculosis:
Module 1: Prevention Tuberculosis preventive treatment
|
2020
|
|
WHO operational handbook on tuberculosis:
Module 4: Treatment Drug-resistant tuberculosis treatment
|
2020
|
|
WHO operational handbook on tuberculosis:
Module 4: Treatment Drug-susceptible tuberculosis treatment
|
2022
|
|
WHO operational handbook on tuberculosis Module 4: Treatment Drug-susceptible tuberculosis treatment:
Web Annex 1. Clinical outcomes and pharmacokinetics of first-line drugs (rifampicin, isoniazid, ethambutol and pyrazinamide) in children (< 18 years) treated for drug-susceptible tuberculosis: systematic review and meta-analysis
|
2022
|
|
WHO operational handbook on tuberculosis Module 4: Treatment Drug-susceptible tuberculosis treatment:
Web annex 2. Optimization of dosage of the first-line medicines rifampicin, isoniazid, ethambutol and pyrazinamide in treatment of drug-susceptible tuberculosis: summary of evidence from four systematic reviews
|
2022
|
|
WHO Policy Brief::
Clinical management of COVID-19
|
2022
|
|
WHO POLICY GUIDANCE ON INTEGRATED ANTIMICROBIAL STEWARDSHIP ACTIVITIES
|
2021
|
|
WHO POLICY ON DISABILITY
|
2021
|
|
WHO POSITION PAPER:
Building health systems resilience for universal health coverage and health security during the COVID-19 pandemic and beyond
|
2021
|
|
WHO position paper on mammography screening
|
2014
|
|
WHO preferred product characteristics for gonococcal vaccines
|
2021
|
|
WHO preferred product characteristics for herpes simplex virus vaccines
|
2019
|
|
WHO preferred product characteristics for vaccines against enterotoxigenic Escherichia coli
|
2021
|
|
WHO presence in fragile and conflict-affected situations (FCS), 2021
|
2021
|
|
WHO PROGRESS BRIEF:
VOLUNTARY MEDICAL MALE CIRCUMCISION FOR HIV PREVENTION IN 14 PRIORITY COUNTRIES IN EAST AND SOUTHERN AFRICA
|
2015
|
|
WHO Public consultation on the draft proposal on Principles for global consensus on the donation and management of blood, blood components and medical products of human origin:
Service Delivery and Safety Department Health Systems and Innovations Cluster Services Organization and Clinical Interventions Unit
|
2017
|
|
WHO PUBLIC HEALTH RESEARCH AGENDA FOR MANAGING INFODEMICS
|
2021
|
|
WHO R & D Blueprint COVID 19:
Experimental Treatments
|
2020
|
|
WHO R&D Blueprint:
Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection Geneva, Switzerland, 24 January 2020
|
2020
|
|
WHO R&D Blueprint:
Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection
|
2020
|
|
WHO R&D Blueprint novel Coronavirus:
Working with Community Advisory Boards for COVID-19 related clinical studies
|
2020
|
|
WHO R&D Blueprint novel Coronavirus:
WHO Working Group – Core Protocol for therapeutics against COVID-19
|
2020
|
|
WHO R&D Blueprint novel Coronavirus:
Prospects for evaluating cross-reactivity of nCoV with SARS-CoV
|
2020
|
|
WHO recommendation on community mobilization through facilitated participatory learning and action cycles with women’s groups for maternal and newborn health
|
2014
|
|
WHO recommendation on tocolytic therapy for improving preterm birth outcomes:
Web Annex. Evidence-to-decision frameworks
|
2022
|
|
WHO recommendations:
Policy of interventionist versus expectant management of severe pre-eclampsia before term
|
2018
|
|
WHO recommendations:
Drug treatment for severe hypertension in pregnancy
|
2018
|
|
WHO recommendations::
Intrapartum care for a positive childbirth experience Web annex. Evidence base
|
2018
|
|
WHO recommendations for care of the preterm or low-birth-weight infant:
Web Supplement. Evidence base
|
2022
|
|
WHO RECOMMENDATIONS FOR THE PREVENTION AND MANAGEMENT OF tobacco use and second-hand smoke exposure in pregnancy 2013
|
2013
|
|
WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections:
Web annex 3: GRADE evidence tables
|
2018
|
|
WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections
|
2018
|
|
WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections:
Web annex 4: CERQual evidence tables
|
2018
|
|
WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections:
Web annex 1: Strategies to reduce caesarean sections identified in the scoping review
|
2018
|
|
WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections:
Web annex 2: Description of included interventions
|
2018
|
|
WHO RECOMMENDATIONS ON Adolescent Health:
GUIDELINES APPROVED BY THE WHO GUIDELINES REVIEW COMMITTEE
|
2017
|
|
WHO recommendations on adolescent sexual and reproductive health and rights
|
2018
|
|
WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes:
Web annex. Evidence-to-decision framework
|
2022
|
|
WHO RECOMMENDATIONS ON Child Health:
GUIDELINES APPROVED BY THE WHO GUIDELINES REVIEW COMMITTEE
|
2017
|
|
WHO recommendations on drug treatment for non-severe hypertension in pregnancy
|
2020
|
|
WHO recommendations on health promotion interventions for maternal and newborn health 2015
|
2015
|
|
WHO recommendations on home-based records for maternal, newborn and child health:
Web annex B. Characteristics of included studies, key informants and related documents.
|
2018
|
|
WHO recommendations on home-based records for maternal, newborn and child health:
Web annex A. Evidence base (GRADE and CERQual profiles)
|
2018
|
|
WHO recommendations on home-based records for maternal, newborn and child health
|
2018
|
|
WHO recommendations on home-based records for maternal, newborn and child health
|
2018
|
|
WHO recommendations on induction of labour, at or beyond term:
Web Annex. Evidence-to-decision framework
|
2022
|
|
WHO recommendations on maternal and newborn care for a positive postnatal experience:
Web Annexes
|
2022
|
|
WHO recommendations on maternal and newborn care for a positive postnatal experience:
Web Supplement. Evidence base
|
2022
|
|
WHO recommendations on maternal and newborn care for a positive postnatal experience:
Executive summary
|
2022
|
|
WHO recommendations on mechanical methods for induction of labour:
Web Annex. Evidence-to-decision framework
|
2022
|
|
WHO RECOMMENDATIONS ON Newborn Health:
GUIDELINES APPROVED BY THE WHO GUIDELINES REVIEW COMMITTEE
|
2017
|
|
WHO recommendations on outpatient settings for induction of labour:
Web Annex. Evidence-to-decision framework
|
2022
|
|
WHO recommendations on prevention and management of tobacco use and second-hand smoke exposure in pregnancy
|
2014
|
|
WHO recommendations on self-care interventions:
Self-collection of samples for sexually transmitted infections (STIs)
|
2020
|
|
WHO recommendations on self-care interventions:
Self-administration of injectable contraception
|
2020
|
|
WHO recommendations on self-care interventions:
Human papillomavirus (HPV) self-sampling as part of cervical cancer screening
|
2020
|
|
WHO recommendations on self-care interventions:
Self-management of medical abortion
|
2020
|
|
WHO recommendations to reduce risk of transmission of emerging pathogens from animals to humans in live animal markets or animal product markets
|
2020
|
|
The WHO Recommended Classification of Pesticides by Hazard and Guidelines to Classification 2019
|
2020
|
|
WHO RECOMMENDS ASSISTANCE FOR PEOPLE WITH HIV TO NOTIFY THEIR PARTNERS
|
2016
|
|
WHO RECOMMENDS HIV SELF-TESTING
|
2016
|
|
WHO Regional Office for Europe meeting on strengthening primary care contribution to the prevention and control of non-communicable diseases:
Amsterdam, The Netherlands 25-26 January 2012
|
2012
|
|
A WHO REPORT OF THE Eliminate Yellow Fever Epidemics (EYE)Strategy Partners’ Meeting:
Geneva, Switzerland May 9-10, 2017
|
2018
|
|
WHO Report on Surveillance of Antibiotic Consumption:
2016 - 2018 Early implementation
|
2018
|
|
WHO research agenda for hand hygiene in health care 2023–2030::
summary
|
2023
|
|
A WHO REVIEW:
Health in the Nationally Determined Contributions
|
2020
|
|
WHO SAGE ROADMAP FOR PRIORITIZING USE OF COVID-19 VACCINES
|
2022
|
|
WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination
|
2020
|
|
WHO SAVE LIVES::
CLEAN YOUR HANDS IN THE CONTEXT OF COVID-19
|
2020
|
|
The WHO Special Initiative for Mental Health (2019-2023)::
Universal Health Coverage for Mental Health
|
2019
|
|
WHO SPRP September update::
an urgent call to fund the emergency response
|
2021
|
|
WHO standards for prosthetics and orthotics Assessment package:
User manual
|
2023
|
|
WHO standards for prosthetics and orthotics Assessment package:
Assessment guide
|
2023
|
|
WHO standards for quality, safety and efficacy of health products:
Stakeholder feedback report
|
2023
|
|
WHO statement:
on levonorgestrel-releasing intrauterine device nomenclature
|
2021
|
|
WHO statement on Progestogen-only implants
|
2015
|
|
WHO Strategic Advisory Group on Malaria Eradication:
Malaria eradication: benefits, future scenarios and feasibility Executive summary
|
2019
|
|
WHO Strategic and Technical Advisory Group for Antimicrobial Resistance (STAG-AMR):
Report of the first meeting 22 24 June 2021
|
2021
|
|
WHO Strategic Priorities on Antimicrobial Resistance:
Preserving antimicrobials for today and tomorrow
|
2021
|
|
WHO strategy for prevention and control of chronic respiratory diseases
|
2002
|
|
WHO STRATEGY MEETING ON THE USE OF FISCAL POLICIES FOR PUBLIC HEALTH:
4-5 December 2017 Geneva, Switzerland
|
2018
|
|
WHO Technical Advisory Group on Innovations in Male Circumcision:
Report of teleconferences October 2018 and June 2019
|
2019
|
|
WHO technical brief for countries preparing malaria funding requests for the Global Fund (2020—2022)
|
2020
|
|
WHO technical consultation on newborn health indicators:
EVERY NEWBORN ACTION PLAN METRICS Ferney Voltaire, France 3-5 December 2014
|
2015
|
|
WHO technical consultation on oxygen access scale-up for COVID-19
|
2021
|
|
WHO TECHNICAL SPECIFICATIONS FOR AUTOMATED NON-INVASIVE BLOOD PRESSURE MEASURING DEVICES WITH CUFF
|
2020
|
|
WHO Technical Working Group on creation of an oral cholera vaccine stockpile:
Meeting report Geneva, 26–27 April 2012
|
2012
|
|
WHO tool for benchmarking ethics oversight of health-related research involving human participants:
User guide
|
2023
|
|
WHO tool for benchmarking ethics oversight of health-related research involving human participants
|
2023
|
|
WHO TOOLKIT:
FOR THE CARE AND SUPPORT OF PEOPLE AFFECTED BY COMPLICATIONS ASSOCIATED WITH ZIKA VIRUS
|
2017
|
|
WHO Traditional Medicine Strategy:
2014-2023
|
2013
|
|
WHO-convened Global Study of the Origins of SARS-CoV-2：:
Terms of References for the China Part
|
2020
|
|
WHO/HIVRESNET HIV DRUG RESISTANCE:
LABORATORY OPERATIONAL FRAMEWORK
|
2017
|
|
WHO/IAPB MEETING ON CATARACT SURGERY OUTCOMES MONITORING SYSTEMS
|
2019
|
|
WHO-ITU global standard for safe listening devices and systems
|
2019
|
|
Whole genome sequencing for foodborne disease surveillance:
Landscape paper
|
2018
|
|
Whole-of-society challenges and solutions to respond to infodemics
|
2021
|
|
WHO's response to Zika virus and its associated complications:
Report to donors
|
2016
|
|
WHO’s Six-Year Strategic Plan to Minimize the Health Impact of Emergencies and Disasters:
2014-2019
|
2015
|
|
WHO’s work in emergencies::
prepare, prevent, detect and respond
|
2019
|
|
WHO/UNAIDS CONSULTATION ON THE ETHICS OF PREP AND EARLY INITIATION OF ART FOR PREVENTION: HOW SHOULD COUNTRIES REACH A DECISION?:
10-11 October 2012 Geneva, Switzerland
|
2013
|
|
WHY CHILDREN:
TRAINING FOR HEALTH CARE PROVIDERS SECOND EDITION
|
2019
|
|
WHY CHILDREN:
TRAINING FOR HEALTH CARE PROVIDERS THIRD EDITION
|
2023
|
|
WHY GENDER MATTERS:
IMMUNIZATION AGENDA 2030
|
2021
|
|
WHY PALLIATIVE CARE IS AN ESSENTIAL FUNCTION OF PRIMARY HEALTH CARE
|
2018
|
|
WINDING UP THE WORM:
DRACUNCULIASIS
|
2013
|
|
Women on the Move:
Migration, care work and health
|
2017
|
|
Women on the Move:
Migration, care work and health
|
2017
|
|
Work in progress in relation to Articles 9 and 10 of the WHO Framework Convention on Tobacco Control:
Report by WHO’s Tobacco Free Initiative
|
2012
|
|
WORKING FOR HEALTH:
2022–2030 Action Plan Education and employment
|
2022
|
|
WORKING FOR HEALTH:
2022–2030 Action Plan
|
2022
|
|
WORKING FOR HEALTH:
2022–2030 Action Plan Planning and financing
|
2022
|
|
WORKING FOR HEALTH:
2022–2030 Action Plan Protection and performance
|
2022
|
|
Working together:
an integration resource guide for immunization services throughout the life course
|
2018
|
|
Working with Individuals, Families and Communities to Improve Maternal and Newborn Health::
A Toolkit for Implementation
|
2017
|
|
Workshop report Shaping the message: “Towards a WHO European Region free of asbestos–related diseases”:
Report of a meeting in Bonn, Germany 10-11 June 2014
|
2015
|
|
World Blood Donor Day 2013:
Give the gift of life: donate blood
|
2013
|
|
World Blood Donor Day 2014:
Give blood for those who give life
|
2014
|
|
World Food Safety Day 2021:
Overview of festivity and creativity
|
2021
|
|
World Health Organization Alliance for the Global Elimination of Trachoma by 2020:
Second Global Scientific Meeting on Trachomatous Trichiasis Cape Town, 4–6 November 2015
|
2016
|
|
World Health Organization COVID-19 Essential Supplies Forecasting Tool (COVID-19 ESFT):
An overview of the structure, methodology, and assumptions used
|
2021
|
|
World Health Organization Generic Protocol for surveillance of initial drug-resistant HIV-1 among children < 18 months of age newly diagnosed with HIV
|
2012
|
|
WORLD HEALTH ORGANIZATION GLOBAL STRATEGY FOR THE SURVEILLANCE AND MONITORING OF HIV DRUG RESISTANCE
|
2012
|
|
World Health Organization Protocol for Cross Sectional Surveillance of Acquired HIV Drug Resistance in Populations Failing First-line Antiretroviral Therapy
|
2012
|
|
World Health Organization Protocol for Population-based Monitoring of HIV Drug Resistance Emerging During Treatment and Related Program Factors at Sentinel Antiretroviral Therapy Clinics:
2012 Update
|
2012
|
|
World Health Organization Protocol for Surveillance of Transmitted HIV Drug Resistance::
2012 update
|
2012
|
|
World Health Organization strategy for engaging religious leaders, faith-based organizations and faith communities in health emergencies
|
2021
|
|
WORLD HEALTH STATISTICS 2020:
MONITORING HEALTH FOR THE SDGs
|
2020
|
|
WORLD MALARIA REPORT 2012
|
2012
|
|
WORLD MALARIA REPORT 2013
|
2013
|
|
WORLD MALARIA REPORT 2014
|
2014
|
|
WORLD MALARIA REPORT 2015
|
2015
|
|
WORLD MALARIA REPORT 2015:
Summary
|
2016
|
|
WORLD MALARIA REPORT 2017
|
2017
|
|
WORLD MALARIA REPORT 2018
|
2018
|
|
WORLD MALARIA REPORT 2019
|
2019
|
|
World malaria report 2020:
20 years of global progress and challenges
|
2020
|
|
WORLD REPORT ON:
AGEING AND HEALTH
|
2015
|
|
World report on child injury prevention
|
2008
|
|
WORLD REPORT ON HEARING:
WEB ANNEXES
|
2021
|
|
WORLD REPORT ON HEARING:
EXECUTIVE SUMMARY
|
2021
|
|
WORLD REPORT ON HEARING
|
2021
|
|
World report on vision
|
2019
|
|
Worldwide country situation analysis::
response to antimicrobial resistance
|
2015
|
|
Worldwide country situation analysis::
response to antimicrobial resistance
|
2015
|
|
Worldwide prevalence of anaemia 1993―2005:
WHO Global Database on Anaemia
|
2008
|
|
YAWS STRATEGY DEVELOPMENT:
Report of a meeting, 27–28 October 2014, Atlanta, GA, USA
|
2015
|
|
YELLOW FEVER:
STRATEGIC RESPONSE PLAN JUNE-AUGUST 2016
|
2016
|
|
YOUNG PEOPLE’S FIGHT AGAINST CLIMATE CHANGE::
actions we can take for health and well-being
|
2021
|
|
YOUR 5 MOMENTS FOR HAND HYGIENE CARE IN A MATERNITY UNIT
|
2020
|
|
Youth and Tobacco in the Western Pacific Region::
Global Youth Tobacco Survey 2005–2014
|
2016
|
|
Youth-centred digital health interventions:
A framework for planning, developing and implementing solutions with and for young people
|
2020
|
|
Zambia Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|
|
Zdrowie psychiczne i funkcjonowanie psychospołeczne podczas pandemii COVID-19
|
2020
|
|
ZEROING IN ON MALARIA ELIMINATION::
Final report of the E-2020 initiative
|
2021
|
|
ZIKA:
STRATEGIC RESPONSE PLAN REVISED FOR JULY 2016 - DECEMBER 2017
|
2016
|
|
ZIKA:
STRATEGIC RESPONSE FRAMEWORK & JOINT OPERATIONS PLAN JANUARY-JUNE 2016
|
2016
|
|
ZIKA:
STRATEGIC RESPONSE PLAN QUARTERLY UPDATE JULY - SEPTEMBER 2016
|
2016
|
|
ZIKA SITUATION REPORT:
NEUROLOGICAL SYNDROME AND CONGENITAL ANOMALIES
|
2016
|
|
ZIKA SITUATION REPORT:
ZIKA AND POTENTIAL COMPLICATIONS
|
2016
|
|
Zika virus country classification scheme Interim guidance
|
2017
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME:
SITUATION REPORT
|
2016
|
|
ZIKA VIRUS RESEARCH AGENDA
|
2016
|
|
Zimbabwe Contraception within the context of adolescents’ sexual and reproductive lives::
Country profile
|
2020
|